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Background: Osteoarthritis (OA) is the most common long-term condition managed in UK general
practice. However, care is suboptimal despite evidence that primary care and community-based
interventions can reduce OA pain and disability.
Objectives: The overall aim was to improve primary care management of OA and the health of patients
with OA. Four parallel linked workstreams aimed to (1) develop a health economic decision model for
estimating the potential for cost-effective delivery of primary care OA interventions to improve population
health, (2) develop and evaluate new health-care models for delivery of core treatments and support
for self-management among primary care consulters with OA, and to investigate prioritisation and
implementation of OA care among the public, patients, doctors, health-care professionals and NHS trusts,
(3) determine the effectiveness of strategies to optimise specific components of core OA treatment using
the example of exercise and (4) investigate the effect of interventions to tackle barriers to core OA
treatment, using the example of comorbid anxiety and depression in persons with OA.
Data sources: The North Staffordshire Osteoarthritis Project database, held by Keele University, was the
source of data for secondary analyses in workstream 1.
Methods: Workstream 1 used meta-analysis and synthesis of published evidence about effectiveness of
primary care treatments, combined with secondary analysis of existing longitudinal population-based cohort
data, to identify predictors of poor long-term outcome (prognostic factors) and design a health economic
decision model to estimate cost-effectiveness of different hypothetical strategies for implementing optimal
primary care for patients with OA. Workstream 2 used mixed methods to (1) develop and test a ‘model
OA consultation’ for primary care health-care professionals (qualitative interviews, consensus, training
and evaluation) and (2) evaluate the combined effect of a computerised ‘pop-up’ guideline for general
practitioners (GPs) in the consultation and implementing the model OA consultation on practice and patient
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outcomes (parallel group intervention study). Workstream 3 developed and investigated in a randomised
controlled trial (RCT) how to optimise the effect of exercise in persons with knee OA by tailoring it to the
individual and improving adherence. Workstream 4 developed and investigated in a cluster RCT the extent
to which screening patients for comorbid anxiety and depression can improve OA outcomes. Public and
patient involvement included proposal development, project steering and analysis. An OA forum involved
public, patient, health professional, social care and researcher representatives to debate the results and
formulate proposals for wider implementation and dissemination.
Results: This programme provides evidence (1) that economic modelling can be used in OA to extrapolate
findings of cost-effectiveness beyond the short-term outcomes of clinical trials, (2) about ways of
implementing support for self-management and models of optimal primary care informed by National
Institute for Health and Care Excellence recommendations, including the beneficial effects of training in
a model OA consultation on GP behaviour and of pop-up screens in GP consultations on the quality of
prescribing, (3) against adding enhanced interventions to current effective physiotherapy-led exercise for
knee OA and (4) against screening for anxiety and depression in patients with musculoskeletal pain as an
addition to current best practice for OA.
Conclusions: Implementation of evidence-based care for patients with OA is feasible in general practice
and has an immediate impact on improving the quality of care delivered to patients. However, improved
levels of quality of care, changes to current best practice physiotherapy and successful introduction of
psychological screening, as achieved by this programme, did not substantially reduce patients’ pain and
disability. This poses important challenges for clinical practice and OA research.
Limitations: The key limitation in this work is the lack of improvement in patient-reported pain and
disability despite clear evidence of enhanced delivery of evidence-based care.
Future work recommendations: (1) New thinking and research is needed into the achievable and
desirable long-term goals of care for people with OA, (2) continuing investigation into the resources
needed to properly implement clinical guidelines for management of OA as a long-term condition, such
as regular monitoring to maintain exercise and physical activity and (3) new research to identify subgroups
of patients with OA as a basis for stratified primary care including (i) those with good prognosis who can
self-manage with minimal investigation or specialist treatment, (ii) those who will respond to, and benefit
from, specific interventions in primary care, such as physiotherapy-led exercise, and (iii) develop research
into effective identification and treatment of clinically important anxiety and depression in patients with
OA and into the effects of pain management on psychological outcomes in patients with OA.
Trial registration: Current Controlled Trials ISRCTN06984617, ISRCTN93634563 and ISRCTN40721988.
Funding: This project was funded by the National Institute for Health Research (NIHR) Programme Grants
for Applied Research Programme and will be published in full in Programme Grants for Applied Research
Programme; Vol. 6, No. 4. See the NIHR Journals Library website for further project information.
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PSC practitioner self-confidence
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STAR Short Telephone Activity Rating
TDF Theoretical Domains Framework
TEA targeted exercise adherence
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WISE Whole systems Implementing
Self-management Engagement
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Plain English summary
Osteoarthritis (OA) is a common painful condition in mid to later life that affects daily activities such aswalking and climbing stairs. Research shows that simple things such as providing information about
OA and exercise can reduce the symptoms, but many sufferers do not receive this information or get
advice and encouragement to put it into practice.
Our programme addressed how to make OA interventions more available and more effective by
conducting four large research studies:
1. We developed ways to use existing data sets to investigate how to offer the best possible treatments
for OA in ways that are effective for patients as well as being affordable for the NHS.
2. In a large trial, we tested how the best care for OA can be delivered in general practitioner (GP)
practices with an OA guidebook and structured support by the GP and practice nurse. We showed that
it is possible to improve the quality of OA care and we are now using this information to implement
best-quality OA care more widely in primary care in the NHS.
3. We conducted a trial comparing different ways to help people to find the right exercise routine and
maintain it over time. We found that more intense exercise programmes did not improve symptoms
more than exercise already offered by NHS physiotherapists to people with OA.
4. We investigated detecting and managing concurrent depression and anxiety in people with OA.
This did not improve OA symptoms more than usual care in general practice.
Overall, this programme has added valuable information about which primary care treatments are effective
and which are not effective for people with OA. It has also provided evidence to guide the direction of
future research into improving care for people with OA.
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Scientific summary
The National Institute for Health Research (NIHR) programme described in this report concerns people with
osteoarthritis (OA) and their primary health care.
Osteoarthritis, a common cause of pain and stiffness in the joints in older adults (adults aged ≥ 45 years), is:
l a major global cause of disability
l the most frequent cause of restricted physical and social activity in older people in the UK
l the most common long-term condition managed in UK general practice
l estimated to become the dominant preventable cause of chronic disability in the UK by the year 2030.
Osteoarthritis is a long-term condition. Relief of pain and the maintenance of active participation in daily
work, domestic and social life are the goals for treatment of most patients, rather than complete cure.
Dramatic improvements can be achieved by joint replacement surgery, which is conducted in the minority
of patients who develop advanced and severe OA.
The context for the programme
This programme was formulated in 2008–9 on the basis of questions raised by evidence from two sources
about OA and its treatment. First was the published research evidence base about OA which is considered
below. Second was input from, and work carried out with, members of the research user group (RUG) in
the Institute of Primary Care and Health Sciences.
1. There was evidence that:
i. simple primary care interventions can provide short-term relief of pain and restricted activity in
persons with OA. This evidence underpinned core guidance on care for patients with OA from the
UK National Institute for Health and Care Excellence (NICE) published in 2008 (National Institute for
Health and Clinical Excellence. Osteoarthritis: The Care and Management of Osteoarthritis in Adults.
Clinical Guideline CG59. London: NICE; 2008)
ii. most people with OA have other health conditions (comorbidities) and if effective care is provided
for these other conditions, then the pain and disability of OA improves
iii. self-management programmes can improve outcomes in patients with long-term conditions, such as
irritable bowel syndrome, which, like OA, are managed predominantly in primary care and
the community.
2. However, there was also evidence that:
i. the quality of OA primary care ranks as low compared with other long-term conditions
ii. there was much variability in the content and quality of primary care offered to patients with OA,
and treatments often targeted the diseased joint rather than the person with symptoms
iii. most persons with OA were not receiving the full range of NICE core treatments for OA, including
advice and information
iv. persons with OA and other long-term conditions want help and support to self-manage
their condition
v. short-term changes in behaviour that benefit persons with OA, such as increased physical activity,
are often not maintained in the long term
vi. comorbidities in persons with long-term painful conditions such as OA are under-recognised in
primary care.
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3. There was an absence of evidence and information about important aspects of OA care in the
community and primary care, including:
i. no clear estimate of the potential for population prevention and health-care benefits among older
people with joint pain and disability in the UK community. Small effects from simple core treatments
applied to large numbers of people with OA could result in substantial population health gains at
reasonable cost
ii. the best way for general practitioners (GPs) and the primary care team to consult with persons with
OA to manage their condition and support self-management. There had been few attempts to
involve OA patients in shaping what information they wanted or needed and what to do to manage
their condition
iii. no formally developed indicators of the quality of primary OA care such as those that existed for
other long-term conditions in the UK.
4. There was evidence that most OA patients and health-care professionals were pessimistic (or at best
stoical) about the long-term course of OA and the likelihood of getting effective care until the condition
was bad enough to require an operation. Patients often perceived doctors’ views to be negative: ‘not
much to be done’ and ‘what else can be expected at your age?’.
The conclusion was that OA care in the UK was suboptimal, despite evidence that primary care and
community-based interventions can reduce pain and disability. The research gaps identified included the
need for development and evaluation of better information for public health, patients and clinicians, and
for new approaches to delivering OA care in practice.
The overall ambition of the programme was to provide an evidence base for optimising the primary care
delivered to OA patients by:
l filling gaps in the evidence and information base about optimal primary care for persons with OA
l providing evidence about how to close the gap between established evidence of effective and efficient
OA care and the effective and efficient delivery of that care to patients in practice
l providing practical evidence-based outputs and resources for primary care to support self-management
by patients with OA.
The programme consisted of four workstreams. These workstreams were developed in parallel during the
period of the programme, linked but independent.
The general aims were as follows.
Workstream 1: to develop a model for estimating the potential for effectively delivered primary care OA
interventions to improve population health.
Workstream 2: to develop and evaluate new approaches and services for better delivery and monitoring of
OA primary care – the Managing Osteoarthritis In ConsultationS (MOSAICS) studies.
Workstream 3: to investigate the long-term effect of targeting patients’ adherence to physiotherapy-led
exercise and physical activity for OA knee – the Benefits of Effective Exercise for knee Pain (BEEP) trial.
Workstream 4: to investigate the effect of screening for two major comorbidities (depression and anxiety)
in patients with OA in primary care – the Primary care Osteoarthritis Screening Trial (POST).
SCIENTIFIC SUMMARY
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Workstream 1
Objective
To develop a model to estimate cost-effective population prevention of pain and disability by interventions
in patients with OA in primary care.
Methods
Meta-analysis and synthesis of published evidence about effectiveness of primary care treatments,
combined with secondary analysis of existing longitudinal population-based cohort data, to identify
predictors of poor long-term outcome (prognostic factors); and creation of a health economic decision
model to estimate cost-effectiveness of different hypothetical strategies for implementing optimal primary
care for patients with OA.
Results
A hypothetical model of effectively delivered ‘stepped care’ for OA, comprising good advice and pain relief
for all patients with OA and offering more extensive treatment (including supervised exercise) to those with
poor response to initial treatment was likely to be more cost-effective than current primary care. However,
long-term cost-effectiveness is still in need of an evidence base.
Practical outputs
Practical outputs include a population impact model that can be updated and adapted with new
information on prognosis and treatment of OA in the general population. The lack of published research
and evidence about a constructive and effective approach for long-term analgesic use by OA patients
was highlighted.
Workstream 2: the MOSAICS studies
Objectives
l To develop and evaluate a linked ‘model’ GP and practice nurse consultation and optimal general
practice-based service provision for patients with OA (the ‘MOSAICS model-of-care’) as support for
self-management and as a means to implement NICE core OA guidance (NICE, 2008).
l To develop and evaluate methods to measure and monitor the quality of primary care for patients with OA.
l To determine the clinical effectiveness and cost-effectiveness of implementing NICE core OA guidance
through the MOSAICS model-of-care in general practice.
Methods
A suite of studies, using a mixture of methods, within the framework of a cluster randomised controlled
trial (RCT). Outcomes were (1) process [to measure implementation of evidence-based care informed by
NICE guidance (NICE, 2008)] and (2) clinical (to measure the impact on patient symptoms and activities of
daily life).
Results
The NICE core OA guidance (NICE, 2008) can be successfully implemented and monitored in primary care
practice and is well received by patients. However, the impacts on pain and disability for primary care OA
patients have not been demonstrated.
Practical outputs
Practical outputs developed, delivered and evaluated in the programme included an OA guidebook
developed with patients and health-care professionals, a training programme for a ‘model OA
consultation’ by GPs, a practice nurse-led primary care service for OA and a training programme for
practice nurses, an OA quality-of-care monitoring tool for use in routine primary care computerised
records, and a general practice-based OA service model that is being disseminated.
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Workstream 3: the BEEP trial
Objective
To determine whether or not early changes in pain and disability in patients with knee OA from
physiotherapy-led exercise and physical activity can be better maintained in the long term by enhanced
interventions targeting adherence.
Methods
Individual patient three-arm RCT comparing two enhanced exercise interventions led by physiotherapists
with usual physiotherapy care (UC) in patients with knee OA (pilot and full trial phases).
Results
Neither of the two experimental enhancements bettered the clinical effectiveness and cost-effectiveness of
UC for pain and disability in patients with OA of the knee.
Practical outputs
Renewed support for ensuring that current best practice for physiotherapy-supported physical activity is
available to all patients and evidence to support (1) future research identifying the characteristics of
patients who respond to exercise interventions and (2) the importance of the therapeutic relationship in
improving long-term change in exercise habits.
Workstream 4: the Primary care Osteoarthritis Screening Trial
Objective
To investigate whether or not GP screening for depression and anxiety among older primary care patients
presenting with joint pain or OA is acceptable and is clinically effective and cost-effective in improving pain
and disability.
Methods
Pragmatic two-arm cluster RCT (pilot and full trial phases).
Results
Systematically screening older patients who present with joint pain and OA in UK general practice is not
effective in reducing pain and disability.
Practical outputs
Renewed support for focusing on the OA symptoms (notably joint pain) with which patients present to the
GP. One implication of the trial for future research is the need to investigate the usefulness of screening
and identifying comorbid joint pain, depression and anxiety in patients being monitored for other
long-term conditions.
Conclusions
The programme has provided evidence:
l about the potential for a hypothetical stepped-care model of primary care for patients with joint pain
to have a cost-effective impact on population levels of disabling OA
l about ways to implement practical care and support for self-management of OA in UK general practice
l about how to put optimal primary care for OA informed by NICE recommendations into place in the
general practice setting
l about ways to monitor and improve the quality of care for patients with OA in UK general practice
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l against an additional effect on pain and disability outcomes of adding enhanced interventions to
current effective ‘usual’ physiotherapy-led exercise interventions for patients with knee OA
l against adding screening to current best practice for OA in UK general practice for comorbid
depression and anxiety in older patients presenting with musculoskeletal pain.
However, despite workstream 2 providing evidence of successful implementation of optimal evidence-based
primary care practice for patients with OA, as supported and endorsed by patients with OA, clinical outcomes
(pain and disability) in the study population did not improve as a result. Furthermore, despite successful
introduction of a novel screening programme in workstream 4 for two known predictors of poor long-term
outcome in older patients with joint pain (depression and anxiety), this also did not lead to subsequent
improvement in pain and disability.
Explanations for this absence of impact on clinical outcomes include:
l the possibility that the total pool of patients aged ≥ 45 years with joint pain during the GP consultation
in these studies, and considered to have the potential to benefit from these primary care interventions,
contains many patients with a good prognosis unaffected by the interventions
l the possibility that the interventions resulted in too little appropriately intensive evidence-based treatment
for patients with joint pain who were at moderate or high risk of persistent pain and disability. This includes,
in workstream 2, the lack of physiotherapy-led exercise targeted at these groups and, in workstream 4,
the lack of active treatments for patients with anxiety and depression targeted at these groups.
But, workstream 1 has provided the basis for modelling of new evidence to investigate alternative
strategies, such as stepped care, for resolving these issues. Workstream 2, despite the lack of change in
clinical outcomes, has provided evidence of successful implementation of interventions that had been
previously evaluated as clinically effective and cost-effective by NICE. This is now the basis for a wider
programme of dissemination and evaluation. Workstream 3 patients were selected to have moderate or
more severe pain and there was evidence that intensive interventions designed to improve adherence to
exercise had been delivered. Usual-care physiotherapy improves pain and disability, but the two novel
interventions developed for the BEEP trial did not achieve improved primary clinical outcomes. There was
evidence from both the quantitative and qualitative studies that early gains from physiotherapy are not
maintained for more than 3 months after the end of physiotherapy treatment. It is likely that community
resources and cultural changes, as well as the improvement of therapeutic relationships, are needed to
extend the established effectiveness of physiotherapy-led exercise interventions.
Implications for future research and NHS care for patients
with osteoarthritis
The conclusions above raise important questions about the need for new conceptual thinking and
discussion on OA management in primary care and about the need for further research.
Potential topics for new conceptual thinking and discussion
1. NICE core guidance in practice:
i. Clarification of the expected benefits of implementing NICE core guidance for patients with OA as a
desirable end in itself (e.g. provision of appropriate information and of advice about exercise and
pain relief), regardless of whether or not it demonstrably improves clinical outcomes.
ii. Critical reflection on whether or not current NICE core guidance, even when implemented in the
way that MOSAICS has done, results in big enough shifts in crucial components of patient behaviour
to achieve change in clinical outcomes in the short term. An example of this is physical activity when
there is evidence from other research that implementation of physiotherapy-guided interventions as
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core treatment could achieve bigger change, so that adding such resource to the MOSAICS package
might deliver effects on pain and disability.
iii. Following on from (ii) above, reviewing the delivery of NICE core guidance for primary care and the
capacity of a GP- and nurse-led service alone to improve clinical outcomes without additional resources
such as physiotherapy services to provide individualised and supervised exercise interventions.
2. Continuing debate and critical enquiry about the role, benefits and costs of systematic screening for
anxiety and depression in all people with long-term conditions in primary care.
3. The need for new concepts about OA within the research and clinical community:
i. regarding achievable goals of long-term care for people with this condition, including whether or
not it is appropriate to seek more than small short- to medium-term clinical effect sizes in patients’
pain and disability in practice. Maintenance of activity and participation, despite continuing pain,
may, for example, be a better long-term measure of effect.
ii. regarding a combined approach to the management of OA as a long-term condition (importance of
good information, adequate advice and resources for exercise and physical activity and other core
interventions, and identification of individuals at high risk of unfavourable future course and
targeted interventions for those most likely to benefit).
Recommendations for new research
1. Outcomes in long-term conditions.
2. Research into new models of long-term care for OA, in the context of other long-term disabling
conditions, that focus on the necessary and desirable process and clinical outcomes from patient,
clinician and societal perspectives.
3. Stratified care for OA patients.
4. Research to identify subgroups of patients with OA who may, on the basis of combined evidence from
previous cohorts, clinical effectiveness and cost-effectiveness studies, and the successful implementation
strategies described in this programme, benefit from specific interventions in primary care. This includes
identification of patient subgroups such as (i) those with good prognosis who can be supported to
self-manage without additional investigation or treatment and (ii) those who will benefit from specific
treatments, such as physiotherapy-led exercise.
5. Exercise and physical activity levels in people with long-term conditions:
i. research to identify new approaches to improving long-term adherence to exercise and physical
activity among patients with OA such as regular monitoring.
6. Depression and anxiety in people with OA:
i. research into more efficient and effective ways of identifying and treating clinically important levels
of anxiety and depression in patients with OA.
ii. research into the effects of pain management on psychological outcomes in patients with OA.
Trial registration
The trials in this programme are registered as ISRCTN06984617, ISRCTN93634563 and ISRCTN40721988.
Funding
Funding for this study was provided by the Programme Grants for Applied Research programme of the
National Institute for Health Research.
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Chapter 1 Introduction
The National Institute for Health Research (NIHR) programme described in this report concerns peoplewith osteoarthritis (OA) and their primary health care.
Osteoarthritis is a condition of pain and stiffness in the joints that is common among older adults (adults
aged ≥ 45 years) and constitutes a major portion of the global causes of disability.1 It is the most frequent
cause of restricted physical and social activity in older people in the UK,2 the most common long-term
condition managed in UK general practice3,4 and estimated to become the dominant preventable cause of
chronic disability in the UK by the year 2030.5
Osteoarthritis is a long-term condition. Relief of pain and the maintenance of active participation in daily
work, domestic and social life are the goals for treatment and management of most patients, rather than
complete cure.6 However, dramatic improvements can be achieved by joint replacement surgery, which is
conducted in the minority of patients who develop advanced and severe OA.7
At the time that this programme was formulated (2008–9), there was evidence that simple interventions
that were available in primary care could provide short-term relief of pain and restricted activity in persons
with OA.8–14 This evidence provided the basis and support for core guidance on care for patients with
OA by the UK National Institute for Health and Care Excellence (NICE), which was published in 2008.15
It was also apparent that most people with OA have other health conditions (comorbidities)16,17 and, if
effective care is provided for these other conditions, the pain and disability of OA improves.18 We also
knew that self-management programmes could improve outcomes in patients with long-term conditions
(such as irritable bowel syndrome) which, like OA, are managed predominantly in primary care and the
community.19–21 However, there was also evidence that the quality of OA care ranked lower than care for
other long-term conditions managed in primary care22,23 and there was much variability in the content
and quality of primary care offered to patients with OA.24 For example, most persons with OA were not
receiving the full range of NICE core treatments for OA,24 including advice and information regarded by
NICE as a core requirement.15 Patients with OA told us that they wanted help and support to self-manage
their condition,6,22,25–28 because short-term changes in behaviour that benefit persons with OA, such as
increased physical activity, are often not maintained in the long term,29–34 and their comorbidities were
often under-recognised in primary care and the community.35–39
Our interpretation of the literature at that time highlighted an absence of evidence and information about
key aspects of OA care in the community and primary care, including no clear estimate of the potential for
prevention of OA in the population and health-care benefits among older people with joint pain and
disability in the UK community. It is likely that small effects from simple core treatments applied to large
numbers of people with OA could result in substantial population health gains at reasonable cost.40
Although evidence about the effectiveness of certain non-pharmacological interventions was encouraging,
we did not know the best way for general practitioners (GPs) and the primary care team to consult with
persons with OA to deliver these interventions and support self-management, or how to measure quality of
OA primary care.23 Prior to our programme, there had been few attempts to involve OA patients in shaping
what information they wanted, or needed, and what to do to manage their condition24 (see Appendix 1).
Lastly, there was evidence that most OA patients and health-care professionals were pessimistic (or, at best,
stoical) about the long-term course of OA and the likelihood of getting effective care until the condition
was bad enough to require an operation.22,41,42 Patients perceived doctors’ views to often be negative: ‘not
much to be done’ and ‘what else can be expected at your age?’.41–44
The conclusion was that OA care in the UK was not as good as it could be, despite evidence that primary
care and community-based interventions can reduce pain and disability. The research gaps identified
included the need for development and evaluation of better information for public health, patients and
DOI: 10.3310/pgfar06040 PROGRAMME GRANTS FOR APPLIED RESEARCH 2018 VOL. 6 NO. 4
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Hay et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
1
clinicians, and for new approaches to delivering OA care in practice. The ambition of our programme was
to address these gaps.
Methodological note
The studies in this programme were developed in parallel and not in series. This had two methodological
implications. First, the development of a theoretical model for estimating the cost-effectiveness of different
primary care approaches to OA management (study 3, workstream 1) could not draw on the results of
the other workstreams. However, it has been designed so that it can be populated with new data in the
future. Second, EuroQol-5 Dimensions, five-level version (EQ-5D-5L) was not available at the time of the
development of the protocols for the studies and this explains the use of the earlier EuroQol-5 Dimensions,
three-level version (EQ-5D-3L) in this programme.
INTRODUCTION
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Chapter 2 Workstream 1: modelling optimal
primary care for osteoarthritis
Parts of this chapter have been reproduced from Wulff.59
Abstract
Background: The cost-effectiveness of primary care approaches for patients with OA in primary care is
not known.
Objectives: (1) Identify key predictors of 3-year outcomes of pain and function in a population-based
sample of people aged ≥ 50 years with joint pain and OA, (2) summarise evidence regarding the
effectiveness of core primary care interventions for OA and (3) design a decision model to estimate the
cost-effectiveness of implementing evidence-based, core primary care management for OA.
Methods: Secondary analysis of population cohort data to identify predictors. An evidence synthesis and
meta-analysis to summarise evidence of the effectiveness of four core primary care interventions [advice
and information, simple analgesics, topical non-steroidal anti-inflammatory drugs (NSAIDs), and exercise]
for OA. The effect estimates derived from the evidence synthesis were used to populate an economic
decision model.
Results: The prediction models showed that, in this population, the strongest predictors of future pain
and functional limitation include baseline pain, function, physical activity, general health, obesity and
socioeconomic indicators. The models showed good internal validity, but needed to be further developed
to account for generalised pain in people with OA and to investigate the predictive value of modifiable
prognostic factors (including physical activity and obesity) to identify groups that benefit from specific
treatments. The meta-analysis showed statistically significant small to moderate improvements in pain and
function from advice and information, topical NSAIDs and exercise interventions compared with controls,
while simple analgesia failed to demonstrate statistically significant improvements in either pain or function.
The decision model examined the cost-effectiveness of two hypothetical approaches to delivering primary
care interventions for hip and knee OA (stepped care and ‘one-stop-shop’ care) compared with current
primary care. The hypothetical stepped-care intervention was the most cost-effective, dominating
‘one-stop-shop’ and current care, and this result was robust to the sensitivity analyses conducted.
Conclusion: This work provides a platform for modelling the long-term cost-effectiveness of interventions
for OA. The model will require further development, including use of more accurate data on the
short-term course of OA pain to provide better estimates and the incorporation of evidence on hand
and foot OA.
Introduction
Reliable information regarding the likely course of symptoms and factors predicting poor long-term
outcomes in people with joint pain and OA is important to inform public health about the burden of these
conditions in local communities and, linked with evidence about treatment efficacy and effectiveness, to
estimate for policy-makers the probable costs and benefits of health interventions. Such information would
provide evidence to inform the potential usefulness of identifying subgroups of persons with OA at higher
risk of poor outcomes who may preferentially benefit from targeted timely interventions.
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Previous studies have developed prediction models for OA, but most were developed to predict the onset
of OA45,46 or the outcome of a specific treatment,47,48 or were focused on a specific joint – usually the
knee.49–52 Most people with OA have multiple joint pains53–55 and our aim was to develop prognostic models
and estimate the cost-effectiveness of offering core treatments for OA regardless of the site of pain.
Modelling studies help to identify desirable resource shifts and guide public health and health-care policy.56 In
estimating potential health gains and reductions in disability in relevant subgroups of patients and estimating
the costs associated with these gains, policy-makers can determine the gaps between current treatment
and optimal management for OA and quantify the need to invest in services and research.57 Few modelling
studies in OA have been carried out in population-based or primary care cohorts58 and there are not many
studies that have used longitudinal data on the long-term outcomes of pain and function.57 We aimed to
address and avoid these limitations by using data from a large, prospective population-based cohort with
linked morbidity records from health care in order to estimate the probability and key predictors of
unfavourable long-term outcome in people with OA, and the cost-effectiveness of implementing core
primary care management for OA.
The objectives of this workstream were to (1) identify key predictors of long-term (3-year) pain and limitation
in function in a population-based sample of people with joint pain and OA, (2) synthesise evidence regarding
the effectiveness of core primary care interventions and (3) estimate the cost-effectiveness of implementing
evidence-based, core primary care management for OA. The study also aimed to provide a basic model as a
resource for future analyses of the cost-effectiveness of primary care interventions for joint pain and OA,
including novel approaches such as those under investigation in the other workstreams of this programme.
The population-based cohort (used in study 1) and the evidence synthesis (study 2) provided data to support
the design of this basic health economic model (study 3).
The work described in this chapter was undertaken in the framework of a Doctor of Philosophy (PhD).59
The cohort and modelling studies in this workstream were based on an existing population-based cohort
[the North Staffordshire Osteoarthritis Projects (NorStOP) study], which included people aged ≥ 50 years.
This age criterion contrasts with the criterion of people aged ≥ 45 years who took part in workstreams 2–4
of the programme. The high prevalence of joint pain found in NorStOP was one reason for lowering the
minimum age for these other workstreams in order to include interventions early in the course of OA.
Study 1: predicting long-term outcome in people with joint pain
and osteoarthritis
This section describes the methods and results of a prognostic study aiming to identify predictors of future
long-term (3-year) risk of pain and functional limitation in a population-based sample of older adults with
joint pain.
Methods
Design and study population
Data were used from the NorStOP study, a series of population-based prospective cohorts of adults aged
≥ 50 years who were registered with one of eight general practices in North Staffordshire, UK.60 These
cohorts were originally set up through Medical Research Council (MRC) programme funding and NIHR
primary care centre funding, and continue to be a resource for researchers from inside and outside Keele
University. A two-stage mailing strategy was used, comprising a health survey sent to all persons in the
sampling frame and a subsequent regional pain questionnaire sent to those who had responded to the
health survey, given consent to be contacted again and indicated they had experienced pain in the hip,
knee, hand or foot in the previous year. Participants received similar follow-up questionnaires at 3 years.
Ethics approval was obtained from the North Staffordshire Local Research Ethics Committee (NS-LREC
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1351 and 1430). This analysis includes all responders who reported hand, hip, knee or foot joint pain at
baseline that had lasted ≥ 3 months over the previous 12 months and who returned the 3-year follow-up
survey.
Outcome measures
Outcome measures for the prognostic models were (1) moderate or more severe pain in at least one joint
site and (2) limitations in physical function in accordance with the Outcome Measures in Rheumatoid
Arthritis Clinical Trials (OMERACT) consensus statement on key outcome measures for OA.61
The pain subscales of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
(range 0–20),62 Australian/Canadian Osteoarthritis Hand Index (AUSCAN) (range 0–20)63 and Foot Pain
Disability Index (FPDI) scores (range –3.32 to 3.33)64,65 were used to measure pain related to the hip/knee,
hand and foot, respectively. All three questionnaires have been validated in relevant populations. To define
a dichotomous measure of at least moderate pain, cut-off points for increased scores on the WOMAC,
AUSCAN or FPDI scores were selected using receiver operating characteristic (ROC) curve analysis with a
0- to 10-point numerical rating scale (NRS) for pain with a validated cut-off point of 5 as the anchor
(0–4 mild pain, 5–10 moderate to severe pain).66 Based on maximal area under the ROC curve, the cut-off
points for at least moderate pain obtained for WOMAC pain were 6 and 5 for the hip and knee, respectively,
9 for AUSCAN hand pain, and –0.479 for FPDI foot pain. Participants with scores below any of the relevant
cut-off points at the 3-year follow-up were classified as having ‘no or mild pain’, while those with scores
equal to or above the cut-off point were classified as having ‘moderate to severe pain’.
Limitations in physical function were assessed with the 10-item physical functioning subscale of the Short
Form questionnaire-36 items (SF-36) (range 0–100, higher scores indicating better physical functioning),67
which was completed by all participants regardless of the location of pain. The scale was converted into a
binary variable based on its median score of 55, as its distribution was heavily skewed. Respondents with
a score of less than the median value were classified as having important functional limitation.
Potential predictors
The baseline health survey included questions on physical functioning, joint pain, participation restriction,
general health, sociodemographic factors, lifestyle characteristics, comorbidity, medication use and
psychosocial factors (including illness perceptions, anxiety and depression). Full details of the variables
and their descriptions have been reported elsewhere.59 These variables were all considered as potential
predictors in the prognostic analysis as they have been shown to be associated with symptoms of OA or
are considered to be potential predictors of outcome in pain conditions more generally. All variables with
prevalence of < 10% or > 90% or with fewer than 30 participants giving a positive response were
excluded from the analysis to facilitate successful convergence of the models68 and optimal discrimination
between people with favourable or unfavourable outcome.
Statistical analysis
Model development and internal validation
Poisson regression was used to develop prognostic models, as it estimates the true risk as incidence rate
ratio (IRR) for each predictor. The number of events (i.e. those with at least moderate pain or functional
limitation at follow-up) was high and consequently the odds ratios (ORs) from logistic regression would not
approximate true underlying risk, which was required to estimate population attributable risk (PAR) and
number needed to treat (NNT) (see Selection of the most important predictors based on population
attributable risk and number needed to treat). Robust variance estimation was used to provide accurate
effect estimates and their uncertainty.69 The models were constructed using a backward stepwise variable
selection procedure, retaining only those variables with a statistically significant association with outcome
(p < 0.05) based on the likelihood ratio test. The c-statistic was used as a measure of the predictive
performance of the models. Bootstrapping (500 samples) was subsequently used to adjust performance
estimates for optimism.70
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Selection of the most important predictors based on population attributable risk and
number needed to treat
Epidemiological parameters (PAR and NNT) were calculated for each predictor to allow for better
understanding of the potential impact of individual prognostic factors and to support the selection of the
most relevant predictors for identification of vulnerable subgroups of people with joint pain.71
The PAR and NNT were estimated for each predictor selected in the models.
The PAR represents the proportion of the risk of poor outcome in the whole population that is explained
by a particular predictor. It provides an indication of maximum achievable population health gain if
exposure to that predictor was completely eliminated by successful intervention. PAR, adjusted for other
predictors in the model, was calculated using the Stata® version 12 (StataCorp LP, College Station, TX,
USA) command aflogit, based on a formula proposed by Greenland and Drescher.72
The NNT represents the number of people needed to be treated to prevent one additional person from
suffering from an unfavourable outcome. It was calculated as the inverse of the absolute risk difference
between the exposed and unexposed groups. NNT is usually presented as an estimate of treatment effect.
In this observational study, following the procedure proposed by Smit et al.,71 PAR and NNT were used as
impact measures in order to select a limited set of predictors based on high effect size (IRR), high PAR and
low NNT. The predictive performance of this key set of predictors was compared with the performance of
the original Poisson models.
Non-response and missing values
A non-response analysis has previously been carried out for the NorStOP cohorts by comparing age and
sex distribution of responders and non-responders to the baseline questionnaire.73 We also compared
demographic characteristics, pain, physical function, mental health and obesity between participants who
completed the 3-year follow-up questionnaire and those dropping out of the study. Furthermore, multiple
imputations by chained equation were used to generate data for predictor variables with > 3% missing
values. Content and performance of prediction models based on the imputed data sets were similar to that
of the complete case analysis; hence, only results of complete cases have been reported here. All analyses
were performed using Stata version 11 (StataCorp LP, College Station, TX, USA).
Results
Response
In the original NorStOP cohorts, a total of 26,705 people aged ≥ 50 years were identified from eight
general practices and posted the health survey. A total of 18,474 participants responded (estimated
response 71.8% after adjustment for age and sex). Among this group of responders were 10,057 persons
who reported joint pain in the previous year and gave their consent for further contact. This group was
sent a second questionnaire at baseline (the regional pain questionnaire) and a follow-up questionnaire
3 years later.
The cohort for the current analysis, which is described here and was supported by the NIHR programme
grant, was the subgroup of 3563 responders at the 3-year follow-up (57.6% of all 3-year regional pain
questionnaire responders) who responded at 3 years and had reported pain in at least one joint site at
baseline for a duration of ≥ 3 months over the 12 months prior to the baseline survey.
Characteristics of participants
Table 1 presents demographic characteristics of the sample, stratified according to the presence of severe
pain and functional limitation at the 3-year follow-up. The mean age of participants was 64 years (range
50–93 years) and 60% were female. Non-responders at baseline and at the 3-year follow-up were slightly
younger and more often male. At the 3-year follow-up, more than two-thirds (71%) of the participants
WORKSTREAM 1: MODELLING OPTIMAL PRIMARY CARE FOR OSTEOARTHRITIS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
6
reported severe pain, while 43% had poor function. The distribution of pain, physical function, obesity,
anxiety and depression scores were similar for individuals responding at follow-up and those who dropped
out from the study at 3 years (data not shown).
Predictors of poor outcome at three years
Multivariable Poisson regression identified a large number of baseline predictors that were statistically
significantly associated with increased risk of moderate to severe pain at 3 years, including variables related
to pain severity, poor physical function, socioeconomic factors, obesity, anxiety, hypertension and little use
of pain medication or other remedies. Baseline predictors associated with increased risk of functional
limitation at 3 years included several measures of poor function, being unemployed or retired from work,
lower levels of activity, fewer years in education, joint pain severity, obesity, hypertension and poor health
perceptions. Predictive performance was good for both models with c-statistics adjusted for optimism of
0.83 [95% confidence interval (CI) 0.81 to 0.85] for predicting moderate to severe pain and 0.91 (95% CI
0.90 to 0.92) for predicting limitation in function at 3 years.
Selection of important predictors
Both models included a large number of predictors, which limited their clinical utility. In this study, the most
relevant predictors for severe pain and poor functional limitation at 3 years were selected using the rule
employed by Smit et al.71 to select subgroups of participants at increased risk of developing anxiety in later
life. The rule selects predictors based on large effect size (IRR), high PAR and low NNT, which have the
TABLE 1 Baseline characteristics of the 3563 NorStOP cohort 3-year responders with clinical OA in at least one joint
at baseline, stratified for outcome categories of moderate to severe pain and functional limitation at 3 years
Variables
Pain at 3 years, n (%) Functional limitation at 3 years, n (%)
Mild or no pain Moderate to severe pain Good function Poor function
N= 1019 (29%) N= 2544 (71%) N= 2028 (57%) N= 1535 (43%)
Age group (years)
50–64 556 (55) 1306 (51) 1221 (60) 641 (42)
65–74 322 (32) 852 (34) 617 (30) 557 (36)
≥ 75 141 (13) 386 (15) 190 (10) 337 (22)
Median (IQR) 63 (56–70) 64 (57–71) 62 (56–68) 66 (59–74)
Female sex 567 (56) 1556 (61) 1175 (58) 948 (62)
Married 788 (78) 1810 (72) 1575 (78) 1023 (67)
Employment status
Employed 314 (32) 584 (24) 729 (37) 169 (11)
Retired 538 (54) 1352 (55) 965 (48) 925 (63)
Unemployed 145 (14) 525 (21) 292 (15) 378 (26)
BMI
Normal weight
(20–24.9 kg/m2)
383 (39) 728 (29) 736 (38) 375 (26)
Overweight
(25–29.9 kg/m2)
452 (47) 1052 (43) 885 (45) 619 (42)
Obese (≥ 30 kg/m2) 137 (14) 678 (28) 341 (17) 474 (32)
BMI, body mass index; IQR, interquartile range.
The denominator number used for calculating the column percentages for some categories are different to the column
total shown because of missing data for that item.
DOI: 10.3310/pgfar06040 PROGRAMME GRANTS FOR APPLIED RESEARCH 2018 VOL. 6 NO. 4
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Hay et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
7
ability to select factors for which the highest possible health benefit (IRR and PAR) and the lowest possible
effort and cost (NNT) can be achieved if interventions are completely successful. In addition, the predictive
performance of the set of predictors had to be comparable to that of the original Poisson regression models.
Based on high effect size (IRR), high PAR and low NNT, the following prognostic factors were selected as
the most relevant predictors of moderate to severe pain at 3 years: presence of knee pain in the last year
(IRR 1.31, 95% CI 1.19 to 1.43), high WOMAC knee pain score (IRR 1.15, 95% CI 1.06 to 1.24), poor
physical function (IRR 1.14, 95% CI 1.07 to 1.22), hand pain in the last year (IRR 1.12, 95% CI 1.05 to
1.20), not attended further full-time education after secondary school education has been completed
(IRR 1.12, 95% CI 1.01 to 1.23) and obesity (95% CI 1.11, 1.05 to 1.17). The predictive performance
(apparent c-statistic) of this reduced set of predictors was 0.75 (95% CI 0.73 to 0.77), indicating some
reduction in performance for the reduced pain model. The adjusted PAR estimates for these factors were
17%, 9%, 11%, 7%, 9% and 2%, respectively, while their (unadjusted) NNT estimates were n = 5, n = 6,
n = 4, n = 7, n = 9 and n = 6, respectively (Figure 1).
Using the same procedure for selecting predictors, poor physical function (subscale SF-36, IRR 2.48,
95% CI 2.02 to 3.05), poor physical health [SF-12 physical component score (PCS), IRR 1.44, 95% CI
1.24 to 1.67], being retired from work (IRR 1.39, 95% CI 1.18 to 1.64), reporting reduction in time of or
change in activities in the past year (IRR 1.31, 95% CI 1.01 to 1.70), with IRR estimates shown separately
for ‘much’ and ‘little’ reduction in Figure 2 and not going out for long walks (> 2 miles on any day)
(IRR 1.28, 95% CI 1.10 to 1.48) were identified as the most important predictors for functional limitation
(see Figure 2). Their adjusted PAR estimates were 48%, 21%, 19%, 8%, 13% and 15%, respectively,
with unadjusted NNT estimates of n = 2, n = 2, n = 3, n = 3, n = 2 and n = 3, respectively (see Figure 2).
The predictive performance (apparent statistic) of this reduced model was 0.71 (95% CI 0.69 to 0.73),
indicating a considerable reduction in predictive performance when compared with the full Poisson model.
Discussion
This study identified key baseline predictors of moderate to severe pain and functional limitation at 3 years
in a community sample of older people with joint pain or OA. The predictive performance was good for
the full prediction models but lower (as expected) for the reduced models, especially for the model
predicting functional limitation. Key predictors of poor outcome included high baseline levels of pain
and poor function, poor general physical health, low levels of physical activity, indicators of lower
socioeconomic status and obesity.
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FIGURE 1 The PAR and NNT for the most important predictors of moderate to severe pain at 3 years.
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Our data set provided the opportunity to derive prognostic models for long-term outcomes of joint pain in
a community sample. The study identified a mix of potentially modifiable and non-modifiable predictors,
taking into account a wide range of factors. Selection of predictors for the reduced, more feasible models
was not only based on the strength of association of predictors with outcome (IRR), but also on the PAR
and NNT associated with these predictors. These indicators take the prevalence of the predictor in the
sample into account, providing a measure of impact and facilitating interpretation of findings (Box 1).
Although these indicators are useful for presenting findings, and can serve as useful indicators for planning
health-care resources and identifying vulnerable subgroups, they have to be interpreted with caution. The
PAR assumes there are no other competing risks and, when the PAR is interpreted as an indicator of
maximum achievable health gain, the assumption is that predictors are causally associated with outcome
and can be optimally addressed by an effective intervention.74
This study uniquely derived outcome prediction models for OA regardless of the joints involved. We felt
this to be important as most people with OA have multiple pains and may consult with pain and problems
at different joints. The onset of multiple joint pain has been shown to be associated with more frequent
or severe pain at follow-up and larger increases in locomotor disability.75,76 The presence of generalised
pain is likely to influence the outcome of treatment and should be taken into account when managing
musculoskeletal conditions such as OA.77
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FIGURE 2 The PAR and NNT for the most important predictors of limitation in function at 3 years.
BOX 1 Interpretation of indicators
For example: the adjusted PAR of 17% for presence of knee pain at baseline (IRR = 1.33) indicates that 17% of
the risk of severe pain 3 years later in the population of all people who start off with pain in at least one joint
(adjusted for known confounders) is explained by having pain located specifically in the knee.
The NNT of n = 5 indicates that were baseline knee pain to be successfully treated or prevented in five individuals
in this population, this would prevent one additional person having long-term severe pain 3 years later.
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Our analysis started with a large number of potential predictors. The shortcomings of using many variables
in a stepwise model include a lack of stability of the selected set of predictors and potential bias in the
estimation of regression coefficients due to multiple testing.78 However, testing of our performance
estimates using bootstrapping showed limited optimism, indicating adequate internal validity of our models.
Approximately 29% of the total sample did not respond to the baseline health survey. A comparison of
non-responders with responders at baseline showed non-responders to be slightly younger and more
often male. Therefore, they may also differ with respect to levels of pain, functional limitation or other
characteristics. However, this is not likely to greatly influence associations between baseline predictors and
3-year outcomes of pain and function in our subsample of participants with joint pain at baseline. More
importantly, approximately one-third of participants did not respond to the follow-up questionnaires at
3 years, mainly because they did not provide consent for further contact or declined to continue with the
study. The non-response analysis showed a slightly different age and sex distribution in responders, but
very similar baseline scores for other sociodemographic variables and for pain, function, and physical and
mental health, limiting the risk of bias when identifying key predictors of long-term pain and functional
limitation in this study. A recent study of the potential effects of attrition in the NorStOP cohorts confirmed
that there was little evidence that responders at follow-up points represented any further selection bias to
that present at baseline.79
Conclusion
In a population sample of older people with symptoms of joint pain that is probably attributable to OA,
the strongest predictors of moderate to severe pain and functional limitation 3 years later are baseline
measures of:
l location and severity of pain
l physical function
l physical activity
l general health
l obesity
l socioeconomic indicators.
Outputs
1. These findings were used as the basis for the modelling of primary care strategies for population health
gain in OA (see Study 3: estimating cost-effectiveness of delivering core primary care management
for osteoarthritis).
2. One potential implication of the findings for the primary care of OA is that improving the most severely
affected patients will be needed in order to shift population levels of pain and disability in the long
term. However, the analysis presented here was based on a general population sample, which may
over-represent prevalent cases when compared with a sample of primary care consulters, and included
some characteristics that may not be modifiable, at least in the short term. Future work will need to
take better account of the presence of generalised pain in people with joint pain or OA and investigate
the specific predictive value of modifiable prognostic factors (including physical activity and obesity) to
identify risk groups and individuals for targeting treatment, such as the interventions investigated in
the Managing OSteoArthritis In ConsultationS (MOSAICS) studies and Benefits of Effective Exercise for
knee Pain (BEEP) trials (see Chapters 3 and 4). The second output of this programme is, therefore, a
development of the analysis based on a more selective category (‘joint pain that interferes with daily
life’) as the primary outcome, designed to reflect a more severely affected population. Predictors will
focus on modifiable prognostic factors for poor outcome.
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Study 2: summarising evidence regarding the effectiveness of core
primary care interventions
An evidence synthesis and meta-analysis was conducted to summarise available evidence regarding the
effectiveness of primary care interventions recommended by NICE for patients with OA (i.e. advice and
information, paracetamol, topical NSAIDs and exercise). The aim of the evidence synthesis was to obtain
effect estimates that can be used to populate the health economic decision model presented in study 3
(see Study 3: estimating cost-effectiveness of delivering core primary care management for osteoarthritis).
Interventions to lose weight were not included in this analysis as the decision model did not solely concern
overweight or obese patients.
Methods
There are numerous published systematic reviews of the effectiveness of conservative treatments for OA,
which made it possible to design an efficient search strategy, identifying relevant randomised trials first
from existing systematic reviews and then by an updated search of trials not yet included in the reviews.
As this work was conducted at the start of the funding period for this Programme Grants for Applied
Research report, this evidence synthesis included trials published until August 2010.
Search strategy
Systematic reviews and meta-analyses were searched in MEDLINE and The Cochrane Library from January
1990 to August 2010. Subsequently, an additional search in MEDLINE, covering the period from the year
2000 to August 2010, was conducted to identify individual trials that were not yet included in reviews.
The search terms were developed in consultation with an information specialist and were based on the
following (exploded) medical subject heading terms: OA, family practice, general practice, primary health
care, community health services, ambulatory care, non-steroidal anti-inflammatory agents, exercise therapy.
Reference lists from all retrieved systematic reviews and randomised controlled trials (RCTs) were checked
to identify additional potentially eligible RCTs.
Selection of trials
Included in the evidence synthesis were full reports of RCTs, published in English, that evaluated the
effectiveness of advice or information regarding self-management approaches and of paracetamol, topical
NSAIDs and exercise in patients diagnosed (radiographically or symptomatically) with OA at one or more
joint sites (hand, hip, knee or foot). Given the focus of this study on primary care, RCTs were only selected
if they had been conducted in a primary care or direct access setting. One reviewer (JW) scored eligibility of
all identified publications, with an additional reviewer (DvdW, MB or SJ) judging eligibility of all potentially
relevant studies.
Data extraction
Data were extracted from RCTs included in this review to enable description of setting, study design, trial
population, interventions and outcome measures. Estimates of absolute mean or changes in mean scores
after treatment and their respective standard deviations (SD) were extracted and used to calculate
standardised mean differences (SMDs) for outcomes of pain and functional limitation.80 When relevant
reports were available, effect estimates were calculated based on intention to treat analysis. Effect
estimates of 0.2, 0.5 and 0.8 were described as small, moderate and large, respectively.81
Assessment of risk of bias
Risk of bias of RCTs was assessed using The Cochrane Risk of Bias tool.82
The risk of bias domains considered most important in this analysis were adequacy of randomisation,
concealment allocation, blinding of outcome assessors and loss to follow-up. These were scored by JW as
high risk, low risk or unclear risk of bias. Sensitivity analyses were performed, omitting trials with high risk
of bias in at least one of the domains considered.
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Meta-analysis
Meta-analysis focused on comparisons that were of interest to the design of the decision model (see Study 3:
estimating cost-effectiveness of delivering core primary care management for osteoarthritis): (1) advice and
information versus no treatment, (2) simple analgesics versus advice/placebo/no treatment, (3) topical
NSAIDs versus advice/placebo/no treatment and (4) exercise versus advice/simple analgesics/no treatment.
Pooled effect estimates for each comparison were calculated using a fixed- or random-effects model
depending on the extent of heterogeneity present. Fixed-effects models were used when the I2 estimate
was ≤ 50%, otherwise random-effects models were used. Depending on the data presented in the original
trial reports, SMDs for pain and functional limitation were derived using either mean change or the final
outcome score at the end of treatment. This does not pose a problem in meta-analysis as both scores are
considered to be addressing the same underlying intervention effect in RCTs.83 Differences in mean final
scores will be the same as differences in mean change scores if randomisation has been successful and
baseline values of outcome measures are similar.
Funnel plots and Egger’s test84 were used to assess the risk of small-study bias for comparisons including
an adequate number of studies.
Results
Search results
A total of 41 RCTs (27 from Cochrane reviews, 11 from other reviews and three additional trials from
MEDLINE) met the selection criteria and were included in the evidence synthesis. Four RCTs investigated
the clinical effectiveness of advice and information, two investigated simple analgesics, four investigated
topical NSAIDs and 31 examined exercise interventions. A full list of references and summary of the main
characteristics of the included RCTs are available from the authors of this report.
The knee was the most commonly affected joint among the RCTs considered in this review, with 24 RCTs
investigating the knee only and 17 enrolling participants with either knee or hip OA. No trials investigating
hand or foot OA met the inclusion criteria for this evidence synthesis and none assessed treatment effects
independently of the joint affected.
Risk of bias
In general, the RCTs included in this review appeared to have good methodological quality and none of
the medication trials (analgesics or NSAIDs) showed a high risk of bias on any of the domains. All 41 trials
were judged to be at low risk of bias in terms of random allocation of interventions. Among four trials
investigating advice and information interventions, one was at a high risk of bias in terms of loss to follow-up.
For exercise interventions, the proportion of RCTs at a high risk of bias was 7 out of 31 (23%) for blinding of
outcome assessment and 5 out of 31 (16%) for loss to follow-up.
Clinical effectiveness of primary care interventions for osteoarthritis
The 41 RCTs included in this review provided data on 6715 subjects assessed for pain and 5322 subjects
assessed for functional limitation. Table 2 summarises the results of the meta-analysis for each of the
four comparisons.
Only one of the four RCTs investigating advice and information showed statistically significant improvement
when compared with control. There was no evidence of heterogeneity across the studies for either pain
(I2 = 0.0%) or functional limitation (I2 = 1.7%) outcomes. The pooled analysis showed a small, statistically
significant, reduction in pain (SMD = –0.17, 95% CI –0.31 to –0.03, n = 771) as well as a small, statistically
significant, improvement in function (SMD = –0.20, 95% CI –0.34 to –0.06, n = 771) in favour of advice
and information (mean duration of treatment was 19 weeks) when compared with control.
The two RCTs investigating the effectiveness of analgesia (paracetamol, mean duration of treatment was
9 weeks) failed to demonstrate a significant difference compared with control interventions. The pooled
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TABLE 2 Summary of the results of meta-analyses for the four main comparisons
Comparison
Pain outcomes Functional limitation outcomes
Number
of trials
Number of
participants
I 2 (Cochran’s Q-test
for heterogeneity
p-value) Pain SMD (95% CI)
Number
of trials
Number of
participants
I 2 (Cochran’s Q-test
for heterogeneity
p-value)
Functional
limitation SMD
(95% CI)
Advice and information vs.
no treatment
4 771 0.0%, p = 0.961 –0.17
(–0.31 to –0.03)
4 771 1.7%, p= 0.384 –0.20
(0.34 to –0.06)
Analgesics (paracetamol) vs.
advice/placebo/no treatment
2 400 – –0.11
(–0.31 to 0.08)
1 57 – –0.01
(–0.53 to 0.51)
Topical NSAIDs vs. advice/
placebo/no treatment
4 790 0.0%, p = 0.985 –0.35
(–0.49 to –0.21)
4 789 0.0%, p= 0.900 –0.31
(–0.45 to –0.17)
Exercise vs. analgesics/
advice/no treatment
31 1389 0.0%, p = 0.990 –0.32
(–0.43 to –0.21)
27 1240 0.0%, p= 0.726 –0.27
(–0.39 to –0.16)
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effect estimates were small and not statistically significant: SMD = –0.11(95% CI –0.31 to 0.08, n = 400)
for pain and –0.01 (95% CI –0.53 to 0.51, n = 57) for function. Given the small number of studies, these
estimates have to be interpreted with caution.
Four RCTs compared the efficacy of topical diclofenac with placebo, with three RCTs showing beneficial effects.
There was no evidence of heterogeneity of effects among the studies for either pain (I2= 0.0%; p= 0.985) or
functional limitation (I2= 0.0%; p= 0.900). Pooled estimates of SMD showed moderate reduction in pain
(–0.35, 95% CI –0.49 to –0.21, n= 790) and moderate improvement in function (–0.31, 95% CI –0.45 to
–0.17, n= 789) of topical diclofenac compared with placebo after a mean duration of treatment of 5.5 weeks.
A wide range of exercise interventions was assessed among the 31 exercise trials, comprising both
individual and group programmes, and with variable content focusing on strength, flexibility, balance and/or
aerobic exercises. These references are included in Figure 3. Three RCTs showed a statistically significant
reduction in pain (see Figure 3) and a statistically significant improvement in functional limitation. There
was minimal statistical heterogeneity among the studies for both outcome measures (see Table 2). The
pooled analyses showed a moderate reduction in pain (SMD –0.32, 95% CI –0.43 to –0.21, n = 1389) and
moderate improvement in function (SMD –0.27, 95% CI –0.39 to –0.16, n = 1240) for exercise (mean
duration of 19 weeks) compared with control interventions.
The number of trials of exercise interventions was sufficient to reliably assess the risk of small-study bias.
The funnel plots for both outcome measures appear to be symmetrically shaped (Figure 4) and Egger’s bias
estimates confirm the lack of evidence for small-study bias for pain (bias estimate –0.49, 95% CI –1.41 to
0.44; p = 0.292) and function (bias estimate –1.14, 95% CI –2.47 to 0.18; p = 0.087).
– 5.0 – 2.5 0.0 2.5
SMD
(+) favours control(–) favours treatment
Study ID SMD (95% CI) % weight
Pain
Bautch (1997)85
Ettinger (1997)86
van Baar (1998)87
Maurer (1999)88
O’Reilly (1999)89
Péloquin (1999)90
Deyle (2000)91
Hopman-Rock (2000)92
Baker (2001)93
Fransen (2001)94
Halbert (2001)95
Patrick (2001)96
Belza (2002)97
Thomas (2002)98
Topp (2002)99
Foley (2003)100
Quilty (2003)101
Talbot (2003)102
Hughes (2004)103
Keefe (2004)104
Lin (2004)105
Messier (2004)106
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Bennell (2005)108
Cochrane (2005)109
Tak (2005)110
Hay (2006)34
Mikesky (2006)111
Fransen (2007)112
Hinman (2007)113
Wang (2007)114
Subtotal (I 2 = 0.0%; p = 0.990)
 
1.13
1.60
4.63
4.56
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3.04
3.91
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4.80
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3.32
3.94
3.39
4.23
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4.68
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– 0.23 (– 1.27 to 0.81)
– 0.53 (– 1.40 to 0.35)
– 0.55 (– 1.06 to – 0.04)
– 0.19 (– 0.70 to 0.33)
– 0.36 (– 1.54 to 0.82)
– 0.40 (– 0.90 to 0.09)
– 0.94 (– 1.57 to – 0.31)
– 0.14 (– 0.70 to 0.41)
– 0.65 (– 1.41 to 0.10)
– 0.47 (– 0.97 to 0.04)
– 0.17 (– 0.78 to 0.43)
– 0.11 (– 1.53 to 1.31)
– 1.12 (– 3.36 to 1.13)
– 0.22 (– 0.83 to 0.38)
– 0.47 (– 1.03 to 0.08)
0.00 (– 0.60 to 0.60)
– 0.22 (– 0.75 to 0.32)
– 0.29 (– 1.15 to 0.58)
– 0.34 (– 0.85 to 0.17)
– 0.43 (– 1.30 to 0.44)
– 0.19 (– 0.71 to 0.34)
– 0.19 (– 0.65 to 0.27)
– 0.15 (– 0.73 to 0.42)
– 0.10 (– 0.58 to 0.37)
– 0.24 (– 1.18 to 0.69)
– 0.07 (– 0.64 to 0.51)
– 0.19 (– 0.65 to 0.26)
– 0.28 (– 1.14 to 0.57)
– 0.72 (– 1.26 to – 0.18)
– 0.59 (– 1.19 to 0.01)
– 0.53 (– 1.35 to 0.28)
– 0.32 (– 0.43 to – 0.21)
FIGURE 3 Effect estimates (SMD) for pain outcomes of exercise interventions for OA. Reproduced with permission
from Jerome Wulff.59
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Sensitivity analyses were performed for advice and information, and exercise intervention studies, with
results showing minimal differences in the pooled effect estimates after exclusion of studies with a high
risk of bias.
Discussion
This evidence synthesis and meta-analysis involved summarising the results of RCTs that had evaluated the
effectiveness of advice and information, simple analgesics, topical NSAIDs and exercise interventions for
primary care patients with OA. All trials investigated knee and/or hip OA. The meta-analyses demonstrated
statistically significantly more reduction in pain and functional limitation for information and advice, topical
NSAIDs and exercise interventions than control treatments. This was not the case for simple analgesics,
namely paracetamol. The effect sizes varied (0.17 and 0.49) and may be rated as small to moderate.
Although our evidence synthesis only included trials carried out in primary care or open access settings,
the results of the meta-analyses are in agreement with findings of previous or subsequent reviews on
advice and information,115 medication,116–119 and exercise120–122 in people with hip or knee OA, which show
effect sizes for pain and function of similar magnitude.
This evidence synthesis showed that a minority of RCTs have been carried out in primary care settings,
in particular those on advice and medication. Furthermore, this synthesis was mainly based on a search of
available systematic reviews and only included full-trial reports published in English. This is a weakness of
this review but it is reassuring that the magnitude of effect sizes were comparable with those reported in
other systematic reviews based on broader search strategies, that is, including studies from health-care
settings other than primary care and, therefore, not the focus of this review and evidence synthesis.
The quality of the RCTs included in the evidence synthesis appeared to be good, although information
was often lacking regarding the methods used for concealing treatment allocation, blinding of outcome
assessment and loss to follow-up. We accept that single reviewer assessment of quality was a weakness in
the methods of this evidence synthesis, but sensitivity analyses excluding RCTs with a high risk of bias for
at least one domain resulted in very similar effect estimates, which justifies use of estimates based on all
available evidence.
Conclusion
This work provided effect estimates for the four primary care interventions included in the decision-modelling
study (see Study 3: estimating cost-effectiveness of delivering core primary care management for osteoarthritis),
which aimed to estimate the cost-effectiveness of different strategies to deliver core primary care management
– 3
1.5
1.0
0.5
0.0
– 2 – 1 0
SMD
1 2
St
an
d
ar
d
 e
rr
o
r
FIGURE 4 Funnel plot for trials investigating exercise interventions for OA (pain outcomes). Reproduced with
permission from Jerome Wulff.59
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for OA. The main shortcomings of the available evidence for this particular purpose concerned the relatively
small number of trials carried out in primary care, the lack of trials focusing on hand or foot OA and the lack of
long-term follow-up in available primary care trials.
Outputs
1. As stated above, estimates were provided for the modelling in the section Study 3: estimating
cost-effectiveness of delivering core primary care management for osteoarthritis
2. The specific aim and content of the review presented here was extended into a full review and network
meta-analysis of randomised trials of exercise interventions for OA as a linked output of workstreams
and workstream 3.122
Study 3: estimating cost-effectiveness of delivering core primary care
management for osteoarthritis
This section presents work undertaken to develop a decision model for optimal OA primary care and
provides a basic template that can be developed and further refined using new or accumulating evidence
on the cost-effectiveness of interventions.
The model aimed to evaluate the cost-effectiveness of two hypothetical interventions for delivering core
primary care compared with current care for adults with OA, from a health-care perspective.
The two modes of delivery chosen to illustrate the template were (1) stepped care and (2) a ‘one-stop shop’,
with both interventions containing four of the core primary care interventions for OA: advice and information,
paracetamol, topical NSAIDs and exercise. The individual interventions were selected because they are
recommended by NICE,15 European League Against Rheumatism (EULAR) and Osteoarthritis Research
Society International (OARSI)10–14,32 as core interventions for managing OA. Therefore, the evidence synthesis
described in study 2 (see Study 2: summarising evidence regarding the effectiveness of core primary care
interventions) did not influence selection of interventions for the modelling study (paracetamol was found
to be no more effective than placebo or alternatives, as judged by statistical significance, in the synthesis),
but the synthesis did provide the standardised effect estimates for all four interventions included in the
modelling study. The two hypothetical strategies were proposed by a consensus meeting consisting of
clinicians and OA researchers.
Methods
Study population
The patient population was adults aged ≥ 50 years with symptomatic knee and/or hip pain or OA in a
primary care setting in the UK, using data from the NorStOP cohort.60 The original idea was to use a similar
target population to that used for the prediction modelling study described above in study 1 (see Study 1:
predicting long-term outcome in people with joint pain and osteoarthritis), in which participants had pain
at baseline at one or more joint site (hand, hip, knee or foot). However, the proportion of participants with
only hand or foot OA was low (< 5% each) and the evidence synthesis (described in study 2, see Study 2:
summarising evidence regarding the effectiveness of core primary care interventions) provided effect
estimates only for hip and/or knee OA. Therefore, it was decided to define this sample more narrowly than
in study 1 of the workstream and the pain scores provided by the WOMAC questionnaire from study 1
were used to represent hip or knee pain status. If an individual had pain scores for both joints, the highest
score was used to reflect the joint with greater pain.
Model structure
A Markov cohort model was built to reflect the clinical history of OA. The model considered four health states
(no pain, mild, moderate and severe pain), defined using baseline WOMAC scores (range from 0 to 20).
WORKSTREAM 1: MODELLING OPTIMAL PRIMARY CARE FOR OSTEOARTHRITIS
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A score of zero was defined as no pain, 1–5 as mild pain, 6–10 as moderate pain and 11–20 as severe
pain.62 Everyone started in the model with some pain (mild, moderate or severe) and moved health state
when their condition improved or worsened; alternatively, they could remain in the same health state.
Therefore, the model includes no pain as a state through which people could pass during follow-up, even
though persons in that state were not included as one of the start points. Movement could only be to the
next better or worse health state. A time horizon of 3 years was used in the base-case analysis, reflecting
the follow-up period of the NorStOP cohorts used in this model. Death was not included in the model as
the time horizon was short and the condition does not directly lead to death. A 3-month time cycle was
used, as it was considered to be a clinically meaningful time period for OA in terms of expected changes
in the symptoms of OA, duration of treatment and timing of decision-making by a GP. The structure is
presented in Figure 5.
Interventions
Three packages of primary care were considered by the model: stepped care, ‘one-stop shop’ and current
care. These hypothetical scenarios were discussed with clinicians to ensure assumptions were realistic.
Stepped care
This intervention included all four core interventions and assumed that interventions were prescribed by
GPs in a stepped fashion. The first line of treatment was advice and paracetamol, and all patients were
modelled as being offered this regardless of their baseline level of pain. If pain worsened or did not
improve from a moderate or severe pain state, then the next (second) line of treatment prescribed was
topical NSAIDs. The same principle applied for movement from the second to the third line of treatment
(exercise, assumed to be supervised by a physiotherapist). If there was no improvement after the third line
of treatment, patients returned to current care. Those who were originally in a severe pain health state and
whose condition improved to moderate pain were moved to a ‘moderate-from-severe’ health state. If they
remained in this ‘moderate-from-severe’ health state, the same line of stepped-care treatment was received,
as maintaining any improvement from the most severe state was assumed to be a positive situation. Each
step-up of treatment was assumed to involve a practice nurse appointment to introduce the new treatment.
‘One-stop shop’
In the ‘one-stop-shop’ package of care, participants were offered all four core interventions simultaneously.
It was assumed that the package was prescribed by a GP, with a physiotherapist offering the initial exercise
package. The rationale behind this intervention was that it allowed patients to receive all optimal interventions
at the same time, irrespective of pain severity. If a patient moved to a worse health state or did not improve
from a moderate or severe pain state, they returned to current care. The rationale behind this assumption was
that some participants will not respond or adhere to treatment and will then return to their GP to be placed
under current care. The assumption regarding the continuation of an intervention once a moderate health
state has been achieved after improvement from the more severe state also applied here.
Severe pain
Moderate
pain
No pain Mild pain
FIGURE 5 Markov model structure. Reproduced with permission from Jerome Wulff.59
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Current care
Current care for OA was informed by the observational cohort study (NorStOP) and a primary care-based RCT
from the UK, which included a usual-care arm.123,124 Data from the cohort study indicated that many patients
only consult their GP about their condition once within a period of 3 years. Patients consulting their GP were
likely to be initially offered advice and pain medication(s) according to the severity of their symptoms and,
thereafter, stronger pain medications, referral for physiotherapy and eventually surgery as the last treatment
option if the pain persisted. Surgery was not considered in this study given the 3-year time horizon, during
which arthroplasty was not very likely. Owing to the lack of detailed data on health-care resource use in the
cohort, the costs of current care were considered to be as reported in the control arm (current GP-led care)
in a trial of exercise in knee OA patients.123,124 Treatments included advice, exercise and pain medication(s)
including simple analgesia (paracetamol and aspirin), topical and oral NSAIDs, and opioids.
Data inputs
Table 3 contains information on the baseline proportion of patients in each health state at baseline and
provides estimates for the clinical effectiveness of individual treatments. The initial distributions in each
health state at the start point of the model were estimated from NorStOP baseline data. Participants with
no knee or hip pain at baseline were excluded because the model assumed only participants with pain
would consult primary care and receive treatment. The numbers excluded from the sample used in study 1
above (i.e. those with only foot or hand pain) were small. Estimates of the SMD for each of the primary
care interventions compared with their controls were obtained from the review in study 2.
Table 4 presents the transition probabilities for current care and all interventions. Current-care data on
pain severity at baseline and 3 years from the NorStOP cohort was used to provide transition probabilities
for the model. Matrix multiplication was utilised to transform actual transitions over 3 years into 3-monthly
transitions. The treatment effect estimates were then applied to the current-care transition probabilities to
obtain new transition probabilities. In the stepped-care intervention, only the effectiveness of the specific
intervention at that step was applied, even though the patient was likely to be continuing to receive
previous interventions. The estimate of effect (SMD) for the ‘one-stop shop’ was set at 0.5. This estimate
was agreed during the consensus meeting of clinicians and OA researchers as it is larger than the strongest
effect estimate of the individual primary care interventions. The clinicians in particular were clear that
they often used the interventions as a package and agreed that a large additive effect between these
concurrent interventions was unlikely.
TABLE 3 Model parameters
Parameter Value Source
Start point health state (pain) Baseline proportion
No pain 0 NorStOP data
Mild 0.3245
Moderate 0.4177
Severe 0.2578
Treatment effect estimates SMD (95% CI)
Advice and information vs. no treatment –0.17 (–0.31 to –0.03) Systematic review (see Table 2)
Simple analgesia (paracetamol) vs. advice/placebo/no treatment –0.11 (–0.31 to 0.08) Assumption
Topical NSAIDs [diclofenac gel (Voltarol® gel, GlaxoSmithKline)]
vs. advice/placebo/no treatment
–0.35 (–0.49 to –0.21)
Exercise vs. analgesics/advice/no treatment –0.32 (–0.43 to –0.21)
‘One-stop shop’ –0.50
WORKSTREAM 1: MODELLING OPTIMAL PRIMARY CARE FOR OSTEOARTHRITIS
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Costs
Table 5 shows the unit cost data applied in this study. The cost of current care for each pain severity
health state was estimated using patient-level data from the current-care arm of the exercise trial by Hurley
et al.124 The unit cost of drugs was updated from a price year of 2003/4 to 2010 using British National
Formulary (BNF) costs126 and an average cost per 3 months of treatment calculated.
In stepped care, there was an initial cost for consultation with a GP, a nurse appointment for each new
line of treatment and the cost of the intervention. The exercise intervention was six sessions of exercise at
30 minutes per session over a period of 6 weeks with an experienced physiotherapist.128 It was assumed
that when participants moved to the next line of treatment, they all continued to use the preceding
interventions. The ‘one-stop-shop’ intervention cost included the cost of an initial GP consultation, ongoing
TABLE 4 Transition probabilities for pain health states
Pain health states by health-care
category or intervention No pain Mild Moderate Severe
Baseline probabilities 0 0.3245 0.4177 0.2578
Current care
No pain 0.6022 0.3978 0 0
Mild 0.0613 0.8836 0.0551 0
Moderate 0 0.0456 0.9194 0.0350
Severe 0 0 0.0462 0.9538
Advice and paracetamol
No pain 0.6022 0.3978 0 0
Mild 0.1301 0.8148 0.0551 0
Moderate 0 0.0969 0.8681 0.0350
Severe 0 0 0.0980 0.9020
Topical NSAIDs
No pain 0.6022 0.3978 0 0
Mild 0.2940 0.6509 0.0551 0
Moderate 0 0.2189 0.7461 0.0350
Severe 0 0 0.2215 0.7785
Exercise
No pain 0.6022 0.3978 0 0
Mild 0.2729 0.6720 0.0551 0
Moderate 0 0.2032 0.7618 0.0350
Severe 0 0 0.2056 0.7944
‘One-stop shop’
No pain 0.6022 0.3978 0 0
Mild 0.4010 0.5439 0.0551 0
Moderate 0 0.2986 0.6664 0.0350
Severe 0 0 0.3021 0.6979
Apart from the baseline probabilities, each figure shown is the probability of transition from the column status to the
relevant row status.
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costs for paracetamol and topical NSAIDs, a consultation with an experienced physiotherapist to introduce
the exercise intervention at an initial consultation and the cost of exercise. Costs were accumulated over
the 3-year time horizon to give total costs for each of the three modelled treatment strategies.
Outcomes
Baseline Short Form questionnaire-6 Dimensions (SF-6D) component scores of the NorStOP participants
with hip and/or knee pain were used to derive utility values for each health state, using the algorithms
developed by Brazier and Roberts.128 Table 6 shows the mean utility scores for the four health states used
in this study. Utilities were accumulated over the 3-year time horizon to give total quality-adjusted
life-years (QALYs) for each strategy in the model.
Analysis
Base case
An incremental cost–utility analysis was undertaken to compare the cost-effectiveness of the two proposed
primary care strategies with current care, from a health-care perspective. The interventions were ordered
in descending order according to cost. Costs and QALYs were discounted at an annual rate of 3.5% in
TABLE 5 Costs (price year 2010)
Parameter Cost/person/3 months (£) Source
Current care
No pain 9.60 Hurley et al.124
Mild pain 24.00 Hurley et al.124
Moderate pain 39.70 Hurley et al.124
Severe pain 65.70 Hurley et al.124
Intervention
Advice in GP consultation 28.00 PSSRU125
Paracetamol 7.78 BNF126
Topical NSAIDs 16.17 BNF126
Exercise 34.75 Whitehurst et al.127
Staff costs
GP consultation 28 PSSRU125
Nurse-led consultation 14 PSSRU125
Physiotherapist 34 PSSRU125
PSSRU, Personal Social Services Research Unit.
TABLE 6 Baseline utility scores for health statesa
Variable Mean (95% CI)
No pain (n = 131) 0.7925 (0.7706 to 0.8144)
Mild pain (n= 964) 0.7604 (0.7518 to 0.7690)
Moderate pain (n= 1193) 0.6886 (0.6803 to 0.6969)
Severe pain (n= 718) 0.5593 (0.5499 to 0.5687)
a Source: NorStOP data at baseline.60
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accordance with the current UK treasury guidelines.129 Costs were expressed in Great British pounds using
2010/11 as the price year. A threshold of cost-effectiveness of £20,000 per QALY gained was adopted for
this study.15
Deterministic sensitivity analyses
Sensitivity analyses were carried out to test the robustness of the primary results by changing some of the
most important assumptions used in the model construction.
The following sensitivity analyses were performed:
l Extension of the time horizon of the model from 3 years to 5, 10 and 20 years.
l Application of GP costs instead of nurse costs for subsequent consultations in stepped care.
l Selection of only those subgroups with moderate or severe pain categories (excluding mild pain
patients) to reflect a health-care seeking population.
l Varying the effect size (SMD) of exercise using 95% CIs.
l Varying the effect size (SMD) for ‘one-stop shop’ between –0.4 and –0.6.
Results
The results of the base-case analysis are presented in Table 7. Current care and the ‘one-stop shop’
intervention are both dominated by stepped care, which is cheaper and more effective. However the
difference in QALYs is marginal. The ‘one-stop-shop’ intervention was cost-effective when compared with
current care, with an incremental cost-effectiveness ratio (ICER) of £1341 per additional QALY gained.
Stepped care continued to dominate in all but one of the sensitivity analyses and the one-stop shop was
always more cost-effective than current care. If a patient were assumed to visit a GP rather than a nurse at
every change of treatment in stepped care, mean costs were only marginally increased (£24). Running the
model for an equal proportion of patients with moderate or severe pain increased the costs of all the three
interventions and decreased total QALYs. The lower effectiveness estimate for exercise slightly decreased
the QALYs for stepped care. If the SMD for ‘one-stop shop’ is changed to –0.4 then stepped care still
dominates, but if it is changed to –0.6 then total QALYs become greater than for stepped care, giving an
ICER of £29,281 per QALY gained. This value is above the suggested lower threshold for NICE of £20,000/
QALY and so ‘one-stop shop’ is still unlikely to be interpreted as cost-effective.
Discussion
This is the first model-based economic analysis of primary care interventions for knee and hip OA. The results
of this study have demonstrated that the hypothetical stepped-care intervention was the most cost-effective,
dominating ‘one-stop-shop’ and current care. This result was robust to the sensitivity analyses conducted.
TABLE 7 Base-case results
Treatment Cost (£) QALYs Cost difference QALY difference ICER (£/QALY)
Comparison of all three options
Stepped care 393.00 2.01 – – –
Current care 427.15 1.94 34.16 –0.06 (Dominated)
One-stop shop 507.62 2.00 114.62 –0.01 (Dominated)
One-stop shop vs. current care
Current care 427.15 1.94 – – –
One-stop shop 507.62 2.00 80.47 0.06 1341.17
ICER, incremental cost-effectiveness ratio.
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Inevitably, building a model of this type with hypothetical strategies has required a large number of
assumptions to be made. First, the data used to provide transition probabilities for current care were
available only for baseline and 3 years, and were converted to 3-month probabilities. It is highly unlikely
that the long-term trajectory of 3 years can represent the short-term fluctuations in pain every 3 months.
In addition, one-third of the cohort participants were lost to follow-up. As explained in Characteristics of
participants, these participants had a slightly different age and sex distribution from responders. However,
their other baseline measures (sociodemographic, pain, function, physical and mental health) were similar,
limiting the likelihood of selection bias. The model was run for only 3 years in the base case, a short time
horizon for a Markov model, although sensitivity analyses were conducted for long time periods. A longer
time horizon would require the model structure to incorporate both joint replacement and all-cause death,
both omitted from this model.
Second, assumptions were included regarding the effectiveness and cost of treatments. The level of effect
of an intervention was assumed to be the same irrespective of the current pain health state, and the
effect was assumed to be constant over time, even though estimates were from studies with short time
frames. In reality, different types of patients may have different levels of benefit from interventions and the
effectiveness of interventions may decrease over time. As patients moved from one treatment to the next
in stepped care, there was no additive effect of treatment, even though it was assumed that the patient
would still be receiving the previous intervention. Finally, the effect estimate for ‘one-stop shop’ was obtained
from expert opinion to reflect the strength of the combined effect of the interventions. The value is likely to
be reasonable, given that an additive effect is improbable when several interventions are combined. The
current-care cost estimate used in this study was obtained from a data set for chronic knee pain, although
this model considered both knee and hip OA.
Further assumptions were made with regard to patient pathways. When all treatments in the hypothetical
interventions ceased to provide any improvement, the model assumed that patients moved back to current
care in the next 3-month cycle, with a worse patient trajectory. In reality, this time frame may be too short.
GPs may, for example, persevere with current interventions for longer and patients may be offered stronger
medications, such as opioids, or be referred for surgery. The nature of the model does not allow the pain
history of a patient to be taken into account. This limitation could be resolved by creating additional Markov
health states or changing the type of model to one that can be run with individual patient histories (e.g. an
Individual Sampling Model).130
Despite these many assumptions, the results concur with a common-sense view of how these alternative
strategies for primary care interventions in OA would work out in practice. The basic difference between
‘one-stop shop’ and ‘stepped-care approaches’, based on the same set of possible core interventions, is
that the former strategy will, by definition, mean that all consulters will receive all possible interventions,
whereas the latter strategy can potentially be more parsimonious in restricting the proportion of people
who will receive all four interventions.
Conclusion
Building this model and estimating the cost-effectiveness of two hypothetical primary care intervention
strategies illustrates that economic modelling can be used to extrapolate beyond short-term clinical trials in
OA. The results presented here are indicative of the type of output that can be produced and provide a
template for future analysis. As they stand, they are not designed to provide immediate guidance for
decision-makers.
However, it is likely that current care for some OA patients already follows either a stepped care or
‘one-stop-shop’ approach, although its content and delivery may differ from the assumptions made in the
hypothetical models. Therefore, this work provides a platform for modelling long-term cost-effectiveness
of interventions for OA, to which additional data can be added.
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Outputs
1. The template developed, described and tested here is a stand-alone resource for future
modelling exercises.
2. The practical application and content of the template described here was constrained by available data
at this stage of the programme (population data and secondary care trials). A second application of the
model will use the output of the primary care trial data, such as that which has now emerged from
the later stages of the programme in workstreams 2–4 for new analyses in the future. This second
application will also further develop the template through:
i. probabilistic sensitivity analysis, taking into account all parameter uncertainty simultaneously, which
was not undertaken here in this first application
ii. inclusion of data on the course of OA pain over time, including short-term fluctuations, to provide
more appropriate transition probabilities
iii. adaptation to look at a broader range of OA pain sites.
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Chapter 3 Workstream 2: The MOSAICS studies
Parts of this chapter have been reproduced from Dziedzic et al.131 © 2014 Dziedzic et al.; licenseeBioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly credited. The Creative
Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to
the data made available in this article, unless otherwise stated.
Abstract
Background: UK NICE guidance for primary care of OA patients is not implemented in practice.15,24
Aim: To develop and evaluate novel ways to deliver core NICE guidance for OA in primary care, and to
investigate their implementation and clinical effectiveness and cost-effectiveness.
Methods: A suite of mixed-methods studies within the framework of a cluster RCT, in which four general
practices implementing a new model of OA care (MOSAICS) were compared with four control practices.
Results: Pre randomisation: practical support for delivering NICE guidelines was developed, including
training in model OA consultations for GPs and practice nurses, and OA patient guidebook developed with
patients and health-care professionals.
A novel pop-up computerised template (the ‘e-template’) to record quality markers of care was
implemented in the eight participating practices132 and associated with improved recording of components
of quality OA care and changed clinician prescribing and referral behaviour.
Post randomisation: the MOSAICS approach improved delivery of NICE core treatments, including provision
of written information, simple analgesia and reduced radiography and increased physiotherapy referrals.
Only a minority of patients were referred to the practice nurse-led service. Among patients followed up
post-consultation, MOSAICS innovations were regarded positively (by patients and health-care
practitioners), pain and disability did not improve compared with controls, and visits to orthopaedic
specialists and time off work declined.
Problems of implementation included difficulty maintaining change over time (patients and practitioners),
practitioner variation in recording care and variable patient response to nurse-led clinics.
Conclusion: Improved implementation of NICE OA guidance can be achieved in primary care at no
incremental cost, but does not result in better patient-reported pain and disability.
Ethics permission: This study was approved by the North West 1 Research Ethics Committee (REC),
Cheshire (REC reference 10/H1017/76).
Trial registration: Current Controlled Trials ISRCTN06984617.
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Introduction and overview of the MOSAICS studies
In the UK, OA is the second most frequent reason for consultations with older patients in primary care.3
Most such consultations are with a doctor (the GP or family practitioner).133 Primary care provides the arena
in which most patients with OA in the population who seek care from the UK NHS are seen and managed.
In 2008, the UK NICE identified evidence-based interventions for patients with OA consulting in primary
care (Figure 6).15 These included a core set of interventions considered potentially applicable to all patients
consulting about OA in primary care (represented by the inner circle in Figure 6).
Evidence has shown that most OA patients in primary care were not receiving or continuing with these
interventions24 and that there was widespread dissatisfaction and pessimism among doctors, health
professionals and patients about primary care management of OA and about the potential to alter the
natural history of the minority who will progress to joint replacement surgery.22,41,42,44
This context provided the ambition and purpose for this second workstream of the NIHR programme
RP-PG-0407-10386. The workstream comprised a suite of studies (MOSAICS) designed to develop practical
evidence-based ways to support the implementation of NICE guideline core interventions in primary care
and, thereby, to enhance the value of the primary care consultation for patients with OA.
The focus of the NICE core guidance is on self-management.15 The guidance characterises self-management
in terms of access to information and advice, including specific advice about exercise and physical activity,
optimal use of simple oral and topical analgesia and, when appropriate, weight loss. The OA research user
group (RUG) at Keele (see Appendix 1) had highlighted, prior to submission of the NIHR programme proposal,
that their main concern about NHS recommendations for self-management was, from the perspective of
patients, the lack of information, support and help to adopt and maintain self-management approaches.
This user view provided the underlying rationale for the content of the MOSAICS interventions. A model
OA consultation for GPs in primary care backed up by new patient information, an electronic template for
monitoring quality of care and referral for a series of practice nurse-led model OA consultations formed the
‘MOSAICS model of care’, and this was defined as the vehicle to deliver NICE guidelines into practice.
The theoretical basis for developing the intervention to change GP behaviour is described in detail by
Porcheret et al.134
Core self-care interventions
• Education, advice, information access
• Strengthening exercise, aerobic fitness training
• Weight loss if overweight or obese
First-line analgesia
• Paracetamol
• Topical NSAIDs 
FIGURE 6 The NICE core recommendations for treatment of OA (redrawn using relevant components from NICE15).
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The components of the MOSAICS approach were based on the Whole systems Implementing
Self-management Engagement (WISE) model,19 which embraces the needs of the patient, the health-care
professional and the service. The key components in MOSAICS that were developed and evaluated in this
workstream were as follows:
l Model OA consultations by GPs and practice nurses.
l Training for primary care health professionals to deliver model OA consultations.
l A new guidebook for patients, developed by patients and health-care professionals together, as the
principal source of written information.135
l An electronic computer-based method (the ‘e-template’) for routine recording of components of quality
OA care by GPs and practice nurses.
l New nurse-led OA clinics in general practice.
The suite of individual studies developing and evaluating different components of the MOSAICS model were
embedded in a framework provided by a cluster RCT. The trial investigated implementation of the new model of
care at a practice level (process outcomes) in four primary care practices that adopted the different components
of the model OA consultation compared with four practices that (with the exception of the e-template) did not,
as well as the impact of this implementation on pain and disability in a subgroup of patients recruited into a
follow-up study (clinical outcomes). The trial was based on UK MRC complex trial principles.136
A second framework for studying aspects of adoption and implementation of the model OA consultation
was provided by normalisation process theory (NPT).137 Adoption of new or complex interventions in primary
care is influenced by factors at three levels: the clinical encounter, the management and organisation of
the practice, and the wider health service context. Recognition of these influences is increasing,138 but there
are few concrete examples that have investigated them. In studying the implementation of MOSAICS, we
examined how GPs and practice nurses made sense of this complex intervention, what this meant for the
way they worked and how this had to change, as well as which factors from the three levels were influencing
this ‘sense-making’.139 The framework supplied by these concepts from NPT was used in two ways. First, it
provided a structure for the research team in its approach to engaging with the practices by identifying
factors facilitating implementation and overcoming barriers to delivering the MOSAICS intervention. Second,
it provided a framework for analysing and evaluating the process of implementing the intervention.
Each component of the model OA consultation was studied separately, using a mixture of quantitative and
qualitative techniques in order to establish its rationale, develop and evaluate its content and associated
training, and test its acceptability with patients and professionals. The implementation of the components
of the new model was investigated at a practice level in the trial through process measures of frequency of
delivery and recording of care, and at an individual level through qualitative studies and surveys of patients
and health-care professionals. The clinical effectiveness and cost-effectiveness of the programme was
evaluated in the individual-level analysis of the subgroup that was followed up by self-report questionnaire
in the cluster RCT.
Patient and public involvement (PPI) was present at every step of the process through a dedicated OA RUG
(see Appendix 1).
The framework and component studies of MOSAICS
Each MOSAICS study or analysis is presented separately below, grouped into chapter sections: background
(group 1), development and testing of interventions and quality-of-care measures including the e-template
(groups 2 and 3), implementation of the new model of care (practice-level analysis), clinical effectiveness
and cost-effectiveness (individual-level analysis) (group 4), patient and practitioner experience (group 5)
and dissemination (group 6). Each study has aims, methods, results and published and practical outputs.
The cluster RCT framework and populations are shown in Figure 7. The total practice population for the
practice-level analysis is shown in blue and the subsample of the total practice population for the individual
patient-level analysis is shown in green.
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Practice-level analysis
Eligible to be mailed
survey questionnaire
(n = 28,443)
Responded to survey
questionnaire
(n = 15,083)
Consent to follow-up and
medical record review if and
when they consult
(n = 11,290)
Reported joint pain in one
of four OA sites
(n = 9110)
Population consulting with
clinical OA
Intervention
0–6 months
n = 364
(7.74/100)
Control
0–6 months
n = 287
(6.51/100)
n = 4408n = 4702
Four 
intervention
practices
Four control
practices
Records tagged
Subsample of
practice-level
cluster trial for
individual
follow-up
(n = 9110) 
Population consulting
with clinical OA
0–6 months 
[n = 1118 (5.94/100)]
Population consulting
with clinical OA
0–6 months
[n = 842 (5.65/100)]
Total registered
population ≥ 45 years
(n = 18,835)
Total registered
population ≥ 45 years
(n = 14,891)
Four intervention
 practices
Four control
 practices
Total population consulting with
a defined Read code for joint pain or
OA
0 to 6 months
[n = 1960 (5.78/100)]
Registered population of eight general
practices who are aged ≥ 45 years
(n = 33,726)
Total population consulting with a
defined Read code for joint pain or OA
(‘clinical OA’)
– 18 to – 12 months
[n = 1761 (5.22/100)]
– 12 to 6 months
[n = 1827 (5.24/100)]
Total population consulting with a
defined Read code for joint pain or OA
– 6 to 0 months
[n = 1851 (5.49/100)]
Template inserted in all eight practices
Cluster randomisation
Individual 
patient-level analysis
FIGURE 7 Cluster trial framework and population.
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The study populations
The registered populations of the eight participating general practices who were aged ≥ 45 years
(n = 33,726) provided the population base for the MOSAICS studies. The eligibility for the participation of
these practices, their staff and their patients is listed in Appendix 2 (see MOSAICS eligibility criteria).
There were three populations selected from this base in the pre-randomisation phase.
l Population survey responders. All persons aged ≥ 45 years registered with one of eight participating
practices were sent a general health questionnaire to establish baseline pre-randomisation patterns of
joint pain and OA in the population. A series of baseline analyses of all ‘survey responders’ were
performed to determine the background frequency of multisite pain, self-reported uptake of NICE
recommended treatments and prevalence of physical activity among persons with joint pain in this
population (MOSAICS study 1.1, see Study 1.1: self-reported prevalence and patterns of osteoarthritis
and its treatment in the registered population of primary care).
l Total OA consulting population. All consulters aged ≥ 45 years who were coded on the practice
medical records system as having consulted about joint pain or OA, regardless of whether or not they
had responded to the baseline population survey, formed the ‘total OA consulter population’ (Figure 7
and Box 2). This anonymised population provided occurrence estimates of joint pain and OA in the
participating practices, using the total registered population aged ≥ 45 years of the participating
practices as the denominator (n = 33,726) (see Figure 7).
l Consenter population. Those who responded to the survey, who consented to follow-up and a recorded
review, and who had reported pain in at least one OA joint site (hand, hip, knee or foot) at baseline
were eligible for individual follow-up in the cluster trial. This population was a subgroup of the second
population above, drawn from the baseline survey responders in the first population. A consent form to
further contact and to use of individual medical records was included in the survey. Survey responders
with pain in at least one joint who gave their consent formed the ‘consenter population’. This identified,
pre-randomisation, the pool of patients in all practices who would be willing to be recruited and
followed up individually in the main cluster trial if they consulted their GP with joint pain during the
randomisation phase. Such pre-randomisation of a consenting population of potential future eligible trial
participants guards against bias in recruiting individuals within a cluster design post randomisation.109
This subgroup, the self-reported questionnaires they completed during the follow-up phase and details
from their medical records created the basis for the ‘individual-level’ analysis in the cluster RCT of clinical
effectiveness and cost-effectiveness of the implementation of the new model of care (MOSAICS studies
4.2–4.3, see Study 4.2: effect of the MOSAICS programme on patient-reported outcomes and Study 4.3:
cost-effectiveness of the MOSAICS intervention: health economic evaluation). The subgroup also
provided the sampling framework for additional ‘individual-level’ quantitative and qualitative studies of
implementation (MOSAICS studies 5.1–5.4, see Study 5.1: implementing a complex intervention in
practice – an evaluation using a theoretical framework, Study 5.2: experiences of model consultations –
patients, Study 5.3: experiences of model consultations – general practitioners, and Study 5.4:
experiences of the model consultation – nurses).
BOX 2 ‘Read coding’ of OA-related consultations
All UK GPs, including those in the participating practices, record on their practice computer software the reason
why a patient consults them, using an established morbidity coding system called ‘Read codes’. These codes
can be symptoms or diagnoses. Preliminary work in MOSAICS by academic GP members of the team identified
a complete list of symptom and diagnostic codes (summarised throughout this report as ‘joint pain and OA
codes’) which were agreed as representing all possible presentations of clinical OA. The list of Read codes
appears in www.keele.ac.uk/mrr,140 Jordan et al.141 and Edwards et al.132
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A practice-level intervention (the quality-of-care e-template, which prompted OA assessment and NICE
core OA interventions by the GP) was developed and introduced into all eight practices. This template was
a pop-up computer screen that appeared whenever joint pain and OA consulting codes were entered. The
effect of this intervention on routinely recorded items of care (such as prescriptions for OA) was investigated
by a before-and-after comparison of downloaded anonymised practice record data 12 months before and
6 months after installation of the template in all eight practices [MOSAICS study 3.1, see Study 3.1: the
osteoarthritis quality-of-care template (the ‘e-template’)]. In the subsequent cluster RCT of the MOSAICS
intervention, this population (all patients consulting with OA symptoms or diagnosis in the participating
practices) and the anonymised measures of quality of care provided by the template generated the level
and method, respectively, of outcome analysis for the ‘practice-level’ implementation study. This compared
anonymised downloaded consultation data between intervention and control populations (MOSAICS
study 4.1, see Study 4.1: implementation of the MOSAICS intervention – practice-level effect on quality of
care for patients with osteoarthritis).
Development studies
The development and testing of components of the model OA consultations and of the e-template were
conducted in the pre-randomisation phase [MOSAICS studies 1.2, 2.1–2.5, 3.1 and 3.2, see Study 1.2:
establishing the current evidence base for multidisciplinary osteoarthritis interventions in primary care settings;
Study 2.1: development of the content of a ‘model’ general practitioner consultation and the training
intervention to deliver it; Study 2.2: evaluation of intervention workshops; Study 2.3: development of the
content of a model osteoarthritis consultation with a practice nurse and the training package for nurses to
deliver it; Study 2.4: evaluation of practice nurse training to support osteoarthritis self-management; Study
2.5: development of the opportunistic osteoarthritis consultation with health-care professionals; Study 3.1:
the osteoarthritis quality-of-care template (the ‘e-template’); and Study 3.2: developing patient-reported
outcomes with the osteoarthritis research user group).
The main trial process
The eight practices were randomly allocated to intervention practices and control practices to form the
cluster trial design. All practices continued to use the e-template to record care. Following training of GPs
and practice nurses, consulters with joint pain or OA in the intervention practices received the MOSAICS
model of care, whereas consulters with joint pain or OA in the control practices received usual care.
Practice-level outcomes
Practice-level outcomes in the cluster trial provided process measures of implementation of the model
consultation in the intervention practices compared with controls and included:
l the proportion of consulters with joint pain or OA, whose e-template was completed in the
post-randomisation period and who met the quality criterion for each item of care on the template
l the proportion who were referred to the nurse OA clinic
l changes in routine measures of OA care, such as prescribed medication and referrals to physiotherapy
and radiography departments.
Individual-level outcomes
In the subgroup of individuals recruited within the cluster trial who were followed up post consultation at
0, 3, 6 and 12 months with self-report questionnaires, the extent of implementation of the MOSAICS
model of care was further explored (e.g. in questions recalling the content of the consultations they had
experienced, together with items on satisfaction with care). The main clinical outcomes of pain and
disability were measured in this subgroup. Health economic analysis used both self-report questionnaires
and data drawn from the medical records of this subgroup.
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Qualitative interviews
Qualitative interviews were conducted with samples of patients after consultation and with health-care
professionals delivering the new model of care (GPs and practice nurses) to explore experience and
perspectives on the interventions.
Patient and public involvement in the MOSAICS studies
The OA RUG at Keele University had provided the initial impetus and thread for the whole programme
(see Appendix 1) by highlighting that a desire expressed by patients to try self-management approaches
was not matched by sufficient active and informed professional NHS support to do so.
The RUG continued to play a substantial part in the creation, shaping, delivering and evaluation of many
important components of the MOSAICS suite of studies. An overview of RUG activity in MOSAICS is
as follows.
Development and design of a guidebook for use in the osteoarthritis consultations
This was a stand-alone piece of work that pre-dated the NIHR programme RP-PG-0407-10386 and was
published collaboratively by researchers and patients.135,142 It was introduced and evaluated in the
programme as a component of the model GP and nurse OA consultations. The OA guidebook differs from
conventional patient education materials in that it contains lay, as well as biomedical, evidenced-based
knowledge.
Five members of the OA RUG helped to shape the content of the guidebook. They reviewed a summary of
qualitative research of people’s experiences of living with OA to identify information needs, drawing on
their own lived experience to suggest what information was required to meet the information needs of
newly diagnosed patients. They also reviewed all draft materials.
Advice on content of the baseline population questionnaire
The aim of patients’ involvement here was to critically assess a postal questionnaire that was used both as
the basis for the background survey and as a means to recruit potential participants for the later follow-up
stage of the cluster RCT. As a result of their feedback, changes to the questionnaire were made.
Involvement in the Delphi consensus study to inform the content of a model general
practitioner consultation with osteoarthritis patients
The aim was to ask patients what they think should happen or should be done when older people with
joint pain consult a GP for the first time. A 1-hour meeting was held to explain the consensus exercise and
to discuss aspects of consultations. OA RUG members then completed two postal questionnaires that listed
all the possible things that could happen during the consultation and decided which they thought should
be included. For the first round, they were asked to consider this if time was no object. In the second
round, they were asked what should be included in an initial 10-minute consultation. OA RUG members
then returned for a follow-up meeting to discuss items on the questionnaires and to give feedback on the
consensus method used to create the final content for the model consultations.143,144
Development of quality indicators for general practice consultations
A quality indicator describes the performance of something. It could be an action or task (e.g. GP recording
information) or a heath outcome (e.g. lower blood pressure or reduced pain). Quality indicators are used to
measure standards of care and whether or not they are consistent with what is thought to be best care. A list
of quality indicators for the content of general practice consultations for the MOSAICS studies was defined
by a systematic review.145 This list was taken to the OA RUG and translated by the OA RUG into questions
that could go into a questionnaire as part of the main study to ask patients about their experiences of the
new consultation being tested. Therefore, some of the questions in this ‘patient consultation questionnaire’
are patient-defined questions (using the words suggested by OA RUG members).
DOI: 10.3310/pgfar06040 PROGRAMME GRANTS FOR APPLIED RESEARCH 2018 VOL. 6 NO. 4
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Hay et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
31
This work by the OA RUG was also used as the basis to explore international comparisons of PPI methods.
In collaboration with Norwegian, Danish and Portuguese colleagues, results of patient involvement across
these three countries were compared. The format developed by the OA RUG was found to be almost
identical to a format being tested for OA quality indicators in Norway, which also included patient partners.146
Analysis of data from the qualitative studies
Four members of the RUG assisted one of the qualitative research teams with the analysis of audio-
recordings of nurse-led OA clinics. The RUG members were provided with transcripts of the clinics and
asked to identify themes and to comment on the interactions between the nurse and the patients. The
results of this were incorporated in the wider analysis of the clinics and were used to corroborate or
amend the research team’s existing coding frame for analysis.
Involvement in developing training for health-care professionals
At an OA RUG meeting in November 2011, researchers introduced members to four pieces of qualitative
data from a previous study that investigated how people with knee pain self-managed their pain. These
pieces of data were considered by researchers as good examples to use for training nurses in how people
cope with joint pain and adopt self-management approaches. The OA RUG discussed and voiced their
own thoughts on how patient experiences might influence a model OA consultation with the practice
nurse and gave their critical consideration as to whether or not these examples would be suitable to help
nurses to see the patient’s view. The results of this session were fed into the training programme for the
nurse-led consultation.
Four members of the OA RUG recorded extracts of patient stories for the training video for the practices.
Summary
The MOSAICS is a complex suite of studies. This created challenges for the RUG members and for
researchers. We have managed this by:
l generating of a glossary which is available to all RUG members
l providing support for RUG members at meetings via a PPI co-ordinator and user support worker
l producing lay summaries in advance of meetings
l continuing to provide feedback to patients who have been involved
l offering training (e.g. Contributing Assertively in Meetings, a regular workshop run for staff by Keele
University’s Learning and Professional Development Centre).
The MOSAICS studies
The studies are presented separately below, grouped into background studies (group 1), studies of the
development and testing of interventions and quality-of-care measures including the e-template (groups 2
and 3), implementation of the new model of care (practice-level analysis) and clinical effectiveness and
cost-effectiveness (individual-level analysis) (group 4), patient and practitioner experience (group 5) and
dissemination (group 6).
Group 1 studies: background evidence about osteoarthritis in primary care
Study 1.1: self-reported prevalence and patterns of osteoarthritis and its
treatment in the registered population of primary care
This study incorporated three analyses of the baseline survey of the registered populations of the eight
practices participating in the cluster trial. The survey was both a vehicle to identify a pool of consenters for
potential future recruitment into the main trial if they consulted about joint pain or OA, and a basis for
background studies of OA and its treatment in the general population.
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The latter was the purpose of study 1.1 and is based on the fact that > 95% of people in the UK are
registered with a general practice and so a survey of a registered practice population is a suitable vehicle
for assessing a local general population sample.
Aims of the baseline survey
l To provide a well-characterised population sample of adults aged ≥ 45 years who consent to
engagement in a follow-up study if they were to consult in the future about joint pain or OA.
l To provide the basis for three background analyses of OA, with the specific aims to:
¢ describe the prevalence and characteristics of adults aged ≥ 45 years with multisite joint pain in the
general population
¢ determine the use of NICE recommended core OA treatments in a general population sample of
adults aged ≥ 45 years with joint pain.
l estimate prevalence of physical activity in adults aged ≥ 45 years with joint pain in the general population.
Methods
Eligible adults on the register of one of eight practices identified for the cluster RCT were sent a letter of
invitation to take part in the MOSAICS studies, together with information about the study and a copy of
the baseline survey and a request to return the survey. On the last page of the survey there was a request
for consent to further contact. Non-responders after 2 weeks were posted a reminder letter and survey.
Those who did not respond or who indicated they did not wish to take further part were excluded from
future engagement in the cluster RCT.
The questionnaire collected demographic and work-related data and information regarding general and
psychological health, physical activity and joint pain in the 12 months prior to the survey as well as
consultation behaviour and the management of their joint pain (hands, hips, knees and feet).
Figure 7 illustrates that the target population for the postal survey was 33,726 and, after exclusions by the
practices, 28,443 were eventually mailed. There were 15,083 persons who completed and returned their
questionnaire, a 53% response rate. Average age of responders was 63.9 years (SD 11.2 years) and
approximately half were female.
Analysis 1: multisite peripheral joint pain – prevalence, impact and multidisciplinary
support in community dwelling older adults
Parts of this text have been reproduced with permission from Andrew Finney.147
Introduction/background Patients present in primary care with symptoms rather than diseases and, if
caused by musculoskeletal problems, such symptoms often take time to evolve into a recognisable form.148
Therefore, people often live with joint pain without a formal diagnosis of OA. Joint pain is the most
frequent reason for consulting with a GP in primary care.149 Most publications focus on OA in single joint
sites, such as the knee, overlooking the fact that most people with pain at one joint site will have pain in
other joint sites concurrently.54,150,151 This investigation used the baseline survey data to characterise
patients with symptoms in multiple joint sites and aimed to provide context for the NIHR programme aim
to develop optimal multidisciplinary primary care for patients with OA.
Objective To investigate the prevalence, distribution and impact of multisite peripheral joint pain in a
community-dwelling population.
Methods ‘Multisite’ was defined as self-reported pain in two or more of the four main locations for OA pain
in humans (hands, hips, knees, feet) using items enquiring about pain in the location during the past year.
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Prevalence was defined as the proportion of people in the responder population who reported multisite pain.
Distribution was investigated with respect to age, sex and social deprivation. Social deprivation was measured
using linked census data that provides a small local area score (the Index of Multiple Deprivation) applied to
the individual and is based on multiple characteristics of the locality area.152 Multisite joint pain intensity
was measured using a composite pain intensity score from four individual NRSs (scored 0–10) of the hand,
hip, knee and foot, as well as total number of sites of joint pain reported and self-reported primary care
consultations. ‘Impact’ of multisite joint pain was defined as cross-sectional association with scores from
validated self-report instruments measuring physical [Short Form questionnaire-12 items (SF-12) PCS],
mental (SF-12 mental health component score) and general health status as well as quality of life (QoL)
[EuroQol-5 Dimensions (EQ-5D)].
Analysis Five subgroups of persons were formed, based on their reporting of the total number of joint
locations with pain (i.e. 0–4). Descriptive statistics were used to describe the target population surveyed.
Linear regression analysis was used to investigate the association of multisite peripheral joint pain with
measures of general health, QoL and pain intensity, after adjusting for potential covariates [age, sex, body
mass index (BMI) and social deprivation]. Logistic regression was used to calculate ORs as a measure of
association between presence and intensity (moderate to severe) of multisite peripheral joint pain and
recalled consultations with GPs, practice nurses and allied health professionals.
Results Among the 15,083 survey responders, 11,928 (79%) had any peripheral joint pain and 8206
(54%) had multisite peripheral joint pain. The distribution of multisite peripheral joint pain by number of
locations involved is shown in Table 8, together with age and BMI.
Multisite pain was statistically significantly associated with increasing age, raised BMI and higher levels
of social deprivation. It was also associated with increased pain intensity. Both the number of sites of
peripheral joint pain and the levels of pain intensity were separately and independently associated with
reduced general health and QoL (data not shown).
Self-report of primary care consultations for peripheral joint pain revealed that GPs were the main contact
for this problem and that there was substantially lower reported contact with the wider multidisciplinary
team. The odds of consulting with primary care health professionals were increased in those with multisite
peripheral joint pain and in those with moderate to severe pain intensity. The likelihood of consulting a GP
or a practice nurse with peripheral joint pain increased with each increase in the number of painful joint
sites and was at its highest in those with pain in four sites (GP consultation: OR 4.51, 95% CI 3.98 to
5.11; practice nurse consultations: OR 4.30, 95% CI 3.41 to 5.39) compared with one site (the reference
group for analysis, with OR assigned a value of 1.0). The odds of having consulted a GP or practice nurse
with multisite peripheral joint pain rather than single site peripheral joint pain increased with age.
TABLE 8 Distribution of number of joint pain sites and mean (SD) age and BMI of persons in different categories
defined by number of painful sites
Population
characteristic
0 painful
sites
1 painful
sites
2 painful
sites
3 painful
sites
4 painful
sites ANOVA
Number of people (%) 3155 (21) 3722 (25) 3565 (23) 2688 (18) 1953 (12.9)
Age (years) 62.6 (11.3) 63.0 (11.1) 63.8 (11.0) 64.8 (11.2) 66.3 (10.9) F = 43.6**
BMI (kg/m2) 25.6 (4.0) 26.3 (4.1) 27.0 (4.5) 27.7 (5.1) 28.4 (5.6) F = 138.1**
**p < 0.001.
ANOVA, analysis of variance.
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Conclusion Multisite peripheral joint pain is the most common form of joint pain in a UK general
population sample of adults aged ≥ 45 years. In this study, it was associated with increasing age, raised
BMI, higher levels of social deprivation, worse levels of general health, worse levels of QoL and higher pain
intensity. The important result that is of relevance to the aim of the NIHR programme as a whole is that
people consulting with the clinical syndrome of OA in primary care (i.e. peripheral joint pain affecting hip,
knee, foot or ankle) are likely to have pain in multiple sites and yet their reported contact with all members
of the multidisciplinary team who might provide treatments that get beyond a single site was very low.
Implications for optimal primary care in practice are as follows.
1. Training and education of primary care practitioners should highlight the need to establish the extent of
joint involvement in patients with clinical OA, even when the presentation concerns a single joint.
2. Research, training and education should develop and evaluate methods of self-management relevant to
pain and disability at multiple joint sites. This is likely to include multidisciplinary care, such as podiatry.
3. The effect of multidisciplinary care on multisite joint pain outcomes is a gap in the evidence.
Analysis 2: uptake of National Institute for Health and Care Excellence osteoarthritis core
treatments in community-dwelling older adults who have consulted for joint pain
Parts of this text have been reproduced with permission from Healey EL, Afolabi EK, Lewis M, Edwards JJ,
Jordan KP, Finney A, Jinks C, et al. Keele University. 2017.
Introduction/background The uptake of NICE OA core treatments15 in community-dwelling older adults
with a self-reported primary care consultation for joint pain is unknown.
Aim The aims of this study were to use the population survey to:
1. describe the uptake of the core NICE OA treatments153 in a community-dwelling older adult population
with a self-reported primary care consultation for joint pain
2. determine whether or not a self-reported clinical diagnosis of OA is associated with the uptake of
these guidelines.
Methods Participants in the population survey provided information on the presence of joint pain (hand,
hip, knee, foot) and also reported on consultations about (and management of) their joint pain over the
last 12 months. Uptake of NICE recommended treatments in responders who consented to medical record
review and reported a consultation for joint pain in the previous 12 months was compared between those
with and without a coded diagnosis of OA in their medical records.
Results Figure 7 shows that 9110 survey responders consented to medical record review and had
reported joint pain in at least one of the target sites in the population survey. Of these, 4059 (44.6%)
reported consulting primary care in the last 12 months and 502 of these (12.4%) had been given an OA
diagnosis, rather than joint pain symptom codes only or no diagnostic code relevant to OA.
Reported uptake of the core non-pharmacological treatments was low. Responders reporting joint pain
were more likely to report having received pharmacological treatments such as paracetamol and topical
NSAIDs. Those with an OA diagnosis in their medical records were more likely to report having received
treatment in line with the guidelines (Table 9). Responders aged ≥ 65 years were statistically significantly
more likely to report the use of paracetamol than responders aged < 65 years (p = 0.01) and were less
likely to report receiving the core non-pharmacological treatments of education and access to information
(p = 0.01) and muscle-strengthening exercise (p < 0.001).
Conclusions Reported uptake of core non-pharmacological treatments for OA was lower than for
recommended pharmacological treatments in this general population sample of those aged ≥ 45 years
who responded to a postal questionnaire, reported having consulted in the previous year about joint pain
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and gave consent to use of their medical records for the research project. Those with a diagnosis of OA in
their medical records reported receiving treatment more in line with NICE recommendations than those
without such a diagnosis, while older people with joint pain received proportionally more pharmacological
than non-pharmacological treatments than younger people. This is in contrast to NICE guidance15
recommending these treatments irrespective of age.
Implications for optimal primary care of patients with OA in practice are as follows:
1. Persons with the highest prevalence of OA and the highest risk of side-effects from pharmaceuticals
[i.e. older persons (those aged ≥ 65 years)] have the lowest uptake of non-pharmacological OA therapies
and, therefore, represent a specific target for development of ways to support self-management.
2. Research needs to explore the specific barriers or attitudes among patients and professionals towards
adopting non-pharmacological approaches to OA management.
Analysis 3: self-reported physical activity levels – measurement and assessment in
community-dwelling older adults with, or at risk of, osteoarthritis
Parts of this text have been reproduced with permission from Robert Smith.154
Introduction/background NICE recommends that physical activity should be a core treatment for all
adults with OA.15 Adults aged ≥ 45 years with symptomatic joint pain either are likely to have already
developed OA or be at risk of OA. Joint pain is one of the main symptoms experienced by individuals with
OA and yet in the UK the levels of physical activity in adults with joint pain or diagnosed OA are unknown.
Aim The aim was to estimate current levels of physical activity in adults with joint pain.
Methods This was an analysis of the baseline survey described above. A questionnaire item from the
survey used for this analysis was the measurement of physical activity using the Short Telephone Activity
Rating (STAR) questionnaire. The STAR questionnaire is scored corresponding to Department of Health
(DH) guidelines for weekly physical activity levels155 (participating in moderate physical activity for
30 minutes at least five times per week or participating in vigorous physical activity at least three times
a week). Participants are scored as ‘inactive’ if they report participating in moderate or vigorous activity
less than once a week, ‘somewhat active’ if they report participating in moderate or vigorous activity more
than once a week but less than recommended by the DH, or ‘active’ if they report participating in
moderate or vigorous activity that meets or exceeds DH recommendations.
This analysis included all participants who returned a baseline survey and who had fully completed the
STAR questionnaire (n = 11,310). The prevalence of activity and inactivity in relation to the presence of
joint pain and other characteristics was calculated, with associations estimated by logistic regression.
TABLE 9 Reported use of NICE core treatments in consulters with and without an OA diagnostic Read code in their
medical records
Treatment Joint pain group, n (%) (N= 3557) OA code group, n (%) (N= 502)
Written information about: treatment,*
self-management,* OA***
358 (10.1), 361 (10.1), 208 (5.8) 68 (13.5), 70 (13.9), 61 (12.2)
Muscle-strengthening exercises,
general aerobic fitness, weight lossa
452 (12.7), 130 (3.7), 230 (9.5) 80 (15.9), 24 (4.8), 31 (8.9)
Paracetamol,*** topical NSAIDs*** 1067 (30.0), 889 (25.0) 203 (40.4), 166 (33.1)
*p< 0.05; **p< 0.01 ***p < 0.001.
a Recommended for overweight and obese individuals.
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Results More adults with self-reported joint pain were inactive than those with no reported joint pain and
fewer adults with self-reported joint pain achieved the recommended levels of physical activity than those
with no reported joint pain. Participants with self-reported joint pain were less likely to be physically active
than participants with no reported joint pain (OR 0.75, 95% CI 0.68 to 0.77).
Conclusion There is convincing evidence that physical activity is beneficial for older persons with joint pain
and OA. However, in this population survey, current levels of physical activity were lower in older adults
with joint pain than those without. This is a cross-sectional analysis and joint pain might have prevented
physical activity or physical activity might have prevented joint pain. However, the results suggest that
there is scope for substantial increase in activity levels in persons with joint pain and OA.
Implications for optimal primary care of patients with OA in practice are as follows:
1. There may be specific barriers to exercise as a means of self-management of OA.
2. Research needs to explore these barriers to exercise (e.g. patient fears of joint damage), the individual
benefits of exercise and the potential and/or willingness for such barriers to be overcome.
Study 1.2: establishing the current evidence base for multidisciplinary osteoarthritis
interventions in primary care settings
Parts of this section have been reproduced from Finney et al.156 ©The Author(s). 2016. This article is
distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creative
commons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available
in this article, unless otherwise stated.
A systematic review of randomised controlled trials using a multidisciplinary approach to
managing the patient with osteoarthritis in multiple joint sites
Introduction/background The NICE OA guidance identified core treatments and highlighted the need to
consider combination therapies for persons with OA in multiple sites.15 The term ‘combination therapy’
suggests packages of care that cover a range of interventions delivered by a wide range of health
disciplines (i.e. multidisciplinary care). There is as yet no evidence about the effects of a multidisciplinary
package of care targeting multiple sites of OA.
Aim To undertake a systematic review to provide a synthesis of evidence for the clinical effectiveness and
cost-effectiveness of NICE core treatments delivered by a multidisciplinary team (defined as two or more of
the following: GP, practice nurse, physiotherapist, occupational therapist, podiatrist, community pharmacist,
nutritionist, orthopaedic specialist) in primary care settings, targeting multiple sites of OA across the
peripheral joints (hands, hips, knees or feet).
Methods Computerised bibliographic databases were searched from database inception until June 2013
[MEDLINE, EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycINFO, British
Nursing Index, Health Business Elite, Health Management Information Consortium (HMIC), Allied and
Complementary Medicine Database (AMED), Web of Science and The Cochrane Library]. Studies were
included if they met the following criteria: a RCT, a primary care population with OA in at least two different
joint sites, and interventions undertaken by at least two different health disciplines. The Cochrane Risk of
Bias Tool was utilised for quality assessment.82 A narrative analysis was used to summarise the findings.
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Results The searches identified 1148 titles. The screening of titles reduced the number of papers down to
211. The review of abstracts left 79 eligible papers. A deductive process left five papers describing a total
of three studies that were eligible for the review (including one protocol and one preliminary results
paper). Reference checks of current guidelines found no studies beyond those found within the searches.
Reference checks of a systematic review identified one further study that was eligible for the review.
Therefore, the total number of eligible studies was four.
The four trials each used core interventions endorsed by OA guidelines. The trials targeted multiple sites of
OA in either hips and knees, or hips, knees and hands, yet were very heterogeneous. None of the trials
reported a multidisciplinary package of care deemed clinically effective or cost-effective for adoption in
UK primary care, yet there were several moderately effective outcomes across the four trials. Educational
approaches demonstrated moderate reductions in health service utilisation in primary care. Exercise
interventions, although initially effective, were shown to decline over time. An interdisciplinary GP and
practice nurse intervention showed the most positive outcomes.
Conclusion This systematic review identified four trials investigating differing multidisciplinary approaches
for multiple-site OA. The review identified no strong evidence to support the adoption of any one of the
trial methods as a package of care, but did identify positive aspects of each trial. The review highlighted
that a consistent approach to outcome measurement is required for future studies of this nature as there is
limited consensus on outcome measures at present, which leads to greater heterogeneity across studies.
Implications for optimal primary care of OA in practice are as follows:
1. This review gives some support for
i. the effectiveness of non-pharmacological interventions for OA (education and exercise) in managing
whole-person multisite OA
ii. shaping the primary care OA team around nurses and GPs.
2. The review did not identify clear evidence for the effectiveness of the models of delivery that are
already in place in practice. This provided an additional rationale for investigating new models of
primary care in MOSAICS.
Group 2 studies: developing interventions to support self-management of osteoarthritis
in primary care and to monitor the quality of care delivered
Study 2.1: development of the content of a ‘model’ general practitioner consultation
and the training intervention to deliver it
Parts of this section have been reproduced from Porcheret et al.134 © 2014 Porcheret et al.; licensee BioMed
Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public
Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made
available in this article, unless otherwise stated; and from Porcheret et al.143 © 2013 Porcheret et al.; licensee
BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Introduction/background
The MOSAICS studies required design and implementation of an intervention to enhance management for
persons with OA in primary care. The MOSAICS OA model of care, which centred on consultations by
GPs and practice nurses, was developed as a patient-focused complex intervention and designed for the
assessment and treatment of older adults (those aged ≥ 45 years) presenting in general practice with
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peripheral joint problems and to enhance support for self-management for people with OA in primary
care. The content aligns with recommendations in the NICE OA guidelines.15 It was implemented in the
intervention practices of the MOSAICS studies.
The implementation necessitated a change in GPs clinical practice during consultations with patients
with OA. The use of theory, systematically selected and used in the development and implementation
of complex interventions, is recommended in the MRC guidance on complex interventions.136,157
Implementation science has developed and tested theoretically derived models and frameworks for the
development of behaviour change interventions to change clinical behaviour, and these were used as a
basis for this first substudy.134
Aim
The aims of this substudy were to (1) develop the content of the model GP consultation for patients
with OA and (2) use theory to develop the training package to enhance the delivery of the model OA
consultation by GPs in the MOSAICS studies intervention practices.
Methods
Phase 1: development of the model OA consultation with a GP A postal Delphi consensus exercise
was undertaken with two expert groups: (1) 15 GPs with expertise in OA management and (2) 14 patients
with experience of living with OA. An advisory group generated 61 possible consultation tasks for
consideration in the consensus exercise. The expert groups were asked to consider which tasks should be
included in the model OA consultation. The level of agreement for inclusion in the model was set at 90%.
Phase 2: development of the GP training package The training package was developed as a
behaviour change intervention to implement the model OA consultation and its development was guided
by four theoretical models/frameworks: (1) an implementation of change model to guide the overall
approach, (2) the Theoretical Domains Framework (TDF) to identify relevant determinants of change,
(3) a model for the selection of behaviour change techniques to address identified determinants of
behaviour change and (4) the principles of adult learning.
The Phase 2 development was undertaken in three steps.
Step 1: development of a concrete proposal for change The behaviour change required of the GPs
was the delivery of the model OA consultation. Following phase 1 development of the model for the
OA consultation, two activities were undertaken. First, the characteristics of the model OA consultation
were compared with characteristics known to promote or hinder the implementation of an innovation.
Second, three general practice advisory groups were formed and meetings arranged. The meetings were
audiotaped and field notes made. The model OA consultation for GPs was presented to the groups and
their views and understanding obtained. From the results of the comparison and feedback from the
advisory groups, the model consultation was refined to enhance uptake by GPs.
Step 2: analysis of performance, target group and setting At the same meetings as those arranged
for step 1, the advisory groups were asked about (1) their current management of OA, (2) their awareness
of, and agreement with, the NICE OA guidelines15 and (3) any gaps that they perceived between their
current practice and that recommended by NICE and in the model consultation. In addition, they were
asked to suggest which barriers and/or incentives might be relevant to implementing the model
consultation in practice. Their responses were mapped by the study team to the domains in the TDF.
Step 3: development or selection of strategies and measures to change practice There were four
parts to the development of the behaviour change intervention: (1) defining content, (2) selecting
behaviour change techniques, (3) deciding on style of delivery and (4) addressing local practicalities. The
content was developed by the study team and informed by the views of GPs from step 2. The mapping of
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behaviour change techniques to TDF domains was utilised to select the techniques to address the domains
identified in step 2. The adult learning principles and the Cochrane Effective Practice and Organisation
of Care Group’s reviews were used to decide on the style of delivery.158 Practical issues, such as venues,
timings and duration of meetings, how best to deliver the behaviour change intervention, and what was
feasible in the MOSAICS studies, were addressed by the study team in consultation with the general
practices in the study. More details of methods appear in Porcheret et al.134
Results
Phase 1 The model OA consultation included 25 tasks to be undertaken during the initial consultation
between a GP and a patient presenting with peripheral joint pain. The 25 tasks provide detailed advice
on how the following elements of the consultation should be addressed: (1) assessment of chronic joint
pain, (2) patients’ ideas and concerns about their condition, (3) exclusion of red flags, (4) examination,
(5) provision of the diagnosis and written information, (6) promotion of exercise and weight loss, (7) initial
pain management and (8) arranging a follow-up appointment. Both GP and patient groups prioritised a
biomedical approach to the consultation, rather than a biopsychosocial model, suggesting discordance
between current thinking and research evidence. The 25 tasks are detailed in Porcheret et al.143
Phase 2 The behaviour change intervention presented the GPs with a clearly defined proposal for change,
it addressed seven of the TDF domains, it incorporated 10 behaviour change techniques and it was
designed to be delivered in workshops that incorporated the expertise and professional values of the GPs.
The programme for the workshops used a mixture of interactive and didactic sessions facilitated by opinion
leaders, and utilised ‘context-bound communication skills training’.
Conclusions
Phase 1 enabled expert, patient and GP views to be used to reach consensus on a model OA consultation.
Phase 2 enabled the systematic and theory-driven development of the training package for GPs, which was
designed as a behaviour change intervention to enhance their care for people with OA.
Study 2.2: evaluation of intervention workshops
Parts of this text have been reproduced with permission from Porcheret et al.159 This article is distributed
under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.
org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication
waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this
article, unless otherwise stated.
Introduction/background
Evaluation of intervention workshops to change clinical practice was undertaken at three levels: (1) learner
reaction to workshops, (2) clinical practice in a simulated setting and (3) clinical day-to-day practice.
Aim
The aim of this study was to develop methods and measures to evaluate the workshops developed in
study 2.1 and to undertake the evaluation.
Methods
Methods and measures were developed for the three levels of evaluation.
Learner reaction to workshops A learner reaction questionnaire was developed and administered at
the end of the final workshop. It encompassed level 1 Kirkpatrick educational outcomes, such as level of
enjoyment, views on content and confidence in delivering the model OA consultation.
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Clinical practice in a simulated setting GPs were video-recorded consulting with simulated OA patients
at three time points: before the workshops, 1 month after the workshops and 5 months after the
workshops. Detailed scenarios and biographies were developed for the simulated patients and training was
undertaken so that the ‘patients’ presented to the GPs and responded to them in a consistent manner.
Videos were rated using a specially developed instrument by four trained assessors whose accuracy had
been established. Assessors viewed, in random order, all videos of their allocated GPs. The presence or
absence of 14 consultation tasks was assessed for each GP at each time point. The 14 tasks used in the
experiment are shown in Appendix 2 (see MOSAICS model consultation task list).
Two measures were developed to evaluate change in clinical practice: a GP competency score which
measured the extent to which a GP delivered the consultation (how many of the 14 behaviours were
present in an individual video), and a task delivery score which measured the overall extent to which a task
was delivered by the GPs (how many of the GPs undertook the task at a given time point).
1. Development of the rating instrument: draft rating criteria were developed based on key elements of
the model OA consultation, which could be observed on a video-recording. The criteria were refined by
a panel of four reviewers (academic GP, pain specialist, physiotherapist and epidemiologist) using two
demonstration videos of the model OA consultation that were used in the assessor training sessions.
The rating instrument contained criteria for rating 14 consultation tasks necessary for the delivery of the
model OA consultation.
2. Establishing acceptability and accuracy of use of the rating instrument: gold standard ratings –
behaviour present or absent – were produced by the panel for five video consultations of participating
GPs obtained before and after the training. Four other GPs, who were not members of the practices
participating in the training, learned to rate video-recorded consultations using the rating instrument.
They then individually rated the five videos, which were presented to them in random order. For each
rater, percentage agreement and sensitivity and specificity compared with the gold standard ratings
were determined. Assessors were able to rate all the tasks for all five videos. The percentage agreement
with the gold standard for the four assessors ranged from 80% to 86%. The sensitivity (proportion of
tasks rated present if gold standard rated present) ranged from 85% to 98% and specificity (proportion
rated absent if gold standard absent) ranged from 46% to 83%. The rank order of the videos by the
number of tasks present was comparable between assessors and gold standard (Table 10). Further
training was undertaken with the assessors to improve specificity.
Clinical practice in day-to-day primary care During the MOSAICS studies, an audit was undertaken
of the extent to which four consultation tasks had been undertaken in daily practice by GPs in the
participating practices. Patients who visited the GP for OA-related problems in the intervention practices,
TABLE 10 Assessor ranking of videos, ordered by gold standard rating rank
Video Gold standard rating rank Assessor 1 Assessor 2 Assessor 3 Assessor 4
D 1 1= 1 1= 1
C 2 1= 3= 1= 3=
A 3 3 3= 1= 2
B 4 5 3= 4= 3=
E 5 4 5 4= 5
=, of equal rank. The statistical analysis here uses rank order as the basis for testing.
Parts of this text have been reproduced with permission from Porcheret et al.159 This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted
use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source,
provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless
otherwise stated.
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and subsequently attended the nurse-led OA clinic, were asked to report on the content of the previous
GP consultation. Four consultation tasks were asked, namely, did the GP (1) elicit ideas about the problem,
(2) give the diagnosis, (3) explain the diagnosis and (4) hand out the guidebook?
Results
Learner reaction An extract of the results is shown in Table 11.
Clinical practice in a simulated setting Fifteen GPs were video-recorded consulting with simulated OA
patients at the three time points. Median GP competency score at baseline was 7, at 1 month after the
workshops it was 11 and at 5 months after that it remained at 11 (Table 12). Task delivery score increased
for eight tasks after workshops; for other tasks the delivery score was either high before the workshops or
not affected by workshops.
Clinical practice in day-to-day primary care This was undertaken as part of the main MOSAICS trial
through patient questionnaires completed after their consultation with the GP about joint pain and is
reported in Study 2.4: evaluation of practice nurse training to support osteoarthritis self-management.
Conclusions
Methods and measures were developed for the five levels of training evaluation. Learner reaction to
workshops was positive and the workshops were associated with changes in GP consulting behaviour with
simulated patients.
TABLE 11 Participant ratings of the GP consultation training and its delivery
Statement
Number (%) of participants (n= 23)
Strongly disagree Disagree Agree Strongly agree
I enjoyed the training sessions 16 (70) 7 (30)
The training has helped me to better manage OA 14 (61) 9 (39)
The training covered a lot of ground I already knew 4 (17) 16 (70) 3 (13)
The training has helped with other aspects of my practice 6 (26) 13 (57) 4 (17)
The trainers were proficient in delivering the sessions 14 (61) 9 (39)
I would recommend these training sessions to a colleague 1 (4) 15 (65) 7 (30)
TABLE 12 Summary statistics for GP Competency Score by time point
Summary statistics Baseline 1 month after workshops 5 months after workshops
Median 7 11 11
IQR 5–8.5 10–12 10–11
Range 5–11 8–14 7–13
IQR, interquartile range.
Parts of this text have been reproduced with permission from Porcheret et al.159 This article is distributed under the terms of
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Implication for optimal primary care for OA GPs vary in the extent to which they deliver identifiable
components of optimal care for OA, but training programmes can substantially improve their competence.
Study 2.3: development of the content of a model osteoarthritis consultation with a
practice nurse and the training package for nurses to deliver it
Parts of this section have been reproduced from Healey et al.160 © The Author(s). 2016 This article is
distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creative
commons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available
in this article, unless otherwise stated.
Introduction/background
Evidence suggests that practice nurses are the health-care professionals who are most likely to provide
self-management support for patients with chronic disease and, therefore, may be best placed to offer
core treatments recommended in the NICE OA guidelines. The MOSAICS studies are the first to develop a
system for delivering these core recommendations in the form of a linked GP–practice nurse model of care
for OA patients.
Aim
To describe the development and content of the nurse-led component of optimal primary care for OA and
the training package that aimed to provide practice nurses with the knowledge and skill set needed to
enable self-management support for patients with OA in line with the NICE guidelines.
Methods
A rapid review of the literature and a mapping exercise of OA and chronic disease self-management
programmes was conducted. Common elements were identified and, along with the NICE OA guidelines,15
the content of the model consultation by the practice nurse (when referred patients with OA by the GP) was
developed. Initial feedback on content was obtained from a practice nurse advisory group and the OA RUG.
Once the content was agreed, a training package was developed to provide the nurses with the
knowledge and skill set needed to deliver the content. The training package was piloted with a mixed
group of five nurses (a rheumatology nurse and a practice nurse, who were both also researchers, and
three non-researching practice nurses) and results of the pilot used to refine the training package prior to
delivery to all nurses in the intervention practices of the cluster RCT.
The training package was evaluated through (1) trainer reflections, (2) ‘real-time’ observations and
suggestions from trainers and trainees and (3) formal daily evaluation by trainees.
Results
The content of the nurse-led OA service was finalised by the advisory group and the RUG as consisting of
four 20- to 30-minute appointments over 3 months, following initial referral by the GP. The training
package was agreed on as a 4-day programme.
The outcome of the development of intervention and training was that nurses were to focus on encouraging
a patient-centred approach, the use of an OA guidebook, goal-setting, pain management and the core NICE
recommendations (information and advice, exercise and physical activity, and weight management).
Evaluation of the pilot training resulted in theoretical material being reduced substantially, allowing more
time during training to be dedicated to experiential elements (role play and simulated patient sessions).
It was also suggested that an experienced facilitator should be involved throughout the training and that
more time should be dedicated to practising the joint examination and to demonstration of exercise.
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The training programme was changed to reflect these findings of the pilot study.
Conclusion
Traditionally, OA management is not seen as a high priority for primary care and patients believe that little
can be done. The NICE guidelines15 highlight the therapeutic gains of positive self-management; practice
nurse care and the training for this was developed and tailored to deliver and support these core messages.
Study 2.4: evaluation of practice nurse training to support osteoarthritis self-management
Parts of this section have been reproduced from Healey et al.160 © The Author(s). 2016. This article is
distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creative
commons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available
in this article, unless otherwise stated.
Introduction/background
Evaluation of the practice nurse training package was undertaken in a number of ways. All nurses who
attended the training were asked to complete three evaluation questionnaires (pre training, 1-month post
training and 6 months after initial intervention delivery).
In addition, the same pre-training questionnaire was given to practice nurses from the control practices to
provide a baseline comparison. However, this group of nurses otherwise had no training as part of the trial
and there was no special nurse-led referral service or OA clinics in the control practices.
The pre training and 1-month post-training questionnaires are presented here. Two other components of
evaluation of the practice nurse training are considered in later sections of this chapter (see Study 4.2: effect
of the MOSAICS programme on patient-reported outcomes, Study 5.2: experiences of model consultations –
patients, and Study 5.4: experiences of the model consultation – nurses.) These were:
1. Patients recruited into the cluster RCT in both intervention and control practices were asked to
complete a questionnaire about their experience and some of the questions were relevant to patients’
experiences of the nurse-led clinics in the intervention practices.
2. Direct observations of the practice nurse-led clinics in the intervention practices during the cluster RCT
were conducted and one-to-one interviews were conducted with a subsample of patients and practice
nurses from the intervention practices.
Aims
To measure baseline knowledge and confidence of practice nurses in providing self-management support
for patients with OA, and to examine the impact of an OA self-management training programme designed
for practice nurses on the nurses’ knowledge and confidence.
Methods
Practice nurses (n = 25) from all eight participating general practices in intervention and control arms of
the MOSAICS trial were invited to complete a pre-training questionnaire to determine their knowledge and
confidence regarding the management of OA using a 5-point Likert scale (higher scores = greater knowledge/
confidence) and the practitioner self-confidence (PSC) scale (score range 4–20, > 7 = low confidence).161
Nurses (n = 9) from the practices that were randomised to deliver the trial intervention then attended a
4-day training programme designed to enable delivery of the core NICE recommendations (information
and advice, exercise and physical activity, and weight management) using a patient-centred approach, the
patient-designed OA guidebook and goal-setting to support self-management. Everyone who attended the
training programme was asked to complete a post-training questionnaire.
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Results
Pre-training questionnaire Of those invited to participate at baseline, 21 (84%) of the 25 nurses
completed the initial questionnaire. All nurses were female, average years qualified was 25.8 years
(SD 10.8 years), 9.5% were further qualified as nurse practitioners and some had experience or training
in musculoskeletal medicine (23.8%) or orthopaedics/rheumatology (33.3%).
In terms of knowledge, only 4.8% scored ≥ 4 on the Likert scale when asked how much they had heard or
read about the NICE OA guidelines. All nurses reported very low confidence on the PSC scale (16.1 SD 3.0)
regarding the decisions needed when caring for patients with chronic joint problems, with 67% reporting
no confidence in examining peripheral joints.
One-month post-training questionnaire Of the nine nurses who undertook the training, eight completed
the post-training questionnaire. Training was associated with an increased knowledge of OA, with all nurses
scoring ≥ 4 when asked how much they had heard or read about the NICE OA guidelines. Confidence also
improved statistically significantly, with scores improving by 8.6 points on average (p < 0.001). Similarly, there
was a clear shift post training in the proportion of nurses feeling OA management was part of their role (from
4.7% before training to 62.5% afterward scoring ≥ 4).
Conclusion
National Institute for Health and Care Excellence recommend that health-care professionals should support
patients with OA to self-manage their condition. The results of this study in a small sample of nurses
involved in the cluster RCT suggest an important gap between what is recommended and what nurses feel
they can currently provide in terms of OA management. The development of a practice nurse training
programme provided a systematic approach for developing the nurse contribution to delivery of optimal
primary care for OA. Evaluation of the training suggests that it does contribute to practice nurses feeling
more knowledgeable and confident in supporting patients to manage their OA more effectively.
Implications for primary care
Osteoarthritis appears to be an area in which practice nurses feel a lack of knowledge and confidence.
Training for nurses in how best to support patients to self-manage their OA provides one route to meeting
NICE guideline expectations of health professional engagement in OA care.
Study 2.5: development of the opportunistic osteoarthritis consultation with health-care
professionals
Parts of this section have been reproduced with permission from Finney A, Porcheret M, Grime J, Jordan KP,
Handy J, Healey E, et al.144 Defining the content of an opportunistic osteoarthritis consultation with primary
health care professionals: a Delphi consensus study. Arthritis Care Res 2013;65:962–968. © 2013 by the
American College of Rheumatology.
Delphi consensus study
Introduction/background There is evidence that many older people with disabling joint pain do not
mention this problem to health-care professionals or, if they do, it is in passing or as a lower priority than
other conditions. Therefore, as part of developing an optimal approach to OA, there is a need to consider
the whole primary care team, as any member of the team may encounter a patient with joint pain in the
course of consultations about other conditions. This idea of such ‘opportunistic consultations’ about joint
pain and OA is in addition to the model OA consultations with GP or practice nurse.
Aim The aim of this study was to define the content of a ‘model’ opportunistic primary care consultation
for OA with any health-care professional in the primary care team.
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Methods A two-round Delphi consensus exercise was conducted with four expert groups: GPs (n = 30),
practice nurses (n = 19), allied health professionals (n = 37) (physiotherapists, occupational therapists,
podiatrists, community pharmacists) and lay participants (n = 18).
Members of Arthritis Care, the NICE OA guideline development group and researchers at the Arthritis
Research UK Primary Care Centre, Keele University, Keele, UK, helped to develop the potential
consultation tasks. An ideas generation round and a two-round Delphi postal consensus study allowed
participants to rank the importance of tasks for an opportunistic consultation.
Using the Calgary–Cambridge consultation framework,162 the consultation tasks were developed into
35 statements. Participants in the consensus exercise were asked to rate the importance of the statements
to include in the consultation. Agreement was defined as endorsement by ≥ 80% of participants across
the groups.
Results There was a 50% response rate to the two-round postal exercise (n = 52). The response to the
Delphi exercise varied between groups: GPs (n = 11, 37%), practice nurses (n = 9, 47%), allied health
professionals (n = 16, 43%) and lay participants (n = 16, 89%).
The ideas generation round formulated 35 potential consultation tasks. Consensus was reached on 12 tasks
for an opportunistic OA consultation using a ≥ 80% level of agreement across all groups.
Consensus was gained on three tasks using a 100% level of agreement across all groups: the health-care
professional asks the patient (1) how things are going with their OA, (2) the type and amount of pain they
have and (3) whether or not they are taking regular analgesia. In all, 12 consultation tasks were defined at
a ≥ 80% level of agreement across all groups.
Conclusion In a Delphi study to define the content of an opportunistic primary care OA consultation,
12 consultation tasks provided the content of a comprehensive consultation. Three of these tasks with
100% agreement could be adopted in any multidisciplinary consultation for OA in primary care. These
three tasks (a general enquiry about the condition, a question about the type and amount of pain the
patient has and asking whether analgesia is being taken) form a core set of questions considered
important by both lay and health professional groups in any opportunistic consultation with a patient who
presents with OA or OA-related symptoms in primary care.
Implication for primary care Consensus between health-care professionals and patient groups suggest
that a set of three simple enquiries could provide a practical guide for an opportunistic OA consultation:
1. General enquiry about the joint pain or OA.
2. How much pain is there and what it is like?
3. Are painkillers being used?
Dissemination workshops
Engagement and training of the wider primary care team in the intervention practices of the cluster RCT
was achieved through a series of four workshops.
Aim To raise awareness of the MOSAICS model of primary OA care with allied health professionals in primary
care linked with the intervention practices and to enhance consistency of care and continuity of care.
Methods Participants were all members of the multidisciplinary team linked to the four intervention
practices. Representatives of allied primary health-care services linked to intervention practices were invited
to four dissemination workshops facilitated by a nurse.
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Results A total of 42 allied health professionals, one practice manager and two RUG members attended
the four meetings. Community pharmacists were represented by nine participants, physiotherapy by
16 participants, occupational therapy by 10 participants and podiatrists five participants. There was one
chiropodist and one health visitor.
The dissemination was undertaken by one of the Keele nurses responsible for running OA referral clinics in
the intervention practices and supported by the research team. A video of a simulated consultation with the
GP was shared. Information on the NICE guidelines,15 the OA guidebook163 and Arthritis Research UK
‘Hands On’ for OA were all distributed.163,164 A mapping exercise of local services was performed and
practical issues discussed.
Allied health-care professionals attending the workshops expressed their understanding of the potential
value of the service and were willing to support patients referred to them as part of the new service or to
refer patients back to the GP to enter the new service if they had come in by another route. Participants were
keen to engage in feedback of the outcome of the programme and in future development of OA care.
Conclusion Good multidisciplinary representation in facilitated workshops produced a mapping of services
for opportunistic consultations that might occur in sequence with the new model of care in the MOSAICS
intervention practices.
Group 3 studies: development and evaluation of novel methods to measure quality of
primary care for osteoarthritis patients
Outcomes in the cluster RCT were of two general types: measures of the implementation of good
quality primary care for patients with joint pain and OA, and measures of the clinical effectiveness and
cost-effectiveness of such care. Group 3 studies concerned the first type, namely measures of the quality
of care delivered and received.
Measurement of the implementation of good-quality care used two approaches aligned with two of the
populations of observed patients described in the introduction to this chapter (also see Figure 7):
1. Practice-level analysis of the total consulter population: all persons aged ≥ 45 years who were registered
with one of the participating practices and who had consulted during the trial period about joint
pain or OA. Outcomes used anonymised medical record data and included development of a novel
computerised template to record items of care delivered [see Study 3.1: the osteoarthritis quality-of-care
template (the ‘e-template’)].
2. Patient-level analysis of the total consenting population: the subgroup of the total consulting population,
representing all persons responding to the baseline survey and who reported joint pain in the survey, who
consented to future involvement and who subsequently consulted during the intervention period with
joint pain or OA. Outcomes used individual self-reported data and included development with the OA
RUG of a patient questionnaire for reporting experience of the consultation with the GP (see Study 3.2:
developing patient-reported outcomes with the osteoarthritis research user group).
Study 3.1: the osteoarthritis quality-of-care template (the ‘e-template’)
Parts of this section have been reproduced from Edwards et al.132 © The Author 2014. Published by
Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access
article distributed under the terms of the Creative Commons Attribution Non-Commercial License
(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and
reproduction in any medium, provided the original work is properly cited. For commercial re-use, please
contact journals.permissions@oup.com; and from Edwards et al.145 This is an Open Access article distributed
in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which
permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative
works on different terms, provided the original work is properly cited and the use is non-commercial.
See: http://creativecommons.org/licenses/by-nc/3.0/.
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Introduction/background
Study 3.1 is concerned with the outcomes measured in the total consulting population, the whole
registered populations of the participating practices aged ≥ 45 years who consulted about joint pain or OA
during the trial period. Outcomes drawn from anonymised medical record data potentially represent
indicators of the quality of care being provided by the practices. However, the number of such indicators
routinely collected are limited and one aim of this study was to create and test additional markers that
could be collected during the course of every OA consultation.
These markers (routine and new) were to be collected in all practices in the cluster RCT (intervention and
control) in order to use them as an outcome measure for the trial, and were to be measured during a
baseline period pre intervention as well as post intervention.
A novel method of collecting the new additional markers was developed in the form of a computerised
pop-up ‘e-template’ for completion by the GP during a consultation with any patient aged ≥ 45 years who
consulted about joint pain or OA. Such e-templates can be routinely triggered to appear on the computer
screen and may act as aide-memoire, stimulus to action and method of recording that action.
However, although there is evidence that adherence to recommended processes of care may be improved
through the use of such templates, there is no direct evidence for this effect of their use in OA care.
Therefore, it was important to establish before the main trial began whether or not the use of such
templates on their own, without the additional interventions described in the other group 2 studies above,
might affect the quality of care, as the template was being used in all eight practices to collect outcome
data for the trial. This was carried out by investigating the before-and-after effect of the e-template in all
practices on a set of measures of the process and quality of care for patients with OA (‘routine measures’)
prior to trial randomisation, also identified from anonymised routine primary care medical records but
separate to, and not dependent on, the new e-template (‘template measures’).
Aims
1. To identify indicators of the quality of primary care for OA, which were also process measures of the
implementation of care for patients with OA in general practice.
2. To develop and evaluate a pop-up computerised template (the ‘e-template’) as a method for improving
recording of those indicators not already routinely captured in the medical record, specifically:
i. to test the feasibility of its use in daily practice
ii. to describe the quality of care as measured by the template
iii. to determine the impact of incorporating the template into practice on other aspects of care already
recorded routinely in primary care.
Methods
A systematic review to identify quality indicators for OA, applicable to primary care, was undertaken.145
The outputs from the systematic review were used as the basis for developing methods for assessment and
monitoring of the quality of care for OA in general practice.
The indicators identified in the systematic review were divided into:
l ‘routine measures’ – those which could be measured using routinely recorded information from
consultations (e.g. prescriptions)
l ‘template measures’ – those which required a change to usual consultation recording practice
(e.g. recording of the provision of advice). For this group of indicators, an e-template, designed to ‘pop-up’
during a consultation on the GP’s computer screen, was developed, tested and implemented in all eight
MOSAICS study practices prior to randomised allocation of the practices to intervention or control.
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The recording template was set to be triggered automatically in all study practices by entry of one of a
set of Read codes for OA or joint pain likely to reflect OA in an older patient population of all patients
aged ≥ 45 years consulting and identified with one of the codes (see Box 2). The set of Read codes was
identified by a panel of practising GPs and appears in www.keele.ac.uk/mrr,140 Jordan et al.108 and Edwards
et al.101 The template was installed and training was given regarding its use in all eight study practices.
An anonymised data set containing all routinely recorded data and all information entered into the
templates was downloaded from the primary care computer systems to cover the period from 12 months
before the template installation to 6 months post installation.
Informal feedback was requested from the practices about their views and experience of using the
template at the end of the 6-month baseline period of template installation. In addition, formal feedback
was investigated as part of the qualitative study integrated into the main trial through interviews
conducted with GPs, nurses and other practice staff, and described in group five studies.
Analysis
1. Feasibility of using the template in primary care was measured by the frequency of its use and the
extent of its completion during the 6-month post-installation period (baseline phase).
2. The pre-trial quality of care in the eight practices was measured by the pattern of template-derived
indicators during the same baseline phase.
3. The impact that the installation of the template had on quality of care was estimated by comparing the
pattern of non-template routinely recorded items in the primary care database during the 12 months
prior to template installation with the 6 months after installation.
Results
A total of 25 different indicator themes identified in the systematic review were rated for their feasibility
and applicability to UK primary care. This resulted in 15 indicators, informed by the NICE OA management
guidelines,15 being considered for inclusion in the study as process-of-care quality markers.
The template was designed to capture eight core treatment indicators which could not be measured from
the routine record (pain assessment, functional limitation assessment, topical NSAID use, paracetamol use,
OA information given, weight loss advice, exercise advice, and consideration of physiotherapy referral).
A single-page e-template (10 items, eight quality indicators) for the Egton Medical Information System
(EMIS) clinical information technology system was designed. This is summarised in Appendix 2 (see Items
on the MOSAICS e-template). The system was such that entry of one of the joint pain and OA codes
immediately registered an administrative code that the template had been fired; a separate code was then
entered for each item answered by the GP or other health professional on the e-template screen. If there
were no coded entries for answers but there was a code indicating the template had been fired, this
meant that the GP or consulting health professional had not used the template on that occasion.
The other measures of quality (‘routine measures’) could be identified through routine medical record data
separate to the e-template and its use (prescribing of paracetamol, topical NSAIDs, opiates, oral NSAIDs
with or without gastroprotection using a proton pump inhibitor, relevant radiography use, and onward
referral to selected specialities including exercise referral or physiotherapy, occupational therapy, weight
loss programmes, orthopaedics, pain medicine, and rheumatology).
The main findings from analysis of the baseline assessment of quality of care using the new e-template
were that:
l The template is feasible, triggering on 93% of 1851 eligible patients during the 6 months baseline
phase. Out of 1730 patients triggering the template, 66% had at least one template item achieved and
20% achieved all template-derived indicators.
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l Quality of care varied by indicator, with good achievement for pain (63%) and function (62%)
assessment; consideration of physiotherapy was the least well-achieved at 36%.
l There was considerable variation in management behaviour between individual clinicians.
l Patients who had a formal OA diagnosis entered into the Read code system, rather than a
symptom-based joint pain code alone, achieved more quality indicators.
l Overall recorded quality of care for those elements common to previous studies on this topic was
similar to that reported in those earlier studies.165
The analysis of the separate routinely recorded measures of primary care OA management showed that:
l Morbidity coding of OA was stable before and after template installation.
l There was a statistically significant increase in prescribing of recommended first-line analgesics,
paracetamol and topical NSAIDs in the 6 months after template installation compared with the
12 months before the template was inserted.
l There was a statistically significant increase in weight recording after template installation, which then
fell but remained above pre-template levels.
l There were no changes in other management actions which appear in routine medical records
separately to the e-template recording.
Informal feedback from the practices covered a range of opinions. In general, the GPs involved reported
that the template was useful initially, although some felt that they then became ‘attuned’ to it and no
longer required the template to trigger in order to record the necessary information. Others reported it to
be useful but wanted some modification to reduce the frequency of triggering, and some identified a need
for a wider spread of quality markers to be collected. Some reported feeling wearied by the number of
such standard pop-up screens and expressed reluctance to continue to use the template. Further feedback
will be reported in the qualitative study (see Study 5.1: implementing a complex intervention in practice –
an evaluation using a theoretical framework, and Study 5.3: experiences of model consultations:
general practitioners).
Conclusion
A template such as the one developed and evaluated here does appear to provide a useful basis for
monitoring, measuring and auditing core primary care for OA patients and for measuring implementation
of care in general practice. In addition, the template appeared to prompt improvements in recommended
initial management of OA, as measured by other routinely collected information.
The introduction of the e-template did not appear to affect or change the way in which morbidity codes
were selected and allocated to older patients presenting with joint pain.
Feedback from doctors and nurses at the participating practices indicated a general level of satisfaction
with the practicality and usefulness of the e-template, but individual practitioners expressed concern at the
workload and desirability of its long-term use. The longer-term effect of the templates was therefore
planned through future analysis of the control practices in the cluster trial, which continued to use the
template alone for a further 12 months.
Implications for primary care
A standard template on a GP’s computer screen, routinely triggered when a consulting code is entered for
joint pain or OA, offers a feasible way to collect information on quality of care not routinely available from
the medical records.
Adoption of such a template appears to improve quality of OA care, but ways to improve its integration into
the consultation and to avoid ‘template’ overload are important issues to be addressed by future research.
WORKSTREAM 2: THE MOSAICS STUDIES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
50
Study 3.2: developing patient-reported outcomes with the osteoarthritis
research user group
Parts of this section have been reproduced from Blackburn et al.166 © 2016 Blackburn et al. Open Access
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction
in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made. The Creative Commons Public
Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made
available in this article, unless otherwise stated.
Introduction/background
There was a need to study process measures in the cluster trial regarding whether or not better quality of
care for OA patients in primary care had been achieved by the new intervention. The previous section has
described the introduction of the OA consultation template, which had the potential to both promote and
record GP activity. However, such templates cannot measure the patient experience of care and so a set of
self-report patient questions was developed to identify the patient experience and perception of the OA
care that they had received. The OA RUG group led the work on this with members of the research team.
Aim
To identify and select items for the MOSAICS self-reported quality-of-care questionnaire.
Methods
The pool of potential indicators was provided by the systematic review by Edwards et al.145
Patients with OA who were members of the OA RUG group were invited to a consultation meeting with
two members of the research team (JE and KD). The RUG members were asked to identify indicators of
quality of care perceived as relevant to primary care consultations. Each RUG member was asked to
prioritise their five most important indicators. RUG members also helped to develop the wording and
scoring of the patient-completed questionnaire that would draw on their selected items (the MOSAICS OA
quality questionnaire).
A draft of the questionnaire was prepared following the meeting and reviewed and amended by
RUG members.
For validation purposes, the draft instrument was compared with a new researcher-generated
questionnaire developed and validated for secondary care by Østerås et al.146 for a Norwegian population
[Musculoskeletal pain in Ullensaker Study Osteoarthritis Cohort Quality Indicator (MUST OA-QI)
questionnaire]. The RUG fed back their views on the MUST OA-QI questionnaire and how it compared
with the MOSAICS questionnaire, both individually and in a follow-up group meeting.
A teleconference was then held between representatives of the RUG group and researchers currently using
the MUST OA-QI questionnaire to discuss the similarities and differences. A final RUG meeting summarised
the process.
Results
Six RUG members with OA (three men and three women) attended up to five meetings. From 30 quality
indicators initially identified, 20 were prioritised as important by RUG members. These covered pain
self-management, medication usage and side effects, help with daily activities, information about OA,
help with improving QoL, and level of support.
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From this initial list, the RUG members helped to develop and refine the wording of 14 items and determine
the scoring system for the MOSAICS quality questionnaire. The scoring system was the same in the MUST
OA-QI questionnaire of 17 items. RUG members determined that both questionnaires contained the same
or similar concepts. They felt that all of the Musculoskeletal pain in Ullensaker Study Osteoarthritis (MUST)
indicators were important to OA patients, but some of the terminology from back translation was not
applicable for UK primary care. The MUST questionnaire included two items relating to weight
management that were excluded from the MOSAICS questionnaire because they were being separately
recorded on the OA e-template.
Conclusion
Informed RUG members and researchers can agree on important indicators of the quality of care for OA.
Furthermore, while RUG involvement in MOSAICS established the relevance of items and refined wording,
the Norwegian MUST researchers had previously tested the validity and reliability of the instrument ready
for use. The coincidental development of the two questionnaires provided the opportunity to compare the
generalisability of the items from two European countries and to explore the comparative construct validity
of the MOSAICS draft tool. The Keele OA RUG group and researchers produced similar self-reported
measures of quality of OA care to the group of researchers from Norwegian secondary care. Patient
involvement ensured the relevance of quality indicators to patient experience and the refining of
questionnaire wording.
Group 4 studies: clinical effectiveness and cost-effectiveness of the MOSAICS programme
to optimise primary care of osteoarthritis
Once the baseline population survey and the development studies had been completed, including the
evaluation of introducing an e-template in all eight participating practices described in Study 3.1: the
osteoarthritis quality-of-care template (the ‘e-template’), randomisation of the eight practices and
introduction of the MOSAICS model of care into the four intervention practices took place.
There were two main quantitative studies contained within the main trial, reflecting the twin aims
to investigate:
1. implementation of the MOSAICS model of care using practice-level analysis of anonymised consultation
data (study 4.1) and
2. clinical effectiveness and cost-effectiveness of the MOSAICS model using patient-level analysis of
self-report follow-up data and medical record data (studies 4.2 and 4.3).
Qualitative studies addressed implementation questions through interview studies with both patients and
health-care professionals (group 5 studies).
Study 4.1: implementation of the MOSAICS intervention – practice-level effect on quality of
care for patients with osteoarthritis
Parts of this section have been reproduced from Jordan et al.167 © 2017 The Authors. Published by Elsevier
Ltd on behalf of Osteoarthritis Research Society International. This is an open access article under the
CC BY license (http://creativecommons.org/licenses/by/4.0/).
Introduction/background
The introduction of the e-template, prior to randomisation, for recording items of care delivered during the
OA consultation in all eight participating study practices, established a baseline level of achievement of
quality-of-care indicators for OA and demonstrated, through a before-and-after analysis, an improvement
in some non-template routinely recorded items of management of OA [see Study 3.1: the osteoarthritis
quality-of-care template (the ‘e-template’)].
The next questions to be addressed were those from the post-randomisation period and were concerned
with the implementation of the MOSAICS model of care for all patients consulting with joint pain or OA in
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the four intervention practices. The main question to be addressed was whether or not introduction of the
MOSAICS model of care resulted in further change in quality-of-care indicators (as evidence of putting
NICE guidance into practice) for patients consulting with joint pain or OA.
Aims
To determine whether or not implementation of the MOSAICS model of care post randomisation (patient
information booklet, model GP consultation, practice nurse-led series of OA follow-up consultations, training
of all practice staff in opportunistic OA consultations) was successful at practice-level as measured by:
1. process measures of the implementation of the MOSAICS model of care in the four intervention practices
2. improvements in the recorded management of all patients aged ≥ 45 years consulting with joint pain
and OA (e-template and routine) in the four implementation practices compared with the four
control practices.
Design
Cluster RCT in eight general practices (four intervention and four control) with practice-level analysis.
Methods
Training period After the 6-month run-in period, during which all eight practices used the e-template
when any adult aged ≥ 45 years consulted for joint pain and OA, the eight practices were randomised to
intervention or control. All practices continued to use the template but intervention practices were then
trained during a 3-month training period to deliver optimal primary care for OA according to NICE guidance.
Optimal care The MOSAICS model of care for patients with OA, developed as described in the group 2
studies above, was introduced into the four intervention practices, with GPs, nurses and practice staff in
these four practices receiving the training over a 3-month period. Copies of the OA patient guidebook
were supplied to all intervention practices to reinforce verbal information given by GPs and practice nurses
and to provide additional information about OA and its management and about local resources to support
self-management. The GPs were trained in a series of four in-practice sessions (3 × 2 hours; 1 × 1 hour) to
deliver the model OA consultation, including provision of the OA guidebook and the offer of a series of up
to four follow-up consultations with the practice nurse. The practice nurses were trained across 4 days by a
programme of education activities, workshops and simulated consultations in the delivery of OA care to
those patients who were referred to the follow-up clinics by the GP and who chose to attend.
In contrast to the comprehensive training programme developed for the GPs and practice nurses, one-off
workshop events were used to disseminate the core set of consultation questions for use in opportunistic
consultations about OA by any member of the extended primary care team linked to the four intervention
practices.
Usual care No further training or resources were provided for the control practices in caring for patients
consulting with joint pain and OA, apart from continuing support for the use of the e-template as the
method for monitoring and auditing quality of care.
Follow-up period All routinely recorded medical record data for patients aged ≥ 45 years were
downloaded and anonymised from all eight participating general practices for a minimum of 12 months
after the training period ended (i.e. after the end of the 3-month training, a time point designated as the
‘start of the trial’), as were data on quality indicators for the management of patients with OA recorded in
the templates. This included 4 million consultation records and 6 million prescription records, as well as
recorded information on registration status, investigations, tests and referrals.
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Practice-level outcomes
1. Process measures of implementation of the MOSAICS model of care in the intervention practices
included the number of patients who saw the practice nurse in one or more OA follow-up clinics.
2. Effect of implementation of the MOSAICS model of care on the delivery of NICE guidance in the
intervention practices compared with control included any differences after the start of the trial in:
i. the total number of patients coded as consulting with joint pain and OA and the separate numbers
coded with joint pain or OA, expressed as a proportion of the total registered population of
≥ 45 years in the practices
ii. the proportion of patients coded as consulting with joint pain or OA who had at least one item on
the e-template completed, and the proportion with all items completed
iii. the proportion of patients with joint pain or OA and with at least one item completed on the
e-template who met each separate criterion for quality of care on the e-template
iv. the proportion of patients with joint pain or OA who received routinely recorded items of care not
dependent on e-template completion.
Analysis
Items of recorded management and achievement of quality indicators were calculated for all patients at
the eight practices aged ≥ 45 years who were recorded as consulting with OA or joint pain during the first
6 months of follow-up after start of the trial. This was done as follows.
‘E-template measures’ Quality indicator information recorded through the template (fired every time an
OA or joint pain code was entered) was extracted for a 120-day period following an individual patient’s
first consultation after the start of the trial. This information included assessment of pain and functional
impairment, provision of information, advice about exercise and weight loss, and advice and consideration
of pharmacological management involving paracetamol and topical NSAIDs. Achievement of an indicator
was defined as an item recorded in the template as having been performed, considered, offered or
deemed not appropriate. Further analyses also considered specific elements of the template, namely the
recorded provision of written information on OA, written exercise advice, whether or not paracetamol was
offered and whether or not topical NSAIDs were offered.
Additional practice nurse resource Uptake of the additional practice nurse resource in intervention
practices was analysed to explore the extent to which this resource may have contributed specifically to
quality of care in the intervention practices. The proportion of all patients consulting in the intervention
practices who attended the practice nurse OA clinics was calculated and e-template completion was
compared between those who did and did not see the nurse.
‘Routine measures’ Routinely recorded management was identified within 14 days of any OA
consultation (including the first) taking place within 120 days of the first such consultation. This management
covered prescribing (paracetamol, topical NSAIDs, opioids, oral NSAIDs, weight loss agents), investigations
(use of relevant radiography), and referral to selected specialities including exercise referral or physiotherapy,
occupational therapy, weight loss programmes, orthopaedics, pain medicine, and rheumatology.
Prescriptions for a proton-pump inhibitor in those prescribed an oral NSAID were also identified.
Differences between intervention and control practices These differences in achievement of quality
indicators on the e-template and in routinely recorded management were adjusted for age, sex, whether
the initial consultation was recorded as diagnosed OA or joint pain, and baseline level of management or
achievement of the practices (i.e. during the baseline 6 months when the template was introduced prior
to the start of the trial). Clustering of patients within clinicians was accounted for through the use of
multilevel modelling, estimated using iterative generalised least squares with second order penalised
quasi-likelihood approximation. Results are presented as ORs with 95% CIs.
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Sensitivity analyses Sensitivity analyses restricted analyses to:
1. new consulters for OA or joint pain after the start of the trial (first such consultation since the
introduction of the template and no OA or joint pain consultation for the previous 365 days)
2. those with a recorded diagnosis of OA (as opposed to a joint pain record)
and, for the analysis of quality indicators,
1. those with at least one recorded entry on the template under the assumption that if no entry was
recorded, the GP was less likely to believe the patient had OA.
Adverse events
Recorded occurrence of 15 pre-specified adverse events for a median of 14 months after initial OA or joint
pain consultation was also compared between arms.
Results
Ten general practices in Staffordshire and Cheshire were approached to take part and eight were
recruited. Table 13 shows practice characteristics according to status as intervention or control.
Intervention practices had a mean total registered population size of 10,240 (SD 9174.8) compared with
6983 (SD 2060.7) for control practices. The intervention practices were more deprived on average than
control practices. Despite these differences, the mean number of GPs per practice was similar: 6.0 (SD 6.1)
for intervention and 5.5 (SD 2.9) for control practices, and the mean age of the GPs was similar.
Figure 7 shows the flow chart for the practice-level analysis of the trial. There were 33,726 adults in total
aged ≥ 45 years who were registered with one of eight participating practices at the time of the baseline
population survey: 18,835 in the intervention practices 14,891 in the control practices. During the trial
period of 6 months, which began after the completion of training in the intervention practices, 1960
persons from this population base consulted at least once with joint pain or OA when one of the Read
codes was entered by the GP on to the computer record: 1118 in the intervention practices and 842 in
controls. This equates to a 6-month consultation prevalence for joint pain and OA of 5.78 persons aged
≥ 45 years per 100 in the participating practices (5.94 per 100 in the intervention practices and 5.65 per
100 in the control group). In the intervention arm, the mean age was 66.2 years (SD 12.3 years) and 59%
were female, compared with control arm mean age 66.5 years (SD 11.9 years) and 61% female.
There was no change in the proportion of all consulters given an OA code rather than a joint pain code in
the intervention arm in the 6 months before and after randomisation (43% before, 45% after). However,
throughout both periods, these figures were different from those in the control practices (23% received
an OA code in the 6 months before randomisation in the control practices; 29% during the 6 months
after randomisation).
TABLE 13 Characteristics of the eight general practices participating in the cluster trial
Characteristic Control (n= 4) Intervention (n= 4)
Number of registered patients per practice, mean (SD) 6983 (2060.7) 10,240 (9174.8)
Practice Index of Deprivation, median (IQR)a 14,633.5 (4571.5–28,822.0) 9165.0 (2195.7–19,478.5)
Number of GPs per practice, mean (SD) 5.5 (2.9) 6.0 (6.1)
Age of GP (years), mean (SD) 42.8 (23.5) 42.2 (23.7)
IQR, interquartile range.
a The lower the index, the more deprived the area.
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e-template outcomes Successful firing of the template was similarly high in intervention and control
practices – 1061 (95%) of those with a relevant code in the intervention group, 757 (90%) in the control
group. However, in a substantial proportion of patients in both intervention and control groups, no items
in the template were completed at all (40%).
As detailed in study 3.1 [see Study 3.1: the osteoarthritis quality-of-care template (the ‘e-template’)], there
continued to be wide variation in baseline achievement of e-template quality indicators between individual
clinicians and between practices, and this was reflected in baseline differences between the two trial arms.
Although there were generally higher levels of achievement of indicators during the trial period in the
intervention arm, the changes from baseline were not statistically significantly different from baseline levels
when compared with the changes in the control arm (Table 14). There was also evidence of a fall in the
levels of achievement between baseline and trial period for both intervention and control practices,
although this was not apparent in those with at least one entry on the template (data not shown).
TABLE 14 Comparison between intervention and control practices of all consulters firing template, by
(1) e-template quality indicators and (2) routinely recorded management
Quality indicator
Baseline period Trial period
ORa (95% CI)
Intervention,
n (%)
Control,
n (%)
Intervention,
n (%)
Control,
n (%)
e-template quality indicators
Number of consulters 981 749 1061 757
Pain assessment 707 (72) 390 (52) 617 (58) 318 (42) 1.35 (0.58 to 3.14)
Function assessment 691 (70) 384 (51) 611 (58) 309 (41) 1.15 (0.49 to 2.71)
Topical NSAIDs 540 (55) 295 (39) 501 (47) 275 (36) 0.97 (0.48 to 1.95)
Paracetamol 625 (64) 349 (47) 554 (52) 284 (38) 1.42 (0.71 to 2.95)
Information given 578 (59) 274 (37) 554 (52) 268 (35) 1.34 (0.61 to 2.96)
Exercise advice 582 (59) 285 (38) 526 (50) 246 (32) 1.53 (0.75 to 3.13)
Physiotherapy referral 426 (43) 192 (26) 348 (33) 173 (23) 1.45 (0.61 to 3.40)
Weight loss adviceb 325 (53) 159 (34) 341 (49) 136 (31) 1.24 (0.61 to 2.52)
1-plus indicator achieved 727 (74) 419 (56) 635 (60) 330 (44) 1.49 (0.65 to 3.43)
All indicators achieved 246 (25) 106 (14) 240 (23) 116 (15) 1.57 (0.70 to 3.50)
Routinely recorded management
Number of consulters 1015 836 1118 842
Paracetamol 164 (16) 155 (19) 241 (22) 117 (14) 1.74 (1.27 to 2.38)
Topical NSAIDs 267 (26) 194 (23) 327 (29) 186 (22) 1.21 (0.83 to 1.76)
Opioids 344 (33) 244 (29) 367 (33) 232 (28) 0.93 (0.75 to 1.17)
Oral NSAIDs 181 (18) 119 (14) 176 (16) 137 (16) 0.78 (0.52 to 1.16)
Any analgesic 645 (64) 484 (58) 711 (64) 460 (55) 1.20 (0.92 to 1.58)
Proton pump inhibitor 63 (35) 27 (23) 69 (39) 50 (36) 0.92 (0.43 to 1.98)
Weight record 278 (27) 154 (18) 309 (28) 144 (17) 1.36 (0.80 to 2.33)
Referral 233 (23) 139 (17) 252 (23) 175 (21) 1.00 (0.72 to 1.39)
Physiotherapy referral 90 (9) 35 (4) 111 (10) 19 (2) 5.30 (2.11 to 13.34)
Radiography 250 (25) 22(3) 163 (15) 47 (6) 0.45 (0.12 to 1.72)
a Adjusted for age, sex, coded OA or joint pain, practice level of achievement in baseline period and clustering by clinician
(reference is control group).
b In those recorded as overweight.
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However, there were observed changes in the core NICE recommendations which were substantially and
statistically significantly different in the intervention group and the control group. In the intervention
group, supplying written information increased from 4% of patients at baseline to 28% post intervention,
exercise advice from 4% to 22%, and weight loss advice in overweight patients from 1% to 15%. These
increases were more pronounced in those with an OA diagnosis (data not shown). In contrast, the
difference in patient proportions receiving any of the three recommendations between baseline and
follow-up was no more than 1%.
Comparisons of routinely recorded management are shown in Table 14. Prescribing of paracetamol
increased from the baseline period in the intervention arm and decreased in the control arm. Adjusting for
baseline prescribing, the intervention arm patients were statistically significantly more likely to receive
paracetamol and to be referred to physiotherapy, and (non-significantly) less likely to be sent for a
radiograph. There were no differences in the other routinely recorded management actions. Those with an
OA diagnosis were additionally more likely to receive any analgesic and to have weight recorded in the
intervention practices.
Practice nurse attendance Results of e-template quality indicator analysis in the four intervention
practices by practice nurse-led clinic attendance are shown in Table 15.
Table 15 shows the results for the 1060 patients who consulted in the four intervention practices in the
main trial period and were given one of the joint pain or OA Read codes. Most of these patients (79.2%)
TABLE 15 Details of e-template use in 1060 patients recorded as consulting with joint pain or OA in the
intervention practices, by whether or not practice nurse-led clinic attendance occurred
Quality indicator
Coded as consulting but did not attend
nurse-led clinics, N= 840 (79.2%)
Coded as consulting and
did attend nurse-led clinics,
N= 220 (20.8%), n= (%)
Template fired but
no entries, n= (%)
At least one template
entry, n= (%)
Number of consulters 424 416 220
OA diagnosis 135 (31.8) 198 (47.6) 149 (67.8)
Core recommendations
Written information – 100 (24) 195 (89)
Written exercise advice – 55 (13) 177 (80)
Written weight loss advice – 29 (10) 75 (44)
Quality indicator achievement
Pain assessment – 398 (96) 218 (99)
Function assessment – 392 (94) 218 (99)
Topical NSAIDs – 316 (76) 184 (84)
Paracetamol – 352 (85) 201 (91)
Information given – 338 (81) 215 (98)
Exercise advice – 309 (74) 216 (98)
Physiotherapy referral – 215 (52) 132 (60)
Weight loss advice – 193 (69% of those
overweight)
147 (87)
At least one indicator achieved – 416 (100) 218 (99)
All indicators achieved – 132 (32) 107 (49)
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did not attend the nurse-led clinic subsequently but for about half, the GPs bypassed the template (i.e. the
template fired but the GP chose not to complete it), while for the other half, the GPs completed the
templates although the patients did not attend the nurse-led clinic.
Among patients who had at least one item completed on the template, the pattern of items completed
was compared between those patients who did and did not see the nurse. The main contrasts are (1) the
higher proportion of patients who were provided with written (rather than verbal only) information,
exercise advice and weight loss advice and (2) the higher proportion who met the criteria for discussion of
physiotherapy referral (52%) in the group who saw the nurse.
Adverse events
There were 13% of the intervention arm and 11% of the control arm with a recorded adverse event. Just
under half of recorded adverse events overall were falls. Differences between arms were small and the sole
statistically significant difference between arms was for heart failure (1.5% intervention arm vs. 0.5%
control arm). Heart failure was not associated with paracetamol or NSAID prescribing.
Discussion
Patients with no e-template entries Across both intervention and control practices, about 40% of
patients who attended with joint pain and OA and received a code which fired the e-template had no
template items completed. There are a number of possible explanations.
1. The pool of potential patients for whom the template would be fired was broad, given the wide range
of eligible joint pain and OA Read codes. It is likely that, for some patients, the GP did not consider
template completion relevant to the clinical presentation, as suggested in Table 15 by the lower
percentage of persons with a diagnostic OA code among those with no template entries. However, this
still means that almost one-third of this group in the intervention practices were diagnosed with OA but
the GP chose not to complete the template.
2. GP variability. There were known to be periods when locum cover resulted in GPs untrained in
MOSAICS consulting with patients and the unfamiliar template may have been bypassed; immediate
workload and other more pressing patient concerns might also have led to this outcome.
Neither explanation should have affected the main trial result, despite substantial differences between
intervention and control practices in the proportions receiving a diagnostic code of OA in particular.
However, the finding is relevant to dissemination: up to two out of five patients may have an uncompleted
template due to patient inappropriateness or GP concerns.
e-template criteria for quality of care As occurred in the pre-randomisation phase [study 3.1, see
Study 3.1: the osteoarthritis quality-of-care template (the ‘e-template’)], criteria for quality of care as
measured by completion of the template were met for most indicators in a substantial majority of patients
in both arms of the trial (pain assessment, function assessment, consideration given to topical NSAIDs and
paracetamol, information given, exercise advice and weight loss advice for those who were overweight).
The main difference between intervention and control practices post-randomisation was the substantially
higher proportion of patients receiving written information in the intervention practices, although the point
estimates for a number of criteria suggested higher but statistically non-significant levels of achievement in
the intervention practices.
Within the intervention practices, GPs, once they decided to complete the template, appeared to do so for
most items, regardless of whether or not the patients were going to see the nurse. However, the proportion
recording that they are providing written (rather than verbal only) information, exercise advice and weight
loss advice was higher in the group seeing the nurse, which suggests that these criteria are less achievable
in a GP consultation, despite the availability of the patient information booklet in all intervention practices.
Variability in the number of trained GPs seeing patients and in workload and priorities may also play a role.
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A limitation of the study is that, for many e-template items, baseline variation between practices and
clinicians was large, and intervention and control practices were already different in aspects linked to higher
quality of care in the intervention practices, notably higher baseline rates of OA diagnosis among people
aged ≥ 45 years presenting with joint pain. However, we have adjusted our results for these differences.
Routinely recorded management Despite the problems of the contrasting baseline proportions of
patients with an OA diagnosis between intervention and controls, and the already high levels of template
criteria achieved pre-randomisation in both intervention and control practices, there were statistically
significant differences between intervention and control practices in objective measures of GP behaviour
drawn from the routine medical records, namely a change in analgesic prescribing and an increase in
physiotherapy referral (although prevalence of the latter was low). This does suggest that the MOSAICS
model of care is shifting GP behaviour in the direction of better OA care.
Nurse clinic attendance as measure of MOSAICS implementation The full implementation of the
MOSAICS model of care implied that patients would receive the booklet and see the practice nurse. Only
one out of five patients consulting with joint pain or OA in the intervention practices attended practice
nurse-led clinics. However, a substantially higher proportion of these patients received written information
about NICE core guidance than patients not seeing the nurse. This suggests two things:
1. The main trial difference between intervention and controls (increase in provision of written information)
was achieved substantially in the subgroup who saw the nurse despite this subgroup being a minority of
the intervention group as a whole.
2. The MOSAICS intervention was not fully implemented.
The implication is that the nurse-led clinic offered further opportunities for template items and quality
criteria to be completed at the time of nurse attendance, and that seeing the nurse was linked to full
implementation of the MOSAICS method of delivering NICE core guidance including the booklet and
opportunities to discuss exercise and physiotherapy referral. It is possible that this was selection on the part
of the GPs; patients may be more likely to be referred to the nurse if the GP had already completed more
e-template activity, but it is also likely to be related to additional activity and recording by the nurse.
Strengths and limitations One strength was the pre-randomisation introduction of the e-template in
all practices. This meant that any initial effect of the e-template on the recording and performance of
quality indicators of OA care should have been the same across all practices and independent of future
intervention or control status. This enabled separation of the effects of the model OA consultation from
those of the template itself. It also meant that the template could be used as a standardised format for
collection of outcome data in both intervention and control practices. However, this came at the cost of
not being able to estimate the effect of the model OA consultation in the absence of the template. Ideally,
a third arm receiving neither template nor model OA consultation would have provided maximum
information from the trial. However, this would have severely restricted the number of process-of-care
measures available as trial outcomes and greatly inflated sample size requirements.
Although GPs in the control practices were of necessity engaged in the use of the template and their
recording of care was influenced by this, they were not involved in any way in the development of the
MOSAICS model OA consultation and its components. This development took place in general practices
entirely outside the eight practices involved in the trial itself and its application in the trial was restricted
entirely to the intervention practices.
One weakness is that we did not test or investigate the additional time taken by GPs to use the template,
deliver the model consultation, introduce the booklet and arrange follow-up. We recognise that there will
be challenges in delivering the intervention in time-constrained general practice and this is one issue that
needs to be studied in future implementation.
DOI: 10.3310/pgfar06040 PROGRAMME GRANTS FOR APPLIED RESEARCH 2018 VOL. 6 NO. 4
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Hay et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
59
Conclusion
This study provides evidence that the MOSAICS model of care was implemented to an extent that
substantially increased the frequency of reported provision of written information to patients consulting
with joint pain and OA in primary care. Most of this increase appeared to take place in association with at
least one visit by the patient to the practice nurse OA clinic in one of the intervention practices.
The conclusion is that the MOSAICS intervention can be implemented and can be carried out to an extent
that improves quality of care beyond that achieved by use of the template alone. However, not all items of
care will be changed by the MOSAICS model of care and only a minority of patients saw the nurse.
The written patient-focused information resource available in the MOSAICS model of care is likely to have
provided the basis for the improvement in written advice and information, but appears to have depended
on a patient attending the nurse-led OA clinics.
The intervention does appear to alter clinician behaviour in practice, as measured by routine records,
beyond changes achieved by the template alone (notably, increased paracetamol analgesia, increased
physiotherapy referrals, and decreased radiography referrals).
Levels of achievement of quality indicators as measured through the template generally fell from baseline levels.
Further work is needed to assess if familiarity with the template meant it was no longer needed in the longer
term as a prompt for management behaviour or if this represents a decline in initial improved quality of care.
Study 4.2: effect of the MOSAICS programme on patient-reported outcomes
Parts of this section have been reproduced from Dziedzic et al.168 © 2018 The Authors. Published by
Elsevier Ltd on behalf of Osteoarthritis Research Society International. This is an open access article under
the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Introduction/background
Aim
The primary aims of this study were to determine:
l patient-reported measures of the effectiveness of implementation of the MOSAICS model of care
l the clinical effectiveness of the model OA consultation in participants aged ≥ 45 years with joint pain
and who were registered in general practice.
Design
Prospective recruitment of eligible individuals who had previously provided consent, conducted at the time
of a consultation about joint pain and OA, into a follow-up using self-report questionnaires, within a
cluster RCT in eight general practices (four intervention and four control).
Methods
Figure 7 illustrates the approach. A population survey was mailed to all adults aged ≥ 45 years who were
registered with one of eight participating practices to establish the potential pool of individual trial
participants in advance of randomisation of the practices to intervention and control. This was done through
written consent for medical record review and future follow-up contact, which was contained within the
questionnaire. All responders to the survey who had reported pain in at least one of four target OA sites (hand,
hip, knee, foot) and who gave this consent had a tag inserted in their general practice medical record as an
identifier. The tagged records identified eligible patients if and when they consulted with joint pain or OA.
After the 6-month run-in period, during which all eight practices used the e-template when any adult aged
≥ 45 years consulted for joint pain and OA, the practices were randomised to intervention or control. All
practices continued to use the e-template but intervention practices were trained for a 3-month period to
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deliver the MOSAICS model of care for implementing NICE guidance for patients with OA, while the control
practices continued with usual care (described in Group 2 studies: developing interventions to support self-
management of osteoarthritis in primary care and to monitor the quality of care delivered).
For the individual patient study, all patients aged ≥ 45 years who consulted with joint pain and OA
(hip, knee, hand and foot) in both intervention and control practices during the 6 months of trial follow-up
(i.e. from the ‘start of the trial’ following the 3-month training period for the intervention practices) and
who had a consent tag inserted in their records, were recruited into the study. A follow-up questionnaire
was mailed to all recruited persons immediately following the index consultation (0 months) and at 3, 6
and 12 months following index consultation.
There were two types of end point measured in the individual patient study.
Process measures of implementation of the MOSAICS model-of-care
1. Uptake of NICE recommendations was measured using patient self-reported questionnaires:
i. A previously validated questionnaire for OA patients enquiring about their use of services and
self-management [the modified Knee Pain Screening Tool (KNEST)169], with a selection of items that
measure care related to NICE guidance topics.
ii. The osteoarthritis quality indicators (OA-QIs) questionnaire for UK primary care, the development of
which is described in study 3.2 (see Study 3.2: developing patient-reported outcomes with the
osteoarthritis research user group).
2. Additional process measures of the implementation of the MOSAICS model were provided by:
i. a measure of fidelity of the intervention – the proportion of patients in the intervention practices
visiting the nurse after their index consultation with the GP in the individual-level analysis [similar to
its use in the whole population analysis described in study 4.1 (see Study 4.1: implementation of the
MOSAICS intervention – practice-level effect on quality of care for patients with osteoarthritis)
ii. a set of questions about what had happened in the consultation, developed as part of the GP
training programme (see Group 2 studies: developing interventions to support self-management of
osteoarthritis in primary care and to monitor the quality of care delivered)
iii. Physical Activity Scale for the Elderly (PASE)170 and International Physical Activity Questionnaire (IPAQ)
iv. enablement as measure of confidence to self-manage.
Measures of clinical effectiveness of implementing the MOSAICS model of care measured at
6 months after the index consultation The primary outcome was general physical health (SF-12 PCS171).
Secondary outcomes were joint pain intensity and pain self-efficacy.
Analysis
1. Baseline comparability
The baseline survey responder and practice characteristics were compared between practices according
to their intervention control status. The survey characteristics of the subgroup subsequently recruited
into the individual trial follow-up were then also compared between intervention and controls.
2. Process outcomes
The self-report items were compared between intervention and control groups using logistic regression.
The proportion of patients seeing the nurse was analysed within the intervention group according to
information in the 3 month follow-up questionnaire as it was judged that this would give adequate
time for all patients who were referred to the nurse to have had the opportunity of at least one visit.
Among those who did visit the nurse, a case report form (CRF) was completed for each patient as a
measure of the content of care provided by the GP and the practice nurse.
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3. Clinical outcomes
A linear mixed model was used to compare intervention and control group participants with respect to
the primary clinical outcome (SF-12 PCS). A three-level mixed model was fitted to test for the effect of
the intervention from baseline across all follow-up points, taking into account clustering by practice,
participant and repeated measures follow-up.
A per-protocol complier average causal effect (CACE) sensitivity analysis was also performed. The purpose
of this was to provide an unbiased estimate of the treatment effect in the subgroup of patients who
received treatment administered per protocol in the intervention arm. This was defined as all those who
saw the practice nurse as a follow-up to the GP consultation.
Sample size calculation This was based on the primary clinical outcome (SF-12 PCS at 6 months post
consultation). Published estimates of the minimal clinically important difference for the SF-36 (version 2)
puts it at 2–4 points on the PCS subscale, which has a normalised population SD of 10 points. Hence, a
difference between groups of 0.3 effect size was calculated as the threshold for demonstrating difference
between control and intervention groups in the MOSAICS studies.
A total of 500 participants had to be recruited at consultation to allow for a drop-out rate of 20% and to
detect an effect size of 0.3 with 90% power at 6 months, given a 5% two-tailed significance level.
Randomisation was by practice, so the sample size calculation was inflated to correct for an intracluster
correlation coefficient (ICC) (adjusted ICC of 0.005). Varying practice size recruitment was taken into
account (including coefficient of variation of 0.5)131 and included (× 0.67 and × 1.25, respectively for
intervention and control practices) adjustments for repeated-measures design.
Results
The flow chart for recruitment to the study is shown in Figure 7. There were 15,083 persons who
completed and returned their questionnaires in the baseline survey out of a total of 28,443 adults aged
≥ 45 years registered with the practices and considered eligible for the survey: a 53% response. The
average age of responders was 63.9 years (SD 11.2 years) and approximately half were women.
Of the persons who responded to the population survey, 9110 (60.4%) gave their consent to taking part
in a follow-up and for their medical records to be reviewed for research purposes. These persons had
also reported pain in one of four joint sites (hand, hip, knee or foot) in the previous 12 months when
responding to the survey. This was the pool of eligible participants for the individual patient follow-up and
analysis in the trial, whose GP medical records were tagged. There were 4702 patient records tagged in
the intervention practices and 4408 in the controls.
Active trial participants recruited at the time of consultation about joint pain or OA from this pool of
eligible persons numbered 651 in total: 364 in the intervention practices and 287 in the controls. The
mean age was 67.3 years (SD 10.5 years) and 59.6% were women. The OA consultation prevalence over
the 6 months of the trial recruitment of individuals for follow-up was 651 per 9110 across all practices
(7.15 per 100 persons aged ≥ 45 years). The figure was 7.74 per 100 in the intervention practices and
6.51 in the controls (see Figure 7).
All 651 eligible patients who consulted with joint pain and OA in the trial period were contacted within
2 weeks of the consultation by postal questionnaire (‘post-consultation questionnaire’). There were
525 responses from the 651 eligible patients in all practices (an overall response of 80.6%), 288 from
364 eligible in the intervention practices (a response of 79.1%) and 237 from 287 eligible in controls
(a response of 82.5%).
The demographic characteristics of post-consultation questionnaire responders are shown in Table 16.
Process outcomes Uptake of NICE core guidance and reported items of self-management (Tables 17 and 18).
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TABLE 16 Characteristics of eligible patients who have consulted about joint pain or OA and responded to the first
post-consultation questionnaire
Participant characteristics Intervention (N= 288) Control (N= 237)
Sex, n (%)
Female 167 (58.0) 146 (61.6)
Male 121 (42.0) 91 (38.4)
Age (years), mean (SD) 66.9 (10.6) 67.7 (10.3)
BMI (kg/m2)
Mean (SD) 28.1 (5.1) 28.5 (4.8)
Marital status, n (%)
Married 186 (65.0) 168 (71.0)
Separated 2 (0.7) 4 (1.7)
Divorced 29 (10.1) 13 (15.6)
Widowed 44 (15.4) 37 (15.6)
Cohabiting 10 (3.5) 9 (3.8)
Single 15 (5.2) 6 (2.5)
Employment status, n (%)
Employed 77 (27.2) 59 (25.2)
Not working/retired 206 (72.8) 175 (74.8)
Deprivation Index
Median (IQR) 21,868 (15,144–28,649) 20,182 (15,989–24,635)
Number of pain sites, n (%)
1 55 (19.1) 45 (19.0)
≥ 2 233 (81.0) 192 (81.0)
IQR, interquartile range.
Parts of this table have been reproduced from Dziedzic et al.168 © 2018 The Authors. Published by Elsevier Ltd on behalf of
Osteoarthritis Research Society International. This is an open access article under the CC BY license (http://creativecommons.
org/licenses/by/4.0/).
TABLE 17 Self-reported receipt or uptake of items indicating quality of care among 525 eligible patients who have
consulted about joint pain or OA and returned a post-consultation questionnaire (OA-QIs questionnaire)
Characteristics
Control
(N= 237)
Intervention
(N= 288)
ORa (95% CI); p-valueOA QIs (i.e. interventions offered) n (%) n (%)
Written or verbal information about joint problem 133 (56.6) 180 (63.2) 2.15 (1.02 to 4.53); p= 0.045
Information about treatments 142 (61.5) 186 (66.7) 1.88 (0.85 to 4.13); p= 0.117
Advice on self-management of joint problem 128 (54.5) 157 (56.0) 1.22 (0.60 to 2.46); p= 0.586
Support on how to help self with joint problem 89 (38.4) 110 (39.0) 1.97 (0.74 to 5.23); p= 0.174
Information/advice about exercises, muscle-strengthening
or physical activities
101 (43.2) 149 (53.0) 2.18 (1.01 to 4.69); p= 0.046
Referral to strengthening or physical activities 61 (26.1) 95 (34.1) 1.75 (0.90 to 3.39); p= 0.099
Advice to lose weightb 60 (32.1) 66 (30.0) 1.46 (0.47 to 4.60); p= 0.513
continued
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TABLE 17 Self-reported receipt or uptake of items indicating quality of care among 525 eligible patients who have
consulted about joint pain or OA and returned a post-consultation questionnaire (OA-QIs questionnaire)
(continued )
Characteristics
Control
(N= 237)
Intervention
(N= 288)
ORa (95% CI); p-valueOA QIs (i.e. interventions offered) n (%) n (%)
Referral to services for losing weightb 8 (4.3) 16(7.1) 2.68 (1.09 to 6.60); p = 0.031
Need for walking aid assessed 37 (23.3) 53 (29.4) 1.58 (0.83 to 3.00); p = 0.161
Need for appliances/aids to daily living 19 (14.8) 13 (10.4) 0.80 (0.31 to 2.07); p = 0.652
Paracetamol recommended for pain 119 (53.1) 176 (63.8) 1.50 (0.94 to 2.41); p = 0.092
Information about drugs effect provided 124 (52.3) 133 (46.2) 0.45 (0.23 to 0.89); p = 0.021
Surgery evaluation 46 (19.4) 50 (17.4) 0.95 (0.21 to 4.24); p = 0.947
a Reference is control group.
b Analysis restricted to participants who were overweight.
TABLE 18 Self-reported use of items of care and self-management among 525 eligible patients who have consulted
about joint pain or OA and returned a post-consultation (KNEST) questionnaire
Characteristics
Control
(N= 237)
Intervention
(N= 288)
OR (95% CI); p-valueKNEST: medication/treatment prescribed/used n (%) n (%)
Paracetamol 165 (69.6) 204 (70.8) 1.05 (0.48 to 2.30); p = 0.894
Anti-inflammatory creams/gels (e.g. topical NSAIDs) 159 (67.1) 183 (63.5) 0.60 (0.27 to 1.32); p = 0.202
Capsaicin cream 23 (9.7) 23 (8.0) 1.18 (0.46 to 2.99); p = 0.730
Anti-inflammatory tablets (e.g. oral NSAIDs) 138 (58.2) 143 (49.7) 0.23 (0.09 to 0.57); p = 0.001
Stronger painkillers (e.g. opioids, co-proxamol) 114 (48.1) 130 (45.1) 0.88 (0.35 to 2.19); p = 0.787
Glucosamine or chondroitin sulphate 67 (28.3) 90 (31.3) 2.01 (0.70 to 5.80); p = 0.196
TENS 29 (12.2) 34 (11.8) 0.88 (0.48 to 1.61); p = 0.675
Warmth, heat or cold application 101 (42.6) 137 (47.6) 1.32 (0.58 to 3.01); p = 0.506
Walking aids 86 (36.3) 89 (30.9) 0.21 (0.06 to 0.68); p = 0.009
Shock-absorbing shoes or insoles 42 (17.7) 52 (18.1) 1.46 (0.50 to 4.30); p = 0.488
Appliances and support and braces 55 (23.2) 59 (20.5) 0.70 (0.16 to 2.97); p = 0.629
Assistive devices 29 (12.2) 37 (12.8) 1.46 (0.44 to 4.80); p = 0.488
Community pharmacy 16 (6.8) 34 (11.8) 2.33 (0.93 to 5.84); p = 0.071
Physiotherapy 60 (25.3) 73 (25.3) 0.47 (0.18 to 1.25); p = 0.131
Muscle-strengthening exercises 63 (26.6) 117 (40.6) 2.87 (1.37 to 6.02); p = 0.005
General fitness exercises 51 (21.5) 67 (23.3) 0.66 (0.25 to 1.75); p = 0.405
Diet to lose weight 69 (29.1) 73 (25.3) 0.89 (0.52 to 1.52); p = 0.669
Written information about treatments 53 (22.4) 76 (26.4) 1.50 (0.91 to 2.47); p = 0.110
Written information about joint problem management 34 (14.4) 71 (24.6) 2.17 (1.25 to 3.74); p = 0.006
Written information about OA 38 (16.0) 90 (31.2) 3.29 (1.97 to 5.46); p ≤ 0.001
TENS, transcutaneous electric nerve stimulation.
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Reported receipt of the OA-QIs of care (OA-QIs questionnaire; see Table 17) was statistically significantly
higher for some items in the intervention practice patients than the control group, notably for provision of
written or verbal information about their joint problem, and specifically:
l written information about management of their joint problem and about OA
l information and advice about exercises, muscle-strengthening or physical activities
l among those who were overweight, referral to services for losing weight.
However, receipt of information about the effect of drugs being prescribed was reported by a significantly
lower proportion of patients in the intervention arm than controls.
Reported use of items of care for OA (the KNEST questionnaire; see Table 18) was also statistically
significantly different between patients in the intervention and control groups, notably lower use of oral
anti-inflammatory medication and walking aids and higher reported use of muscle-strengthening exercises
in the intervention group versus the control group. These differences continued to be observed in
the reports of care received or adopted by patients, recalled over an extended period of 3 months in the
second follow-up questionnaire (data not shown).
Other process measures of implementation of the MOSAICS model of care
Fidelity of intervention At 3 months after their index consultation, 70 persons in the intervention group
(29%) reported having consulted with a practice nurse about their joint problem compared with 26
(13.5%) in the control group.
Patient report on consultation In the post-consultation questionnaire, patients in the intervention
practices were also asked to report on the consultation with the GP. Responses were obtained from
273 patients. There were 127 (46.5%) who reported that the GP had asked them what they thought the
problem was caused by, 184 (67.4%) who reported that the GP told them what the problem was caused
by, 99 (36.3%) who reported that the GP explained what OA is and 229 (83.9%) who reported that the
GP gave them the OA guidebook.
Physical activity outcome In Table 19, the physical activity scale is shown and includes the follow-up
measures. There is a difference at baseline but this becomes exacerbated at 3 and 6 months, with the
PASE mean score being statistically significantly lower and declining in the intervention group than in the
control group. This is further explored in Table 20, which examines the 3- and 6-month differences in each
component category of the PASE scale. The differences lie almost exclusively in lower walking scores in
the intervention group compared with the control group. IPAQ scores were not statistically significantly
different between the groups at any point of follow-up.
Enablement Enablement as an indicator of confidence to self-manage is shown in Table 19. Patients in
the intervention group reported higher mean enablement scores at 3 months but this had become a
statistically non-significant difference at 6 and 12 months.
Clinical outcomes At 6 months there were 239 responders in the intervention practices (83.0% response)
in patients from the intervention arm and 185 (78.1% response) in the control arm. There were no
statistically significant differences in SF-12 PCS at 6 months (Table 21) or in the secondary clinical outcomes
(data not shown) between intervention and control groups.
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TABLE 19 Process measures of implementation of MOSAICS: exercise, walking and physical activity, and
enablement
Process measures
Control Intervention
Mean
differenceb 95% CIc p-valuecna Mean SD na Mean SD
IPAQ
Post-consultation 171 3124.79 3829.79 200 2745.52 3285.00
3 months 157 3305.81 4073.19 182 2378.55 2912.15 –693.31 –1446.77 to 60.15 0.071
6 months 144 2519.33 2786.78 181 2200.90 2967.76 –628.88 –1396.63 to 138.85 0.108
12 months 142 3040.81 3459.51 167 2355.51 2413.99 –594.63 –1396.05 to 206.80 0.146
PASE
Post-consultation 195 147.49 85.28 237 138.71 75.88
3 months 176 147.50 86.64 203 123.65 71.95 –22.01 –36.53 to –7.49 0.003
6 months 143 136.24 73.15 190 123.02 68.67 –18.01 –33.33 to –2.68 0.021
12 months 142 148.23 77.90 157 134.22 69.55 –20.61 –36.42 to –4.80 0.011
Patient enablement
Post-consultation – – – – – – –
3 months 202 2.61 3.24 253 2.82 3.16 0.86 0.13 to 1.61 0.022
6 months 178 2.28 2.96 224 3.21 3.43 1.42 –1.50 to 4.35 0.340
12 months 162 2.60 3.19 198 2.80 3.18 2.47 –0.90 to 5.85 0.151
a Number in the sample.
b Calculated as mean difference for intervention – control score by linear mixed modelling adjusted for age, sex, practice
size and corresponding baseline measures (‘clustering’ accounted for in the mixed model).
c CIs and p-values relate to adjusted results from the linear mixed modelling.
TABLE 20 PASE components analysis: intervention vs. control
Components of the PASE questionnaire Mean differencea 95% CI p-value
Exercise/strengthening
3 months 0.02 –0.05 to 0.09 0.584
6 months –0.02 –0.10 to 0.05 0.550
12 months 0.003 –0.08 to 0.08 0.933
Walking
3 months –0.27 –0.48 to –0.06 0.010
6 months –0.31 –0.52 to –0.09 0.005
12 months –0.18 –0.41 to 0.05 0.125
Light sport/recreation
3 months –0.16 –0.32 to 0.01 0.061
6 months –0.11 –0.28 to 0.06 0.187
12 months –0.05 –0.23 to 0.12 0.560
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In the CACE sensitivity analysis (see Table 21), there were no statistically significant differences in the
primary outcome between those participants who received the full intervention (GP and practice nurse)
and those who did not.
Pre-specified subgroup analysis After stratification by SF-12 PCS scores (< 36.9 vs. ≥ 36.9) at the
immediate post-consultation assessment, there were no significant differences in the SF-12 PCS at
6 months in the intervention versus control groups.
TABLE 20 PASE components analysis: intervention vs. control (continued )
Components of the PASE questionnaire Mean differencea 95% CI p-value
Moderate sport/recreation
3 months 0.07 –0.01 to 0.15 0.077
6 months 0.03 –0.05 to 0.12 0.391
12 months 0.04 –0.05 to 0.12 0.406
Vigorous sport/recreation
3 months –0.06 –0.13 to 0.01 0.100
6 months –0.02 –0.09 to 0.06 0.602
12 months –0.02 –0.10 to 0.06 0.623
a Calculated as mean difference for intervention – control score by linear mixed modelling adjusted for age, sex, practice
size and corresponding baseline measures (‘clustering’ accounted for in the mixed model).
Note
Higher PASE scores denote greater levels of physical activity. Negative differences in both Tables 19 and 20 mean that the
intervention group had worse scores on that item. The absolute scores for each PASE component are smaller than overall
PASE scores (data not shown).
TABLE 21 Primary outcome measure (SF-12 PCS) by study groups including sensitivity analyses
SF-12 PCS
Control Intervention
Mean
differencea 95% CIb p-valuebn Mean SD n Mean SD
Post-consultation 231 36.48 11.00 280 36.49 11.48
3 months 204 38.12 11.58 250 38.03 12.32 –0.31 –1.87 to 1.25 0.698
6 months 180 38.89 12.00 229 38.98 12.12 –0.38 –2.31 to 1.54 0.696
12 months 166 39.22 11.83 200 38.78 12.57 –0.89 –3.33 to 1.55 0.476
Sensitivity analysis of SF-12 PCS at 6 months
1. In multilevel model,
practices replaced
with individual GPs
– – – – – – –0.39 –2.31 to 1.54 0.696
2. CACE – – – – – – –0.11 –4.96 to 4.74 0.963
3. Two-stage cluster
level analysisc
– – – – – – n/a 0.824 to 0.838c 0.832c
n/a, not applicable.
a Calculated as mean difference for intervention – control score by linear mixed modelling adjusted for age, sex, practice
size and corresponding baseline measures (‘clustering’ accounted for in the mixed model).
b CIs and p-values relate to adjusted results from the linear mixed modelling.
c Two-stage cluster level analysis using permutation test provides test with the advertised Type I error in conjunction with
95% CIs.
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Conclusion
Self-reported outcome measures from the subgroup of individuals within the cluster RCT who were
recruited to follow-up for the individual patient-level analysis confirmed the practice-level analysis of the
‘whole practice’ populations presented in study 4.1:
l interventions developed as part of the MOSAICS workstream resulted in improved delivery of some of
the items of NICE core guidance to patients aged ≥ 45 years who consulted with joint pain and OA in
the intervention practices compared with similar consulters in the control practices, and a modest
short-term increase in patients’ confidence to self-manage, but
l nurse-led OA follow-up clinics in the intervention practices were only used by a minority of patients, and
l this implementation did not result in an improvement in physical function or pain among patients
followed up in the intervention practices compared with those in the control practices.
One possible explanation for the lack of clinical change is the relatively low uptake of the nurse referral
clinics in the intervention group. However, there was no evidence from the per-protocol CACE analysis that
the group who did see the nurse had better clinical outcomes, although the evidence from the practice-level
analysis was that this group had the optimal implementation of quality of care according to NICE guidance.
A second explanation may lie in the data on walking and physical activity. The evidence from the OA-QIs and
KNEST questionnaire was that a higher proportion of patients in the intervention group reported receiving
advice on muscle strengthening and carrying out muscle-strengthening exercise, but there was no difference in
the proportions doing general fitness exercise in the two arms. The PASE scores, surprisingly, indicated that the
intervention group had statistically significantly lower scores (i.e. less physical activity) than the control group
throughout follow-up, not explained by initial differences between the arms post-consultation. The analysis of
PASE domains suggested that the difference lay almost exclusively in lower walking scores in the intervention
group, among which there was also a lower reported use of walking stick. The picture painted is of patients
informed about muscle-strengthening anaerobic exercise, and carrying it out, but without increasing their
walking. This result does not align with the evidence about the benefits of walking and aerobic physical activity
(see the BEEP trial) but does suggest an impact of the MOSAICS model of care on exercise patterns.
However, from the patients’ perspective, there are components of the NICE guidance and the MOSAICS
model of care that are important regardless of their overall effect on pain and disability levels. First,
information provision is highly valued by patients and there was clear evidence that this was improved,
notably with written material, in the intervention group. Second, patterns of analgesia moved towards
safer recommended behaviour (reduced use of oral NSAIDs), as judged by the self-reported process
outcomes in this individual-level analysis, supporting the findings from the routinely recorded outcomes in
the practice-level analysis. The lowered level of advice about medication in the intervention group may
reflect this lower use of NSAIDs. Third, there was some evidence of a shift towards non-pharmacological
interventions in the content of the information provided, referral of overweight patients and a short-term
increase in patient confidence about self-management.
The search for wider explanations of why the implemented best-evidence care does not improve
patient-reported clinical outcomes must consider the appropriateness and timing of outcome measurement,
and the possibility that core NICE interventions developed for single-site OA, such as the knee, may be
insufficient to shift long-term pain and disability for all patients with OA who are seen in primary care, most
of whom have symptoms in multiple joint sites.
However, for some important items, we conclude that the MOSAICS intervention, which provides a model
OA consultation with training for GPs and practice nurses, and an OA guidebook appears to add to the
effect of the e-template in delivering core NICE recommendations and quality OA care in general practice.
One strength of this study was the initial population survey to identify potential eligible persons before any
consultation and recruitment in the trial period. This addressed a major concern for cluster RCTs, namely patient
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selection differences between intervention and control practices. Survey responders with joint pain were, on
average, older and more likely to be female than those with no joint pain and responders with OA were even
more so. This means prevalence estimates are likely to be inflated; however, this response bias is unlikely to have
affected estimated associations between baseline characteristics and future events such as treatment uptake.
One potential weakness here, and in study 4.1, was the baseline difference in median rank of area social
deprivation between intervention and control practices because intervention practices were, on average,
in more deprived localities. However, individual practices were distributed across comparable ranges in
intervention and control, and area deprivation scores for individual patients selected for study 4.2 were
lower (meaning greater deprivation) in the control group compared with the intervention group. It seems
unlikely that this would substantially affect the quality-of-care comparisons.
Study 4.3: cost-effectiveness of the MOSAICS intervention: health economic evaluation
Parts of this section are summaries of material in Oppong et al.172 © The Author(s) 2018. Published by Oxford
University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the
original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
Introduction/background
Aim The aim was to determine the cost-effectiveness of the template and model osteoarthritis consultation
(MOAC) in comparison with template alone in patients who consult with OA in primary care.
Methods A cost–consequence analysis was conducted, describing all the important results relating to costs
and consequences [clinical outcomes, EQ-5D, SF-6D, ICEpop CAPability measure for Adults (ICECAP-A)].
l Costs of the intervention were obtained in discussion with the study co-ordinators. Zero costs were
assigned to the control arm.
l Costs associated with over-the-counter medications were obtained from patient self-report in the
questionnaires or by allocating costs to the drugs mentioned in self-report.
l Resource use was valued by obtaining unit costs (2012/13 prices) from standard sources such as
Personal Social Services Research Unit (PSSRU),173 BNF174 and NHS reference costs175 and applying them
to resource use data from the trial data sets.
An incremental cost–utility analysis was then undertaken using patient responses to the three-level EQ-5D
questionnaire (at ‘baseline’, 3, 6 and 12 months) to estimate incremental costs, QALYs and net benefits
from a UK NHS perspective. Uncertainty was explored through cost-effectiveness acceptability curves
(CEACs). Sensitivity analysis explored the robustness of the results.
Full details of the data and methods, including information on resource use and associated costs, used
to develop the economic model for delivering the MOSAICS intervention, are included in Appendix 2
(see MOSAICS Health Economics Methods).
Results A total of 525 participants from eight general practices were included. There were no statistically
significant differences in health outcomes and capability between the intervention and control arms at any
time point. Occurrence of visits to the orthopaedic surgeon was lower in the intervention arm versus
control arm (mean number of visits per person over the designated follow-up period: 0.28 vs. 0.53;
p = 0.02). There were no other statistically significant differences in primary or secondary care resource use
between the two arms of the cluster trial over the 12 months’ follow-up.
Cost–utility analysis shows that the intervention was associated with an incremental cost of –£2.78
(95% CI –£67.61 to £62.03), an incremental QALY of –0.003 (95% CI –0.03 to 0.02) and a 40% chance
of being cost-effective at a threshold of £20,000 per QALY gained.
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The percentage of participants who took time off and the associated productivity costs were both lower in
the intervention arm.
Conclusion Implementing NICE OA guidelines in primary care using the MOSAICS intervention does not
lead to increased costs and appears to reduce demand for orthopaedic surgery and time lost from work;
however, QoL was little reduced.
Group 5 studies: qualitative evaluation of the MOSAICS studies
Parts of this section have been reproduced from Morden et al.176 © 2014 Morden et al.; licensee BioMed
Central. This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public
Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made
available in this article, unless otherwise stated; and Morden et al.177 © Morden, Brooks, Jinks, Porcheret,
Ong and Dziedzic. 2015. Published by Emerald Group Publishing Limited. This article is published under
the Creative Commons Attribution (CC BY 3.0) licence. Anyone may reproduce, distribute, translate and
create derivative works of this article (for both commercial and non-commercial purposes), subject to
full attribution to the original publication and authors. The full terms of this licence may be seen at
http://creativecommons.org/licences/by/3.0/legalcode.
Study 5.1: implementing a complex intervention in practice – an evaluation using a
theoretical framework
Introduction/background
One approach to the many challenges of implementing results of research into routine practice is to
consider implementation from the start of a research project by using a theoretical framework. Doing so
can help to ensure research (in this case the MOSAICS model of care) is more relevant to the NHS and has
greater potential to benefit patients.137 Such an approach can highlight factors that may influence the
likely success, outcome or long-term implementation of an intervention.
Aim
To understand the way in which health professionals (GPs and practice nurses) made sense of the new
intervention, how they operationalised it and what influenced their continued implementation or rejection
of the new approach.
Methods
Several theoretical models have been developed to understand the social processes associated with the
uptake of complex interventions. However, they pay limited attention to the early stages of ‘sense-making’
work that people do when faced with how to put a new intervention into practice, or the work on
relationships that people do in order to sustain a ‘community of practice’ around a new intervention.
In order to remedy this, we adopted the NPT137 to frame the MOSAICS studies and analyse the data.
A detailed description of the conceptual underpinning of our approach and its application in the MOSAICS
studies and more widely in primary care is provided in Ong et al.178
A qualitative design was utilised. In order to obtain a variety of perspectives of the same phenomena,179
two types of data collection strategies were used. First, there was direct observation. Second, group and
individual interviews were conducted with GPs and nurses who participated in the MOSAICS studies, as
well as staff from the NIHR Primary Care Research Network (PCRN) who acted as intermediaries between
the research team and practices. Observations and interviews were conducted at multiple time points.
Observations included meetings introducing the complex intervention to the practices (all eight
participating practices were observed); the four intervention practices were also observed in subsequent
meetings and training sessions and during post-study feedback meetings. All practice nurses (n = 9) were
WORKSTREAM 2: THE MOSAICS STUDIES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
70
observed delivering their clinics (a total of 27 clinics across all intervention group practices were observed).
Interviews were conducted with network staff at the introductory stages of the intervention (n = 5).
Samples of GPs (n = 10) and nurses (n = 5) were interviewed after receiving training and nine GPs and
four nurses were interviewed post intervention.
More details of the conceptual underpinning of this work and of the methodological processes of data
collection and analysis have been published by Morden et al.180 and Ong et al.181
Results
‘Sense-making’ GPs varied in their views of the relevance of the new intervention to their everyday
clinical work and their organisational priorities. Although they recognised that OA was common and
problematic for patients, and that they lacked up-to-date knowledge and skills to treat and manage the
condition, OA did not appear to be a priority for them because many GPs perceived it to be related to
ageing and it did not figure as a national policy and payment priority. The new intervention was viewed as
potentially helpful in systematising OA care (by use of the e-template) and because of the opportunity it
provided to refer to the practice nurse for further support and advice. The GPs also considered the
guidebook a valuable aid for patients.
The practice nurses saw the nurse-led clinic more positively as an extension of their skill set because it
allowed them to explain OA to patients, discuss treatment options, support self-management and take
account of psychosocial factors.
The research team highlighted the need to establish relationships, understand practice dynamics and engage
key decision-makers as being central to the process of engaging health-care professionals with the study.178
Factors relevant to participation in the MOSAICS studies To facilitate recruitment and
operationalisation of complex interventions, the research team needed to pay attention to the existing
clinical concerns, internal power dynamics and workloads within individual primary care organisations.
Logistics and existing communication channels influenced how health-care professionals made sense of the
study and organised their roles in relation to it.
Most GPs saw the adoption of the template in their decision-making about OA care as useful and the
practice nurses were prepared to take on the bulk of the work required for the new intervention. They
appeared to consider this division of labour appropriate to their role which made the study acceptable.
‘Routinization’ of new complex interventions in practice Practices did not think that they would be
able to routinely use the intervention as designed beyond the period of the funded trial. Continuing with
OA-specific nurse-led clinics was resource intensive and other incentivised priorities took precedence.
However, clinicians suggested that they would be able to continue with selected components of the
intervention and embed them within routine practice, namely using the communications skills and
technical disease-specific knowledge in routine consultations.
Conclusion
Using a theory-based approach such as NPT can help researchers to develop and introduce new interventions
to primary care settings and ensure uptake. The interplay of system-, group- and individual-level factors
shapes the specific context of primary care. The effects on the uptake of new interventions vary depending
on factors such as timing (e.g. a change in policy), actors involved and practice dynamics, perceptions of own
professional identity, and patient needs and demands.
The manner of introduction appears to be highly relevant, with levels of flexibility and negotiation being
crucially important. Furthermore, it is essential to understand the dynamic process of adaptation as an
integral part of implementation and routinisation, and to assess its contribution to eventual outcomes of a
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study and long-term implementation. In the case of MOSAICS, selective adaptation of elements of the
intervention was the route to continued use in practice.
Study 5.2: experiences of model consultations – patients
Introduction/background
Literature23 and research findings which fed into the MOSAICS studies suggested that patients, when they
consult GPs, are not optimally treated for OA, often not given a diagnosis, prognosis or information, and
often not provided with support for self-management. The intervention in our study is a new way of
offering OA care and an important ambition was to understand patient perspectives of the new approach,
what worked, what went less well and why.
Aim
The aim of this study was to explore and understand what patients thought about the intervention, if it
improved their experience of OA care and if it encouraged the uptake of the core NICE OA treatments
(self-management).
Methods
In-depth interviews were used because they can yield rich sources of data on people’s experiences,
opinions, aspirations and feelings.182 They enable respondents to tell their own stories in their own words
and the meaning that people attach to events can be revealed.183
A convenience sample was used and patients who had consulted at intervention practices were recruited.
Weekly medical record downloads from intervention practices identified patients who had consulted for
OA. These patients were issued baseline and 3 month ‘post-consultation questionnaires’ as part of the
broader study evaluation. From returned questionnaires, patients were identified who indicated they had
seen both the GP and practice nurse. Potential participants were sent an invitation letter and information
sheet offering them the opportunity to take part in this interview study. A total of 29 patients who had
consulted for OA and had received the MOSAICS intervention volunteered to take part.
All interviews were audio-recorded and professionally transcribed verbatim. Thematic analysis was
undertaken using some of the principles laid out by Grounded Theory, in particular focusing on identifying
emergent codes, developing themes and constantly comparing data and coding.184
Details of the methods of data collection and analysis have been published in Morden et al.180
Results
Findings from this study suggest that all patients gained something from the intervention, but that
separate components of the intervention may not have been universally helpful for all patients. There are
three key areas that participants discussed in relation to the new intervention: (1) information and
explanations about their condition provided during the intervention, (2) perspectives on holistic care and
support received and (3) responses to self-management advice and support, in particular, exercise/activity.
1. Information and explanations
All participants compared the intervention with previous experiences of consulting for OA. Participants
discussed frustrations with previous consultations stemming from a lack of clear diagnosis, the
perception that they had received few treatment options and answers, and time-consuming referrals to
secondary care (which also provided few answers). Participants suggested that consulting a GP for OA
as part of the new intervention featured less use of the term ‘wear and tear’ to describe joint pain and
resulted in provision of advice about exercise, provision of the OA guidebook and referral to see a
nurse. The guidebook was deemed useful because of the explanation it provided regarding what causes
OA, how OA affects people and a prognosis. Equally, being able to discuss OA with a nurse, clarify
concerns and receive personalised information was appreciated by participants.
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2. Holistic care
The theme of holistic care and support featured differences by sex. Female participants described the
value of time and attention given to discussing personal worries and emotional issues relating to pain.
They also felt that, in combination with information provided by someone perceived to be a clinical
expert, the time and attention provided by nurses offered a sense of ‘legitimation’ because previously
they did not think they had been taken seriously by clinicians and their social contacts. Female
participants suggested that, in combination with the information about OA, they were better able to
‘cope’ and had a better sense of ‘well-being’. Men discussed how information contained in the
guidebook relating to emotions, thoughts and feelings was useful because it offered reassurance that
what they were experiencing was normal. However, male participants did not recount benefits gained
from discussing personal worries, gaining legitimation or a better sense of well-being and being able to
cope as a result of consulting with nurses. They focused their accounts around obtaining technical
information about OA and a ‘cure’ (which was often interpreted as not forthcoming).
3. Uptake of advice about exercise
Uptake of advice about exercise, based on the qualitative evidence, was variable. Patients understood
the rationale for doing aerobic and muscle-strengthening exercises and reported trying them, but they
did not necessarily continue with them. One reason centred on participants’ ‘sense-making’ regarding
the effectiveness of exercise. Put simply, participants monitored and observed symptoms (pain, swelling
and function) for signs of improvement in the short term and mid-term, and their continued use of
exercise (in particular, muscle strengthening) depended on ‘proof’ of effectiveness. A second factor was
the presence (or absence) of comorbidities which influenced people’s ability to exercise (particularly
aerobic exercise). Finally, participants drew attention to the notion of appropriate places to exercise,
with the home and immediate neighbourhood considered to be ‘off limits’ for exercise. Thus, the
availability of affordable venues that felt comfortable (i.e. age appropriate, not feeling self-conscious
because of body size) was another factor influencing patient’s engagement with exercise as
recommended by the nurse.
Conclusion
The intervention overcame some of the limitations and challenges posed to patients by usual care, namely
by providing a diagnosis and information about OA as a disease entity. To differing degrees, the intervention
offered holistic support to patients, more pronounced for female patients. However, uptake of advice about
physical activity and exercise was not universal and was dependent on environmental and individual factors
that the intervention, from patients’ accounts, did not or could not address.
Study 5.3: experiences of model consultations – general practitioners
Introduction/background
The MOSAICS studies intervention was a new way of offering OA care, which involved GP training
programmes and potentially added work for GPs in consultation and recording. It was important to
understand GP perceptions about using this new approach to OA care and about how useful the
intervention was for patients.
Aim
The aim was to explore GPs’ perspectives about delivering the MOAC intervention and about its strengths,
weaknesses, acceptability and feasibility.
Methods
GPs (n = 9) from intervention practices volunteered to take part in semistructured telephone interviews.
Post-intervention feedback meetings were observed by two members of the research team (AM and BNO).
Observation as a qualitative research method involves the researcher ‘going into the field’ and describing
and analysing what has been seen, what people do and what people say, therefore, illuminating behaviour
and interactions in natural settings179 and aims to identify the meaning of, for example, a novel
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intervention to people in that setting.185 All data were analysed using on-going inductive coding,
subsequent theme development and constant comparison.184
Results
The GPs focused on the gains in medical knowledge from participating in the study, stating that knowing
more about OA and its management made it feel like less of a ‘heart sink’ consultation. They felt able to
offer more treatment options, provide better information to patients and, therefore, thought they gave
better care. As a result, they felt more ‘positive’ about seeing patients with joint pain.
The GPs thought that the OA guidebook and the new style of consultations provided a means of
‘empowering’ patients to take responsibility for their condition and alter a perceived relationship of patient
dependency on the GP. They also thought the OA guidebook was a useful tool to help back-up key
messages about the importance of exercising and taking prescribed medications. GPs thought that the
format of the intervention was useful because, by being able to provide a guidebook and/or refer to a
nurse, they could ‘close off’ consultations in a way that felt comfortable; the GPs felt that they were giving
the patient tangible support, while not having to increase their own consultation time. However, GPs did
express some concerns that referral to the dedicated nurse-led OA clinic might add to the burden on
patients with multiple morbidities. Some also doubted that the nurse referral would be suitable for all
patients. Examples of poor candidates for referral that GPs mentioned were patients lacking motivation
and patients with a particular agenda, such as wanting surgery.
Conclusion
In summary, the intervention was deemed to be positive because it ‘up-skilled’ clinical knowledge and
provided additional treatment and management strategies for patients with OA, and it fitted with GPs’
existing ways of working, thus requiring minimal change in their routines. The fact that GPs felt that they
had more to offer to OA patients benefited their individual practice and relationship with patients, and
reflected greater confidence in using and implementing NICE guidelines.
Study 5.4: experiences of the model consultation – nurses
Introduction/background
Practice nurses potentially play a key role in the delivery of supported self-management for musculoskeletal
conditions186 and they were an important part of the delivery of optimal OA care in the MOSAICSs
framework. Because the intervention that was under trial was a new way of offering OA care, qualitative
research was undertaken to explore and understand the nurses’ experience and perspective.
Aim
The aims were to:
l investigate how nurses delivered the intervention and to understand what happened in practice during
the practice nurse OA consultations
l explore nurses’ experiences of delivering the intervention
l investigate nurses’ perspectives about the strengths and weaknesses of the new intervention.
Methods
Two separate methodological approaches were adopted.
1. Nurses (n = 4) from across the intervention practices who participated in the delivery of the trial
volunteered to take part in semistructured interviews after the intervention had ended. Interviews were
used because they can yield rich sources of data on people’s experiences, opinions, aspirations and
feelings.182 They enable the respondent to tell their own stories in their own words and the meaning
that people attach to events in social settings can be revealed.183
WORKSTREAM 2: THE MOSAICS STUDIES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
74
2. All nurses in the intervention practices (n = 9) were observed delivering intervention clinics. A total of
27 clinics across all practices were observed. Post-intervention feedback meetings were observed by two
members of the research team (AM and BNO). Observation as a qualitative research method involves
the researcher ‘going into the field’ and describing and analysing what has been seen, what people do
and what people say, therefore, illuminating behaviour and interactions in natural settings179 and aims
to identify meaning for people in that setting.185
All data were analysed using on-going inductive coding, subsequent theme development and constant
comparison.184
Results
The nurses enjoyed delivering the intervention and, in particular, focused on the gains in medical
knowledge about OA that they attained from participating. They made a distinction between the sense of
achievement that they gained from ‘good’ and ‘motivated’ patients who responded to their support and
advice and patients who they thought were not motivated and whom they could not help.
Nurses suggested that, for the ‘motivated’ patients, the intervention was beneficial because it helped
patients to self-manage, in particular with regard to pain and maintaining valued activities which improved
health outcomes and QoL. However, they suggested that ‘demotivated’ patients were more of a challenge
and nurses were unsure if they could help them.
Nurses thought the OA guidebook was a useful tool to help back up some of the key messages in their
consultations, in particular generic advice about staying positive, the importance of exercise/activity, weight
loss and explaining OA as a disease. But, the nurses implied that it could have benefited from containing
details of muscle-strengthening exercises because they had to rely on other sources such as Arthritis
Research UK (Chesterfield, UK) information sheets to promote muscle-strengthening exercises.
With regard to implementing a whole systems approach (WISE) in the consultations, it seemed, following
the observations, that the nurses structured the consultations around promoting exercise and lifestyle
changes, which was sometimes to the detriment of psychosocial issues (e.g. work or feelings of stress).
This may be because the training focused primarily on the implementation of the NICE OA guidelines and
the nurses considered that shaping the consultation following the core intervention was a priority.
Observations also revealed that the nurses struggled to engage in discussions with patients about barriers to
exercise, underutilised effective motivational techniques and tended to reinforce core messages about the
benefits of exercise in an effort to deliver patient education. Thus, trained practice nurses were challenged in
providing support to patients who had difficulties engaging with their advice to exercise. Nurses tended to
conceptualise self-management as meaning patient adherence to their particular recommendations, goals or
targets. Although overall style of consultation and level of patient participation varied, most consultations
tended to be nurse directed with a focus on promoting specific exercises identified in the guidelines (e.g.
strengthening exercises). They also tended to follow a scripted approach, which might overlook patient
needs and concerns in relation to general physical activity and focus on nurse-led goal-setting. This, in
particular, may have resulted in the counter-intuitive finding from the quantitative data that walking declined
in the group seen by nurses while strengthening exercises increased.
Conclusion
Nurses valued the intervention and found it worthwhile in terms of their individual practice and
professional development. However, some tensions emerged between how nurses positioned the utility
and success of the intervention (ability to motivate patients) and the way that they engaged in discussions
with patients. Although nurses interpreted the intervention as a success from their perspective of delivering
the core interventions and suggested that patient characteristics may contribute to ‘failure’ in uptake
of self-management, challenges with communication and operationalising behaviour change and
communication strategies also played a role. Additional feedback and mentoring as support for nurses in
delivering the model OA consultation intervention might address some of these issues.
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Group 6 studies: wider dissemination of the MOSAICS interventions
The original idea of ‘learning sets’ as the basis for the dissemination phase of MOSAICS was laid out in the
MOSAICS protocol. It focused on direct engagement of primary care trust (PCT) managers. This objective
became impossible to develop and implement because of the major reorganisations in the NHS that were
occurring at the time. In particular, it became clear that setting up ‘learning sets’ during the period when
new structures such as Clinical Commissioning Groups (CCGs) were forming would not be possible.
An alternative strategy was adopted to meet these new circumstances.
First, a 1-day event was held at the end of the study to present interim findings from the MOSAICS studies
to all those who had participated, to the wider patient groups and to local health professional leaders.
This provided further proposals for improving the intervention, the way in which it should be introduced
and supported in primary care and how to maintain it in practices that had adopted the approach.
For example, there was support for the potential to continue to use the computer template as a way to
underpin a systematic approach to OA consultations and as a means to introduce GPs who were newly
arriving at participating practices to the NICE OA guidelines.
Second, two approaches were adopted to achieve wider dissemination: (1) development and evaluation of
modifications to the training programme and (2) extension of the intervention to a new set of practices
beyond the MOSAICS participants. These are described below.
Study 6.1: revising the training programme – engaging control practices post trial
Introduction/background
The research team reviewed the training programme after analysing the feedback from the intervention
practices and designed a new 4-day programme for nurses and 3-day programme for GPs. The training
was made available to staff from the four control practices. The control practices received this refined
training package after the end of the MOSAICS trial evaluation period.
Aim
The aim was to establish how the revised training package could prompt and enable changes in practice
with the aim of enhancing care for patients with OA.
Methods
The method adopted was a single-event facilitated group discussion.
With an ethical amendment and informed consent, all health-care professionals in the primary care teams
in the four control practices who had taken part in the post-trial training (17 GPs and 6 nurses) were
invited to attend a final session, which formed the basis for the facilitated group discussion.
The discussion was led by a clinical researcher (rheumatologist), with a semistructured schedule that
encouraged the group to think about how they could use the skills they had learned, in addition to
capturing their perceptions about the training. All discussions were digitally recorded and transcribed, and
thematic analysis was used.
Results
Three practices participated in the facilitated group discussion, with one declining further involvement.
Participants described individual changes they had made to their practice since the training. However,
the process of now having dedicated time scheduled for group discussion between nurses and doctors
enabled plans to be made for practice-level changes such as referral pathways for OA patients.
The participants discussed areas of need in primary care management of OA, particularly around the use of
exercise, barriers to which were compounded by perceived lack of existing resources. The ‘whole practice’
approach to training, opportunity for individual reflection between sessions and the research-driven
content were elements that were perceived as particularly valuable.
WORKSTREAM 2: THE MOSAICS STUDIES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
76
There were two unexpected findings. First was the way in which primary care teams felt that health-care
support workers and possibly other team members, such as receptionists, may be best placed to deliver
and monitor interventions for OA. Second was that GPs and practice nurses reported benefits to their
management of other long-term conditions as a result of the training. They also perceived that using nurse
time to treat OA would not negatively impact on practice resources as it would benefit the practice in
other ways (e.g. better weight management or blood pressure control).
Conclusion
The training had been well received, had unique aspects that were perceived as addressing areas of real
need in primary care and had surprise potential benefits for management of other long-term conditions.
Further roll-out of the intervention may usefully consider offering training to further members of the
primary care team and include timetabled facilitated discussion for participants to generate locally relevant
changes in practice from the skills learned.
Study 6.2: extending the MOSAICS intervention to new practices via the
new NHS
Introduction/background
A local CCG was engaged through some of its practices that had participated in the MOSAICS studies.
After a combination of grass roots interest and support generated by the training, and with GPs and
practice nurses reporting greater confidence in managing OA, 15 other practices in the locality covered by
the CCG now wished to implement the NICE OA guidelines using refined electronic tools, training and
patient information, and using local expertise to champion the spread of innovation.
Importantly, the CCG (the South Shropshire CCG) recognised that the MOSAICS approach would help to
address some of the challenges in its plans and the priorities for improving quality in primary care. The
CCG worked with the MOSAICS research and user groups, with support from NICE and Arthritis Research
UK, to submit and secure a Regional Innovation Fund award from NHS England to introduce the MOSAICS
interventions across all its practices. Details of this new work [Joint Innovation of Guidelines for
Osteoarthritis in the West Midlands (JIGSAW)] are outlined below.
Aims
The overall aim is to support primary care in addressing the unmet needs of adults consulting for OA through
systematic implementation of NICE OA guidelines at practice level. The specific objective of the JIGSAW
project is to refine and implement MOSAICS innovations as a pilot excellence pathway for OA in primary care.
The information learned from the MOSAICS studies will be utilised to:
1. embed a template in GP clinical records systems to prompt the recording of quality indicators of OA care
2. provide high-quality patient information – the OA guidebook (www.keele.ac.uk/media/keeleuniversity/ri/
primarycare/pdfs/OA_Guidebook.pdf)163 – developed by patients for patients and revised according to
the NICE update in 2014153
3. adopt a model OA consultation with GPs and practice nurses that is transferable to other long-term conditions
4. develop a ‘training the trainers’ model to offer:
i. practice-based training in OA, with one session for the whole practice followed by two brief,
intensive sessions for the GPs, including a knowledge update and skills-based training involving
simulated patient consultations in a group setting.
ii. a 2-day programme of training for practice nurses including knowledge components and skills-based
sessions on advising and demonstrating exercises, facilitating support for self-management and
advising on medication.
5. develop a patient completed audit tool.
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Methods
The JIGSAW has identified 15 general practices in South Shropshire as pilot sites. The CCG has been
engaged as well as the individual practices. The MOSAICS research team and user group are collaborating
in this project, but there are methodological innovations that will develop the dissemination beyond the
MOSAICS approach, building on lessons learned from the MOSAICS studies, notably:
l ‘training the trainers’ as the basis for local delivery of training programmes for GPs and practices nurses
in the OA consultation
l recruitment of four GP and two practice nurse local clinical champions as the basis for leading on the
incorporation of electronic OA templates into practice and to support colleagues in clusters of up to
four practices (workshops at two practice-based meetings introduced them to their roles)
l a 2-hour evening meeting introduced JIGSAW to all practices and practice staff, including clinical champions,
and provided patient stories, the evidence from MOSAICS and demonstration of the e-templates
l a dedicated Health Informatics Specialist from Keele supported local practices to install the template.
Training digital versatile discs (DVDs) were produced
l the template formed the basis for continuing the audit of the uptake of core NICE OA recommendations.
Results
Out of the 15 practices invited to the JIGSAW launch, 12 were represented. Champions had varying
degrees of success in engaging practices with OA updates, but 11 practice staff (practice nurses and
support workers) attended a 2-day training package to enhance consultation skills for management of OA
and other long-term conditions. E-templates were installed in 13 practices and patient guidebooks for OA
used in consultations in these practices.
Additional CCG funding was then provided to allow and support practice nurse time for OA consultations
in general practice. At this point, JIGSAW was adopted by the West Midlands Academic Health Sciences
Network (AHSN), with two further CCGs (Telford and Wrekin, and North Staffordshire) recruited to take
part. The South Shropshire CCG then appointed a project manager to support the adoption of JIGSAW
across all 44 practices in the CCG. Finally, NICE formally endorsed the OA e-template as a tool for
implementing their 2015 OA quality standards.153
Measurement of process and patient outcomes from the JIGSAW project lies beyond the remit and timing of
this NIHR programme, and the study to date represents an end point of practical supported implementation
and dissemination. The outcome of the innovation will be evaluated by:
l change in clinical variation in management of OA
l practice-based process measures, such as reduction in radiography use and referrals to
orthopaedic surgery
l uptake of core NICE interventions captured via the electronic template
l audits of patient-reported quality of OA care, satisfaction with care and access to written information
(OA guidebook)
l increasing the number of GPs and practice nurses trained, as well as requesting feedback regarding
the training.
Conclusions
The JIGSAW has demonstrated to date that innovations developed and tested in MOSAICS, cocreated by
GPs, practice nurses, patients and researchers, can be successfully modified and adapted to deliver an
excellence pathway for OA in primary care. Further adoption will be supported by the AHSN, with a
pan-European partnership proposed in collaboration with NICE.
Overall conclusions
The main result of the cluster RCT is that uptake of optimal primary care for OA that is aimed at
implementing the core treatments recommended by NICE can be increased by training in, and delivery of,
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a model OA consultation by GPs and practice nurses over a 6-month period, with no additional costs,
reduced visits to orthopaedic specialists and reduced time off work. However, the intervention does not
improve patients’ pain and physical function over the same period.
The interpretation of this finding should be set in the context of the whole workstream. Individual studies
have established that the delivery of NICE-recommended core treatments may be improved by the model
GP OA consultation, which is linked to the provision of a resource developed and valued by patients
(the guidebook) and supplemented by referral to a practice nurse OA clinic. Introduction of a systematic
computerised quality-of-care template, linked to consultation, was acceptable to the GPs and resulted in
improved recording of quality of care. In general, the GPs, nurses and patients were positive about this
model of enhanced primary care for OA, which was noted in particular by the qualitative component of
the mixed-methods suite of studies.
The health economic analysis confirmed the main result of no overall benefit to the intervention in terms of
health outcomes. However, the analysis did find that there were no cost consequences for the intervention.
These findings raise major issues for practice, policy and research. OA is the leading cause of disability in
older people and there is general agreement that the main push of preventing pain and disability will be
situated in primary care, unless major public health shifts in physical activity and obesity occur soon. The
assumption that drove this workstream was that the components of the NICE core guidance had sufficient
evidence of efficacy in relieving pain and reducing disability, which meant that the main challenge lay in
the implementation of these interventions and treatments. The MOSAICS studies have provided evidence
about how to overcome this challenge and to achieve implementation of the core guidance, including
support for self-management and referral on to other services, such as physiotherapy, if the core
interventions are ineffective. However, despite this, the individual-level analysis did not provide evidence of
a subsequent improvement in the primary clinical outcome.
Limitations of implementation
Implementation of a complex intervention designed to provide an integrated primary care service for
patients with OA that was focused on model GP and practice nurse consultations did prove a challenge.
Notably, only a minority of patients saw the nurse and so not all eligible patients were offered exercise,
which is known to be effective in improving pain and increasing function in knee OA.122 In addition, those
that did see the nurse appeared not to have adopted the optimal change in exercise. The qualitative
studies provided further insight into this to show that the patients understood the importance of exercise,
but that barriers persisted for aerobic walking exercise because of comorbidities and lack of a suitable
environment to encourage exercise.
It is possible that, despite the success of the training programme for GPs in changing some of their
behaviours (as shown by changes in the content of their consultations with simulated patients), there has
been less of an impact in practice and the impact has been insufficient to influence patients. However, the
patient guidebooks, which met criteria for strong patient engagement in guidebook development and
incorporated local information, were successfully delivered as part of the model OA consultation and, in
the qualitative studies, patients reported relevant GP behaviours in the intervention arm and evaluated
the guidebook as helpful. The e-template study provided evidence that prescribing did change and that
relevant advice was recorded as being given. However, there were limitations. Only one-third of patients
attended the nurse follow-up clinic in the intervention arm. There may be a number of reasons for this,
including explanations for low referrals such as:
l non-referred patients did not have OA (this would happen if the GP fired the template, then
considered later on in the consultation that the patient’s problem was not due to OA and decided not
to refer the patient to the nurse)
l some GPs were untrained because of staff turnover rates
l behavioural change in GP competencies did not translate into changed performance.
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The low referral rate to nurse-led clinics may be one explanation for the lack of clinical improvement.
It meant that the full integrated MOSAICS model of care, incorporating improved consultations with the
GP and referral to practice nurse-led OA clinics were not delivered as intended. Evidence has been provided
that seeing the nurse was linked to full implementation of the MOSAICS method of delivering NICE core
guidance, including the provision of written information and advice, and opportunities to discuss exercise
and physiotherapy referral. This appeared sufficient to explain differences between control and intervention
practices in meeting quality-of-care criteria for provision of written information.
However, the fact that only a minority of patients saw the practice nurse cannot finally explain the lack of
improvement in pain and disability outcomes in the trial, as even in the subgroup who saw the nurse there
was no difference between the intervention and control groups in these outcomes, although it may have
affected power to show a difference. There was clear evidence in the practice-level analysis that the
combination of GP consultation and nurse referral was achieving the highest level of implementation of
NICE core guidance and quality of care. The qualitative studies confirmed the nurses’ enthusiasm for the
new model of care and provided evidence of patient engagement being driven by the nurse-led clinics, but
they also raised some questions about the clinics, based on patients’ judgement of the nurse intervention
and from direct observation and audio-recording of the nurse-led clinics. In addition, the GPs’ use of the
template did reduce with time and a similar drift may have occurred in the content of their consultations.
Maintenance of behaviour change in clinicians and patients is a challenge for the primary care of OA patients.
Limitations of the intervention
It is possible that crucial elements of an effective intervention were lacking. It is notable that OA treatment
remains focused on single-site disease and yet the evidence from this workstream emphasises that it is the
person with multiple joint pain who is most commonly seeking help. Elements of primary care may still not
be properly targeted or shaped for the majority of patients with multiple joint pain. The emphasis in the
NICE guidelines on the importance of advice about exercise and weight loss may be an insufficient
intervention in primary care; the guidelines recommend a whole range of further adjunctive treatments
should the core intervention be ineffective.15 The evidence about effectiveness of physiotherapy-led
exercise interventions in reducing pain and disability in the short term among OA patients (reviewed and
emphasised in Chapter 4, Introduction, describing workstream 3 of the programme) may mean current GP
or nurse advice alone is insufficient to improve activity to levels which will relieve pain and disability. The
finding about the shift in balance towards muscle strengthening and away from aerobic exercise in the
intervention practices supports this possibility. Increasing the availability and use of physiotherapist-led
exercise and activity as part of a revised MOSAICS intervention is one potential way forward.
However, this raises issues of resource. One question for future research is whether or not there are
subgroups of patients in primary care for whom the NICE core interventions are both sufficient and
effective. One important issue is the context of multimorbidity, as the baseline population survey confirmed
that this is the most frequent state among older people in the community reporting joint pain. There is a
continuing need to investigate the role of multimorbidity in determining differential outcomes in primary
care patients with OA and how best to manage this.
Limitations of expectation
It is important to consider if process measures of successful delivery of care might be valued as important
in their own right, given that there is evidence from elsewhere that the treatments and interventions are
worth doing and that feedback from patients and clinicians indicate that the interventions produce a
clearer and more positive model of care for patients with OA. Therefore, a second question for future
research arising from this workstream is how far process measures of successful implementation of
treatments of known efficacy should be used to drive policy in the absence of strong evidence that they
are shifting clinical outcomes, and in the presence of evidence that some patient goals (better information,
satisfaction with care) are being met by the model of care. One important issue when considering, for
example, the application of evidence, to everyday primary care, that physiotherapy-led exercise and activity
is efficacious and effective in reducing pain and disability, is that the evidence may have been gained
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outside the context in which it would be applied. One of the arguments for complex trials is that the
evidence of efficacy is being examined in its practical context.
Limitations of resource
It must also be accepted that support for self-management provided in the GP consultation and the
nurse-led clinic may be limited in its potential for impact on long-term clinical outcomes by the limited
resources available to the patient outside the primary care setting. The qualitative study of patients
highlighted challenges in the outside world, such as limited access to places to exercise, for patients
continuing on a self-management path. Such external barriers will undermine the immediately beneficial
effects of advice and information also observed in MOSAICS (e.g. shifts in knowledge, initial engagement
in exercise). Similar challenges were highlighted in a German study of why GPs felt that implementation of
guidelines for back pain would fail – lack of an external environment to meet the requirements of the
guideline.187 Future research could investigate integration between primary care, public health and
community resources to support sustainability of OA self-management.
The last two points lead to the question of how implementation of the MOSAICS model might now
proceed. A local CCG has engaged in the first stage of planned dissemination and views the evidence of
effective processes of GP training, quality templates, nurse-led clinics and patient-generated information
(the ‘process outcomes’ of the MOSAICS studies) as sufficient basis for the new approach. The finding of
cost neutrality provides further reassurance for such implementation. Delivering high-quality care with a
reduction in orthopaedic visits and use of imaging are desirable outcomes for health-care commissioners.
The NPT model, which has framed the work on implementation throughout this workstream, highlights
that there remain barriers to implementation, including clinician variation and lack of resource to deal with
the dominant problems of low physical activity and obesity.
The lack of evidence demonstrating clinical effectiveness of the current model of optimising care is an
important issue to tackle, as clinicians and patients will need evidence that new models of care do
ultimately benefit patients if resources to implement them fully are available. However, the evidence that
implementation of the model has achieved a higher quality of care, as judged by current standards, is
relevant to policy decisions at the same time as future research tackles some of the questions about how
those current standards might need to change in order to improve clinical outcomes.
It follows from this that the alternative explanation is that the MOSAICS model of care was not a sufficient
intervention to shift pain and disability, and that its focus on core interventions limited the capacity of the
individual-level analysis to assess the effect of the full spectrum of adjunctive treatments recommended by
NICE if core interventions fail to benefit. Successful implementation of NICE core guidance itself, as
demonstrated by both practice- and individual-level analysis of the MOSAICS model of care, may not lessen
pain and disability. Optimal and accessible information for patients may be desirable for many reasons but
may not, in itself, result in lessened pain and disability and, using the GP and practice nurse consultation as
the means to deliver exercise and weight loss advice (although, again, desirable as a first step), may not
deliver the full ‘dose’ of support and intervention needed to shift patient behaviour sufficiently to achieve
the reductions in pain and disability that efficacy trials of, for example, physiotherapy-led exercise and
physical activity have demonstrated in patients with OA.
One further question that arises is the conceptual one of the extent to which NICE guidelines will be
effective when put into practice. One clear novelty of our study is that it has attempted to test the clinical
effectiveness and cost-effectiveness of guideline implementation in practice. We have provided process
evidence that health-care professionals and health-care systems can change sufficiently to implement
components of guidelines, but patient benefits remain elusive to demonstrate.
Summary: the MOSAICS research story
The aim of the project was to develop and evaluate ways to put NICE core guidance for OA into primary
care practice in a combination of implementation study (evaluating ways to put NICE guidance into practice
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on the assumption that evidence-based clinical efficacy for patients would follow) and effectiveness study
(actually investigating whether or not clinical efficacy does follow in real-world practice).
The implementation study
l This focused on improved resources/technologies for primary care (including a patient-developed
guidebook, computerised consultation template, nurse-led OA clinic, training for GPs and nurses)
designed to promote behavioural change in GPs and nurses, and (via guidebook and advice)
self-management behaviours in patients.
l The MOSAICS intervention demonstrated that a ‘whole-system’ implementation of NICE guidance can
be achieved in primary care and can change clinician behaviour and support patient self-management.
The study produced evidence of improved capacity for NICE implementation at the:
¢ GP level (the training delivered behavioural change, guidebooks were handed out to patients, items
on the template were carried out, prescribing changed and nurse referrals occurred)
¢ nurse level (clinics were carried out and template items were reinforced)
¢ patient level (patients received guidebooks, attended nurse-led clinics and improved their
physical activity).
l On the basis of these findings, a wider implementation exercise is taking place in collaboration with
commissioners, which incorporates changes and refinements to the MOSAICS model to tackle
problems of generalisability (e.g. by using briefer, more focused health professional training).
The clinical effectiveness study
This did not show evidence of improved levels of pain and disability. Potential explanations include:
l The evidence base of clinical effectiveness in NICE guidance may not be strong enough to achieve
change in clinical end points in practice, or some of the aims of the guidance (e.g. provision of
satisfactory information for patients) are worthwhile and necessary in their own right regardless of
effect on clinical measures of outcome.
l The implementation was not complete enough to achieve changes in clinical outcomes. There was
evidence (quantitative and qualitative) for this in terms of:
¢ content of consultations (e.g. exercise advice may have encouraged muscle strengthening at the
expense of aerobic exercise such as walking)
¢ numbers of patients engaged in full implementation – only a proportion of patients were engaged
with the full template or referred on to the nurse and the trial may have lacked power to show an
effect at the group level
¢ heterogeneity of this patient group
¢ resources – the primary care package may be insufficient to achieve patient behavioural change
(exercise and weight reduction) without more structured or specialised input to support it
(e.g. physiotherapists).
l It may be inappropriate to seek more than minor clinical effect sizes in pain and disability in practice.
Maintenance of activity and participation, despite continuing pain, may, for example, be a better
long-term measure of effect.
The future
l Evidence from MOSAICS of how to implement the NICE OA guidance in practice is now driving wider
dissemination projects (e.g. Chapter 3, Study 6.2: extending the MOSAICS intervention to new
practices via the new NHS). These provide an opportunity to adapt MOSAICS to generalisable formats
and to improve on those areas listed above which limited its implementation.
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l Given the findings that patients with an OA diagnosis had better indicator outcomes and that the GP
task of giving a diagnosis of OA did not improve after training suggests future implementation and
research should address this component of the consultation.
l There is also a need in future research to reflect critically on whether or not:
¢ pragmatic trials of clinical effectiveness of NICE guideline implementation are appropriate
compared with a combination of implementation studies and new efficacy studies to strengthen
the evidence base for the guidelines
¢ OA outcomes in practice need to be concerned with aspects over and above improving short-term
levels of pain and disability.
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Chapter 4 Workstream 3: improving the
effectiveness of exercise for osteoarthritis – the
BEEP trial
Parts of this chapter have been reproduced from Foster et al.188 © 2014 Foster et al.; licensee BioMedCentral Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly credited. The Creative Commons
Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data
made available in this article, unless otherwise stated. Parts of this chapter are reproduced with permission
from Moore AJ, Holden MA, Foster NA, Jinks C. Keele University. 2017.
Abstract
Background: Exercise is consistently recommended for older adults with knee pain related to OA, but the
effects are typically small and short term. Individualising interventions and supporting adherence are
possible ways to improve outcomes of exercise programmes delivered by physiotherapists.
Aim: To test clinical effectiveness and cost-effectiveness of an individually tailored exercise (ITE)
programme and a targeted exercise adherence (TEA) intervention compared with usual physiotherapy
care (UC).
Methods: A multicentre, pragmatic, parallel group, individually randomised controlled trial, with
embedded longitudinal qualitative interviews (ISRCTN93634563). Adults in primary care aged ≥ 45 years
with knee pain in one or both knees were recruited through medical records, population survey or referrals
to physiotherapy. Participants were randomised to one of three physiotherapy programmes: UC, ITE
(individualisation of a lower limb exercise programme) or TEA (support to adhere to longer-term general
physical activity). Primary outcomes were pain and function measured by the WOMAC index. Semistructured
interviews with a subsample of 30 participants (10 per treatment group) were undertaken soon after
treatment ended and then again 12–18 months later.
Results: A total of 526 participants were randomised; 87% provided 6-month data and 79% provided
18-month data. Changes in pain and function were no different between ITE or TEA and UC at 6 months
[WOMAC pain UC 6.4 (SD 4.0), ITE 6.4 (SD 4.0), TEA 6.2 (SD 3.8), and WOMAC function UC 21.4 (SD 14.1),
ITE 22.3 (SD 13.7) and TEA 21.5 (SD 13.2)] or at other time points. All three groups improved over time, with
participants reporting greater control over their knee problem at 6 months than at baseline. UC was less
costly than ITE and TEA, yet was as effective and is therefore the dominant treatment. Thematic analysis of
interview data highlighted therapeutic alliance between patient and therapist. Physiotherapists’ attitudes,
beliefs and clinical behaviours about exercise for chronic knee pain changed in line with the specific training
package they received, although some reverted by 12–18 months.
Conclusion: Physiotherapy providing individualised interventions or support for exercise adherence
did not improve pain and function compared with usual physiotherapy advice and exercise. UC was
cost-dominant, meaning it remains the treatment of choice in the NHS.
Trial registration: Current Controlled Trials ISRCTN93634563.
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Introduction
Knee pain in older adults is a common disabling problem, managed in the UK mostly in primary care.189
OA is the most likely underlying diagnosis and refers to a clinical syndrome of joint pain accompanied by
varying degrees of function limitation and reduced QoL.190 The most commonly affected peripheral joint is
the knee and OA has been shown by radiography to be present in 70% of community-dwelling adults
aged ≥ 50 with knee pain.190 Structural changes before radiography are common in the remainder.191
Clinical trials and systematic reviews consistently show the benefit of exercise, in a variety of forms, for this
patient group.33,122,192–194 Exercise improves muscle dysfunction and reduces pain and disability without
exacerbating joint damage.195 It can reduce the risk of other chronic conditions196 and improve the physical
status of people with OA.197,198 Physiotherapists are the largest group of exercise advisors for musculoskeletal
problems in the UK NHS and are therefore an appropriate group with whom to develop and test strategies
to improve outcomes from exercise with older adults experiencing knee pain. Previous studies have shown
that older adults with knee pain and the physiotherapists involved in their treatment have concerns about
the safety of exercise, do not consider exercise as an effective treatment for pain, do not focus on issues of
exercise adherence and fail to translate traditional lower limb-focused exercise into sustainable lifestyle
changes.199
Our previous Treatment Options for Pain in the Knee (TOPIK) trial34 tested two primary care services for
knee pain in older adults, an enhanced pharmacy review and community physiotherapy (based on advice
and exercise) and compared these with usual GP-led care and advice. At 3 months, pain reduction was
three times greater and functional improvement four times greater in those patients randomised to
physiotherapy than to GP-led care and advice, and more people obtained clinically meaningful changes
than those in the other two groups.200,201 Patients received, on average, four physiotherapy treatment
sessions. There was evidence that the benefits in pain and function declined in the longer term, suggesting
that most patients require some form of monitoring or regular access to physiotherapy or exercise
supervision for potential ongoing benefit. The Acupuncture, Physiotherapy and Exercise (APEX) trial,202
which incorporated a more intensive exercise intervention that was supervised and progressed over six
treatment sessions, resulted in greater improvements in pain than the exercise programme in the
TOPIK trial.34,203
Similarly, other recent trials30,98 and reviews204 showed small to moderate, short-term reductions in knee
pain and disability that are not sustained in the long term.192 Exercise is clearly worth doing but we need to
find out if, and how, the beneficial effects can be maintained over time. This is crucial to the management
of a chronic long-term condition like knee OA. Conversations with patients during telephone follow-ups in
the APEX trial helped to explain why the effects of exercise might be suboptimal.202,203 Participants reported
misconceptions about exercise in the presence of knee joint damage and pain, difficulty fitting the
exercises into a daily routine, overly complex exercise programmes, insufficient tailoring of the exercise
programmes for their individual needs and, in some cases, they simply forgot to do the exercises.
These reviews highlight a lack of information about how to optimise exercise for this patient group.33,193,194
Most studies are short term, use limited measures of adherence and standardised exercise programmes.205
Adherence, independent of exercise type, may be an important factor in the success of exercise
interventions. There is evidence that better adherence to exercise improves pain relief192 and disability205
and that the addition of booster sessions may be helpful in maintaining positive effects on pain and
function.204 A UK consensus32 identified adherence and tailoring of exercise to individuals as important
research topics. One trial showed that greater reduction in knee pain occurred in individuals who reported
greater exercise adherence but, unfortunately, ‘adherence’ was not specifically defined.145 In the general
physical activity literature, a Cochrane review concluded that physical activity programmes that include
patient goal-setting, individually tailored and written exercise programmes, some professional guidance
and ongoing support, may be the most effective approach.206
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Recent national and international clinical guidelines support the overall effectiveness of exercise in knee OA,
placing it as a key component of core treatment in primary care.9,15,32 However, there is a lack of evidence
around the practical aspects of exercise delivery and maintenance, including how to support individuals to
continue to exercise in the longer term. UK guidelines from NICE first published in 2008 recommended
that future research should test ways to improve adherence with exercise,15 and the Chartered Society of
Physiotherapy ranked testing ways to help patients incorporate exercise behaviours in their everyday life
and increase the long-term effects of exercise as the top musculoskeletal research priority in its national
priority setting exercise in 2010.207
The BEEP trial188 is a logical consequence of recent primary care trials, systematic reviews and guidelines
for knee pain in older adults, which consistently support exercise-based interventions but highlight the
short-term, small- to moderate-sized, benefits.34,192 The overall aim of the BEEP trial was to test, in older
adults with knee pain attributable to OA, whether or not pain and function outcomes can be improved
through changing the characteristics of the exercise programme in comparison with UC. The research
hypotheses were (1) a physiotherapy-led individualised, supervised and progressed lower limb exercise
programme would be superior to UC and (2) a physiotherapy-led intervention targeting exercise adherence
in the longer term and supporting the transition from lower limb exercise to general lifestyle physical
activity would be superior to UC.
Development
In preparation for the BEEP trial, we conducted two studies. First, a Cochrane systematic review summarised
the evidence to date about interventions to improve adherence with exercise in patients with chronic
musculoskeletal pain.208 Second, the Attitudes and Beliefs Concerning knee pain (ABC knee) study
investigated the exercise attitudes and behaviours of older adults with knee pain in the community (n = 611)
and physiotherapists involved in managing older adults with knee pain (n = 538), to identify potential barriers
to, and facilitators of, exercise for knee pain.27–29 The findings of our Cochrane review, based on 42 trials with
over 8000 patients, suggested using a multifaceted programme combining educational and behavioural
strategies to enhance exercise adherence, and incorporating individualisation of the exercise, follow-up and
supervision to improve exercise adherence.208 No one theoretical model underpinning exercise adherence was
shown to be superior and the interventions that incorporated motivational strategies showed promise. A
subsequent review by Bennell and Hinman209 stated that the optimal exercise dosage is yet to be determined
and an individualised approach to exercise prescription is required based on an assessment of impairments,
patient preference, comorbidities and accessibility. They suggested that maximising adherence is a key
element dictating success of exercise therapy and that adherence can be enhanced by the use of supervised
exercise sessions in the initial exercise period followed by home exercises. Bringing patients back for
intermittent consultations with the exercise practitioner, or attendance at ‘refresher’ sessions, was also
suggested to assist long-term adherence and result in improved patient outcomes. Our ABC knee study
showed that, while physiotherapists use advice and exercise routinely for older adults with knee pain, they do
not consider exercise to be an effective treatment for pain, they have worries about its safety, they provide
care over relatively few treatment sessions, thus reducing the capacity to adequately individualise, supervise
and progress the exercise programme, and they do not routinely follow up patients to check adherence or to
support the translation of lower limb-focused exercise into sustainable lifestyle changes in physical activity.
Although patients are aware of risk factors for progression of knee pain and OA (e.g. sedentary lifestyles),
they find it hard to make and maintain appropriate lifestyle changes and express the desire for more support
from health professionals. Marks210 describes the many factors that influence exercise adherence in patients
with knee OA as either intrinsic (personal factors such as self-efficacy, motivation, age, sex and disease status)
or extrinsic (e.g. environmental or social factors or other lifestyle issues). These barriers can vary both over
time and between individuals, meaning that one single approach to enhancing exercise adherence might not
be as effective as an individually tailored approach. The World Health Organization advocates an ‘adherence
counseling toolkit’ that can be used to systematically assess barriers and facilitators to adherence, and
suggests that new interventions to enhance adherence are required.211
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In addition to the above, prior to the funding application to the NIHR, we held an Arthritis Research
UK-supported trial network meeting with 24 participants (including physiotherapists, rheumatologists,
GPs, biostatisticians, a systematic reviewer and two patient representatives) to further discuss and reach
consensus about the trial design and the content and delivery of the interventions. Key decisions made at
this networking meeting included agreeing:
l for the design to be a three-arm parallel trial design
l to include 18-month and 3-year follow-ups to provide long-term outcome data
l that the UC arm should be UC rather than usual GP care given the results of previous trials and reviews
l not to include group-based treatments given the known challenges of limited NHS facilities to conduct
groups/classes (e.g. attendance in group interventions has been low in previous trials and some
patients have strong preferences not to be treated within groups)
l to include objective physical activity data collection on a sample of included BEEP trial patients.
We considered and discussed the potential for group-based treatment but we chose one-to-one
physiotherapy sessions for the following reasons:
l We wanted our UC intervention to reflect UC in the UK and our national survey of physiotherapists in the
UK199 showed that only 10% of 538 responding physiotherapists used group-based treatments for knee
OA patients, whereas 90% treat patients in a series of one-to-one sessions.
l We wanted to ensure that, if one intervention in the trial was offered in one-to-one sessions, then all
interventions should offer care similarly in one-to-one sessions so that different modes of delivery of
treatment could not bias the results of the trial.
l A key component of the exercise intervention in the ITE and TEA treatment arms was individualisation
of the exercise programme, with patients prescribed a programme that was specific to their individual
assessment findings, and this was progressed over time.
l There are considerable challenges in terms of access to facilities in the NHS to hold group-based
treatment sessions (particularly in community physiotherapy services where the BEEP trial was based),
whereas all services have facilities to offer one-to-one treatment sessions (this might help explain the
results of our national survey).
l Although there have been good clinical results from class-based treatment in some previous trials
(for which they have been shown to be similarly effective when compared with one-to-one care),
attendance at classes or group treatments has been lower than in one-to-one sessions (e.g. Hurley
et al.123) as it is almost impossible to offer sufficient flexibility in days and times of classes to suit all
trial participants.
l Previous research, including our own qualitative interviews with patients with knee OA in the
community, highlighted that some patients have strong preferences not to be treated in groups
or classes.212
The following section describes the content and rationale for the three BEEP trial interventions.
Interventions development
Intervention 1: usual physiotherapy care
Usual physiotherapy care consisting of advice and exercise was the most appropriate control group for the
BEEP trial given that randomised trials34 and systematic reviews33 consistently show that interventions that
include exercise are superior to those that do not. We did not use an attention control group as this trial
was designed explicitly as a pragmatic trial, building on evidence about the effectiveness of exercise
interventions. Clinical practice guidelines recommend exercise for all patients with OA.15 In current UK
clinical practice, patients are seen in relatively few treatment sessions and are provided with brief and
relatively standardised exercise programmes that do not take into account differences between individual
patients. Our ABC knee study described usual UK physiotherapy practice and formed the basis for the
BEEP trial protocol for UC.199
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The BEEP trial protocol for UC consisted of advice and lower limb exercise previously tested and shown to
be more effective in the short-term than GP-led care and advice alone.34 Exercises were selected from an
agreed template of commonly prescribed exercises {printed from the commonly used PhysioTools computer
software [PhysioTools©, Product ID RG-PT1ENG, General Exercises Second Edition (English), Tampere,
Finland]}, including specific lower limb muscle strengthening (non-weight-bearing and weight-bearing)
and range of movement or stretching exercises. Patients were to receive up to four one-to-one treatment
sessions with a physiotherapist over a period of 12 weeks, during which advice to continue to exercise
was provided but individualisation, progression and supervision of the exercise programme was minimal,
limited to up to four sessions as in UC. Other interventions used frequently by physiotherapists such as ice
therapy, manual therapy and electrotherapy were permitted as per UC and they were recorded on CRFs,
but the emphasis of the intervention was on supporting the patient to self-care and to follow the advice
and exercise programme at home. This UC protocol matched usual UK practice in that it:
l focused on lower limb-strengthening exercises
l relied on self-report rather than the use of exercise diaries to monitor adherence and progress
l was delivered over few treatment sessions and, thus, had limited opportunity for good
individualisation, supervision or exercise progression
l provided advice about general physical activity only
l did not offer refresher or booster sessions following the end of the episode of care.199
Intervention 2: individually tailored exercise
Standardised exercise programmes such as those used in the UC group in the BEEP trial do not take into
account differences between individual patients. Consequently, individuals will be working at relatively
different intensities, which may be too little for some to get a training effect and may be too difficult for
others. To be optimally beneficial, exercise should be progressed so that appropriate physical stress is
placed on the individual for further improvements to be obtained.213 Exercise self-efficacy (confidence
to exercise despite the knee pain) has been identified as a predictor of exercise behaviour in many
populations.214,215 Supervision of exercise can enhance patients’ exercise self-efficacy and self-regulatory
skills and reassure them that they can perform the exercises. It also provides good opportunity to reassure
the patient about pain responses to specific exercises and to change the exercise prescription to ensure
optimal performance or more tolerable pain response. Lack of adequate individual tailoring, supervision
and progression of the lower limb exercise programme may, in part, explain the small benefits seen in
some previous exercise trials. Our previous trial results suggested that a lower limb exercise programme
that was supervised and progressed over six treatment sessions resulted in greater improvements in pain
than one that was provided over an average of four sessions.34,203 Therefore, the protocol for ITE was
developed to ensure the prescription of an individualised, supervised and progressed lower limb
exercise programme.
The BEEP trial protocol for ITE consisted of a supervised, individually tailored and progressed exercise
programme. The aim of the intervention was to initiate and progress an ITE programme, which was
supervised in clinic, practised at home and progressed in terms of intensity over 12 weeks. The intervention
was modelled on a previously successful exercise intervention from one of our previous trials203 and
focused on individualised lower limb muscle strengthening (non-weight-bearing and weight-bearing),
range of movement or stretching exercise and balance exercise. The patient and physiotherapist were
expected to agree a lower limb exercise programme and targets were to be reviewed and progressed.
Individualisation was based on the findings of the physiotherapy assessment of each individual, including
biomechanical and physiological observations, pain responses to specific exercises, starting levels of
strength, range of movement and balance. Exercises were prescribed for each individual and participants
were given their own individual print out of their specific exercise prescription (selected and printed from
PhysioTools computer software), and these exercise prescriptions (and print-out instructions) were expected
to change over time as the exercise programme was progressed. Physiotherapists were to encourage
exercise behaviour change using self-monitoring through use of the BEEP trial lower limb exercise diary to
record their adherence with their lower limb exercise prescription (see trial protocol188). In order to provide
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greater opportunity for individualisation, supervision and progression of exercise, patients were to receive
between six and eight one-to-one treatment sessions with their physiotherapist. Physiotherapists were to
provide advice about general physical activities and there were no scheduled follow-ups (refresher or
booster sessions) with the physiotherapist beyond 12 weeks.
Intervention 3: targeted exercise adherence
Adherence to long-term treatment regimes, particularly those involving behavioural components such as
exercise, is consistently lower than adherence to medication.15 Exercise adherence, irrespective of exercise
type, may be a key factor determining the success of exercise. In a previous trial of exercise for this patient
population, we observed high exercise adherence rates in the short term through to the end of treatment
at 12 weeks, which fell to just over 50% at 12 months.203 Long-term adherence to lower limb exercise is
perhaps unrealistic, as these can be challenging to incorporate into daily routines and individual lifestyles,
and many patients do not consider them enjoyable, stopping them once symptoms reduce or resolve. In
order to support engagement in and adherence to exercise, it may be more realistic to target general
physical activities that individuals have previously engaged in and enjoyed (as previous exercise behaviour
is, theoretically, the strongest source of self-efficacy information),215 or physical activities that individuals
have positive expectations about (as these positive expectations may increase exercise intentions and
ultimately exercise behaviour). Our previous ABC knee study216 highlighted the many different barriers to
and facilitators of exercise and physical activity, and that no single exercise type or exercise setting is
acceptable to all. Thus, we designed this TEA intervention to include an adherence-enhancing ‘toolkit’
of optional tools and techniques for physiotherapists to use with different participants, based on their
assessment of individual participants and early feedback from participants (see trial protocol188 for a
summary of the contents of the toolkit). The content of the intervention was directly informed by the
results of our Cochrane systematic review208 and a networking meeting supported by Arthritis Research
UK, during which national experts and patient representatives agreed the intervention. Although the
general physical activity that was identified and encouraged by physiotherapists was individualised for
participants, we anticipated that many may choose walking as it is seen as inexpensive and accessible.
Pedometers have been shown to increase step counts in older people217 and to generally increase physical
activity218 and, therefore, we included pedometers within the suite of options for physiotherapists to give
participants who wished to target increases in walking activity.
The BEEP trial protocol for TEA began with a focus on the lower limb (as in the ITE group) but transitioned
to focus increasingly on general physical activity adherence over time. In addition to prescribing an
individualised, progressed and supervised lower limb exercise programme, physiotherapists were trained to
assess patients’ current general physical activity levels, their intentions to increase their physical activity levels
and their attitudes to exercise for knee pain and general health, as well as exploring their individual barriers to
and potential facilitators of exercise. This group was to receive four treatments up to week 12 and a further
four to six contacts from week 12 through to 6 months (a total of 8–10 treatment contacts). In the first four
treatments, the aim was for participants to initiate and progress an exercise programme with supervision that
would include lower limb and general exercise, and to identify (with the support of the physiotherapist)
general physical activity opportunities within the local community that were suitable for, and of interest to,
the individual. Proactive follow-up from the physiotherapist from week 12 through to 6 months was
expected, using choices of telephone and face-to-face contact, providing an additional four to six contacts
with each participant. The aim was to enhance long-term exercise adherence, promote increased general
physical activity and encourage participants to develop an exercise and physical activity ‘habit’, shifting the
focus away from lower limb exercise in the earlier treatment sessions and towards sustainable lifestyle
changes in physical activity in later treatment sessions. The follow-up sessions were designed to ascertain and
promote exercise adherence and increases in physical activity levels, support patients to integrate exercises
into their activities of daily living, allow repetition and amendment of the exercise programme based on
individuals’ experiences or concerns, and support progression at a pace suitable for the individual. The
adherence enhancing ‘toolkit’ contained different educational, behavioural and cognitive–behavioural tools
and techniques for facilitating physical activity behaviour change, selected for use based on an individualised
assessment of each patient. As our Cochrane review identified that no one model of behaviour change was
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superior for facilitating adherence to exercise for chronic musculoskeletal pain, different theoretical models
underpinned the development of the toolkit, including self-efficacy214 and self-regulation theory.219
Educational tools included written education material on a range of relevant issues (including healthy eating
and pain medication) and individualised PhysioTools exercise sheets. Behavioural strategies included ‘How
exercise/physical activity feels’ and ‘How to monitor heart-rate’ guides to facilitate physical activity intensities
at moderate levels, self-monitoring through use of physical activity diaries,188 heart-rate diaries, a visual
feedback chart, and graded activity sheet, reminder post-cards for physiotherapists to post to patients, and
pedometers to support increases in walking. Cognitive–behavioural strategies included guides to questions
to elicit patients’ health-related beliefs; assessment of patient barriers and motivators; several ‘rulers’ to use
with patients to assess their readiness; perceived importance and confidence to engage in physical activity;
decisional balance sheets; specific, measurable, achievable, realistic, time-related (SMART) goal-setting and
behavioural contracting for physical activity to facilitate the translation of intention into physical activity
behaviour;212 and example templates to discuss and generate an individual exercise set-back plan. Finally,
physiotherapist-generated information about local physical activity opportunities and facilities in the
community were developed for each treatment site, with a focus on easy to access and inexpensive options.
The target by the end of the 6-month period was that participants would be engaged in physical activity
opportunities within their locality and have had support from the physiotherapist to overcome initial
problems or barriers in engaging in these activities. Therefore, the emphasis was on maintenance of physical
activity beyond the period of support from a health professional and NHS-based programme.
BEEP trial physiotherapy training programme
In the main BEEP trial, a total of 53 physiotherapists from 11 NHS clinics in the West Midlands and
Cheshire Physiotherapy Research Network were trained to deliver one of the three interventions within the
BEEP trial: UC, ITE and TEA. This training programme was finalised following the delivery of a draft training
programme in the pilot study to 11 physiotherapists from six NHS clinics.
Content of the training programme
The content of the BEEP trial training programme was informed by our previous national surveys of
physiotherapists and of older adults in the community with and without knee pain, and our Cochrane
review (described in Development). It primarily focused on the rationale and specific content of each
intervention, but also included practical information for physiotherapists about treating patients within
RCTs [e.g. the importance of blinding, working to intervention protocols, prevention of contamination and
summaries of procedures for serious adverse event (SAE) reporting].
The training programme was ‘stepped’, in that all physiotherapists attended the first day and received an
update about OA, based on the NICE OA guidelines.15 Key components of the first day included the
primary care (clinical) diagnosis of knee OA, the central role of exercise as a ‘core’ treatment for older
adults with knee pain, current physiotherapy practice for knee pain in older adults and OA, and the
comparison between current practice and guidelines.15,32,199,220
The second and third days were attended by physiotherapists delivering the ITE and TEA interventions and
focused on how to improve outcomes from exercise for older adults with knee pain. The importance of
individualisation, progression and supervision of lower limb exercise was highlighted from both physiological
and psychological perspectives. Exercise self-efficacy was discussed as an important predictor of exercise
behaviour214,215 and emphasis was placed on the importance of ‘selling’ exercise to patients. Tools to
facilitate physiotherapists to individualise, supervise and progress exercise were provided and practised,
including developing written individualised exercise programmes using PhysioTools computer software and
use of lower limb exercise diaries.
The fourth and fifth (final) days were only attended by physiotherapists delivering the TEA intervention and
focused on the importance of exercise adherence, the physiotherapist’s role in facilitating exercise and
physical activity behaviour change, and shifting from a lower limb exercise programme to physical activity
that might be more likely to be sustained in the long term. A number of behavioural models were drawn
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on within the TEA training programme, including self-efficacy214 and self-regulation theory.219 Each
physiotherapist was provided with their own ‘adherence enhancing toolkit’ containing multiple strategies
to be used on an individualised basis with patients to facilitate and sustain physical activity behaviour
change (described in Interventions development). Use of each strategy was practised through role play and
participating physiotherapists were encouraged to practise using the tools with patients in their routine
clinical practice, prior to the commencement of BEEP participant recruitment.
The training programme included lectures, interactive workshops, role play, group discussion, problem-solving
and case studies, with homework set to consolidate learning. In addition, approximately 10 months after the
training programme, all physical therapists were invited to attend a half-day workshop to share best practice
and discuss any challenges faced with other physical therapists delivering the same intervention. This was
designed to help support physiotherapists to deliver the treatments in line with the intervention protocols.
A total of 26 physiotherapists attended this additional workshop.
Evaluation of the training programme
We investigated whether or not taking part in the BEEP trial training programme increased physiotherapists’
confidence in managing older adults with knee pain and altered their intended clinical behaviour and their
attitudes and beliefs about the role of exercise for chronic knee pain, and explored whether or not the more
intensive training for physiotherapists delivering the ITE and TEA interventions led to greater changes in
these variables than in those physiotherapists delivering UC.
All physiotherapists were asked to complete a questionnaire before (pre training), immediately afterwards
(post training) and after delivering the BEEP trial exercise interventions (post intervention, approximately
12–18 months after their training). The content of the questionnaire was based on our previous national
survey of physiotherapists. It included a vignette describing a ‘typical’ patient ≥ 45 years with knee pain,
associated clinical management questions, attitude statements about the potential benefits of exercise
against which physiotherapists rated their level of agreement, and a measure of PSC in diagnosing and
managing older adults with knee pain (adapted from a scale developed for back pain161). In order to fully
describe participating physiotherapists, the pre-training questionnaire also included questions on their
clinical characteristics (e.g. number of years in practice and previous training undertaken on OA and
exercise therapy).
Analysis
Descriptive statistics were used to describe the sample as a whole, compare results over time (pre training,
post training and post intervention) and between the groups of physiotherapists trained to deliver each
BEEP trial intervention. Level of agreement with each attitude statement about the role of exercise for
knee pain was determined by the percentage of respondents who ‘largely’ or ‘totally agreed’. We defined
consensus as follows: 100% = unanimity, 75–99%= consensus, 51–74% =majority view, and 0–50% = no
consensus, in line with our previous research.216,220 Median scores were provided for the measure of
physiotherapists’ self-confidence in diagnosing and managing knee pain in older adults, as data were
positively skewed. Changes over time and differences between groups of physiotherapists (i.e. those
trained to deliver each BEEP trial intervention) were not tested for statistical significance owing to the
relatively small number of participating physiotherapists overall.
Results
In total, 52 out of the 53 physiotherapists returned the pre-training questionnaire, 44 (83%) returned the
post-training questionnaire and 39 (74%) returned the post-intervention questionnaire. The majority of
physiotherapists who took part in the training programme were female (63%), worked exclusively within
the NHS (67%), had treated at least one patient ≥ 45 years with knee pain per week (62%), and had not
received previous post-graduate training in the field of chronic knee pain (73%) or exercise therapy (62%).
The mean number of years of clinical experience was 14 (SD 11 years), but ranged from 1 to 42 years
(Table 22).
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Physiotherapists who did not return their questionnaires post training and post intervention were similar in
terms of the characteristics that were assessed to those who did complete and return their follow-up
questionnaires. Several had moved jobs or had maternity leave during the lifetime of the BEEP trial.
Self-confidence in managing older adults with knee pain
Before the training programme for the BEEP trial, physiotherapists had a median self-confidence score of 8
on a scale of 4–20 [interquartile range (IQR) 7–9]. Scores reduced post training and post intervention
(i.e. self-confidence increased) in physiotherapists who received the ITE and TEA training packages, but
remained the same in physiotherapists who received UC training (Table 23).
TABLE 22 Questionnaire response rate and characteristics of participating physiotherapists
Physiotherapist characteristics Total (N= 53)
UC
physiotherapists
(N= 15)
ITE
physiotherapists
(N= 22)
TEA
physiotherapists
(N= 16)
Questionnaire response
Pre training, n (%) 52 (98) 15 (100) 22 (100) 15 (94)
Post training, n (%) 44 (83) 12 (80) 17 (77) 15 (94)
Post intervention, n (%) 39 (74) 13 (87) 15 (68) 11 (69)
Number of years in practice
Mean (SD; range) 13.5 (11.1; 1, 42) 18.1 (12.0; 1, 32) 13.8 (12.1; 2, 42) 8.9 (6.4; 1, 23)
Male, n (%) 19 (37) 6 (40) 9 (41) 4 (27)
Work exclusively in NHS, n (%) 35 (67) 12 (80) 14 (64) 9 (60)
Number of patients usually seen aged ≥ 45 years with chronic knee pain
< 1 per month, n (%) 4 (8) 1 (7) 1 (5) 2 (13)
≥ 1 per month, n (%) 15 (30) 7 (47) 3 (15) 5 (33)
≥ 1 per week, n (%) 31 (62) 7 (47) 16 (80) 8 (53)
Received postgraduate training in chronic knee pain
Yes, n (%) 14 (27) 5 (33) 4 (18) 5 (33)
Received postgraduate training in exercise therapy
Yes, n (%) 20 (38) 3 (20) 12 (55) 5 (33)
Individual items may not add to totals due to missing data.
TABLE 23 Physiotherapists’ confidence in diagnosing and managing older adults with knee paina
Intervention group Pre training Post training Post intervention
UC 8 (8–10) 8 (6–8) 8 (5–8)
ITE 8 (7–8) 6 (5–7) 5 (4–7)
TEA 8 (5–10) 6 (4–7) 4 (4–6)
Total 8 (7–9) 6 (5–8) 5 (4–8)
a All scores are median (IQR) measured by the PSC scale, developed for use regarding patients with low back pain,
adapted for use regarding older adults with knee pain.122 This is the sum of four items of self-confidence in diagnosing
and managing older adults with knee pain, measured on a 5-point Likert scale. Lower scores indicate greater confidence
(potential range: 4–20).
DOI: 10.3310/pgfar06040 PROGRAMME GRANTS FOR APPLIED RESEARCH 2018 VOL. 6 NO. 4
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Hay et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
93
Intended clinical behaviour
Treatment approaches Pre training, the most commonly reported treatment approaches for the vignette
patient were exercise therapy (100%), heat/ice (69%), manual therapy (29%), acupuncture (15%) and
electrotherapy (12%). Post training, the reported use of exercise and heat/ice remained the same, but the
use of manual therapy, acupuncture and electrotherapy all reduced (to 27%, 5%, 2%, respectively). This
pattern was maintained post intervention 12–18 months later (to 10%, 5%, 8%, respectively) and was
evident across all groups of physiotherapists (data not shown), highlighting that participation in the BEEP
training programme appeared to effect a shift to a clearer focus on exercise therapy without the addition
of other treatment approaches.
At all time points, nearly all physiotherapists reported including advice within their treatment package.
This commonly focused on weight loss, pacing, use of heat/ice at home and analgesic use. Pre training,
only 45% of physiotherapists reported that they would provide advice about increasing general physical
activity. Although this increased post training (80%), this increase was only maintained post intervention
by physiotherapists who had attended the training programme for the ITE and TEA interventions
(Table 24).
Use of therapeutic exercise At all time points, local strengthening exercises and flexibility/range of
movement exercises were the most common types of exercise reported by physiotherapists for use with
the patient vignette described in the questionnaire. Pre training, only 17% of physiotherapists reported
that they would prescribe an aerobic training programme and 50% reported that they would prescribe
functional task training. Although this increased post training, particularly for physiotherapists trained to
deliver the TEA intervention, this was not maintained 12–18 months later (Table 25).
Pre training, most physiotherapists reported that they would provide written and verbal advice on home
exercises during the case vignette’s initial treatment session, but only 65% would supervise the exercise
TABLE 24 Types of advice included for the patient case vignette by participating physiotherapists
Advice type Pre training Post training Post intervention
Any 51 (98) 44 (100) 38 (97)
Weight loss 47 (92) 43 (98) 37 (97)
Pacing of activities 46 (90) 39 (89) 30 (79)
Use of heat/ice at home 44 (86) 42 (95) 33 (87)
Analgesia 41 (80) 39 (89) 31 (82)
Use of walking aids 23 (45) 19 (43) 18 (47)
Use of knee support 6 (12) 3 (7) 4 (11)
Increasing activity level
UC 8 (53) 10 (83) 7 (58)
ITE 8 (38) 14 (82) 12 (80)
TEA 7 (47) 11 (73) 8 (73)
Total 23 (45) 35 (80) 27 (71)
Data are number (%) unless otherwise stated.
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programme. Supervision during the initial treatment session increased post training (84%) and post
intervention (95%), a pattern that was seen across all three groups of physiotherapists (Table 26).
Changes in the delivery of exercise in follow-up treatment sessions differed according to the training package
received (see Table 26). In those delivering UC, approximately 50% reported that they would provide written
information on home exercises at all time points. Although the proportions reporting that they would supervise
exercise and deliver verbal advice on home exercise increased post training, this was not maintained post
intervention. Within the group of physiotherapists trained to deliver the ITE intervention, the proportions that
reported they would supervise exercise and provide verbal and written advice on home exercise increased from
pre training to post training, and this was maintained post-intervention. These patterns were also evident in
physiotherapists trained to deliver TEA. However, within this group, the proportion of physiotherapists who
reported they would deliver verbal advice on home exercise post training declined 12–18 months later (after
delivery of the BEEP intervention to trial participants).
Nearly all physiotherapists reported that they would check that the patient was completing their exercise
programme, mainly through observing technique of exercise and verbal questioning. Pre training, only 6%
of physiotherapists reported monitoring adherence using an exercise diary (UC 0%, ITE 10% and TEA
7%). This markedly increased in physiotherapists trained to deliver the ITE and TEA interventions after the
training programme (53% and 60%, respectively) and after the period of delivery of the BEEP interventions
12–18 months later (60% and 73%, respectively). It did not change in the group of physiotherapists who
were trained to deliver UC (post training 8%, post-intervention 15%).
TABLE 25 Types of exercise for the patient case vignette reported by physiotherapists
Exercise type Pre training Post training Post intervention
Local strengthening 52 (100) 44 (100) 39 (100)
Flexibility/range of movement 48 (92) 42 (95) 35 (90)
Proprioception/balance
UC 13 (87) 9 (75) 11 (85)
ITE 11 (50) 14 (82) 13 (87)
TEA 10 (67) 11 (73) 9 (82)
Total 34 (65) 34 (77) 33 (85)
Functional tasks
UC 8 (53) 10 (83) 10 (77)
ITE 12 (55) 15 (88) 11 (73)
TEA 6 (40) 14 (93) 7 (64)
Total 26 (50) 39 (89) 28 (72)
Aerobic training
UC 6 (40) 5 (42) 2 (15)
ITE 1 (4) 5 (29) 3 (20)
TEA 2 (13) 6 (40) 1 (9)
Total 9 (17) 16 (36) 6 (15)
Data are number (%) unless otherwise stated.
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Number and patterns of treatment
Pre training, physiotherapists reported that they would provide a mean of 3.25 (SD 0.46) treatment
sessions for the vignette patient. This remained stable over time in the physiotherapists trained to deliver
UC, but increased slightly in those trained to deliver the ITE and TEA interventions. Pre training, 40% of
physiotherapists reported offering the patient some form of follow-up after discharge from care. This
decreased post intervention in those trained to deliver UC and ITE, but increased in physiotherapists
delivering TEA. This group also changed how they would offer follow-up. Pre training, no physiotherapist
reported offering the vignette patient a telephone follow-up appointment. This increased to 45% post
training, which was maintained post intervention.
Attitudes and beliefs about the role of exercise for knee pain
Prior to the BEEP trial training programme, consensus was reached in only 2 out of the 13 attitude
statements relating to the perceived benefits of exercise for knee pain: ‘exercises are effective for patients if
a radiograph shows mild knee OA’ and ‘exercises are effective for patients if a radiograph shows moderate
knee OA’.161 Consensus was reached post training and then maintained post intervention on seven of the
attitude statements. Although consensus was reached post training on the effectiveness of exercises for
patients if a radiograph showed severe knee OA, this was not maintained post intervention. Consensus on
the statements ‘physiotherapists should prescribe general exercise for every patient with chronic knee pain’,
and ‘general exercise is safe for everybody to do’ was only achieved by the groups of physiotherapists
trained to deliver ITE or TEA, not in the group of physiotherapists delivering UC (Table 27).
TABLE 26 Exercise delivery for the patient case vignette
Action chosen by physiotherapist
Pre training Post training Post intervention
Initial
treatment
session
Follow-up
treatment
session(s)
Initial
treatment
session
Follow-up
treatment
session(s)
Initial
treatment
session
Follow-up
treatment
session(s)
Written information on home exercises
UC 15 (100) 8 (53) 12 (100) 7 (58) 13 (100) 7 (54)
ITE 22 (100) 14 (64) 16 (94) 15 (88) 15 (100) 12 (80)
TEA 13 (87) 10 (67) 15 (100) 11 (73) 11 (100) 8 (73)
Total 50 (96) 32 (62) 43 (98) 33 (75) 39 (100) 27 (69)
Verbal advice on home exercises
UC 14 (93) 8 (53) 11 (92) 9 (75) 11 (85) 7 (54)
ITE 19 (86) 15 (68) 15 (88) 14 (82) 13 (87) 13 (87)
TEA 14 (93) 9 (60) 15 (100) 14 (93) 10 (91) 8 (73)
Total 47 (90) 32 (62) 41 (93) 37 (84) 34 (87) 28 (72)
Supervision of exercises
UC 11 (73) 11 (73) 10 (83) 12 (100) 12 (92) 10 (77)
ITE 15 (68) 19 (86) 15 (88) 16 (94) 15 (100) 15 (100)
TEA 8 (53) 11 (73) 12 (80) 14 (93) 10 (91) 10 (91)
Total 34 (65) 41 (79) 37 (84) 42 (95) 37 (95) 35 (90)
Refer to exercise class/group 6 (12) 22 (42) 2 (5) 11 (25) 6 (16) 14 (37)
Refer to student/assistant/technical
instructor
5 (10) 15 (29) 1 (2) 7 (16) 2 (5) 13 (34)
Data are number (%) unless otherwise stated.
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TABLE 27 Physiotherapists’ agreement with attitude statements about exercise for older adults with knee pain [n (%) who largely or totally agreed]
Attitude statement
Pre training Post training Post intervention
Total
(n= 52)
UC
(n= 15)
ITE
(n= 22)
TEA
(n= 15)
Total
(n= 44)
UC
(n= 12)
ITE
(n= 17)
TEA
(n= 15)
Total
(n= 39)
UC
(n= 13)
ITE
(n= 15)
TEA
(n= 11)
Physiotherapists should prescribe local
strengthening exercises to every patient with
chronic knee pain
37 (71) 11 (73) 13 (59) 13 (87) 34 (77) 8 (67) 15 (88) 11 (73) 34 (87) 9 (69) 15 (100) 10 (91)
Physiotherapists should prescribe general
exercise, for example walking or swimming,
for every patient with chronic knee pain
30 (58) 9 (60) 10 (45) 11 (73) 32 (73) 8 (67) 13 (76) 11 (73) 29 (74) 8 (62) 12 (80) 9 (82)
Knee problems are improved by local
strengthening exercises
36 (69) 11 (73) 15 (68) 10 (67) 39 (89) 10 (83) 17 (100) 12 (80) 32 (82) 9 (69) 13 (87) 10 (91)
Knee problems are improved by general
exercise, for example walking or swimming
28 (54) 9 (60) 13 (59) 6 (40) 35 (80) 8 (67) 16 (94) 11 (73) 33 (85) 10 (77) 13 (87) 10 (91)
Local strengthening exercises for the knee are
safe for everybody to do
29 (56) 9 (60) 10 (45) 10 (67) 36 (82) 9 (75) 13 (76) 14 (93) 34 (87) 9 (69) 15 (100) 10 (91)
General exercise, for example walking or
swimming is safe for everybody to do
22 (42) 7 (47) 8 (36) 7 (47) 30 (68) 8 (67) 10 (59) 12 (80) 28 (74) 7 (54) 13 (87) 8 (73)
It is important that people with chronic knee
problems increase their overall activity
30 (58) 9 (60) 11 (50) 10 (67) 37 (84) 10 (83) 13 (76) 14 (93) 33 (87) 9 (75) 14 (93) 10 (91)
Exercises are effective for patients if a
radiograph shows mild knee OA
44 (86) 10 (67) 20 (91) 14 (100) 39 (89) 9 (75) 16 (94) 14 (93) 36 (92) 12 (92) 15 (100) 9 (82)
Exercises are effective for patients if a
radiograph shows moderate knee OA
41 (79) 9 (60) 18 (82) 14 (93) 39 (89) 9 (75) 16 (94) 14 (93) 36 (92) 12 (92) 15 (100) 9 (82)
Exercises are effective for patients if a
radiograph shows severe knee OA
21 (40) 4 (27) 10 (45) 7 (47) 34 (77) 6 (50) 15 (88) 13 (87) 27 (69) 6 (46) 15 (100) 6 (55)
Exercise works just as well for everybody,
regardless of the amount of pain they have
7 (14) 4 (27) 1 (5) 2 (13) 20 (45) 6 (50) 6 (35) 8 (53) 18 (46) 3 (23) 9 (60) 6 (55)
Increasing the strength of the muscles around
the knee stops the knee problem getting
worse
11 (21) 6 (40) 3 (14) 2 (13) 16 (36) 5 (42) 6 (35) 5 (33) 18 (46) 6 (46) 8 (53) 4 (36)
Increasing overall activity levels stops the knee
problem getting worse
6 (12) 6 (40) 0 (0) 0 (0) 18 (42) 5 (42) 6 (38) 7 (47) 19 (49) 4 (31) 9 (60) 6 (55)
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Discussion
We aimed to determine whether or not taking part in the BEEP trial training programme increased
physiotherapists’ confidence in managing older adults with knee pain and whether or not it altered their
intended clinical behaviours, attitudes and beliefs about the role of exercise for chronic knee pain in line
with the specific training package that they received.
Prior to the BEEP training programme, participating physiotherapists were already quite confident in their
ability to diagnose and manage older adults with knee pain. However, as seen in our previous national
survey of UK-based physiotherapists,201 there were some disparities between their intended clinical
behaviour and current clinical guidelines and exercise recommendations for knee OA.15,32 For example,
although nearly all physiotherapists reported that they would use therapeutic exercise and provide advice
as part of their treatment package, exercise was provided over relatively few treatment sessions, local
(lower limb) muscle-strengthening training was favoured over general physical activity, there was limited
supervision of exercise and there was a lack of focus on exercise adherence. There was also uncertainty
about the potential benefits of exercise for knee pain.
Directly after the training programme, there were some key changes in the intended clinical behaviours of
all groups of physiotherapists, including those who participated in only 1 day of training to support the
delivery of UC in the trial. Even within physiotherapists who participated in the UC training programme,
use of additional interventions (such as electrotherapy and manual therapy) alongside the exercise
programme reduced, there was a greater focus on general physical activity and functional task training,
supervision of exercise increased, and level of agreement with the attitude statements about the role of
exercise for knee pain also increased. Therefore, these results demonstrate that taking part in the BEEP trial
training programme was associated with changes in physiotherapists’ attitudes, beliefs and intended
clinical behaviours with regard to exercise for a typical patient case (an older adult with knee pain).
The results showed that changes in attitudes, beliefs and intended behaviours were more pronounced in
physiotherapists trained to deliver the ITE and TEA interventions. Within these groups, in addition to the
changes described above, the number of treatment sessions that physiotherapists reported that they would
provide also increased, more physiotherapists said they would monitor exercise adherence using an exercise
diary, and there was a higher level of agreement with more of the attitude statements about the role of
exercise for knee pain. In addition, their confidence in managing older adults with knee pain also increased.
This may be linked to the more specific, targeted content in the training programme about how to
individualise, supervise and progress exercise, and how to support longer-term exercise adherence. It may also
relate to the intensity and type of content within the training programme for each group of physiotherapists.
For example, the ITE and TEA training programmes included more time (in days) and more interactive sessions
than the single-day training programme underpinning UC. Previous research has identified that interactive
sessions are more effective than didactic educational techniques at facilitating behaviour change within
health-care professionals, including physiotherapists.221–224 However, even in physiotherapists who had
undertaken the training to deliver the ITE and TEA interventions, not all changes in intended clinical behaviour
and attitudes and beliefs were maintained over the longer term (12–18 months after completing the training
programme), a pattern seen in professional groups within other areas of health care.225 There may be several
reasons for this, including barriers at the level of the patient, the professional and the wider health-care
organisation. Multimodal approaches that not only address the exercise attitudes and beliefs and intended
behaviours of physiotherapists, but also identify and address other potential barriers to long-term behaviour
change in physiotherapists, are likely to be required to achieve greater or more sustained changes in these
variables over time.224,226,227
Although a large number of physiotherapists participated in the BEEP trial training programme (n = 53)
and we achieved good follow-up rates on their self-completed postal questionnaires after training (83%)
and 12–18 months later (74% response rate), the numbers were too small for robust statistical testing
to compare changes in beliefs, attitudes or intended behaviours over time and between groups of
physiotherapists delivering the three interventions. In addition, as with all survey research that utilises
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patient case vignettes, it is possible that intended practice behaviour in response to case vignettes may be
different from actual clinical practice.
Conclusions
Physiotherapists who participated in the BEEP trial training programme to deliver the ITE and TEA
interventions reported greater confidence in their ability to diagnose and manage older adults with knee
pain. For all groups of physiotherapists, the reported attitudes, beliefs and clinical behaviours about
exercise for chronic knee pain changed in line with the specific training package that they received. Some
of these changes appeared to be sustained through to long-term follow-up at 12–18 months following the
training programme and after the end of the period of treatment for BEEP trial participants, while others
reverted back towards pre-training levels. The intensity and content of the training programme delivered
seemed to be important, as changes in the survey variables among those physiotherapists delivering the
ITE and TEA interventions, who attended longer and more interactive training programmes, were greater
and more likely to be sustained. Whether or not these changes in physiotherapists’ self-reported behaviour
translated into changes in their actual behaviour for BEEP trial participants is determined by analysis of the
physiotherapy CRFs in the BEEP trial (see Interventions delivered and adverse events).
The BEEP pilot study
In preparation for the main BEEP trial, we conducted a small pilot study in two NHS PCTs to investigate the
feasibility of training physiotherapists in the new treatment approaches, the acceptability of the treatments
to patients and physiotherapists and to test the processes for the main trial. This section summarises the
BEEP pilot study and its objectives, methods and key findings, and highlights the key changes made to the
main BEEP trial protocol as a result of the learning from the pilot study.
Objective(s) of the pilot study
The primary objectives of the pilot study were to assess the feasibility and acceptability of the ITE and
TEA interventions.
The secondary objectives were to:
l test the training programme for participating physiotherapists and inform decisions about resource
allocation of staff to the three arms of the trial
l test ways to assess whether or not the interventions are delivered per protocol
l test ways to assess if the exercise programme is individualised and adherence achieved, using
physiotherapy CRFs, attendance at clinic sessions, physical activity questionnaires, exercise diaries
and accelerometers
l determine the most appropriate tool for measuring self-reported physical activity in the trial population
by comparing the PASE and IPAQ questionnaires
l test the recruitment processes, data collection methods and outcome measures to be used in the trial
to ensure they operate as expected and they record sufficient information about the detail and fidelity
of the interventions.
Methods
Setting
The pilot study was conducted in two PCTs which included a total of six physiotherapy clinics in the West
Midlands and Cheshire Physiotherapy Research Network.
Participants
We aimed to recruit approximately 45 patients in total for allocation to one of the three interventions over
a period of 6 months.
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Inclusion/exclusion criteria
Patients aged ≥ 45 years with knee pain or stiffness in one or both knees referred from general practice or
self-referred to physiotherapy were invited to participate. We deliberately chose not to restrict the pilot trial
to people with radiographically diagnosed knee OA to reflect current practice in which treatment choices
are made on the basis of symptoms rather than radiography findings. Therefore, we included people
typical of those seen in primary care and seeking health care.
Exclusions were patients with potentially serious pathology (e.g. inflammatory arthritis), those with previous
knee or hip replacement on the affected side(s), those already on a surgical waiting list for total knee
replacement, those who had severely restricted mobility or for whom exercise interventions were
contraindicated [e.g. those with unstable cardiovascular disorders (severe hypertension, unstable angina,
blood pressure > 220/120 mmHg)], and those who had received an exercise programme from a
physiotherapist or an intra-articular injection to the knee in the last 3 months. Normal recreational
involvement in physical activity was not an exclusion.
Recruitment and treatment allocation
In the pilot study, we used one method of patient identification and recruitment, which was identifying
patients who had been referred to physiotherapy by their GP for knee pain, as this had been successful in
one of our previous randomised trials.2 Potentially eligible patients were screened, by a member of the
physiotherapy clinical team, for key study eligibility (aged ≥ 45 years with knee pain or stiffness). If deemed
eligible, patients were contacted to ask them if they would like to receive information about the study. Those
who received the study information were then telephoned by a NIHR Clinical Research Network (CLRN) nurse
to screen further for eligibility. If eligible and willing to participate, patients were asked to sign and date a
consent form and return it, along with a baseline questionnaire, to the CLRN nurse. Once written consent
was received, the study co-ordinator allocated the patient to one of three intervention arms, following the
allocation process for the pilot study developed by the study statistician. Pilot testing of the randomisation
procedure was not needed as we have previously tested these procedures in similar trials.34,203
The BEEP pilot study interventions
Full details of the trial interventions are provided in Interventions. Table 28 provides a summary of
the interventions.
Pilot study training programme for physiotherapists
A comprehensive training programme for participating physiotherapists delivering the three BEEP trial
interventions was developed and delivered to 11 physiotherapists between April and May 2009 (full details
of the BEEP training programme for physiotherapists are provided in BEEP trial physiotherapy training
programme). The physiotherapists were asked to evaluate how helpful the training had been. They rated
each training session on a scale from 1 to 5 with 5 representing the highest level of satisfaction. All sessions
were rated highly (> 4.4). Minor changes only, such as the order and timing of the sessions, were made to
the main trial physiotherapy training programme as a result of the pilot study. Full evaluation of the BEEP
training programme for the main trial can be found in BEEP trial physiotherapy training programme.
Data collection
The acceptability, fidelity and feasibility of the interventions, processes, outcome measures and other
data recording methods were assessed using a combination of quantitative and qualitative data. The CRFs
were developed and used to capture relevant detail about the fidelity of the interventions, adherence to
intervention protocols (for UC, ITE and TEA interventions), the individualisation and progression of the
exercise programmes (for the ITE and TEA interventions) and the strategies used to encourage exercise
adherence and increased physical activity (for the TEA intervention). Acceptability of the interventions
was assessed through semistructured, one-to-one, qualitative interviews with seven patients and six
physiotherapists. All interviews were recorded with permission, anonymised and fully transcribed.
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The majority of interviews were conducted by telephone and the questions sought the perspectives of
interviewees about their experiences of being involved in the study and the interventions themselves, the
associated paperwork and communications with the study team.
Outcome measures
The primary objectives of the pilot study were to test feasibility and acceptability of the interventions.
However, we also collected patient self-report data at baseline (after patient consent) and follow-up at
3 and 6 months later, using self-complete questionnaires. The primary clinical outcome measure was
WOMAC.228 Full information on all the secondary outcomes used in the BEEP trial is given in Outcome
measures. In the pilot study, two measures of physical activity were included (IPAQ and PASE) in order to
determine which single measure of physical activity to use in the main trial, as neither had previously been
used in our trials with older adults with knee pain.
Ethics
Approval for the pilot study was obtained from Birmingham East, North and Solihull REC (09/H1206/77).
Analysis
The analysis was exploratory and provided data on the feasibility and acceptability of the interventions and
the required changes in the recruitment processes, data collection processes and outcome measures to be
used in the main BEEP trial. Interview data were analysed thematically.
Findings
Recruitment and follow-up rates
In total, 53 patients were identified as potentially eligible (31 from South Staffordshire PCT and 22 from
Shropshire County PCT) during the pilot study. Of these, 28 were screened as fully eligible, gave written
informed consent to participate and were allocated to one out of the three interventions. Thus, the same
recruitment method as a previous trial170 led to only 62% of target recruitment in the pilot study (28/45).
The overall consent rate of those potentially eligible was good, at 53% (28/53). The mean age of
TABLE 28 Summary of the BEEP trial interventions
UC ITE TEA
Up to 4 sessions 6–8 sessions 8–10 sessions
Over the course of 12 weeks Over the course of 12 weeks Over the course of 6 months
Advice and information booklet Advice and information booklet Advice and information booklet
Exercises selected from an agreed
written template
Individually tailored and written
exercise programme, aided by
written exercise templates
Written agreed personal plan that includes
general physical activity opportunities in local
community
Focus on lower limb (local)
exercise
Focus on lower limb (local) exercise Focus on both lower limb and general
exercise
Supervised and progressed as per
UC
Attention to careful individualisation,
progression and supervision
Attention to careful individualisation,
progression and supervision
No follow-up after 12 weeks No follow-up after 12 weeks Monthly follow-up and monitoring sessions
using educational, behavioural, and
cognitive–behavioural tools and techniques
within an adherence-enhancing toolkit
Reproduced from Foster et al.188 © 2014 Foster et al.; licensee BioMed Central Ltd. This is an Open Access article distributed
under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative
Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made
available in this article, unless otherwise stated.
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participants in the pilot study was 61 years (SD 7.3 years) and 56% were female. Twelve participants were
allocated an accelerometer to wear at baseline and at 3- and 6-month follow-up time points.
Treatment case report form data
The mean number of treatment sessions for each intervention arm was: UC 3.4 sessions (all patients had
between one and four sessions in line with the intervention protocol), ITE 6–8 sessions (two patients did
not have the protocolised number of sessions; one patient had four sessions and one had five sessions),
TEA 8–10 sessions (only two out of eight patients received the protocolised number of treatment sessions).
Only one protocol violation in terms of intervention content was reported during the pilot study (one
patient received acupuncture, yet acupuncture was excluded from the BEEP trial intervention protocols).
The treatment side effects that were reported on CRFs included muscle/joint soreness, pain, ache and
tenderness (n = 9, 38%). These are all expected and transient side effects of exercise programmes. The
CRFs also showed that all patients were given education and advice, and more than two-thirds had
supervised exercises in the clinic and were provided with a home exercise programme. CRFs showed that
the exercise and physical activity diaries were used as planned in the ITE and TEA intervention arms and
that participants within these trial arms also received an individualised exercise programme (as per
protocol).
Linked qualitative interviews
Thirteen semistructured qualitative interviews were completed after the 6-month follow-up time point in
the pilot study. The interview sample comprised six physiotherapists (one male and five female; two from
each trial arm) and seven patients (two male and five female; two from the UC arm, three from the ITE
intervention arm and two from the TEA intervention arm). Recruitment to participation in the interviews
was slower than anticipated. However, only one planned interviewee was not interviewed despite
numerous attempts. Table 29 provides a summary of the interview findings from both the patient and
physiotherapist interviews.
Outcome measures
Response to the baseline questionnaire was 96% (27/28). The 3- and 6-month follow-up rates were 71%
(20/28) and 57% (16/28), respectively. The primary outcomes (WOMAC pain and function) were well
completed at all time points with minimal levels of missing data (function score missing for one person at
baseline). Missing data rates for secondary outcomes were also low. We had no previous experience of
using the PASE or IPAQ so completion rates were particularly important to assess for these measures.
Unfortunately, an ambiguity in the PASE questions in the pilot study made it difficult to distinguish missing
data from those reporting that they did no exercise. This made comparison between the IPAQ and the
PASE difficult. This ambiguity within the PASE was corrected in the main trial and missing data rates were
further monitored in the main trial. The accelerometers provided good levels of data after the data
cleaning algorithms were applied, with 83% (10/12) of patients wearing accelerometers on ≥ 5 days out
of 7 days, for ≥ 10 hours on each day.
Table 30 provides descriptive information for key outcomes measured at the three time points in the pilot
study. Overall, the data showed that knee pain and function reduced from baseline and that a small
increase in physical activity occurred (as measured by the PASE). Small changes were also seen in the other
outcome measures. Outcomes between intervention arms were not compared in the pilot study.
Key changes from the BEEP pilot study
The key learning from the pilot study was related to challenges in participant recruitment using only one
recruitment method (from patients already referred to NHS physiotherapy services with knee pain). As a
result, two additional recruitment methods were added to the protocol for the main BEEP trial. The
recruitment methods for the main trial are fully described in Invitation, recruitment, consent and
randomisation.
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TABLE 29 Summary of key themes from qualitative interviews in the BEEP pilot study
Theme category Patient interviews Physiotherapist interviews
Common themes
(all arms)
Perceived benefits from the physiotherapy
treatment sessions
Limited time in treatment sessions seen as a
limiting factor in embedding exercise in patient
routines
Trust in the physiotherapist Study instructions were clear
Believed that they have been given appropriate
advice
Study team were approachable and accessible
Found trial information and instructions
comprehensive and clear
Training programme was highly rated
Pleased to be involved in research Involvement in research was valued
Satisfied with contact information and
opportunities during treatment but expressed a
desire for an information point in case of need
after the end of treatment
Key themes in UC Did not regard exercise as ‘treatment’ BEEP UC treatment reflects normal practice
Not fully convinced that general exercise
(e.g. walking) was beneficial
Increase in confidence from training
programme (e.g. about latest research)
Were now thinking about integrating more
activity into their everyday lives
Key themes in ITE Accepted exercise as necessary (e.g. walking) Having more treatment sessions in BEEP trial
enabled better assessment of ‘what works’ for
individual patients
Found ways to integrate exercise into daily
routines
Exercise diaries seen as useful aids for patients
and physiotherapists as reminders and
progress monitors
Intended to keep up increased exercise levels
but not always clear how they would do this
CRFs were felt to be good but would benefit
from more space to write comments
Exercise diaries useful initially but then ‘not
really needed’ because remembered to do the
exercises
Diaries useful as reminders of progress in early
stages when knee painful
Key themes in TEA Pedometers felt to be interesting and useful Greater number of treatment sessions/contacts
allowed physiotherapists to be more ‘creative’
and patient-centred with exercise
Keen to maintain exercise routines developed
during physiotherapy-led treatment sessions
Adherence-enhancing Toolkit contents were
rated highly
Gave examples of behaviour changes already
adopted (e.g. cycling 2 miles to provide daily
elder care instead of taking car)
Rarely used exercise contracts as felt
unnecessary unless patient particularly
resistant or with clear motivator
Certainty that activity is of benefit in
maintaining knee mobility and pain reduction
Pedometers perceived as useful
CRFs were felt to be good but limited room
for extended commentary
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The treatment CRFs from the pilot study showed that the BEEP interventions were deemed feasible and
acceptable to both participants and physiotherapists. UC and the ITE interventions were generally delivered in
line with the intervention protocols in terms of the number of sessions delivered and the content of treatment.
In contrast, the majority of patients allocated to receive the TEA intervention did not receive the number
of treatment contacts initially protocolised (between 8 and 10 contacts, which could be a combination of
face-to-face and telephone contacts). This issue was therefore particularly highlighted within the main BEEP
physiotherapy training programme, for which the importance of treating patients in line with the trial
intervention protocol was emphasised. Overall the training programme in the pilot study was well received
and only minor changes were made to the programme for the main trial.
The qualitative interviews in the pilot study established that both patients and physiotherapists were
generally positive about the BEEP trial and the interventions. However, it was recognised that there was a
need for some minor amendments to the format of the interview paperwork and the procedures for
telephone interviews, and more space for writing on the CRFs was also requested by the physiotherapists.
These amendments were made for the main trial.
In terms of the outcome measures used within the pilot study, these were generally well completed.
However, at 6 months the response rate to the follow-up questionnaire was lower than expected (57%).
In response to this we ensured that, for the main trial, minimum data collection procedures were in place at
the key timepoints (6, 18 and 36 months), as this has been shown to substantially improve response in our
previous trials.34,203 One of the objectives of the pilot study was to determine the most appropriate outcome
measure to assess self-reported physical activity within the main trial. We had no previous experience of
using the PASE and the IPAQ, so completion rates were particularly important to assess for these measures.
Following the pilot study and consultation with the independent Trial Steering Committee, the PASE was
chosen for use in the main trial for three reasons: (1) the scoring is simpler than the IPAQ, (2) it appears
easier for respondents to complete (all questions are closed form rather than open) and (3) it correlated
slightly better with the objective physical activity data from accelerometers (data not shown).
TABLE 30 Summary of patient outcomes in BEEP pilot study (all intervention arms are combined)
Outcome measure (range of possible scores) Baseline 3 months 6 months
WOMAC
Pain (0–20) 7.9 (3.3) 5.3 (3.7) 5.3 (3.9)
Stiffness (0–8) 3.3 (1.8) 2.6 (1.4) 2.4 (1.9)
Function (0–68) 27.1 (9.9) 19.0 (12.9) 16.4 (11.0)
SEE scale (0–10) 5.8 (2.3) 5.8 (2.0) 6.0 (2.0)
OEE
Positive scale (1–5) 3.9 (0.7) 4.0 (0.5) 3.9 (0.4)
Negative scale (1–5) 2.4 (0.8) 2.1 (0.8) 1.9 (0.6)
PASE (0–400) 181 (115) 263 (126) 247 (125)
IPAQ (mets): median (IQR) 2148 (988–4158) 3959 (1122–8800) 7038 (1998–7998)
QoL (EQ-5D-3L) (–0.59 to 1) 0.6 (0.2) 0.8 (0.2) 0.8 (0.3)
Subsample with accelerometry data (count per minute) 324 (166) 332 (150) 295 (84)
OEE, outcome expectations for exercise; SEE, Self-Efficacy for Exercise.
Figures are means (SDs) unless otherwise stated.
The calculation of the PASE outcome measure was not entirely accurate owing to an error on the pilot questionnaire. This error
was corrected for the main trial. WOMAC high score=worse outcome; PASE high score=more active; IPAQ high score=more
active; SEE high score=more confident that exercise can be done; OEE positive and negative subscales high score= higher
expectations that exercise will be beneficial; EQ-5D-3L high score= better health state; and accelerometry high score=more active.
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Aims and objectives
The overall aim of the main BEEP trial was to test, in older adults with knee pain attributable to OA,
whether or not pain and function outcomes can be improved through changing the characteristics of the
exercise programme in comparison to UC.
The research hypotheses were:
1. a physiotherapy-led, individualised, supervised and progressed lower limb exercise programme would be
superior to UC
2. a physiotherapy-led intervention targeting exercise adherence in the longer term and supporting the
transition from lower limb exercise to general lifestyle physical activity would be superior to UC.
Secondary objectives were to compare the cost-effectiveness of the two exercise interventions with the
cost-effectiveness UC, and to investigate differences in (1) the proportions of participants who could be
classified as treatment responders, (2) participants’ knee pain-related perceptions and expectations and
(3) participants’ exercise adherence and physical activity.
A linked qualitative study exploring participants’ views and experiences of the interventions was also
conducted in order to understand participants’ experiences of BEEP treatments and if, and how, the
treatments helped address participants’ barriers to exercise and physical activity in the short and long term.
Methods
Design
BEEP was a multicentre, pragmatic, three-parallel group, assessor-blind, superiority, individually randomised
controlled trial, comparing two physiotherapy-led exercise-based interventions with UC, plus embedded
qualitative interviews with a subsample of participants.
Participants were randomised (independently) at each treatment site, using block randomisation at a
1 : 1 : 1 ratio, to UC, ITE and TEA. The aim was to recruit 500 participants over a period of 18 months.
Each participant’s involvement with the trial was for 36 months, during which time they all had access to
usual primary care. The primary outcome was assessed 6 months from randomisation, but no analyses
were undertaken until the 18-month follow-up time point.
Setting and participants
Participants were recruited from 65 general practices and related physiotherapy services in the West
Midlands and North West regions of the UK. Treatments were delivered within physiotherapy centres in
five NHS PCTs within the geographical regions of the PCRN of the West Midlands North and the North
West. The practices and treatment centres included a mix of urban/suburban/semirural/rural settings.
Participants were eligible for inclusion if they were ≥ 45 years, had current knee pain and/or stiffness in one
or both knees, were able to read and write in English, were willing to participate, able to give full informed
written consent and had access to a telephone (for minimum data collection). We deliberately chose not to
restrict the BEEP trial to people with radiographically diagnosed knee OA in order to reflect current clinical
practice and national guidance,15 in which treatment choices are made on the basis of symptoms rather than
on radiographical findings. Therefore, we included people typical of those seen in primary care. Patients who
were recruited through the population survey and the record reviews at participating general practices had
to have a Chronic Pain Grade229 severity of between 2 and 4, determined through a brief postal screening
survey (see Invitation, recruitment, consent and randomisation). This ensured that participants had a mean
level of pain and functional difficulty similar to those patients referred to physiotherapy (determined from our
previous trials34,203) and that the interventions would therefore be suitable for such patients. Chronic Pain
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Grade 2 to 4 categories have been reported as a clinically significant group of knee pain patients in other
studies.50,229,230
Exclusion criteria were those with potentially serious pathology (such as inflammatory arthritis, malignancy),
those who had a total hip or knee replacement on the affected side, those who were on a waiting list for
a total knee or hip replacement, those for whom their knee problem was caused by a recent trauma
(sports injury, fall or accident), those for whom exercise interventions were contraindicated (such as those
with unstable cardiovascular disorders, severe hypertension, unstable angina or congestive heart failure),
those who had received an exercise programme from a physiotherapist or a knee joint injection in the last
3 months, those resident in nursing home accommodation, those so severely physically restricted that they
could not get to the physiotherapy treatment centres, and those who had a close family member already
participating in the BEEP trial. Normal recreational involvement in physical activity was not an exclusion
criterion.
Invitation, recruitment, consent and randomisation
Identification of potentially eligible participants
The key learning point from the pilot study was the need to increase recruitment to identify all potentially
eligible participants. Therefore, in the main BEEP trial, participants were identified in one of three ways:
(1) from general practice computer record reviews to identify those who have consulted for knee pain in
the last 12 months, (2) from a population survey of older adults registered with participating practices and
(3) from patients referred from their general practice to physiotherapy services for knee pain. The above
three recruitment methods proceeded in parallel until the sample size required was reached, although
methods 1 and 2 were operationalised in different GP practices. The recruitment methods are described in
more detail in numbers (1), (2) and (3) below. Duplication checks ensured that eligible participants were
not invited to the BEEP trial more than once. Figure 8 shows a summary flow chart of BEEP trial recruitment
and reasons for ineligibility.
1. General practice record review
Members of the PCRN informatics team, contracted to work in the participating general practices,
screened computer records for adults aged ≥ 45 years who had consulted with knee pain in the last
12 months at the practice. The electronic screen identified patients based on the 14 most frequent
knee pain-related Read codes informed by our previous research.116 Read codes are the standard clinical
terminology system that GPs enter onto their computer systems in the UK, identifying patients’ clinical
symptoms and diagnosis. In addition, the electronic screening protocol excluded those with potentially
serious pathology (e.g. inflammatory arthritis such as rheumatoid arthritis and malignancy) and those in
nursing home accommodation. GPs were invited to screen the sample list and exclude those patients
whom they considered inappropriate to be invited to participate in the trial. PCRN staff then
administered the mailing of a short screening questionnaire to check eligibility and determine the
patient’s Chronic Pain Grade classification.201 Patients recruited through this method had a Chronic Pain
Grade severity of between 2 and 4. The final section of the brief screening questionnaire asked patients
if they would be happy to give their consent for further contact. Patients returned their screening
questionnaires to the Arthritis Research UK Primary Care Centre at Keele University and only those who
appeared to be eligible and consented to further contact formed the sample that was sent information
about the BEEP trial.
2. Population survey
Older adults (aged ≥ 45 years) registered with participating general practices were posted a short
screening questionnaire to identify potentially eligible trial participants. GPs were invited to screen the
mailing list and exclude those patients whom they considered inappropriate to be invited to participate
in the trial. This screen was used to identify those in the community with knee pain of sufficient severity
to be included in the BEEP trial229 and to exclude those who did not meet the eligibility criteria. Patients
recruited through this method had a Chronic Pain Grade severity of between 2 and 4. The final section
of the brief screening questionnaire asked older adults registered with the practice if they would be
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happy to give their consent for further contact. Those who were eligible and consented to further
contact formed the sample that was sent information about the BEEP trial.
3. Physiotherapy service referrals
Older adults (aged ≥ 45 years) with knee pain and/or stiffness referred by their GP or who self-referred
to participating physiotherapy services were first screened by a member of the physiotherapy service
team for key eligibility criteria. Those potentially eligible were contacted by a PCRN research nurse to
find out if they were willing to receive further information about the BEEP trial.
Adults ≥ 45 years
registered at 63 GP practices
(estimateda n = 216,782)
Knee pain consultation in the
last 12 months
(n = 7611)
No knee pain consultation
in the last 12 months
(estimateda n = 209,171)
Adults ≥ 45 years
registered at two GP practices
(n = 3476)
Excluded prior to mailing
(n = 53)
Excluded prior to mailing
(n = 30)
• Already invited by the
   physiotherapy referral 
   method, n = 2
• Administrative error, n = 25
• Incomplete patient 
   details, n = 1
• Reason unknown, n = 2
• Already invited by the
   physiotherapy referral method,
   n = 3
• GP screen, n = 36
• In a care home, n = 13
• Reason unknown, n = 1
Mailed a screening survey
(n = 11,004)
Eligible for nurse phone call to
determine eligibility
(n = 1313)
Excluded
(n = 5659)
Adults > 45 years referred
to physiotherapy with knee pain
(n = 370)
Eligible for nurse phone call to
determine eligibility
(n = 217)
Not willing or eligible
to receive study
information
(n = 153)
Randomised
(n = 526)
Ineligible
(n = 1004)
Returned a screening survey to
be assessed for eligibility
(n = 5345)
Ineligible
(n = 4032)
GP population surveyGP medical record review
Physiotherapy referrals
FIGURE 8 BEEP recruitment flow diagram. a, Based on the 2012 practice size data from the NHS Information
Centre for Health and Social Care.231
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Recruitment and consent of participants to the BEEP trial
From recruitment methods (1), (2) and (3) above, those who met the eligibility criteria and agreed to
further contact were posted information about the BEEP trial [a cover letter, a participant information sheet
(see trial protocol188), a baseline questionnaire, a consent form and a freepost return envelope]. No less
than 48 hours after receiving the posted information, a PCRN nurse telephoned the person to further
check and confirm eligibility. This check covered the full eligibility criteria in order to ensure that only those
who met these criteria were recruited to the trial. In addition, the nurse screened out individuals with
known unstable cardiovascular disorders and those who had such severely restricted mobility that they
could not get to the physiotherapy clinics for treatment. All potentially eligible participants had the
opportunity to discuss the trial with the research nurse prior to deciding whether or not to participate.
Those who wished to take part in the trial were asked to sign and date the written consent form,
supported by the research nurse over the telephone, and they returned it along with their completed
baseline questionnaire to the nurse in a pre-paid envelope. Those who did not wish to take part were
asked to indicate this on the consent form and to return it to the nurse in the pre-paid envelope provided.
This consent process had been tested in the pilot study and regular audits of the nurse telephone calls
formed part of the quality assurance procedures of the BEEP trial. It was possible, based on this consent
method, that a very small number of participants in the BEEP trial would be found to be subsequently
ineligible, as it was only after consent that participants had a detailed physical assessment by a BEEP trial
physiotherapist. Examples of this were expected to include a very small number of participants who had
radiating leg pain from a spinal problem or a hip joint problem with referred pain in the area of the knee.
Participating general practices were supported to assist with identification of potentially eligible participants
for the BEEP trial through small practice payments to reimburse their time for screening patient lists.
Physiotherapy services were supported to participate through financial reimbursement for the time taken
out from service delivery for the training programme and additional time for BEEP treatments. Participants
did not receive any financial incentives to return screening questionnaires, to take part in the trial or to
return their follow-up questionnaires.
Randomisation and allocation concealment
Following receipt of a signed consent form and baseline questionnaire, the BEEP trial administrator
randomised the participants using a computer-generated randomisation schedule provided by the
musculoskeletal clinical trials unit (CTU) at Keele University, which was password-protected to ensure that
research nurses and trial statisticians remained blind to treatment allocation. Participants were individually
randomised to one of the three treatment groups in a 1 : 1 : 1 ratio using random permuted blocks of
size 3. To ensure that patients at each physiotherapy clinic had a chance of receiving any of the interventions,
randomisation was stratified by physiotherapy clinic. Following randomisation, the trial co-ordinator liaised
with the appropriate physiotherapy clinic staff to arrange the first appointment for each trial participant.
The patient was then informed in writing of the date, time and location of their first appointment in the
physiotherapy clinic. The GP of each trial participant was sent a letter to confirm that their patient was taking
part in the BEEP trial. Thus, our procedures ensured that baseline data were collected prior to randomisation,
that the allocation was concealed until after the patient was recruited into the trial and until the moment of
randomisation, and that the person assigning participants to intervention groups (study administrator) had
no involvement in the eligibility screen, consent or treatment processes.
Interventions
The interventions were delivered by 47 physiotherapists (15 UC, 17 ITE and 15 TEA) in participating
physiotherapy centres in five NHS PCTs. All participants received an advice and information booklet (which
included information about the value of specific lower limb and general exercise and simple self-help
messages such as the use of analgesics and home heat therapy for pain relief, see trial protocol188 for a
copy of the advice booklet) and a home exercise programme. Different physiotherapists were trained to
deliver each of the three interventions. Each of the three intervention groups were detailed previously in
Interventions and development, with supporting explanation and justification (see Table 28 for a summary
of the interventions). They are all examples of complex interventions as they involved a number of separate,
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but interacting, components that were likely to be important to the success of the intervention.136 Although
the key outcomes were knee pain and disability, the interventions were all behaviour change interventions
focused on exercise and physical activity behaviour change.
All participants continued to be able to access usual primary care in addition to BEEP treatment. This could
include ongoing or new medications, further health-care consultations with other health professionals, and
referrals for imaging and surgical opinion, as well as surgical procedures, and these cointerventions were
recorded on participants’ follow-up questionnaires. For the purposes of the trial, physiotherapy services
could contact participants who failed to attend their treatment sessions up to three times in order to try to
(re)engage the participant in BEEP treatment sessions. Hydrotherapy, group-based sessions, acupuncture
and intra-articular injections were not permitted in any of the BEEP trial treatment protocols. Intervention
fidelity was assessed through audits of treatment data collected in trial-specific CRFs (comparing these data
with the intervention protocol and with the physiotherapy clinical records). We collected data on the
number and content of BEEP treatment sessions using physiotherapy CRFs in all three treatment groups
and used those data in our interpretation of the trial results.
Outcome measures
Primary outcomes
This trial had two primary outcomes, lower limb pain and function, measured using the WOMAC Index228
collected at baseline and all follow-up time points (3, 6, 9, 18 and 36 months). The primary time point
was 6 months after randomisation. The primary comparisons were between each of the two new
physiotherapist-led exercise interventions (ITE and TEA) versus UC. The psychometric properties of the
WOMAC228 have been extensively studied in knee pain populations in clinical trials of different interventions
including exercise89,232 and the WOMAC has been recently shown to be the most responsive of five pain
measures.233 The pain subscale ranges from 0 (no pain) to 20 (maximum pain) and the function subscale
ranges from 0 (no disability) to 68 (maximum disability). It is particularly suitable for the BEEP trial as it
specifically captures self-reported pain during activities and the degree of difficulty with everyday physical
activities, both of which are key treatment targets of physiotherapy-led exercise.
Secondary outcomes
A range of secondary outcomes were collected: the proportion of treatment responders using the
internationally agreed OMERACT clinical responder criteria200,201 that combine data on pain and function
from the WOMAC228 with patient’s global assessment of change (recorded using a 6-point Likert scale);
physical activity levels (PASE, which assesses physical activity levels over a 1-week period combining physical
activity from several domains including household, occupational and leisure);169 self-reported BMI (calculated
from self-reported height and weight); exercise adherence (attendance at treatment sessions, self-reported
adherence to prescribed exercise programme); use of local physical activity facilities in the previous 7 days
(single item); a modified version of a measure of treatment acceptability and credibility;234,235 a measure of
illness perceptions (Brief Illness Perceptions Questionnaire236); confidence in ability to exercise [Self-Efficacy
for Exercise (SEE) scale237]; outcome expectations from exercise [Outcome Expectations for Exercise (OEE)
scale 2238]; anxiety [seven-item Generalised Anxiety Disorder Assessment (GAD-7)239]; depression [Patient
Health Questionnaire (PHQ) depression scale240]; self-reported health-care resource use (both NHS and
private health care); and overall health status (EQ-5D-3L241). Resource use and EQ-5D-3L data were used in
the cost–utility analysis (further details are provided in Health economic analysis).
Accelerometry outcomes
Physical activity was also measured in a subsample of participants (n = 89 of the 90 initially planned)
through snapshots of 7-day accelerometry at each follow-up time point. Accelerometers are motion
sensors worn on the hip and were used to estimate physical activity as counts per minute, time spent in
light, moderate and vigorous physical activity and proportions of participants who met guideline levels of
physical activity.242 Accelerometers were allocated at the point of randomisation. The accelerometer units
were posted out to the participants with full instructions. Participants were asked to wear the unit during
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waking hours for 7 consecutive days and then to post the unit back to the research centre where the data
collected were downloaded and analysed. During the trial, accelerometers were allocated at regular intervals
(approximately monthly) to the next three participants randomised to each treatment group. A random
allocation procedure was not used as not all participants were willing to wear them. A regular accelerometer
allocation procedure was needed to enable accelerometers to be available to collect data (at baseline and
follow-up) from a pool of 30 accelerometers available for the trial. The allocation procedure was phased in
at the start of the trial to ensure that the system was running smoothly and that accelerometers were being
returned in time to be reused by other participants. Those who did not return their accelerometers were
posted a written reminder.
Follow-up
Outcome measures were collected by self-report, postal questionnaire before randomisation and at 3, 6, 9
and 18 months (Table 31). They are also being collected at 36 months follow-up for further analysis in the
future. Therefore, adherence to exercise was measured twice throughout the early phase (0–6 months) and
three times during the maintenance phase of the exercise interventions (≥ 9 months). Non-responders were
followed up using our standardised CTU follow-up procedures for trials. This comprised a questionnaire, a
reminder postcard at 2 weeks and a further copy of the questionnaire at 4 weeks. For participants who did
not respond to any of these reminders, we attempted to collect minimum outcome measure data via
telephone (by research nurses who were blind to treatment allocation) and by post at key outcome time
points (6, 18 and 36 months) in order to try to capture primary outcome data and to minimise missing data.
Quality assurance processes within the CTU ensured that training and auditing of the research nurses
conducting minimum data telephone calls. In order to reduce participant burden, the 3 and 9 month
questionnaires were slightly shorter than those at 6, 18 and 36 months. As direct measures of physical
activity may themselves increase physical activity, similar measures of physical activity were used in each
intervention group. Table 31 includes a list of all measures and the time points at which they were
collected.
Adverse events
The occurrence of adverse events from all interventions was monitored and assessed using CRFs. An
expected minor and transient adverse event from unaccustomed exercise and physical activity is temporary,
mild muscle soreness. Physiotherapists delivering the interventions were to advise participants about how
to manage such symptoms. Each physiotherapy site was asked to report any SAE experienced by a trial
participant immediately to the trial chief investigator that may possibly be related to either the interventions
or the trial procedures.
Other data
Other variables collected in participant questionnaires were age, sex, marital status, comorbidities, pain
location using a pain manikin, duration of the knee problem, experience of exercise and work status. The
following process data were also recorded from the physiotherapy CRFs: number of treatment sessions
attended, the main content of each treatment, physiotherapists contact time with participants, the number
of treatment withdrawals and treatment non-attendances.
Sources of bias
Selection bias at recruitment was avoided by separating the processes of determining patient eligibility and
treatment allocation and by using random permuted blocks overseen by the CTU, thereby not permitting
physiotherapists assessing and treating patients to predict the next allocation in their clinic. Trial participants
knew they were having physiotherapy-led exercise and had been given brief details about the three
interventions in the patient information (see trial protocol188). It was not possible to blind physiotherapists
but they delivered treatment to participants in only one of the three intervention groups. A PCRN nurse blind
to treatment allocation obtained informed consent and oversaw the collection of baseline and follow-up
questionnaire data and collected minimum data over the telephone. An evaluation of the success of
nurse-blinding procedures was completed and a procedure for reporting incidents in which blinding has
been compromised was in place.
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TABLE 31 Summary of outcome measures
Data collection Measurement scale
Time points
(months)
Participant characteristics
Age Years 0, 3, 6, 9, 18, 36
Sex Female/male 0, 3, 6, 9, 18, 36
Weight Stones and lbs, or kg 0, 3, 6, 9, 18, 36
Height Feet and inches or centimetres 0
Marital status Married/separated/divorced/widowed/cohabiting/
single
0
Work factors
Current/most recent job title Free text 0, 6
Currently in a paid Job Yes/no 0, 6
Working hours Working full time (≥ 30 hours per week) 6
Working part time (≤ 29 hours per week)
Time off because of knee pain including
time off to visit any health-care professional
Yes/no (during last 6 months) 6
How many days, weeks or months were you
absent from work due to knee problem
Number of days/weeks/months (during last
6 months)
6
Knee problem
Knee with more discomfort Tick boxes for left or right 0
Duration of knee problem In the last 12 months/≥ 1 year but < 5 years
ago/≥ 5 years but < 10 years ago/I have had this
knee problem for ≥ 10 years
0
Global assessment of change in knee
problem
Completely recovered/much better/better/no
change/worse/much worse (since the last
questionnaire)
3, 6, 9, 18, 36
Knee pain (WOMAC228) 0–20 0, 3, 6, 9, 18, 36
Stiffness (WOMAC228) 0–8
Functiona (WOMAC228) 0.68
Illness perceptionsa (IPQ-brief modified for knee pain236)
Consequences 0–10 0, 3, 6, 9
Timeline 0–10
Personal control 0–10
Treatment control 0–10
Identity 0–10
Concern 0–10
Understanding 0–10
Emotional response 0–10
continued
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Data entry, coding, security, storage and management followed the standard operating procedures in the
musculoskeletal CTU at Keele University. Data enterers received training in line with CTU procedures and
were blind to the identification of the three intervention groups. Random 10% data entry accuracy checks
were conducted at regular intervals and data accuracy was audited and accuracy rates recorded. The trial
statistician remained blind until after the creation of a locked analysis data set at 18-month follow-up and
the completion of the primary and secondary analyses.
TABLE 31 Summary of outcome measures (continued )
Data collection Measurement scale
Time points
(months)
Physical activity and exercise
Experience of exercise Personal experiences of exercise 0
Use of local facilitiesa Use of local facilities for physical activity in the last
7 days
0, 3, 6, 9, 18, 36
SEE 0–10 (SEE scale237) 0, 3, 6
OEE 1–5 (OEE-2238) 0, 3, 6
Physical activitya 0–400 + (PASE170) 0, 3, 6, 9, 18, 36
Exercise adherence and treatment credibility Confidence in, and adherence to, treatment plan 3, 6, 9, 18, 36
Accelerometrya Average counts per minute For a subsample
of participants 0,
3, 6, 9, 18, 36Meeting physical activity guidelines (DH Start
Active Stay Active242)
General health and well-being
Depressiona 0–24 (PHQ-8240) 0, 3, 6, 9, 36
Anxietya 0–21 (GAD-7239) 0, 3, 6, 9, 36
QoLa –0.59 to 1 (EQ-5D-3L241) 0, 3, 6, 9, 18, 36
Body manikin (pain) Body area shaded to represent pain in the previous
4 weeks that had lasted a day or longer
0
Managing your knee problem
Current medication for knee problem Prescribed and over-the-counter medications (with
dosage)
0, 3
Prescribed medication for knee problem Prescribed medications in the last 6 months/
18 months (with dosage and length of supply)
6, 18, 36
Cost of over-the-counter treatments/
appliances
For example, painkillers, anti-inflammatory drugs,
TENS machine, hot and cold packs, knee supports
(£ in the last 6 months/18 months)
6, 18, 36
Health-care utilisation Contact with NHS and private health-care
professionals, number of visits/inpatient stays,
types of investigations/treatments in the last
6 months/18 months
6, 18, 36
IPQ-brief, Brief Illness Perception Questionnaire; OEE-2, Outcome Expectations for Exercise scale 2; PHQ-8, Patient Health
Questionnaire 8; TENS, transcutaneous electric nerve stimulation.
a Measure used as an outcome to test for clinical effectiveness (along with BMI and the OARSI responder criteria,201 not
indicated on this table as derived by combining individual measures of height and weight for BMI and WOMAC pain and
function with global assessment of change for the OARSI responder criteria).
Reproduced from Foster et al.188 © 2014 Foster et al.; licensee BioMed Central Ltd. This is an Open Access article distributed
under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative
Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made
available in this article, unless otherwise stated.
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We compared available variables between consenting and non-consenting individuals, trial participant
withdrawals and completers to evaluate external validity. All participants were free to withdraw from
the trial at any time without having to give any explanation. When possible, we collected information
about the reasons for withdrawal from the trial. Using validated outcome measures helped to reduce
measurement error. Treatment was recorded by physiotherapists in standardised formats and audits of
these CRFs were undertaken throughout. Feedback to physiotherapists delivering the interventions was
provided, when necessary, so they can try to modify and improve the delivery of the interventions. Each
intervention was supported by a specific protocol and documentation, developed for the BEEP trial and
previously tested in the pilot study.
Sample size and power
The sample size for the main trial was based on the primary outcome measures: WOMAC pain and function
subscales228 compared at 6 months post randomisation between the UC group and either of the two other
intervention groups. The timeframe selected was 6 months because our TOPIK trial34 showed the benefits
from exercise had reduced by this point with UC in comparison with usual GP-led care and advice only. The
BEEP trial was powered to detect an effect size of 0.35 for both WOMAC pain and function, an effect size
classified as ‘small’ to ‘moderate’ using standard benchmarks by Cohen.81 We chose to power the trial based
on a specified effect size (rather than minimum important change) as Terwee et al.243 reported a lack of
consensus as to minimum important change on the WOMAC. From our previous trials,203 we estimated that
the SD for WOMAC pain and WOMAC function at 6 months’ follow-up would be 5 and 17, respectively.
Therefore, an effect size of 0.35 equated to a 1.75-point difference on WOMAC pain and a 5.95-point
difference on WOMAC function. To achieve 80% power and a 5% significance level (two tailed), we
required 129 patients per treatment group, giving a total sample of 387 patients.244 Allowing for a 20%
loss to follow-up rate (informed by our previous knee pain trials34,203), we aimed to randomise a total of
500 participants to the trial over a period of 18 months.
For practical reasons, the sample size was not inflated to allow for clustering of individual patients being
treated by the same physiotherapist,245,246 but rather the trial provides useful estimates of clustering effects
and we adjusted for therapists in a sensitivity analysis. We anticipated that a minimum of 36 physiotherapists
(12 per treatment group) would be trained to deliver the trial treatments and that each physiotherapist
would treat approximately 18 patients. Thus, at the end of the trial, we anticipated being able to estimate
an ICC to inform future similar trials.
A formal power calculation was not completed to determine the number of patients to wear an
accelerometer. The aim to include 30 per group (a total of 90) was based on practical considerations
(restricted by the number of accelerometers available for data collection) and on having a reasonable
sample size to analyse the data using parametric statistics.
Statistical analysis
The trial statistical analysis plan was conducted and reported using Consolidated Standards of Reporting
Trials (CONSORT) guidelines245–248 and agreed by the BEEP Trial Steering Committee and Data
Monitoring Committee.
Recruitment and follow-up
The numbers of participants identified and recruited using each recruitment method are reported in a flow
chart, along with the numbers of participants returning a questionnaire at each follow-up stage. The baseline
characteristics of participants are reported for the three treatment groups (to explore the effectiveness of
randomisation) and for those with and without data at each follow-up time point (to explore any selective
loss to follow-up).
Primary and secondary trial analysis for clinical outcomes
The primary and secondary trial analyses were conducted blind to intervention group by the statistician and
an independent statistician verified the analysis of the primary outcomes. The primary analysis compared
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each of the ITE and TEA interventions with UC on an intention-to-treat basis for the primary outcome at
6 months post randomisation. Secondary analysis included the analysis of the primary outcome at the
secondary end points (3, 9 and 18 months) and analysis of the secondary clinical effectiveness outcomes at
all follow-up time points. Estimates of clinical effect were derived using analysis of covariance (ANCOVA)
for continuous outcome measures and logistic regression for categorical outcomes and are presented as
mean or percentage differences (as appropriate) with 95% CIs after adjustment for covariates defined a
priori as:
l baseline for the outcome of interest (baseline adjustment is not relevant for the OARSI responder
criteria as it incorporates baseline levels of knee pain and function into the follow-up outcome)
l age
l sex
l duration of the knee problem
l physiotherapy treatment centre (as was used in the randomisation algorithm).
A secondary analysis modelled the longitudinal trajectory of WOMAC pain and function over time (the
primary outcome) and the PASE physical activity measure using generalised estimating equations. Model
predictors included the a priori covariates listed above (with the baseline for the outcome of interest
modelled as a covariate rather than outcome as recommended by Peduzzi et al.249), time, treatment and a
time × treatment interaction. A linear model was fitted to the data (with time as a continuous measure)
initially; however, if the trajectory over time was non-linear, quadratic or cubic terms were explored. We
also explored whether or not conclusions differed if time was represented in the model as a categorical
variable. All model estimates were presented with 95% CIs derived using robust standard errors. The
primary and secondary trial analyses were conducted after imputation of missing data. Missing data was
imputed using the multiple imputation routines in Stata version 12. All primary and secondary clinical
effectiveness outcomes (excluding accelerometry) were included in the imputation model and had their
missing data imputed. The intention-to-treat analysis included participants who were treatment protocol
violators, but did not include participants who were post-randomisation exclusions. Information on any
adverse events is reported.
Sensitivity analysis for clinical outcomes
The following sensitivity analyses were completed and are reported.
l Therapist effects: these were explored by adding a random-effect term (to represent the treating
therapist) to the main treatment models. The models with and without the therapist effect were
compared at each outcome time point to explore the impact of the treating therapist on the effect
estimates obtained.
l Imputation of missing data: a complete case analysis was conducted and the results from this
compared with those from imputed data.
l Model covariates: treatment models were run on an unadjusted basis to investigate if the inclusion of
model covariates had an impact on the main trial findings.
l A per-protocol analysis: this was completed on the subsample of participants judged to have received
treatment in line with the specified treatment protocols. Criteria for determining the per-protocol group
assignment were established by the Trial Management Group and approved by the Trial Steering
Committee before analysis began.
Exploratory subgroup analysis
A specific subgroup analysis with strong theoretical rationale compared the clinical outcomes of pain
and function of those who reported high exercise adherence with those who reported lower exercise
adherence. We hypothesised that those who reported higher adherence would have improved pain and
function outcomes.
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Analysis of adherence data
Descriptive statistics were used to examine exercise adherence and were reported as numbers and
percentages, or means and SDs, as appropriate. Exercise adherence was measured by reporting the
number of treatment sessions attended in each treatment group and by reporting the following measures
at each follow-up time point:
l self-reported exercise adherence (measured by agreement with the statement ‘I have been doing my
exercises as often as I was advised’)
l frequency and duration of physiotherapy exercise completed by the participant
l change (from baseline) in level of physical activity (measured by PASE and, in a subsample of
participants, accelerometry)
l self-reported use of local exercise and physical activity facilities.
Analysis of accelerometer data
Accelerometry data from the subsample of BEEP trial participants was analysed using ActiGraph (version 6.6.3;
Actigraph© Lifestyle Monitoring System, Pensacola, FL, USA)250 accelerometer software. Prior to analysis, data
were cleaned by excluding time periods containing > 60 minutes of zero count (for which it is assumed the
accelerometer was not worn) and by including only those participants who had worn the accelerometer for
at least 5 days for ≥ 10 hours. Two sensitivity analyses were conducted by changing the threshold to exclude
minutes of zero count at 30 and 90 minutes, respectively, with the later threshold recommended for
participants with knee pain.251 For each participant, we generated the following at each data collection point:
number of valid minutes, counts per minute and proportion of time spent at each level of physical activity
using the cut-off points from Freedson et al.252 We also calculated the proportion of participants meeting
exercise/physical activity recommendations.242 Descriptive statistics are given for the accelerometer variables at
baseline and by treatment arm. Change (between baseline and each follow-up time point) in the average
count per minute and in the proportion meeting the exercise recommendations were analysed using
ANCOVA and logistic regression, respectively, with analyses adjusted for the covariates defined for the clinical
effectiveness analysis and by treatment arm.
Health economic analysis
A cost–utility analysis was undertaken to compare ITE with UC and TEA with UC, using QALYs as the
measure of benefit. The base-case analysis for the evaluation adopted a NHS and Personal Social Services
(PSS) perspective. A complete case analysis and a broader perspective incorporating NHS/PSS costs,
patients’ personal expenditure and costs associated with work over an 18-month follow-up period was
considered as the sensitivity analysis.
Responses from the EQ-5D-3L generic instrument were used to measure preference-based health-related
QoL at baseline, 3, 6, 9 and 18 months. For each patient, EQ-5D-3L index scores from responses to the
questionnaire were obtained using the UK value set.253 Using the area-under-the-curve approach that links
each patient’s utility scores at different time points,254 EQ-5D-3L responses were used to generate QALYs
for each patient.
Knee-related health-care resource use data were collected by patient self-report questionnaires administered
at 6 and 18 months. NHS resource use data included primary care contacts (GPs, practice nurses, community
physiotherapy), contacts with other health-care professionals (e.g. hospital consultants, physiotherapists
and acupuncturists), hospital-based investigations and procedures [e.g. radiography, magnetic resonance
imaging scans, knee-related injections and surgical procedure]), and prescribed medications. Additional
information, reported in other trial communication by participants, about any knee surgery undertaken or
planned within the 18-month follow-up period was also recorded. Non-NHS (health-care) costs were
obtained by asking patients about their use of private health care and purchase of over-the-counter
medicines and use of local exercise facilities, treatments or appliances. In order to assess broader economic
consequences of the interventions beyond health-care resources, self-reported data on occupation and time
off work taken because of their knee pain over the 18-month period was also collected.
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Details of the number of trial-related physiotherapy sessions attended by each participant were collected
through the CRFs. The costs required to deliver the two new interventions included additional physiotherapy
sessions, telephone contacts and pedometers supplied to participants in the TEA intervention. The cost of
the interventions included an average 45-minute initial assessment and treatment session, followed by
20-minute face-to-face physiotherapy sessions and 7.5-minute telephone contacts in the TEA intervention.
Unit costs were obtained from various sources, including the BNF,174 NHS Reference Costs175 and Unit Costs
of Health and Social Care173 and applied to resource use items. All unit costs used in this analysis are
reported in Table 32, using a common 2012/13 price year.
All analysis was based on the intention-to-treat principle. In the base-case analysis, multiple imputations
were used to impute all missing values for the EQ-5D-3L and non-surgery NHS costs for non-responders to
the 6- and 18-month questionnaires. The base-case analysis involved imputing only the non-surgery NHS
TABLE 32 Summary of health-care resource unit costs
Health-care resource Unit cost (£)
Primary carea
GP consultation per 11.7 minutes 34
Practice nurse consultation per hour 44
Nurse home visit per hour 60
Community physiotherapist per hour 30
Secondary care contactsb
Orthopaedic surgeon: first attendance 128
Orthopaedic surgeon: follow-up 102
Rheumatologist: first attendance 202
Rheumatologist: follow-up 133
Acupuncturist: first attendance 49
Acupuncturist: follow-up 44
Physiotherapist: first attendance 49
Physiotherapist: follow-up 44
Occupational therapist: first attendance 75
Occupational therapist: follow-up 68
Podiatrist: first attendance 74
Podiatrist: follow-up 68
Intervention cost
First physiotherapist session: 45 minutes 22.50
Follow-up physiotherapist sessions: 20 minutes 10
Telephone physiotherapy consultation: 7.5 minutes 3.60
Pedometer 5
Prescribed medication Patient specificc
Medical investigations/Interventions Patient specificb
a Unit Costs of Health and Social Care 2012.173
b NHS Reference Costs 2012/13.175
c BNF.174
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costs, in order to account for the additional knee surgery data retrieved for the 18-month follow-up period
that were recorded separately from postal questionnaires and trial communication. A complete case
analysis was also undertaken and is presented as a sensitivity analysis. Mean differences are all presented
with bootstrapped 95% CIs.
An incremental cost-effectiveness analysis was conducted to determine the difference in costs and
outcomes between ITE, TEA and UC. The unit of outcome was the incremental cost per QALY gained
(incremental costs divided by QALYs) associated with the ITE and TEA interventions. The estimation of
cost-effectiveness within the trial was based on the principles of dominance. If an intervention was found
to be less effective and more costly than at least one of its comparators, then it was not included further in
the economic analysis. To account for uncertainty, non-parametric bootstrapping was used to derive 5000
paired estimates of mean differential cost and QALY scores. These were then presented graphically on a
cost-effectiveness plane.255,256 The analysis also controlled for any possible between-group imbalance in
baseline utility using a regression-based adjustment in order to avoid biased estimates of QALY scores.257
Although costs were collected over an 18-month period, discounting was not applied to the 18-month
questionnaire data, as this contained resource use data from both the last 6 months of year 1 and the first
6 months of year 2 and could not be disaggregated. When productivity loss was reported, costs were
assigned using the human capital approach; self-reported days of work absence were multiplied by
respondent-specific wage estimates identified from annual earnings data and UK Standard Occupational
Classification coding.258,259 Productivity costs were not imputed and a complete case analysis was
undertaken. Statistical analysis was performed using Stata v12.
Linked qualitative interviews
Qualitative methods have an important role to play in evaluating complex interventions136 and in helping to
interpret the findings from RCTs.260,261 In the BEEP trial, linked, longitudinal, qualitative interviews explored
participants’ experiences of treatment, their views of the acceptability of their treatment, the impact of the
interventions on participants’ exercise and general physical activity behaviour, and explanations for change
in knee symptoms and exercise behaviour over time. The topic guides (see Appendix 3) included questions
that explored participants’ views of their physiotherapy treatment, how they got on with their exercise
programme and what factors they felt helped or hindered them to adhere to the exercises following the
end of their treatment contact with the physiotherapist and approximately 12–18 months later. We also
asked what they felt the future held for their knee problem. Interviews were semistructured, face to face
and lasted approximately 1 hour. Interviews were longitudinal in that they were conducted following
physiotherapy treatment completion and also in the longer term (12–18 months later, timed to take place
after their 18-month BEEP follow-up questionnaire). The number invited was determined by ongoing data
analysis and theme saturation. We anticipated continuing until approximately 30 sets of longitudinal
interviews were conducted. Purposive sampling based on data collected in the 3- and 6-month follow-up
questionnaires ensured a diverse range of characteristics in terms of demographic details (age and sex),
intervention group, severity of knee condition determined by WOMAC pain and function scores (as this
could be linked to participants’ willingness to exercise) and changes in WOMAC scores after intervention
completion (as these could be linked to participants’ views about success of the BEEP interventions and
longer-term exercise adherence). With participants’ written consent, interviews were audio-recorded and
transcribed verbatim by professional transcribers. All transcripts were anonymised and data management
and analysis facilitated by NVivo (version 9; QSR International, Warrington, UK). Earlier interviews (at the
end of physiotherapy treatment completion) were analysed and informed the interview content of the
interviews at the longer-term follow-up.
We used an emergent and layered approach to analysis which allowed for both induction and deduction.262
First, using the principles of constant comparison,184 we open-coded all transcripts. This enabled patient
experiences of the interventions, general views on exercise and barriers and facilitators to exercise to be
explored. A researcher coded the transcribed data, with a sample of interviews being independently coded
by a further three members of the research team to ensure transparency, and agreed emergent themes at
successive stages of the data collection and analysis. Second, we applied a more deductive approach by
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rereading transcripts and allocating data to predetermined codes of individualisation, supervision
and progression (three core characteristics of exercise delivery within the BEEP study). Third, a focused
within-case and cross-case longitudinal analysis was performed by asking descriptive and interpretative
questions of the data.263 Descriptive questions investigated what changed in terms of participants’ knee
condition and use of exercise or general physical activity levels and what were key influences on these
changes. This enabled an overall understanding of differences from the first interviews (post intervention) to
the second interviews (12–18 months after the end of the BEEP intervention) and potential reasons for
those differences. Interpretive questions were then used to investigate, for example, which changes inter-
relate and how they relate to existing theories of exercise adherence. Data summary frameworks facilitated
the identification of patterns across time.262,263 Qualitative data analysis was undertaken separately to the
quantitative data analysis in the first instance to facilitate an interpretative approach and not constrain the
analysis by quantitative variables or findings.
Results
Participant recruitment and flow
Figure 8 illustrates the flow of patients during the trial. Out of 1530 potentially eligible participants, 526 adults
aged ≥ 45 years were eligible and agreed to participate. A total of 364 were recruited using general practice
record reviews, 45 were recruited from the population survey and 117 were recruited from physiotherapy
referrals (Table 33). The three recruitment methods led to similar patients being included in the trial. Those
recruited from physiotherapy referrals were slightly younger on average (60 years) than those recruited from
general practice record reviews and the population survey (63 and 65 years, respectively). Approximately half
of those patients recruited through the GP record review and the population survey had a chronic pain grade
of 2 (moderate pain and disability over the past 6 months).
In total, 526 were randomised (176 to UC, 178 to ITE and 172 to TEA) between October 2010 and
February 2012. The group of patients randomised were the same age as all those who were eligible to
receive the nurse telephone call, but included slightly fewer women (see Table 33). In total, 12 patients
randomised in the BEEP trial were found to be subsequently ineligible at their first physical assessment
with BEEP trial physiotherapists (one from UC, two from ITE and nine from TEA intervention arms). These
12 patients were all found not to have knee pain related to OA; two were diagnosed with meniscal tears
needing onward medical attention, two had referred pain from a back problem, two had referred pain
from a hip problem, two had combined hip/back problems that explained their knee pain, three had
neurological conditions that explained their knee pain and one had no knee pain by the time they
consulted the BEEP trial physiotherapist. We excluded these patients from follow-up and analyses and,
therefore, 514 participants form the data set for the BEEP trial. The data entry of the analysis data set
had a very low error rate (1 in 10 data checks gave error rates lower than 0.1% at baseline and at each
follow-up time point).
There were no important differences between the intervention arms at baseline (Table 34). On average,
participants were 63 years old, were overweight with moderate pain and functional disability scores and
had low anxiety and depression levels; most had been experiencing knee pain for between 1 and 5 years.
Overall, they had low physical activity levels and were not meeting recommended guidelines for physical
activity, and only about one-third had used local facilities for physical activity in the last 7 days. On
average, they strongly believed that their knee problem would last a long time and were highly concerned
about it. Despite these views, on average, they were positive about the ability of treatment to help their
knee problem and had generally positive expectations about the benefits of exercise specifically.
Interventions delivered and adverse events
Treatment was delivered by 47 physiotherapists in 10 treatment clinics. Out of all 514 in the BEEP trial,
39 (7.6%) participants received no physiotherapy sessions despite several attempts at contact to offer an
appointment [n = 12/175 (6.9%), n = 15/176 (8.5%) and n = 12/163 (7.4%) in the UC, ITE and TEA arms,
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TABLE 33 Descriptive characteristics of participants recruited by each recruitment method in the BEEP trial
Key
characteristics
Recruitment via GP record review of consulters with knee
pain in the last 12 months Recruitment via population survey
Recruitment via
physiotherapy referral
Consulters
mailed
survey
(N= 7581)
Survey
responders
(N= 4092)
Eligible for
nurse
telephone call
(N= 1171)
Randomised
(N= 364)
Mailed
survey
(N= 3423)
Survey
responders
(N= 1253)
Eligible for
nurse
telephone
call (N= 142)
Randomised
(N= 45)
Eligible for
nurse phone
call (N= 217)
Randomised
(N= 117)
Age (years)a 64 (55–73) 65 (57–74) 64 (56–72) 63 (56–70) 60 (52–70) 64 (55–73) 65 (57–74) 65 (57–74) 59 (52–66) 60 (54–66)
Sexb
Females 4158 (55) 2252 (55) 656 (56) 187 (51) 1752 (51) 670 (54) 77 (54) 24 (53) 113 (52) 55 (47)
CPGa
No pain c 202 (5) d d c 633 (52) d d – –
Grade I c 1330 (34) d d c 359 (30) d d – –
Grade II c 893 (23)(37)e 514 (44) 170 (47) c 103 (9)(47)e 70 (49) 22 (49) – –
Grade III c 722 (18)(30)e 352 (30) 113 (31) c 56 (5)(25)e 38 (27) 13 (29) – –
Grade IV c 823 (21)(33)e 304 (26) 80 (22) c 62 (5)(28)e 34 (24) 10 (22) – –
–, Data not collected; CPG, Chronic Pain Grade.
a Numbers are medians (IQR).
b Numbers are n (%).
c Data missing for non-responders so overall frequency not reported.
d Data missing owing to trial entry selection criteria.
e Figures in italics are CPC percentages calculated for participants with grades II to IV only.
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TABLE 34 Baseline characteristics of participants (n= 514)
Key characteristics UC (N= 175) ITE (N= 176) TEA (N= 163)
Overall
(N= 514)
Age (years) 62 (9) 63 (11) 64 (9) 63 (10)
Femalea 87 (50) 91 (52) 84 (52) 262 (51)
Married/cohabitinga 135 (77) 134 (77) 126 (79) 395 (78)
Currently in a paid joba 81 (47) 67 (39) 66 (41) 214 (42)
BMI (kg/m2) 29.4 (5.8) 29.4 (5.7) 30.0 (5.5) 29.6 (5.7)
Comorbidities
Heart disease (including high blood pressure,
angina, heart failure, stroke and heart
attack)a
96 (55) 85 (49) 80 (49) 56 (11)
Lung disease (including asthma and
bronchitis)a
28 (16) 36 (21) 24 (15) 88 (17)
Diabetesa 27 (15) 22 (13) 17 (10) 66 (13)
Depressiona 40 (23) 47 (27) 27 (17) 114 (22)
Osteoporosisa 9 (5) 14 (8) 14 (9) 37 (7)
Pain in at least one body site other than the
kneea
173 (99) 175 (100) 162 (100) 510 (100)
Widespread paina,b 25 (14) 30 (17) 24 (15) 79 (15)
WOMAC
Pain (0–20) 8.2 (3.2) 8.5 (3.7) 8.5 (3.5) 8.4 (3.5)
Stiffness (0–8) 3.7 (1.7) 3.7 (1.9) 3.8 (1.6) 3.7 (1.7)
Function (0–68) 27.5 (12.0) 27.8 (12.7) 29.1 (12.0) 28.1 (12.2)
Onset of knee problema
In the past 12 months 39 (22) 46 (26) 42 (26) 129 (25)
> 1 year but < 5 years 74 (42) 60 (34) 67 (41) 200 (39)
≥ 5 years but < 10 years 33 (19) 37 (21) 26 (16) 93 (18)
≥ 10 years 32 (18) 33 (19) 28 (17) 93 (18)
PASE scale (0–590) 176 (80) 175 (87) 180 (83) 177 (83)
Previous personal experience of exercise on a
regular basisa
115 (66) 102 (59) 101 (64) 318 (63)
Used local facilities or opportunities that
involved any form of physical activity in the last
7 daysa
63 (36) 56 (32) 47 (29) 164 (32)
SEE scale (0–10) 5.5 (2.3) 5.4 (2.3) 5.3 (2.5) 5.4 (2.3)
OEE scale
Positive subscale (1–5) 3.9 (0.6) 3.9 (0.6) 4.0 (0.6) 3.9 (0.6)
Negative subscale (1–5)c 3.6 (0.8) 3.6 (0.9) 3.4 (0.8) 3.5 (0.9)
GAD-7 (0–21)d 2.0 (0.0–5.0) 1.1 (0.0–4.1) 2.0 (0.0–4.0) 2.0 (0.0–5.0)
PHQ-8 scale (0–24)d 3.0 (1.0–6.0) 3.0 (1.0–5.7) 2.0 (0.9–5.0) 2.3 (1.0–5.8)
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respectively]. Participants in the UC arm had fewer treatment sessions (median 3, IQR 2–4, range 0–8) than
those in the ITE intervention arm (median 6, IQR 4–6.5, range 0–9) and the TEA intervention arm (median
7, IQR 4–8, range 0–11). Of participants in the TEA arm who had at least one treatment session, 94 (62%)
had one or more sessions that were by telephone call rather than face to face. The median time from the
date of randomisation to the first treatment session was 23 days (IQR 15–32).
TABLE 34 Baseline characteristics of participants (n= 514) (continued )
Key characteristics UC (N= 175) ITE (N= 176) TEA (N= 163)
Overall
(N= 514)
Brief Illness Perceptions Questionnaire (IPQR)
How much does your knee pain affect your
life? (0–10)
5.5 (2.1) 5.5 (2.2) 5.5 (2.4) 5.5 (2.2)
How long do you think your knee pain will
continue? (0–10)d
10.0 (7.0–10.0) 9.9 (7.0–10.0) 9.2 (7.0–10.0) 10.0 (7.0–10.0)
How much control do you feel you have
over your knee pain? (0–10)
4.4 (2.7) 4.0 (2.5) 3.9 (2.8) 4.1 (2.7)
How much do you think treatment can help
your knee pain? (0–10)d
7.0 (5.0–8.6) 7.0 (5.0–8.0) 7.0 (5.0–9.0) 7.0 (5.0–9.0)
How much do you experience symptoms
from your knee pain? (0–10)
6.2 (1.9) 6.2 (2.1) 6.2 (2.3) 6.2 (2.1)
How concerned are you about your knee
pain? (0–10)d
8.0 (6.0–10.0) 8.0 (6.0–10.0) 8.0 (6.8–10.0) 8.0 (6.0–10.0)
How well do you feel you understand your
knee pain? (0–10)
5.7 (2.7) 5.9 (3.0) 5.3 (3.3) 5.6 (3.0)
How much does your knee pain affect you
emotionally? (0–10)
4.7 (3.1) 4.9 (3.1) 4.9 (3.0) 4.8 (3.1)
Accelerometer datae (subsample of trial participants)
n 21 21 18 60
Average number of counts per minute
(measured by accelerometers)d
311 (215–390) 253 (177–302) 232 (163–299) 246 (180–329)
Participants meeting physical activity
guidelinesa,f
4 (19) 1 (5) 0 (0) 5 (8)
IPQR, Brief Illness Perceptions Questionnaire; PHQ-8, Patient Health Questionnaire 8.
a Numbers are n (%).
b Defined using the Manchester definition of widespread pain.264
c Reverse scored (i.e. a higher score on the negative subscale indicates higher expectations of the benefit of exercise).
d Median (IQR).
e Participants are only included if they have worn the monitor for at least 5 days for ≥ 10 hours. Valid time is calculated
assuming that any consecutive runs of zero count lasting for ≥ 60-minutes are counted as non-wear.
f Defined as participants completing 150 minutes each week of moderate-intensity physical activity (accumulated in bouts
of ≥ 10 minutes) or 75 minutes of vigorous intensity activity spread across the week (adapted from DH Start Active Stay
Active242). Bouts calculated using a drop time of 2 minutes (ActiGraph Support252). Missing days of data are imputed
using the average of the average count for days when data are present.
Values are mean (SD) unless otherwise stated.
All figures are based on data after multiple imputation of missing data has been applied (with the exception of the
accelerometer data, comorbidity data and pain at other body sites).
WOMAC higher score =worse outcome; PASE higher score =more active; SEE higher score =more confident that exercise
can be done; OEE positive and negative subscales higher score = higher expectations that exercise will be beneficial;
GAD-7 higher score =more anxious; PHQ-8 higher score =more depressed; IPQR – affects life, higher score =more affected;
IPQR – duration, higher score = lasts a longer time; IPQR – personal control, higher score =more control; IPQR – treatment
control, higher score = higher belief treatment can control; IPQR – symptom experience, higher score =more symptoms that
are more severe; IPQR – concern, higher score =more concerned; IPQR – understanding, higher score =more understanding;
IPQR – emotion, higher score =more emotionally affected.
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Nearly all UC participants received physiotherapy that included assessment and reassessment (98%),
education and advice (98%), a PhysioTools exercise sheet (93%), a home exercise programme (96%) and
the physiotherapist supervised their exercise programme in clinic (87%). Muscle-strengthening exercise was
used for nearly all patients (94%), range of movement or stretching exercise was used for 74% of patients
and balance exercises formed part of the programme for 63% of patients. In total, 156 (89%) of the CRFs
were judged to be in line with the treatment protocol for UC.
All ITE participants received physiotherapy that included assessment and reassessment (100%) and a home
exercise programme (100%), and nearly all received physiotherapy that included education and advice
(99%), an individualised PhysioTools exercise sheet (92%) and the physiotherapist supervised their exercise
programme in-clinic (99%). Most patients also had their exercise programme progressed following review
(87%) and almost three-quarters were given a lower limb exercise diary (74%). Muscle-strengthening
exercise was used for nearly all patients (98%), range of movement or stretching exercise was used for
80% of patients and balance exercises formed part of the programme for 76% of patients. In total, 109
(62%) of the CRFs were judged to be in line with the treatment protocol for the ITE intervention.
Out of the 163 participants in the TEA intervention arm, 94 (62.3%) had physiotherapy contact over the
telephone as well as face-to-face appointments. All TEA participants received physiotherapy that included
assessment and reassessment (100%) and most received physiotherapy that included education and
advice (99%) and supervised exercises in clinic (94%) that included lower limb/knee exercises (99%) and
prescribed general exercise (76%). By far, the most commonly recommended general physical activity was
walking, or combinations of walking and cycling or walking and swimming. However, there was evidence
from the CRFs for the TEA intervention of individualisation of the prescribed activities to participants’
preferences including, bowling, going to the gym, running, golf, Zumba® (Zumba Fitness, LLC, Hallandale,
FL, USA), dancing, pilates, football and tennis. Of the adherence-enhancing toolkit components, the most
commonly used were the educational strategies: written educational material for patients (86%) and the
individualised PhysioTools exercise sheets (85%). The behavioural strategies were used for, at most,
two-thirds of patients only; the most commonly used were the physical activity diary (67%) followed by
pedometers (for 53% of participants) and graded activity charts (15%). Heart rate monitoring during
general exercise, visual feedback charts and reminder postcards were used with < 10 participants in total.
Physiotherapists used the cognitive–behavioural strategies available to them within the toolkit as follows:
l questions to elicit health-related beliefs (36%)
l set-back plans with patients (36%)
l assessment of patient barriers and motivators to physical activity (35%)
l SMART goal-setting/contracting (30%)
l readiness/importance/confidence rulers (13%)
l decisional balance sheets (1%).
A clear signpost to local exercise opportunities/facilities in the geographical locality of the participant was
recorded on the CRFs for 52% of those randomised to the TEA intervention arm. In total, 79 (48%) of the
CRFs were judged to be per protocol for the TEA intervention.
Treatments other than exercise formed part of the package of care for 23%, 33% and 23% of
participants in UC, ITE and TEA, respectively. The three most common additional treatments were advice
about orthotics, ice therapy and manual therapy.
No SAEs and four adverse events were reported attributable to the interventions: one in UC (a sprained
ankle), two in ITE (a sprained ankle and a twisted painful knee) and one in TEA (a fall during walking).
Out of 514 participants, expected muscle soreness or transient increases in pain or aching occurred in
82 participants (19% in UC, 20% in ITE and 12% in TEA). Over the course of the 18 months of follow-up,
there was one death in the BEEP trial (notified July 2012), which was deemed not attributable to the BEEP
trial interventions.
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Clinical outcomes (primary and secondary)
Primary outcome data were obtained from 87% of participants at 6 months (89% in UC, 86% in ITE and
85% in TEA), 77% at 9 months (79% in UC, 76% in ITE and 75% in TEA) and 79% at 18 months (81%
in UC, 80% in ITE and 76% in TEA). Participants lost to follow-up at 6 months had slightly worse baseline
knee pain stiffness and function scores (as measured by the WOMAC) and slightly higher levels of anxiety
or depression at baseline than those who did not respond. They also were less likely to have used local
facilities or opportunities that involved any form of physical activity in the last 7 days. (Data not shown but
available from authors on request.)
The primary analyses of the trial showed that there were no statistically significant differences in the change
in WOMAC pain or function at 6 months between UC and either of the other physiotherapy-led interventions
(Figure 9 and Table 35). Participants had WOMAC pain scores of 8.2 in the UC arm, 8.5 in the ITE arm and
8.5 in the TEA intervention arm at baseline and these reduced to 6.6, 6.8 and 6.8 at 3 months, respectively,
and 6.4, 6.4 and 6.2 at 6 months, respectively, with little further change through to 18 months’ follow-up
(6.2, 6.1 and 6.1, respectively). In terms of WOMAC function, baseline scores were 27.5 in the UC arm,
27.8 in the ITE arm and 29.1 in the TEA arm, which reduced by approximately 4 points in all three groups by
3 months (23.2, 23.1 and 24.7, respectively) and between 5 and 8 WOMAC points by 6 months (21.4, 22.3
and 21.5, respectively). Longer-term outcomes at 9 and 18 months can be seen in Table 35 but remained
at similar levels to those seen at 6 months. A longitudinal analysis of the mean outcome trajectory for the
primary outcomes also did not show any statistically significant differences in the mean trajectory by
treatment arm (data not shown). In terms of effect size estimates for each intervention arm (comparing
follow-up scores with baseline scores), all three interventions led to improvements of moderate effect size at
both 6 months (WOMAC pain Cohen’s effect size estimates of UC 0.56, ITE 0.57, TEA 0.66; and WOMAC
function UC 0.51, ITE 0.43, TEA 0.63) and 18 months (WOMAC pain UC 0.63, ITE 0.65, TEA 0.69; and
WOMAC function UC 0.50, ITE 0.46, TEA 0.51). However, these should be interpreted cautiously given the
lack of a no treatment control group in the comparison.
The sensitivity analyses did not change the interpretation of the trial results. The per protocol analysis
(including only those participants who were judged to have received the BEEP trial interventions in line
with the treatment protocols) also demonstrated no statistically significant differences in the change in
WOMAC pain or function scores, although Table 35 shows a trend for lower pain and function scores in
those in the TEA intervention group who received the intervention per protocol. Results for the primary
outcome at the primary end point also did not differ depending on whether the participant showed high
or low levels of self-reported exercise adherence (Table 36) or when complete case data were analysed,
when baseline covariates were excluded from the analysis and when any group effect from therapists
working in the same clinic (‘clustering’) has been accounted for in the treatment models (data not shown).
In terms of secondary outcomes (Table 37), the analyses showed consistent results overall, of no
statistically significant differences in the change in outcomes between UC and either the ITE intervention
group or the TEA intervention group. In total, at 6 months, 50% of those in the UC group could be
classified as treatment responders using the OARSI responder criteria, compared with 51% in the ITE
group and 55% in the TEA intervention group (differences that were not statistically significant).
Interestingly, these proportions remained relatively stable over longer-term follow-ups (48%, 50% and
51%, respectively, at 18-month follow-up).
Self-reported physical activity, measured using the PASE, was not statistically significantly different between
the intervention groups and the mean trajectory for this outcome over time showed no significant
differences between treatment arms. Participants had scores of 176 in the UC group, 175 in the ITE group
and 180 in the TEA group at baseline and these increased by similar amounts in all three groups by
6 months (188, 189 and 196, respectively), indicating that all three groups reported small increases in their
general physical activity levels. However, by the 18-month follow-up, these self-reported physical activity
levels had returned to baseline (or below baseline) levels (177, 173 and 169, respectively). Participants’
self-reported use of physical activity facilities in the last 7 days appeared to increase in all three treatment
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groups (increasing from 36% in UC, 32% in ITE and 29% in TEA at baseline to 51%, 43% and 49%,
respectively, at 6 months) and these proportions appeared to stay high even at longer-term follow-up, but
there was no further increase. The OR at 9 months in the TEA group compared with UC, for a report of
using local physical activity facilities in the last 7 days, was 1.7 (95% CI 1.0 to 3.0) but there were no
differences between the groups at 18 months.
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FIGURE 9 Means and 95% CIs for the primary outcome at each time point. (a) WOMAC pain; and (b) WOMAC function.
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TABLE 35 Summary of results for primary outcomes at each time point
Outcome measure 3 months 6 months 9 months 18 months
Imputed data: N 514 514 514 514
WOMAC pain (0–20)
UC: mean (SD) 6.6 (3.4) 6.4 (4.0) 6.3 (3.7) 6.2 (3.9)
ITE: mean (SD) 6.8 (3.7) 6.4 (4.0) 6.4 (3.9) 6.1 (4.2)
TEA: mean (SD) 6.8 (3.5) 6.2 (3.8) 6.3 (3.8) 6.1 (4.2)
UC vs. ITE: adjusted mean difference
(95% CI)
0.0 (–0.6 to 0.6) –0.3 (–1.0 to 0.5) –0.2 (–0.9 to 0.6) –0.3 (–1.2 to 0.5)
UC vs. TEA: adjusted mean
difference (95% CI)
0.1 (–0.6 to 0.7) –0.3 (–1.0 to 0.4) –0.3 (–1.0 to 0.5) –0.3 (–1.2 to 0.5)
WOMAC function (0–68)
UC: mean (SD) 23.2 (12.3) 21.4 (14.1) 22.3 (13.3) 21.5 (14.4)
ITE: mean (SD) 23.1 (12.7) 22.3 (13.7) 22.1 (13.8) 21.9 (14.9)
TEA: mean (SD) 24.7 (12.3) 21.5 (13.2) 22.7 (13.3) 23.0 (14.4)
UC vs. ITE: adjusted mean difference
(95% CI)
–0.4 (–2.5 to 1.8) 0.4 (–2.0 to 2.8) –0.6 (–3.2 to 1.9) –0.2 (–3.0 to 2.6)
UC vs. TEA: adjusted mean
difference (95% CI)
0.5 (–1.7 to 2.6) –1.0 (–3.4 to 1.4) –0.7 (–3.3 to 1.9) 0.4 (–2.6 to 3.3)
Per-protocol analysis (imputed data)
WOMAC pain (0–20)
UC: n, mean (SD) 156, 6.4 (3.5) 156, 6.2 (4.1) 156, 6.2 (3.8) 156, 6.1 (3.9)
ITE: n, mean (SD) 109, 6.8 (3.6) 109, 6.4 (4.0) 109, 6.5 (3.9) 109, 6.2 (4.1)
TEA: n, mean (SD) 78, 6.3 (2.8) 78, 5.8 (3.4) 78, 5.9 (3.7) 78, 5.3 (3.7)
UC vs. ITE: adjusted mean difference
(95% CI)
0.1 (–0.6 to 0.8) –0.2 (–1.0 to 0.6) –0.1 (–0.9 to 0.8) –0.2 (–1.1 to 0.7)
UC vs. TEA: adjusted mean
difference (95% CI)
–0.3 (–1.0 to 0.5) –0.6 (–1.5 to 0.3) –0.4 (–1.4 to 0.5) –0.8 (–1.8 to 0.2)
WOMAC function (0–68)
UC: n, mean (SD) 156, 22.5 (12.4) 156, 20.5 (14.1) 156, 22.0 (13.4) 156, 20.9 (14.3)
ITE: n, mean (SD) 109, 22.6 (12.6) 109, 21.7 (13.8) 109, 22.1 (13.7) 109, 21.6 (14.5)
TEA: n, mean (SD) 78, 22.6 (10.0) 78, 20.5 (11.8) 78, 20.8 (12.6) 78, 20.4 (12.7)
UC vs. ITE: adjusted mean difference
(95% CI)
–0.5 (–2.8 to 1.8) 0.1 (–2.6 to 2.9) –0.6 (–3.6 to 2.3) –0.2 (–3.3 to 2.9)
UC vs. TEA: adjusted mean
difference (95% CI)
–1.2 (–3.8 to 1.5) –1.4 (–4.5 to 1.6) –2.2 (–5.5 to 1.0) –1.3 (–4.7 to 2.0)
Figures are presented after imputation of missing data and after adjustment for baseline WOMAC scores, age, sex, onset of
knee problem, and treatment centre unless otherwise stated. Higher WOMAC scores =worse outcome.
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TABLE 36 Analysis of the primary outcome at the primary end point (i.e. the 6-month follow-up) stratified by level
of self-reported exercise adherence at 6-month follow-up
I have been doing my exercises as often as I was advised to . . .
Strongly agree/agree (N= 268) Strongly disagree/disagree (N= 84)
WOMAC pain (0–20)
UC: mean (SD) 6.4 (4.0) 6.1 (3.8)
ITE: mean (SD) 6.1 (4.2) 6.2 (3.5)
TEA: mean (SD) 5.9 (3.8) 6.2 (3.7)
Interaction regression coefficienta (95% CI)
UC 0 0
ITE 0 1.0 (–0.9, 2.9)
TEA 0 0.6 (–1.4, 2.6)
WOMAC function (0–68)
UC: mean (SD) 22.1 (14.0) 20.0 (13.9)
ITE: mean (SD) 20.9 (14.7) 21.0 (12.4)
TEA: mean (SD) 20.8 (13.2) 19.6 (14.1)
Interaction regression coefficienta (95% CI)
UC 0 0
ITE 0 4.8 (–1.7, 11.2)
TEA 0 1.5 (–5.3, 8.3)
a The interaction regression coefficients express the interaction between treatment arm and level of exercise adherence
after the outcome of interest has been adjusted in a regression model for baseline in the outcome of interest, age, sex,
duration of the knee problem and physiotherapy treatment centre (as was used in the randomisation algorithm).
Fifty-three participants reported they were ‘not sure’ if they had been doing their exercises as often as advised so are
excluded from the analysis.
TABLE 37 Summary of results for all secondary outcome measures
Outcome measure
3 months
(N= 514)
6 months
(N= 514)
9 months
(N= 514)
18 months
(N= 514)
OARSI responder criteriaa
UC: n (%) 77 (44) 88 (50) 79 (45) 84 (48)
ITE: n (%) 81 (46) 90 (51) 86 (49) 88 (50)
TEA: n (%) 73 (45) 90 (55) 82 (50) 83 (51)
UC vs. ITE: adjusted OR (95% CI) 1.1 (0.7 to 1.8) 1.1 (0.7 to 1.8) 1.3 (0.8 to 2.0) 1.1 (0.7 to 1.9)
UC vs. TEA: adjusted OR (95% CI) 1.0 (0.6 to 1.7) 1.2 (0.8 to 2.0) 1.3 (0.8 to 2.1) 1.1 (0.7 to 1.9)
WOMAC stiffness (0–8)
UC: mean (SD) 3.1 (1.8) 2.9 (1.8) 3.0 (1.8) 2.8 (1.8)
ITE: mean (SD) 3.1 (1.7) 3.1 (1.9) 3.0 (1.8) 2.8 (1.8)
TEA: mean (SD) 3.1 (1.7) 2.9 (1.7) 3.1 (1.7) 3.1 (1.9)
UC vs. ITE: adjusted mean
difference (95% CI)
0.0 (–0.3 to 0.3) 0.2 (–0.2 to 0.5) 0.0 (–0.4 to 0.3) 0.0 (–0.3 to 0.4)
UC vs. TEA: adjusted mean
difference (95% CI)
0.0 (–0.4 to 0.3) –0.1 (–0.4 to 0.3) 0.1 (–0.3 to 0.4) 0.3 (–0.1 to 0.6)
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TABLE 37 Summary of results for all secondary outcome measures (continued )
Outcome measure
3 months
(N= 514)
6 months
(N= 514)
9 months
(N= 514)
18 months
(N= 514)
PASE (0–590)
UC: mean (SD) 196 (87) 188 (84) 170 (77) 177 (89)
ITE: mean (SD) 188 (86) 189 (89) 162 (85) 173 (80)
TEA: mean (SD) 193 (92) 196 (95) 187 (88) 169 (78)
UC vs. ITE: adjusted mean
difference (95% CI)
–6.4
(–26.1 to 13.3)
3.8
(–14.8 to 22.4)
–4.5
(–23.6 to 14.6)
–2.3
(–20.8 to 16.3)
UC vs. TEA: adjusted mean
difference (95% CI)
–4.1
(–23.4 to 15.2)
8.3
(–10.7 to 27.3)
18.7
(–1.3 to 38.6)
–7.3
(–25.8 to 11.3)
BMI (kg/m2)
UC: mean (SD) 29.2 (5.7) 29.2 (5.6) 29.2 (5.7) 28.9 (5.4)
ITE: mean (SD) 29.3 (5.6) 29.1 (5.8) 29.3 (5.8) 28.8 (5.6)
TEA: mean (SD) 30.0 (5.5) 29.7 (5.5) 29.7 (5.5) 29.7 (5.4)
UC vs. ITE: adjusted mean
difference (95% CI)
0.1 (–0.2 to 0.4) 0.0 (–0.4 to 0.3) 0.2 (–0.3 to 0.6) –0.1 (–0.6 to 0.4)
UC vs. TEA: adjusted mean
difference (95% CI)
0.3 (0.0 to 0.6) 0.0 (–0.3 to 0.4) 0.0 (–0.5 to 0.5) 0.3 (–0.1 to 0.8)
Used local facilities or opportunities that involved any form of physical activity in the last 7 days
UC: n (%) 100 (57) 89 (51) 75 (43) 82 (47)
ITE: n (%) 95 (54) 76 (43) 65 (37) 90 (51)
TEA: n (%) 88 (54) 80 (49) 82 (50) 70 (43)
UC vs. ITE: adjusted OR (95% CI) 0.9 (0.6 to 1.5) 0.8 (0.5 to 1.3) 0.9 (0.5 to 1.5) 1.3 (0.8 to 2.3)
UC vs. TEA: adjusted OR (95% CI) 1.1 (0.6 to 1.8) 1.1 (0.6 to 1.8) 1.7 (1.0 to 3.0) 1.0 (0.6 to 1.7)
GAD-7 (0–21)
UC: median (IQR) 1.0 (0.0–3.4) 1.0 (0.0–4.0) b 1.0 (0.0–4.2)
ITE: median (IQR) 1.0 (0.0–4.0) 1.0 (0.0–3.8) b 1.0 (0.0–4.6)
TEA: median (IQR) 1.0 (0.0–4.6) 1.0 (0.0–3.9) b 0.5 (0.0–3.8)
UC vs. ITE: adjusted meanc
difference (95% CI)
0.2 (–0.5 to 0.9) –0.1 (–0.9 to 0.6) b 0.4 (–0.4 to 1.2)
UC vs. TEA: adjusted meanc
difference (95% CI)
0.5 (–0.2 to 1.2) 0.2 (–0.6 to 1.0) b 0.0 (–0.9 to 0.8)
PHQ-8 depressive scale (0–24)
UC: median (IQR) 2.0 (0.2–5.0) 2.0 (0.0–4.0) b 2.0 (0.0–6.1)
ITE: median (IQR) 2.0 (0.0–5.0) 2.0 (0.0–4.4) b 2.3 (0.0–6.0)
TEA: median (IQR) 2.0 (0.0–5.1) 1.6 (0.0,4.2) b 2.1 (0.0–5.2)
UC vs. ITE: adjusted meanc
difference (95% CI)
0.3 (–0.4 to 1.1) 0.4 (–0.4 to 1.3) b 0.5 (–0.4 to 1.4)
UC vs. TEA: adjusted meanc
difference (95% CI)
0.5 (–0.3 to 1.3) 0.6 (–0.3 to 1.4) b 0.3 (–0.6 to 1.3)
SEE scale (0–10)
UC: mean (SD) 5.6 (2.1) 5.4 (2.3) b b
ITE: mean (SD) 5.9 (2.3) 5.7 (2.1) b b
TEA: mean (SD) 5.5 (2.4) 5.7 (2.2) b b
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TABLE 37 Summary of results for all secondary outcome measures (continued )
Outcome measure
3 months
(N= 514)
6 months
(N= 514)
9 months
(N= 514)
18 months
(N= 514)
UC vs. ITE: adjusted mean
difference (95% CI)
0.3 (–0.2 to 0.8) 0.3 (–0.1 to 0.8) b b
UC vs. TEA: adjusted mean
difference (95% CI)
–0.1 (–0.5 to 0.4) 0.4 (–0.2 to 0.8) b b
OEE scale – positive subscale (1–5)
UC: mean (SD) 4.0 (0.6) 4.0 (0.6) b b
ITE: mean (SD) 4.0 (0.6) 4.0 (0.6) b b
TEA: mean (SD) 3.9 (0.5) 3.9 (0.6) b b
UC vs. ITE: adjusted mean
difference (95% CI)
0.1 (–0.1 to 0.2) 0.0 (–0.1 to 0.1) b b
UC vs. TEA: adjusted mean
difference (95% CI)
–0.1 (–0.2 to 0.1) 0.0 (–0.2 to 0.1) b b
OEE scale – negative subscale (1–5)d
UC: mean (SD) 3.8 (0.7) 3.8 (0.8) b b
ITE: mean (SD) 3.9 (0.8) 3.9 (0.9) b b
TEA: mean (SD) 3.7 (0.8) 3.8 (0.8) b b
UC vs. ITE: adjusted mean
difference (95% CI)
0.1 (–0.1 to 0.2) 0.1 (–0.1 to 0.3) b b
UC vs. TEA: adjusted mean
difference (95% CI)
0.0 (–0.2 to 0.1) 0.2 (0.0 to 0.3) b b
IPQR – How much does your knee pain affect your life? (0–10)
UC: mean (SD) 4.5 (2.4) 4.3 (2.5) b b
ITE: mean (SD) 4.4 (2.3) 4.2 (2.5) b b
TEA: mean (SD) 4.6 (2.4) 4.3 (2.5) b b
UC vs. ITE: adjusted mean
difference (95% CI)
–0.1 (–0.6 to 0.3) –0.1 (–0.6 to 0.4) b b
UC vs. TEA: adjusted mean
difference (95% CI)
0.1 (–0.3 to 0.6) 0.0 (–0.5 to 0.5) b b
IPQR – How long do you think your knee pain will continue? (0–10)
UC: median (IQR) 8.0 (5.1–10.0) 8.5 (5.5–10.0) b b
ITE: median (IQR) 8.0 (5.0–10.0) 8.0 (5.1–10.0) b b
TEA: median (IQR) 7.8 (5.0–10.0) 8.0 (5.0–10.0) b b
UC vs. ITE: adjusted meanc
difference (95% CI)
–0.1 (–0.7 to 0.5) –0.1 (–0.7 to 0.6) b b
UC vs. TEA: adjusted meanc
difference (95% CI)
–0.2 (–0.8 to 0.4) –0.2 (–0.9 to 0.4) b b
IPQR – How much control do you feel you have over your knee pain? (0–10)
UC: mean (SD) 5.0 (2.7) 4.9 (2.5) b b
ITE: mean (SD) 5.2 (2.6) 5.4 (2.6) b b
TEA: mean (SD) 4.6 (2.6) 5.3 (2.6) b b
UC vs. ITE: adjusted mean
difference (95% CI)
0.3 (–0.4 to 0.9) 0.5 (–0.1 to 1.1) b b
UC vs. TEA: adjusted mean
difference (95% CI)
–0.3 (–0.9 to 0.3) 0.4 (–0.2 to 1.1) b b
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TABLE 37 Summary of results for all secondary outcome measures (continued )
Outcome measure
3 months
(N= 514)
6 months
(N= 514)
9 months
(N= 514)
18 months
(N= 514)
IPQR – How much do you think treatment can help your knee pain? (0–10)
UC: median (IQR) 6.1 (5.0–8.0) 6.0 (4.2–8.0) b b
ITE: median (IQR) 7.0 (5.0–8.0) 7.0 (4.2–8.0) b b
TEA: median (IQR) 7.0 (5.0–8.0) 7.0 (5.0–9.0) b b
UC vs. ITE: adjusted meanc
difference (95% CI)
0.2 (–0.3 to 0.8) 0.3 (–0.3 to 0.9) b b
UC vs. TEA: adjusted meanc
difference (95% CI)
0.1 (–0.4 to 0.7) 0.7 (0.1 to 1.4) b b
IPQR – How much do you experience symptoms from your knee pain? (0–10)
UC: mean (SD) 5.3 (2.3) 5.0 (2.3) b b
ITE: mean (SD) 5.2 (2.3) 4.9 (2.5) b b
TEA: mean (SD) 5.4 (2.3) 5.0 (2.3) b b
UC vs. ITE: adjusted mean
difference (95% CI)
–0.1 (–0.6 to 0.4) –0.1 (–0.6 to 0.4) b b
UC vs. TEA: adjusted mean
difference (95% CI)
0.2 (–0.3 to 0.6) 0.0 (–0.5 to 0.5) b b
IPQR – How concerned are you about your knee pain? (0–10)
UC: median (IQR) 6.6 (5.0–8.0) 5.3 (3.0–7.9) b b
ITE: median (IQR) 6.1 (3.9–8.4) 5.5 (3.0–8.0) b b
TEA: median (IQR) 6.4 (5.0–8.1) 5.1 (3.0–8.0) b b
UC vs. ITE: adjusted meanc
difference (95% CI)
0.0 (–0.6 to 0.6) 0.2 (–0.4 to 0.8) b b
UC vs. TEA: adjusted meanc
difference (95% CI)
0.1 (–0.4 to 0.7) 0.1 (–0.6 to 0.7) b b
IPQR – How well do you feel you understand your knee pain? (0–10)
UC: mean (SD) 6.9 (2.5) 7.1 (2.4) b b
ITE: mean (SD) 7.2 (2.5) 7.6 (2.5) b b
TEA: mean (SD) 6.8 (2.6) 7.5 (2.5) b b
UC vs. ITE: adjusted mean
difference (95% CI)
0.2 (–0.3 to 0.8) 0.4 (–0.1 to 1.0) b b
UC vs. TEA: adjusted mean
difference (95% CI)
0.0 (–0.5 to 0.6) 0.5 (0.0 to 1.1) b b
IPQR – How much does your knee pain affect you emotionally? (0–10)
UC: mean (SD) 4.1 (2.8) 3.4 (2.9) b b
ITE: mean (SD) 3.8 (2.9) 3.6 (2.9) b b
TEA: mean (SD) 4.3 (2.8) 3.6 (2.9) b b
UC vs. ITE: adjusted mean
difference (95% CI)
–0.3 (–0.9 to 0.2) 0.1 (–0.5 to 0.7) b b
UC vs. TEA: adjusted mean
difference (95% CI)
0.1 (–0.5 to 0.6) 0.2 (–0.5 to 0.8) b b
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TABLE 37 Summary of results for all secondary outcome measures (continued )
Outcome measure
3 months
(N= 514)
6 months
(N= 514)
9 months
(N= 514)
18 months
(N= 514)
Accelerometer datae (subsample of
trial participants) N = 50 N = 47 N = 51 N = 48
Average number of counts per minute (measured by accelerometers)
UC: n: median (IQR) 15–346 (124–460) 14–338 (138–424) 15–306 (176–414) 14–222 (117–440)
ITE: n: median (IQR) 19–257 (170–278) 17–209 (159–290) 20–201 (157–316) 18–238 (174–348)
TEA: n: median (IQR) 16–239 (193–324) 16–264 (205–278) 16–223 (166–250) 16–205 (161–283)
UC vs. ITE: adjustedf meanc
difference (95% CI)
–28 (–84 to 28) –66 (–147 to 15) –47 (–101 to 7) –17 (–86 to 52)
UC vs. TEA: adjustedf meanc
difference (95% CI)
–51 (–108 to 7) –53 (–138 to 31) –61 (–117 to -4) –56 (–130 to 19)
Proportion meeting physical activity guidelines (measured by accelerometers
g
)
UC: n (%) 5 (33) 4 (29) 5 (33) 3 (21)
ITE: n (%) 0 (0) 0 (0) 0 (0) 3 (17)
TEA: n (%) 3 (19) 1 (6) 0 (0) 1 (6)
UC vs. ITE: adjustedf OR (95% CI) h h h h
UC vs. TEA: adjustedf OR (95% CI) h h h h
IPQR, Brief Illness Perceptions Questionnaire; PHQ-8, Patient Health Questionnaire 8.
Figures are presented after imputation of missing data (with the exception of data from the accelerometers) and after
adjustment for the baseline score on the outcome of interest (with the exception of the OARSI responder criteria), age, sex,
onset of knee problem, and treatment centre, unless otherwise stated.
WOMAC stiffness higher score =more severe stiffness; PASE higher score =more active; SEE higher score =more confident
that exercise can be done; OEE positive and negative subscales higher score = higher expectations that exercise will be
beneficial; GAD-7 higher score =more anxious; PHQ-8 higher score =more depressed; IPQR – affects life, higher
score =more affected; IPQR – duration, higher score = lasts a longer time; IPQR – personal control, higher score =more
control; IPQR – treatment control, higher score = higher belief treatment can control; IPQR – symptom experience, higher
score =more symptoms that are more severe; IPQR – concern, higher score =more concerned; IPQR – understanding,
higher score =more understanding; IPQR – emotion, higher score =more emotionally affected.
a Participants met the OARSI responder criteria if (1) relative change in WOMAC pain or function was ≥ 50% and absolute
change was ≥ 20 or (2) at least two of the following applied: relative change in pain ≥ 20% and absolute change ≥ 10,
relative change in function ≥ 20% and absolute change ≥ 10 or participants reported they were better, much better, or
completely recovered on the global assessment of change question. Absolute change (baseline – follow-up score) and
relative change (absolute change/baseline score) were calculated after WOMAC measures were scaled from 1 to 101 to
avoid dividing by 0 when calculating relative change (Pham et al.201).
b Data not collected at this time point.
c Mean differences are presented, despite a skewed distribution for the outcome at the absolute time point, as, when
adjusted for the baseline value of interest, model residuals followed a normal distribution.
d Reverse scored (i.e. a higher score on the negative subscale indicates higher expectations of the benefit of exercise).
e Participants are only included if they have worn the monitor for at least 5 days for ≥ 10 hours. Valid time is calculated
assuming that any consecutive runs of zero count lasting for ≥ 60 minutes are counted as non-wear.
f Model adjusted for baseline only (adjusting for all a priori model covariates gave unstable model results owing to the
small sample size used for the analysis).
g Defined as participants completing 150 minutes each week of moderate intensity physical activity (accumulated in bouts
of ≥ 10 minutes) or 75 minutes of vigorous intensity activity spread across the week (adapted from Dh Start Active,
Stay Active: A Report on Physical Activity for Health from the Four Home Countries’ Chief Medical Officers242). Bouts
calculated using a drop-time of 2 minutes (ActiGraph Support250). Missing days of data are imputed using the average of
the average count for days for which data are present.
h Not calculated owing to small n.
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The objective data on actual physical activity levels, measured in the subsample of participants allocated to
wear accelerometers at each follow-up time point, showed somewhat different results. Although, again,
there were no statistically significant differences in the changes in activity counts between UC and the
other two intervention groups, the trends were consistently in the direction of higher physical activity
levels in the UC group than in either the ITE or TEA intervention groups. In both the UC and ITE groups,
objective physical activity counts increased during the period of physiotherapy treatment (from baseline
to 3 months) and then reduced to below baseline levels by 18 months. In the TEA group, for which
increasing general physical activity was a key focus of the intervention, objective physical activity counts
increased during the period of physiotherapy treatment (from baseline to 6 months) but again fell to
below baseline levels by the 18-month follow-up. The proportions of participants who could be classified
as meeting recommended physical activity levels, based on their accelerometer data, were very small but
seemed to be highest in the UC group (see Table 37). In addition, when the data were categorised into
pre-defined levels of activity, it was found that the majority of participants’ time was spent in sedentary
activity, irrespective of treatment arm or time point considered (data not shown but available from authors
on request).
In terms of participants’ illness perceptions (measured at baseline and 3 and 6 months only), there were very
few differences between the intervention groups. One exception was participants’ views on how much
treatment could help their knee pain, which appeared to be statistically significantly greater at 6 months in
the TEA group than in the UC group (see Table 37). In general, participants in all three groups appeared to
benefit from the BEEP trial interventions over time, with all groups reporting that they felt they had greater
control over their knee problem and were less concerned about their knee problem than at baseline.
Intervention credibility and exercise adherence outcomes
Table 38 summarises the results for treatment credibility and exercise adherence at each follow-up time
point. Overall, treatment credibility was high in all groups and remained so even at the 18-month follow-up.
The majority of participants who received UC, ITE and TEA felt that their treatment was quite or very logical,
and were quite or very confident that (1) the treatment they received could help their knee problem,
(2) they could recommend the treatment they received to a friend and (3) the treatment would be
successful in helping other types of problems.
At 3 months’ follow-up, self-reported exercise adherence was high in all groups, with ≥ 75% agreeing or
strongly agreeing that they had completed their exercises as often as they had been advised. In the UC
group this reduced to 55% at 6 months and then fell to < 50% at longer-term follow-ups. In the ITE
group, adherence levels also steadily reduced over time, although to a lesser extent than in the UC group,
with adherence dropping only < 50% by 18 months’ follow-up. Adherence to exercise in participants
randomised to the TEA intervention remained consistently high until the 9-month follow-up (6 months:
77%; 9 months: 74%). At 18 months, although adherence was higher in the TEA group than in the other
two intervention groups, the proportion of participants agreeing or strongly agreeing that they had been
doing their exercises as often as advised had reduced to 51%.
At 3 months, more than half of those in the ITE and TEA groups reported exercising every day in
comparison with the UC group (in which more than half of participants reported exercising five times per
week). At 6 months, more than half of those in the TEA group reported exercising six times per week in
comparison with four times per week in the ITE and UC intervention arms. Similarly, at 9 and 18 months,
those in the TEA group reported exercising more frequently than those in the other two groups (as judged
by the median response category reported). There were no differences in the exercise durations between
the intervention groups.
Health economic outcomes
Parts of this section have been reproduced from Kigozi et al.265 © The Author(s) 2018. Published by Oxford
University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed
under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.
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TABLE 38 Treatment credibility and exercise adherence at each follow-up time point
Question
3 months 6 months 9 months 18 months
UC
(n= 143)
ITE
(n= 146)
TEA
(n= 136)
UC
(n= 142)
ITE
(n= 140)
TEA
(n= 131)
UC
(n= 139)
ITE
(n= 135)
TEA
(n= 129)
UC
(n= 141)
ITE
(n= 134)
TEA
(n= 120)
Confident that treatment received can help knee problem
Very confident 30 (21) 49 (34) 45 (33) 26 (19) 43 (31) 51 (40) 22 (16) 31 (23) 39 (31) 15 (11) 30 (23) 31 (27)
Quite confident 70 (50) 66 (46) 63 (47) 63 (45) 62 (45) 45 (35) 59 (44) 66 (49) 53 (42) 59 (44) 59 (44) 49 (42)
Neither 13 (9) 9 (6) 11 (8) 15 (11) 8 (6) 13 (10) 23 (17) 13 (10) 9 (7) 28 (21) 15 (11) 13 (11)
Not very confident 22 (16) 16 (11) 14 (10) 26 (19) 19 (14) 10 (8) 24 (18) 17 (13) 18 (14) 24 (18) 19 (14) 15 (13)
Not at all confident 5 (4) 5 (3) 2 (1) 9 (6) 6 (4) 10 (8) 6 (4) 7 (5) 7 (6) 9 (7) 10 (8) 9 (8)
Confident in recommending this treatment to a friend
Very confident 33 (24) 57 (39) 50 (37) 32 (23) 59 (43) 50 (39) 29 (21) 48 (36) 46 (37) 26 (19) 39 (29) 41 (35)
Quite confident 70 (50) 59 (41) 60 (45) 63 (45) 47 (34) 51 (40) 58 (43) 57 (43) 50 (40) 61 (45) 54 (41) 45 (38)
Neither 16 (11) 13 (9) 13 (10) 22 (16) 21 (15) 9 (7) 31 (23) 14 (10) 10 (8) 26 (19) 13 (10) 15 (13)
Not very confident 19 (14) 10 (7) 8 (6) 17 (12) 7 (5) 12 (9) 10 (7) 10 (7) 16 (13) 18 (13) 15 (11) 10 (9)
Not at all confident 2 (1) 6 (4) 3 (2) 6 (4) 4 (3) 7 (5) 7 (5) 5 (4) 4 (3) 4 (3) 12 (9) 6 (5)
Treatment makes sense to you
Very logical 46 (33) 73 (50) 57 (42) 38 (27) 70 (51) 61 (47) 39 (29) 51 (38) 48 (38) 36 (27) 45 (34) 40 (34)
Quite logical 76 (54) 61 (42) 68 (50) 78 (56) 50 (36) 54 (42) 70 (52) 65 (49) 54 (43) 64 (47) 65 (49) 51 (44)
No opinion 12 (9) 3 (2) 6 (4) 17 (12) 9 (7) 6 (5) 21 (16) 8 (6) 11 (9) 26 (19) 14 (11) 14 (12)
Not very logical 5 (4) 6 (4) 3 (2) 7 (5) 7 (5) 5 (4) 5 (4) 7 (5) 11 (9) 8 (6) 2 (2) 3 (3)
Not at all logical 1 (1) 2 (1) 1 (1) 0 (0) 2 (1) 3 (2) 0 (0) 3 (2) 2 (2) 1 (1) 7 (5) 9 (8)
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Question
3 months 6 months 9 months 18 months
UC
(n= 143)
ITE
(n= 146)
TEA
(n= 136)
UC
(n= 142)
ITE
(n= 140)
TEA
(n= 131)
UC
(n= 139)
ITE
(n= 135)
TEA
(n= 129)
UC
(n= 141)
ITE
(n= 134)
TEA
(n= 120)
Treatment would be successful in helping other types of problems
Very successful 23 (16) 22 (15) 30 (22) 18 (13) 27 (20) 39 (30) 24 (18) 23 (17) 30 (24) 21 (16) 26 (20) 23 (20)
Quite successful 55 (39) 73 (50) 62 (46) 65 (46) 60 (43) 43 (33) 51 (38) 71 (53) 43 (34) 52 (39) 56 (42) 50 (43)
No opinion 54 (39) 46 (32) 41 (30) 54 (39) 46 (33) 40 (31) 53 (39) 34 (25) 46 (36) 52 (39) 43 (33) 35 (30)
Not very successful 7 (5) 2 (1) 1 (1) 3 (2) 4 (3) 6 (5) 6 (4) 3 (2) 7 (6) 9 (7) 5 (4) 4 (3)
Not at all successful 1 (1) 2 (1) 1 (1) 0 (0) 1 (1) 1 (1) 1 (1) 3 (2) 1 (1) 1 (1) 2 (2) 5 (4)
Been doing exercises as often as advised
Strongly agree 23 (16) 39 (27) 39 (29) 12 (9) 27 (20) 36 (28) 15 (11) 23 (17) 22 (17) 12 (9) 19 (14) 18 (15)
Agree 82 (59) 78 (54) 71 (52) 64 (46) 66 (48) 63 (49) 48 (36) 52 (39) 72 (57) 50 (37) 42 (32) 42 (36)
Not sure 13 (9) 12 (8) 12 (9) 21 (15) 21 (15) 11 (9) 23 (17) 12 (9) 14 (11) 17 (13) 15 (11) 22 (19)
Disagree 20 (14) 13 (9) 12 (9) 34 (24) 20 (15) 17 (13) 36 (27) 39 (29) 17 (13) 42 (31) 44 (33) 25 (21)
Strongly disagree 2 (1) 3 (2) 2 (1) 9 (6) 3 (2) 1 (1) 11 (8) 7 (5) 2 (2) 13 (10) 12 (9) 10 (9)
Exercise frequency in the last month
Never 6 (4) 4 (3) 2 (2) 18 (13) 11 (8) 3 (2) 21 (16) 20 (15) 16 (13) 36 (26) 34 (26) 30 (26)
Once a week 5 (4) 4 (3) 1 (1) 11 (8) 3 (2) 3 (2) 17 (13) 20 (15) 5 (4) 21 (15) 21 (16) 9 (8)
Twice a week 11 (8) 3 (2) 2 (2) 23 (17) 18 (13) 10 (8) 24 (18) 18 (14) 7 (6) 23 (17) 23 (18) 13 (11)
Three times a week 11 (8) 17 (12) 11 (8) 12 (9) 23 (17) 19 (15) 13 (10) 18 (14) 23 (18) 17 (13) 15 (11) 12 (10)
Four times a week 17 (12) 16 (11) 7 (5) 14 (10) 17 (12) 14 (11) 13 (10) 11 (8) 13 (10) 5 (4) 3 (2) 8 (7)
Five times a week 21 (15) 8 (6) 11 (8) 19 (14) 10 (7) 10 (8) 11 (8) 5 (4) 11 (9) 8 (6) 11 (8) 13 (11)
Six times a week 3 (2) 10 (7) 10 (8) 10 (7) 10 (7) 6 (5) 3 (2) 3 (2) 7 (6) 1 (1) 1 (1) 3 (3)
Once every day 47 (34) 54 (38) 43 (33) 22 (16) 32 (23) 30 (24) 26 (20) 34 (26) 30 (24) 20 (15) 19 (15) 21 (18)
Twice every day 19 (14) 27 (19) 44 (34) 8 (6) 13 (9) 31 (25) 4 (3) 2 (2) 15 (12) 5 (4) 4 (3) 6 (5)
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TABLE 38 Treatment credibility and exercise adherence at each follow-up time point (continued )
Question
3 months 6 months 9 months 18 months
UC
(n= 143)
ITE
(n= 146)
TEA
(n= 136)
UC
(n= 142)
ITE
(n= 140)
TEA
(n= 131)
UC
(n= 139)
ITE
(n= 135)
TEA
(n= 129)
UC
(n= 141)
ITE
(n= 134)
TEA
(n= 120)
Exercise duration
< 5 minutes 9 (6) 7 (5) 2 (2) 9 (7) 7 (5) 7 (5) 17 (13) 5 (4) 12 (10) 8 (6) 15 (12) 9 (8)
5 minutes to < 10 minutes 23 (17) 27 (19) 36 (27) 28 (21) 28 (20) 34 (27) 25 (20) 41 (32) 30 (24) 28 (22) 44 (34) 28 (25)
10 minutes to < 15 minutes 33 (24) 42 (29) 43 (32) 36 (26) 44 (32) 38 (30) 32 (25) 34 (27) 40 (32) 42 (33) 25 (19) 28 (25)
15 minutes to < 1 hour 62 (45) 58 (40) 49 (37) 50 (37) 48 (35) 44 (34) 39 (30) 37 (29) 33 (27) 23 (18) 22 (17) 27 (24)
≥ 1 hour 8 (6) 8 (6) 2 (2) 3 (2) 2 (1) 3 (2) 1 (1) 1 (1) 3 (2) 4 (3) 3 (2) 3 (3)
I do not do the exercises 4 (3) 2 (1) 1 (1) 10 (7) 9 (7) 2 (2) 14 (11) 10 (8) 6 (5) 23 (18) 20 (16) 16 (14)
Figures are n (%).
Analysis completed on non-imputed data as only the primary and secondary outcomes (excluding accelerometer data) were included in the imputation model.
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org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any
medium, provided the original work is properly cited. For commercial re-use, please contact journals.
permissions@oup.com.
The imputed data set contained 514 patients and this informed the base-case analysis. Complete outcome
data were available for 325 patients (64% of the total sample) and this sample was used as part of the
sensitivity analysis.
Resource use
Details of NHS and total health-care resource use associated with the three trial interventions are reported
in Table 39. Uptake of primary care and secondary care NHS services was similar between the intervention
groups with the exception of knee-related surgical procedures and extra visits to NHS consultants. A higher
proportion of participants in the ITE group had full total knee replacement surgery by the 18-month
follow-up (n = 10, 7%) than either the UC or TEA groups (n = 5, 4%, and n = 3, 2%, respectively).
TABLE 39 Summary of mean resource use by treatment arm over 18 months
Resource category UC (n= 141) ITE (n= 134) TEA (n= 120)
Primary care: GP, mean (SD) visits per patient 1.42 (2.3) 1.50 (3.2) 1.33 (2.7)
Primary care: practice nurse, mean (SD) visits per patient 0.19 (0.7) 0.37 (1.7) 0.45 (2.3)
Primary care: other professionals, mean (SD) visits per patient 0.32 (1.3) 0.28 (1.4) 0.35 (1.6)
NHS consultant, mean (SD) visits per patient 0.93 (2.3) 1.68 (3.6) 1.64 (4.2)
NHS other health-care professionals, mean (SD) visits per patient 0.12 (0.6) 0.17 (0.9) 0.04 (0.2)
Private consultant, mean (SD) visits per patient 0.50 (2.8) 0.43 (2.1) 0.11 (0.8)
Private other health-care professionals, mean (SD) visits per patient 0.45 (0.5) 0.32 (3.1) 0.00 (–)
Full knee replacement,a n (%) 3 (2) 10 (7) 5 (4)
Arthroscopy,a n (%) 6 (4) 4 (3) 4 (3)
Partial replacement,a n (%) 0.00 (–) 0.00 (–) 1 (1)
Investigations/injections,a n (%) 29 (21) 36 (27) 29 (24)
Prescribed medication,a n (%) 50 (35) 44 (33) 37 (31)
Basic analgesic 39 (22) 74 (18) 65 (40)
Moderate combination 1 (1) 2 (1) 2 (1)
NSAIDs and COX2-inhibitors 24 (14) 4 (8) 15 (19)
Strong combination opioids + opioids 19 (11) 27 (15) 25 (15)
Very strong single opioids 0 (–) 1 (1) 1 (1)
Weak combination opioids 17 (10) 19 (11) 13 (8)
Over-the-countera treatments, n (%) 56 (40) 52 (39) 47 (39)
Basic analgesic 71 (41) 74 (42) 65 (40)
NSAIDs 2 (1) 3 (2) 1 (0.6)
Weak combination opioids 4 (2) 8 (5) 3 (2)
COX2-inhibitors, cyclo-oxygenase-inhibitors.
a The n (%) of participants reporting usage within the procedures, investigations, procedures, out-of-pocket and
prescribed medication categories are reported instead of mean (SD) because it was not possible to distinguish multiple
usage, purchases and/or prescriptions.
Adapted from Kigozi et al.265 © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society
for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution
Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution,
and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact
journals.permissions@oup.com.
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Table 40 shows the mean costs associated with the resource use during the trial. From a NHS perspective,
the difference in costs between ITE and UC was £273.33 (95% CI –£62.1 to £562.6), with the ITE arm
incurring higher costs to the NHS. The incremental cost between UC and TEA was £141.80 (95% CI
–£135.6 to £408.1), with TEA incurring slightly higher costs. The differences were attributed to the
increased number of physiotherapist treatment sessions and higher knee surgery costs in the ITE and
TEA groups.
Health outcomes and quality of life
Table 41 details the EQ-5D-3L scores at baseline as well as at 3, 6, 9 and 18 months. On average, participants
in all three intervention groups showed improvements at each follow-up period up to 18 months, with the
exception of the ITE group at 9 months and the TEA group at 18 months. For the base-case analysis, over
the 18-month period, the mean adjusted difference in QALYs between the ITE and UC groups was –0.009
(95% CI –0.068 to 0.048) and between the TEA and UC groups was –0.009 (95% CI –0.073 to 0.045).
Therefore, those patients receiving UC had very slightly higher QALYs over the 18-month follow-up period
than those receiving either the ITE or TEA interventions.
TABLE 40 Mean (SD) costs by treatment arm over 18 months
Items of care for costing UC (N= 175) ITE (N= 176) TEA (N= 163)
Total cost of intervention (£) 43.89 (20.8) 70.83 (32.9) 85.97 (41.7)
Complete case analysis (£) n = 141 n = 134 n = 120
Primary care
GP consultations 34.52 (55.3) 36.73 (73.8) 34.72 (71.7)
Practice nurse consultations 2.45 (8.7) 5.17 (27.1) 6.26 (33.9)
Consultations with other professionals 5.95 (34.9) 4.72 (32.4) 7.04 (35.6)
Prescriptions 7.60 (17.4) 7.64 (21.7) 4.77 (9.6)
Secondary care
NHS consultant 67.05 (191.1) 106.33 (231.4) 103.88 (250.4)
Consultation with other NHS
professional
0.00 (–) 3.28 (19.3) 1.43 (12.4)
NHS investigations and treatments 15.45 (51.6) 61.01 (513.7) 16.73 (64.3)
Knee surgery 213.79 (1194.5) 389.36 (1501.5) 259.93 (1118.6)
Private consultant 26.80 (149.2) 30.93 (166.8) 8.21 (46.1)
Consultation with other private
health-care professional
0.00 (–) 13.75 (138.1) 0.00 (–)
Over-the-counter purchases 17.61 (72.3) 16.80 (44.5) 28.90 (133.3)
Base-case analysis (imputed) n = 175 n = 176 n = 163
Total NHS cost (£) 382.63 (1351.3) 656.03 (1617.1) 524.44 (1258.2)
Adjusted mean difference (95% CI) 273.33 (–62.1 to 562.6) 141.80 (–135.6 to 408.1)
Total health-care costs (£) 427.19 (1457.8) 711.11 (1683.7) 560.41 (1307.1)
Adjusted mean difference (95% CI) 283.92 (–73.43 to 591.6) 133.22 (–178.3 to 410.7)
Adapted from Kigozi et al.265 © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for
Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial
License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in
any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
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Cost-effectiveness analysis
The results indicate that UC is less costly than the ITE and TEA interventions and is at least as effective
(Table 42), and is therefore the dominant treatment. Figures 10 and 11 show the corresponding
cost-effectiveness planes for the base case. Each point results from a separate bootstrap replication, with
the 5000 points scattered in all four quadrants and the majority of points located in the north-west
quadrant in both cases (68% for ITE vs. UC and 45% for TEA vs. UC), showing the dominance of UC.
The corresponding CEACs are represented in Figure 12, showing the very low probability of either the ITE
or TEA physiotherapy intervention being cost-effective.
TABLE 41 Summary of EQ-5D-3L and QALY outcomes by treatment group over 18 months
Variable UC ITE TEA
Primary imputed analysis n = 175 n = 176 n = 163
EQ-5D scores, mean (SD)
Baseline 0.636 (0.23) 0.644 (0.23) 0.629 (0.23)
3 months 0.686 (0.20) 0.708 (0.19) 0.669 (0.23)
6 months 0.690 (0.23) 0.692 (0.22) 0.692 (0.22)
9 months 0.698 (0.22) 0.665 (0.25) 0.702 (0.20)
18 months 0.700 (0.22) 0.700 (0.21) 0.682 (0.23)
QALYs, mean (SD)
Unadjusted 1.0351 (0.27) 1.0258 (0.27) 1.0258 (0.27)
Adjusted mean difference (95% CI)b –0.009 (–0.068 to 0.048) –0.009 (–0.073 to 0.045)
Adjusted 1.0353 1.0198 1.0322
Complete case analysis n = 109 n = 113 n = 103
QALYs, mean (SD)
Unadjusted 1.0581 (0.27) 1.0478 (0.21) 1.0282 (0.29)
Adjusted mean difference (95% CI)b –0.0103 (–0.083 to 0.059) –0.0298 (–0.105 to 0.046)
Adjusteda 1.0614 1.0329 1.0409
a Predicted scores after controlling for baseline imbalances.
b With UC as comparators.
Adapted from Kigozi et al.265 © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for
Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial
License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in
any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
TABLE 42 Cost–utility analysis for 18 months’ follow-up
Intervention Mean costs (SD) (£) Mean QALYs ICER (£/QALY gained)
UC 382.63 (1351.32) 1.0353 N/A
ITE 656.03 (1617.07) 1.0322 Dominated by UC
TEA 524.44 (1617.07) 1.0198 Dominated by UC
Adapted from Kigozi et al.265 © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for
Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial
License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in
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FIGURE 11 Base-case cost–utility plane comparing TEA with UC. Data were based on 5,000 bootstrapped cost–effect
pairs. Incremental costs and incremental QALYs were calculated as TAE minus UC. Adapted from Kigozi et al.265
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FIGURE 10 Base-case cost–utility plane comparing ITE with UC. Data were based on 5000 bootstrapped cost-effect
pairs. Incremental costs and incremental QALYs were calculated as ITE minus UC. Adapted from Kigozi et al.265
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Sensitivity analysis
The mean difference in QALYs for the complete case analysis over the 18-month period between the ITE
and UC groups was –0.0103 (95% CI –0.083 to 0.059) and –0.0298 (95% CI –0.105 to 0.046) between the
TEA and UC groups, leading to similar conclusions as the base-case analysis. The incremental mean QALY
estimates over 18 months were larger than the base-case analysis. The broader health-care perspective,
taking into account private health care and over-the-counter expenditure by patients, showed the
incremental mean health-care costs were also higher in the ITE and TEA groups in the imputed and complete
case data sets (see Table 40). The same implications were replicated in all sensitivity analyses that varied the
costing methodology, including the complete case analysis and imputation of total NHS costs (Table 43).
TABLE 43 Sensitivity analysis mean (SD) costs by treatment arm over 18 months
Costs UC ITE TEA
Sensitivity analysis 1: complete
case analysis n = 141 n = 134 n = 120
Total NHS costs (£) 423.08 (1517.5) 712.01 (1762.2) 519.39 (1278.9)
Adjusted mean difference (95% CI) 288.93 (–147.5 to 656.6) 96.30 (–271.1 to 455.8)
Total health-care costs (£) 467.50 (1643.1) 773.49 (1848.1) 556.51 (1350.2)
Adjusted mean difference (95% CI) 305.90 (–178.2 to 382.4) 89.00 (–320.5 to 474.8)
Sensitivity analysis 2: multiple
imputation of total NHS costs n = 175 n = 176 n = 163
Total NHS costs (£) 395.36 (1324.7) 675.96 (1602.7) 463.71 (1090.08)
Adjusted mean difference (95% CI) 280.60 (–42.8 to 594.3) 68.34 (–177.7 to 322.5)
Total health-care costs (£) 437.38 (1433.4) 732.27 (1676.4) 497.78 (1150.8)
Adjusted mean difference (95% CI) 294.88 (–36.61 to 628.4) 60.39 (–206.1 to 377.9)
Adapted from Kigozi et al.265 © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for
Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial
License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in
any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
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Work-related outcomes
Information regarding paid employment and productivity costs due to time off work resulting from knee
pain is reported in Table 44. At 18 months, the percentage of people taking time off work was higher in the
ITE intervention group (17.4%) and the TEA group (14.6%) than in the UC (3.3%) group. This translated to
higher productivity costs in the intervention groups than in the UC group. The difference between the ITE
and UC groups was statistically significant and the difference between the TEA and UC groups was
not significant.
In summary, the health economic analyses showed that UC was less costly than, and at least as effective
as, the other two interventions in the BEEP trial. Participants in the UC group went on to receive fewer
knee-related surgeries and had fewer visits to NHS consultants and less time off work over the 18 months’
follow-up.
Results from the linked qualitative study
Parts of this text have been reproduced with permission from Moore A, Holden M, Foster N, Jinks C.
Keele University. 2017.266
In total, 30 participants were interviewed shortly following the end of their BEEP treatment. This was the
first interview time point (interview 1). Of these, six (two from each arm) declined to participate in the
follow-up interviews (interview 2) which occurred 12–18 months after completion of BEEP treatment
(timed to occur following participants’ 18-month follow-up questionnaires). Two participants withdrew
from the qualitative interviews (but remained in the trial). One participant withdrew because of a
bereavement while the other gave no reason. Therefore, 22 participants were interviewed at the second
time point. Overall, there was a spread of participants across the three intervention groups at interview 1
(with the smallest number in the ITE group) (Table 45). There was an equal split according to sex across
the interview sample and participants were drawn from across all age ranges (although there were fewer
in the youngest age group). Overall, the interview sample included more participants reporting improved
rather than worsened pain or levels of physical functioning following BEEP interventions.
Participants’ perceptions of BEEP interventions
The interviews revealed patient perceptions of what happened during BEEP treatment sessions.
Physiotherapy-led exercises were described across all three arms of the trial and these data shed light on
how core intervention constructs of supervision, progression and individualisation were experienced.
Different levels (basic and higher) emerged from the data (Figure 13).
TABLE 44 Description of work-related outcomes for participants in paid employment, by treatment group
Work outcome UC ITE TEA
Working in paid employment at
18-month follow-up
61/141 (43%) 46/134 (34%) 41/120 (34%)
Reported time off work due to
knee problem at 18 months
2 (3.3%) 8 (17.4%) 6 (14.6%)
Mean (SD) time off work due to
knee problem over 18 months (days)
1.79 (13.5) 13.55 (33.5) 6.95 (24.2)
Mean (SD) cost (£) of knee-related
work absence
127.84 (963.3) 1313.61 (3368.2) 691 (2382.1)
Values are n (%) unless stated otherwise. The estimation of indirect costs focused on the subsample of respondents in paid
employment at 18 months (148/514).
Adapted from Kigozi et al.265 © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for
Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial
License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in
any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
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Supervision
Basic
•  Demonstrating
•  Observing
•  Explaining
•  Checking
Higher
•  Doing together
    (partnership)
•  Attentiveness
•  Progressing
Individualisation
Basic
•  Some adaptation
•  Reducing
    difficulty
•  Providing
    alternatives
Higher
•  Tailoring
•  Adjusting to
    achieve goals
•  Building on
    valued activity
•  Explaining
•  ‘Moving beyond’
•  Forming habits
•  Monitoring
    progress
Progression
Basic
•  Increasing
    repetitions
•  Introducing
    exercises
•  Maintaining
    improvements
Higher
•  Monitoring
    general physical
    activity
•  Focusing on
    transitions
•  Moving beyond
FIGURE 13 Evidence of intervention constructs described in qualitative interviews in all three intervention arms of
the BEEP trial.
TABLE 45 Summary of characteristics of interviewees
Sampling criteria Subcategory
Age (years) (at time of first interview) 45–55 (n= 5)
55–64 (n= 9)
65–74 (n= 8)
≥ 75 (n= 8)
Sex Female (n= 15)
Male (n= 15)
Treatment group UC (n = 10)
ITE (n = 8)
TEA (n = 12)
WOMAC paina Improvedb (n = 18)
Worsenedc or no change (n = 11)
Missing (n= 1)
WOMAC physical functiona Improvedb (n = 19)
Worsenedc (n= 11)
a WOMAC Pain and Physical Function Scores were taken from self-completed questionnaires returned at 3 months follow-up.
b Improved= any reduction in pain or functional disability subscale scores on 3 month questionnaires since baseline.
c Worsened= any increase in pain or functional disability subscale score on 3 month questionnaires.
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Participants in all arms described how their treating physiotherapist demonstrated the exercises, watched
them, explained the exercises and assessed and monitored for any symptom response to the exercise
programme (basic supervision). Higher levels of supervision were also evident across all three arms.
However, in the ITE arm, a notable difference was the sense of partnership with the physiotherapist that
participants described. This was highlighted by descriptions such as ‘we practised them’, ‘we did them’,
‘we went through them together’ and ‘he literally went through them and I did them all with him.’ In the
other two arms, although participants recalled physiotherapists demonstrating the recommended exercises,
often a more sequential approach occurred with the patient following the physiotherapist’s demonstration.
A basic level of exercise progression included increasing the number of repetitions of exercises, introducing
new exercises and maintaining improvements in exercise. This level was evident from the interviews with
participants from all interventions arms of the trial. Higher levels were described in examples that
participants in the ITE and TEA intervention arms gave about moving beyond specific lower limb BEEP
exercises to more general physical activities. For example:
We went onto weight-bearing exercises then, so I’m doing sort of step ups and squats, and an
exercise bike as well, and I’m using an exercise bike. So you know 12 months ago, I wouldn’t have
been able to try and pedal so, you know, it’s – it’s very good really.
6878, ITE: interview 1
I know she felt quite certain that she could get me walking around the block.
4876, TEA: interview 1
The interviews revealed evidence of a basic level of exercise individualisation in all three intervention arms,
characterised by adaptation of exercises based on the patient’s ability to perform them (at home or at the
treatment centre), reducing difficulty and providing alternatives after a period of testing out at home.
There was no evidence from the interviews that individualisation in the UC arm extended beyond this basic
level. A higher level of individualisation was revealed in the narratives of participants in both the ITE and
TEA arms and this was reflected in participants perceiving that their physiotherapist adjusted their exercise
programme to suit their individual needs. For example:
She was adaptable in her approach, she, erm, said, ‘OK, don’t do that set of exercises. This is another
that’s not exactly dead on for what you want, but it won’t affect your hernia issue’.
7880, TEA: interview 2
Adjusting exercises to achieve goals, providing explanations for those adjustments and exercise
replacements, monitoring progress and moving beyond specific lower limb BEEP exercises were all other
characteristics of a higher level of individualisation.
He gives you very specific exercises to deal with the problem you’ve been referred with. And then he
moved on to thinking about the other things you did, like your cycling which you’d done in the past.
3657, TEA: interview 1
There were clear links between the constructs of supervision, progression and individualisation. For
example, this participant talked about being observed by the physiotherapist (basic supervision) and
moving on to do new exercises (basic progression):
And [physiotherapist] will be watching me doing all these exercises, and she say ‘I know you can do
that one so we’ll cross that off, we’ll go on to the next one’. [. . .] Oh she would watch me close, I can
tell you [laughs].
6153 UC: interview 1
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Another participant described how, after progressing well through the BEEP exercises, he was encouraged
to participate in a general physical activity that was valued by him:
That’s where he started initially to suggest doing something else and he’s probably picked up from me
that I love cycling.
3657, TEA: interview 1
The BEEP interventions included techniques and tools to help increase general physical activity. The ITE and
TEA interventions were to include SMART goal-setting, corrective feedback and reinforcement, and the TEA
intervention in particular included a focus on general physical activity behaviours including techniques such
as behavioural contracting with the physiotherapists’ toolkit. However, from the interviews, there was little
evidence of participants’ recalling SMART goal-setting, no evidence of a behavioural contract being used
specifically, little evidence of active physiotherapy support to access local physical activity opportunities and
facilities, and no evidence of the use of exercise reminders. Although the interviews were based on a small
sample (30 participants, only 8 in the ITE and 12 in the TEA interventions) and the data are subject to recall
problems, the results support the quantitative findings from the physiotherapy CRFs by further suggesting
that the physiotherapists in the BEEP trial did not routinely use all of the tools offered to them as part of the
BEEP interventions.
Facilitators of the uptake and maintenance of exercise and general physical
activity
There were a range of factors that helped participants to engage in the recommended exercises or participate
in general physical activity (Table 46). Patient attributes acting as facilitators included self-motivation, being
‘naturally active’, making a conscious effort, being confident with exercise and having an active identity, for
example ‘not the sort to sit about’. Physiotherapist attributes included reassurance, confidence building and
positivity, being mature and confident in manner, being respectful, listening and giving realistic advice.
Being encouraging and enthusiastic and offering explanations also aided participants to engage with their
prescribed exercises or general physical activity.
A core construct of therapeutic alliance emerged, defined here as the working relationship or collaborative
bond between patient and therapist.237 A therapeutic alliance was generated in treatment sessions with
participants from all arms of the trial. The narratives of participants in the ITE and TEA intervention arms
contained richer accounts of the components of this working relationship and what the impact of this was.
Key features of the therapeutic alliance within each of the intervention groups in the BEEP trial are outlined
in Table 47.
The therapeutic alliance had strong links to changing knowledge, visual motivations, and physiotherapist
and patient attributes, and was aided through supervision, progression and individualisation. Although
physiotherapists’ attributes and therapeutic alliance influenced participants directly during treatment
sessions, they provided a foundation that facilitated a change in knowledge about the role of exercise, the
effects of which continued into the longer term. Those in the usual physiotherapy group spoke of an
increased awareness of the benefits of exercise, the need to maintain strength and stability in their leg(s)
and using painkillers specifically in order to facilitate engagement in exercise. In the ITE group, participants
demonstrated awareness that progress could take time and they reported having gained a better
understanding of the importance of maintaining exercise and building strength to support their knee, as
well as exercising even when they have pain. In the TEA group, participants spoke about an increased
understanding of the purpose and benefit of the exercises and whether or not to exercise when they felt
pain during exercise:
One thing I’ve learnt from the study is that the more exercise I do with it I think the better it is going
to be.
1736 TEA: interview 2
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TABLE 46 Factors facilitating uptake and maintenance of exercise and general physical activity
Activity
category
UC ITE TEA
Post intervention Follow-up Post intervention Follow-up Post intervention Follow-up
BEEP exercises Physiotherapist; patient
(enjoyment, feeling benefit,
increased self-efficacy); time
and place
Patient (feeling benefit,
change in knowledge,
prevention motivations)
Physiotherapist; patient
(change in knowledge,
feeling benefit, prevention
motivations, maintain valued
activity); time and place;
visual motivation;
supervision; social support
Time and place
(fit into work)
Physiotherapist; patient
(change in knowledge,
enjoyment, prevention
motivations); time and place;
visual motivation; tailoring;
progression; supervision;
goal–setting; regular contact
Patient (feeling benefit);
moved on
General physical
activity
Patient (self-motivated,
change in knowledge,
prevention motivation,
weight loss)
Physiotherapist; patient
(change in knowledge,
maintain valued activity);
time and place
Patient (naturally
active, retained
knowledge)
Physiotherapist; patient
(change in knowledge,
enjoyment, prevention
motivations, progression
with valued activity); time
and place; visual motivation;
support from others
Patient (change in
knowledge, naturally
active); regular contact
monitoring by others;
support from others;
epiphany
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Over the longer term (by the time of the second interviews 12–18 months later), patient attributes became
more important to maintaining exercise or physical activity. These included, for example, feeling and
observing the benefit of exercise and motivations to avoid future surgery or reliance on medication, and
were thus linked to participants’ notions about how they might prevent further decline in their knee
problem.
Barriers to uptake and maintenance of BEEP exercises
A range of barriers emerged from the qualitative data (Table 48). Patient attributes acting as barriers
included lack of enjoyment of exercises, lack of will power, beliefs about limited effectiveness of exercise
and low health expectations related to ageing. Participants from all three BEEP intervention arms also
reported pain as a barrier to exercise at their second interviews. In all three arms, patients found that the
time taken to do the exercises and the place in which exercises had to be completed adversely affected
adherence. Some commented on how they found it difficult to find the time to fit the exercises into their
daily life either at home or at work, others found that finding the right place to do the exercises was a
barrier as they were either distracted at home or felt that they ‘looked silly’ doing them at work.
TABLE 47 Features of the therapeutic alliance in BEEP trial interactions
Features of the therapeutic alliance
UC ITE TEA
Equity of labour (not letting
physiotherapist down, doing
my bit) (7058)
Regularity aided recall and enhanced discussion
(1481)
Physiotherapist inspired
participant to join gym (3657)
Sense of partnership (1135) Continuity – ongoing dialogue with same
physiotherapist enabled openness, trust, rapport
(6517, 6878, 1481)
Physiotherapist was respectful of
whole person (3)
Negotiating exercise
frequency with
physiotherapist (6153)
Physiotherapist offered reassurance, ‘so felt
could keep going’, comforting, eased concerns
(6517, 6878, 1481)
Offered reassurance about pain
(7880, 6436)
Generated connection with patient, ‘talked
about herself’, ‘got to know me’, ‘interested in
me’, encouraged questions (61, 26)
Considerate of patient’s issues
(7880)
Enjoyable interaction, felt at ease, relaxed, did
not rush, (61, 26)
Physiotherapist was focused and
attentive (7880)
Felt valued as person (26) Listening (7880, 6436)
Appreciative of physiotherapy help (61) Sense of responsibility to
physiotherapist (3657)
Reciprocity (1481) Building an alliance, continuing
relationship with a physiotherapist
who could be trusted (7880)Offered explanations, good at explaining, full
explanations (26, 6517, 1481)
Attentive to me – gave realistic advice, noticed
weight loss, get balance right for me (26, 1481)
Social not medical approach
Support (1481)
Encouragement, motivating ‘got pushed in a
pleasant way’, make it happen, external to
family (1481)
Challenge pre-existing ideas, new thoughts,
new focus (1481)
Numbers in brackets are codes for individual interviews.
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In the UC participants, patient beliefs about the exercises were a barrier as some participants felt that
their physical status was so severe that the exercises were simply ineffective. Others had received knee
replacement surgery by the time of their interview and were unable to complete the exercises for a time as
a result, while some experienced an increase in the amount of pain they felt during the exercises and so
stopped doing them. Although there was evidence of a change in knowledge and understanding of the
TABLE 48 Barriers to the uptake and maintenance of exercise and general physical activity
Type of
activity
UC ITE TEA
Post
intervention Follow-up
Post
intervention Follow-up
Post
intervention Follow-up
BEEP
exercises
Pain Pain free Patient
attributes
Pain Pain Pain free
Time and place Patient beliefs Lack of
enjoyment
Drifting back Time and place
Patient beliefs Replacement Substitution for
other valued
activities
Lack of
monitoring
Ineffective
delivery of
intervention
No change in
Knowledge
Time and place Substitution Lack of
explanations
Severity of
exercises
Conflicting
advice from
HCPs
No change in
knowledge
Lack of
supervision
Reduced
self-efficacy
(fear of falling)
Patient attributes
Physiotherapist
Attributes
Time and place No motivation
when no
longer seeing
physiotherapist
Physical status Access: proximity
to clinic
Patient beliefs
Comorbidity
Physical status
Lost motivation
as could not
attend
General
physical
activity
Time Pain Patient attributes Pain
Substituted for
BEEP
Self-identity (‘not
natural athlete’)
Weather
Lack of
enjoyment
(‘gym is boring’)
Fear of unknown
(self-efficacy)
Financial
Lack of will
power
Already active Anxiety
Weather Lack of
motivation
Environment:
local facilities not
in working order
or inaccessibleWeather
Comorbidity
HCP, health-care professional.
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purpose and nature of physiotherapy exercises in other treatment arms, a lack of change in knowledge in
participants in the UC arm was perceived as a barrier – some patients perceived that the exercises were
‘too easy’ and, therefore, must be ineffective. One patient found the exercises ‘too severe’ for her, causing
more pain. Therefore, the physical status of the patient as well as the patient’s (mis)understandings about
the nature of the exercises they were prescribed by the physiotherapist (either too easy and thus ineffective
or too difficult and causing more pain) appear to be important barriers. Overall, pain status acted as a key
barrier to exercise or physical activity in participants across all three arms of the trial.
Suggestions for improvements to the BEEP interventions
The main suggestion that interviewees made to improve the BEEP interventions was for more regular
physiotherapy reviews or monitoring (either at 6, 12 or 24 months). This was suggested by interviewees
from all three treatment arms. Regular reviews were felt to be important in order for ongoing assessment
of physical status and exercise activity, to enable changes in exercises to be made appropriately and to
enable physiotherapists to remind patients of why they were exercising and why it was important to
continue and persist with exercise and physical activity. Participants in the UC and ITE groups felt that
regular reviews with physiotherapists rather than GPs or consultants were more appropriate as they
provided the right kind of advice and support and were ‘easier to talk to’. Other suggestions included
more treatment sessions, treatment spread over a longer time period and different modes of delivery
(e.g. e-mail or telephone sessions and reminders, physiotherapists making visits to participant’s homes and
community-based activities).
Discussion
Summary of trial aim and key results
Any exercise programme that is carried out regularly and monitored by health-care professionals will
improve pain and function in the short term.33 We aimed to improve both the short- and long-term pain and
physical function outcomes from exercise in older adults with knee pain by changing the key characteristics
of physiotherapy-led exercise programmes prescribed. UC was based on up to four treatment sessions over
12 weeks and was a relatively standardised approach to lower limb exercise prescription with limited
opportunity for ongoing supervision, progression or individualisation. In the ITE group, physiotherapists
offered more treatment sessions (between six and eight sessions over 12 weeks) to deliver a more highly
individualised, supervised and progressed lower limb exercise programme for participants, using clear
monitoring tools such as exercise diaries. In the TEA intervention, the treatment period was extended from
12 weeks to 6 months and the number of treatment contacts increased to between 8 and 10, so that
physiotherapists had the time to actively support participants to make the transition from a lower limb
exercise programme to engage in, and maintain, general physical activities that interest them and are
available locally. Physiotherapists providing the TEA intervention had an adherence-enhancing toolkit of
techniques with which to individualise the way in which they supported participants to increase their general
physical activity levels, including physical activity diaries, pedometers, SMART goal-setting, behavioural
contracts and set-back plans. We hypothesised that the ITE and TEA interventions would lead to greater
improvements in pain and functional outcomes than UC and that these improvements would be sustained
for longer.
The BEEP trial results showed no statistically significant differences in the change in pain and function
between treatment groups. All three groups showed improvements in pain and function and the size of
those improvements in pain and function are in line with, or slightly greater than, those reported in
previous meta-analyses,33 and with the most recent Cochrane review, which reported an effect size of 0.4
for short-term pain and 0.37 for short-term function.120 Furthermore, approximately half of all participants
in the treatment groups were classified as treatment responders using the OARSI responder criteria but,
again, there were no differences between the groups. Several sensitivity analyses did not change the
results, although the per-protocol analysis suggested a non-significant trend towards superiority in the TEA
compared with UC comparison. We showed that the moderate benefits in pain and function gained
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during the treatment phase (3 months in the UC group and ITE intervention group and 6 months in the
TEA intervention group) were maintained at longer-term follow-up time points (9 and 18 months). This
was unexpected in the UC group, given the results of previous trials which have shown short-term effects
that are lost over the longer term.34
There is no consensus on optimal methods with which to measure exercise adherence, and we used several
different approaches in the trial: self-reported adherence to the exercise programme prescribed by the
physiotherapist, self-reported frequency and duration of exercise, self-reported use of physical activity facilities
in the last 7 days, attendance at physiotherapy treatment sessions, and measures of general physical activity
(self-reported using the PASE for all participants and objective physical activity data collection with a
subsample of 89 participants). Self-reported adherence was high during the treatment phase in all three
groups (≥ 75% agreeing or strongly agreeing that they had completed their exercises as often as they had
been advised) and remained high for longer in the TEA group than the other two groups. In addition,
participants in the TEA intervention arm reported exercising more frequently than those in the ITE or UC
arms. Self-reported use of local physical activity facilities increased across all treatment groups and remained
higher than baseline levels, even at the 18-month follow-up. Other than a trend towards superiority in the
TEA group at 9 months, the changes were not different between the groups. PASE scores increased slightly
in all three treatment groups during the treatment phase, but the changes were not sufficient to make a
difference to the proportion of participants meeting physical activity guidelines. By 18 months, self-reported
physical activity levels and objective physical activity levels (in a subsample of participants) had dropped back
to baseline levels or lower, highlighting that without ongoing monitoring or supervision from the health
professional, older adults with knee pain do not sustain exercise and physical activity behaviours.
Treatment credibility was high in all three groups and remained so even at the 18-month follow-up.
Confidence to exercise (or exercise self-efficacy) and outcome expectations about exercise were reasonably
high at baseline and we observed small improvements in these scores in all treatment groups. In general,
participants in all three groups appeared to benefit from the BEEP trial interventions over time, with all
groups reporting that they felt they had greater control over their knee problem and were less concerned
about their knee problem than at baseline.
Given the lack of differences in clinical outcomes, the cost–utility analysis is key to informing decision-makers
about the most appropriate treatment choice. Based on outcomes over 18 months’ follow-up, the results
show clearly that UC is the most cost-effective treatment compared with either of the other interventions for
older adults with knee pain. Both the ITE and TEA interventions were more costly than UC and resulted in
slightly lower QALYs, meaning that both were dominated by UC. UC remained the dominant cost-effective
treatment in sensitivity analyses. The higher costs of the ITE and TEA interventions were associated with the
increased physiotherapy sessions and slightly more secondary care knee procedures (total knee replacements)
within the ITE group. Time off work was also higher in the ITE group and this may be linked to the greater
number of knee replacements in this group over the 18-month period of follow-up. Further data on
proportions of patients proceeding to secondary care consultations and knee surgery are currently being
collected at the 3-year follow-up.
Potential reasons for trial results
One potential reason for the trial results is a lack of sufficient difference between the three interventions.
All participants received a thorough assessment, advice and education based on best evidence, and all were
prescribed a physiotherapy-led exercise programme that was at least in line with clinical guidelines. The
differences in terms of numbers and content of intervention sessions may not have been sufficient to lead
to differences in patient outcomes. Fransen and McConnell33 showed that although treatment courses of
< 12 supervised sessions were effective, those with ≥ 12 provide greater effect sizes. Our trial was designed
and delivered with the UK NHS and, thus, the decision about the number of treatment contacts was
influenced by what physiotherapists and their managers perceived would be deliverable within the NHS,
given that current practice is to offer these patients, on average, up to four treatments. We protocolised
between 8 and 10 treatment contacts (this could include telephone contacts as well as to face-to-face
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contacts) in the TEA interventions and, although there was evidence that physiotherapists and patients used
the telephone contact option, patients, on average, received only seven treatment contacts. We do not
know from this trial whether or not offering a course of ≥ 12 treatment sessions would have led to better
outcomes. Although that is possible, we doubt it would be implemented within the UK NHS because the
physiotherapy resource to deliver treatment on this scale is unlikely to be available. The qualitative data
highlighted that, at least for those who were interviewed, participants experienced different levels of
supervision, individualisation and progression of their exercise programme in ways that matched the trial
protocols for each treatment arm and provided evidence that these components of the trial interventions
were delivered, at least to some extent, as intended. Analysis of the physiotherapy CRFs highlighted that the
number of treatment sessions differed between the treatment groups (three, on average, in UC, five, on
average, in ITE and six, on average, in TEA intervention arms) and this would therefore have provided more
opportunity for physiotherapists to provide a greater level of supervision, progression and individualisation
of exercise for participants. In addition, the CRF data showed the high fidelity of the interventions to
delivery of exercise programmes, with low use of other additional treatment approaches (mostly ice and
manual therapy which is in line with our previous national survey of practice by Holden et al.199). The CRFs
for the TEA intervention arm showed that only some strategies to enhance adherence and general physical
activity were frequently used and these were mostly the ‘simpler’ educational tools (PhysioTools exercise
sheets and written education materials) and behavioural tools (physical activity diaries and pedometers).
The per-protocol analysis showed a trend towards superiority of the TEA intervention compared with UC in
those participants who received the intervention contacts planned. Therefore, it is possible that, to some
extent, the trial results are explained by a lack of intervention fidelity. The interview and CRF analyses
showed that some aspects, particularly of the TEA intervention protocol (e.g. reminder postcards, clear
signposting to local physical activity facilities and behavioural contracting), were infrequently used. This may
indicate that the toolkit was too multifaceted and complex to use and this may have reduced the
effectiveness of the intervention.
In addition, all patients in the BEEP trial were managed with physiotherapy-led advice and exercise, and
received high-quality care from physiotherapists who were confident in managing knee OA and who
received specific training in the delivery of the BEEP trial interventions. The analysis of physiotherapist
questionnaires over time in the BEEP trial showed that even within physiotherapists who participated in the
UC training programme, the following was found: use of additional interventions (such as electrotherapy
and manual therapy) alongside the exercise programme reduced, there was a greater focus on general
physical activity, supervision of exercise increased and the level of agreement with the attitude statements
about the role of exercise for knee pain increased. This might help explain why the BEEP trial showed
sustained improvements in participants’ pain and function scores even at the 18-month follow-up in the
UC arm.
The qualitative analysis highlighted a central role of the therapeutic alliance between patient and
physiotherapist for all three treatment groups and this may help to explain the results of the BEEP trial. The
interviews showed how changes in participants’ knowledge fostered during interactions in treatment sessions
could have an impact on an individual’s exercise and physical activity > 12 months later. Therapeutic alliance
was evident from the interviews in all arms of this trial and could have diluted the effect of the additional
components in the ITE and TEA interventions. The influence of the therapist–patient relationship on
treatment outcomes in musculoskeletal conditions was the subject of a systematic review by Hall et al.267 The
authors reported positive associations between therapeutic alliance and global perceived effect of treatment,
as well as changes in pain, physical function, patient satisfaction with treatment, depression and general
health status.267 Our findings are supportive of the authors’ recommendation for further investigation of the
factors that underpin this therapeutic alliance. The interview results of our study also highlighted other factors
that facilitated or inhibited exercise and physical activity similarly across all three treatment arms, and which
may help explain the trial results. In line with previous research,210,268 we found that a wide range of intrinsic
(e.g. personal factors) and extrinsic (e.g. environmental) barriers and facilitators influenced exercise behaviour
in this patient group. However, these factors shifted over time from an initial mix of facilitating factors that
were both intrinsic and extrinsic at the end of the treatment phase to primarily patient-related (intrinsic)
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facilitators over the longer term. All three interventions appeared to facilitate those who saw themselves as
‘naturally active’ to maintain levels of physical activity despite their knee pain.
A further potential contributor to the trial results is the difference in clinical experience in the physiotherapists
delivering the three intervention arms. Those delivering UC who needed to attend only 1 day of BEEP training
were the most clinically experienced therapists on average in the trial, as shown in Table 22, which shows
that physiotherapists who delivered UC had a greater mean number of years in clinical practice (18.1 years)
compared with physiotherapists who delivered ITE and TEA (13.8 and 8.9 years, respectively). Whether or
not this may partially explain the trial results is unclear, but adjusting the analysis for the length of time of
clinical experience of the physiotherapist did not change the overall conclusions. The questionnaires from
physiotherapists showed greater changes in attitudes, beliefs and intended behaviours that were more likely
to be sustained in the long term in those therapists trained to deliver the ITE and TEA interventions.
Finally, although the proportion of treatment responders in all three treatment arms is encouraging (at
approximately ≥ 50% at both short- and long-term follow-up), this still means that about half of all adults
randomised to the trial did not respond well to exercise, in terms of pain and function outcomes and
overall global impression of change. Future research that helps identify more clearly who responds and
who does not respond to exercise would be helpful in targeting treatment and resources.
We cannot explain why slightly more participants in the ITE intervention arm went on to receive secondary
care specialist consultations and knee replacements (10 in the ITE group vs. 5 and 3 in UC and TEA
groups, respectively). It may be that greater progression of the lower limb exercise over more treatment
sessions led to a slight increase in the likelihood of participants and therapists discussing the merits of
surgery for the individual, or that more participants struggled with the lower limb exercise prescribed
for them and they sought other health-care advice as a result. We would have expected that the ITE
intervention might lead to fewer secondary care consultations and fewer knee replacement surgeries,
given the increase in muscle strength, movement and stability of the lower limb due to the prescribed
exercise programme.
Comparison with other trials and systematic reviews
Recent systematic reviews clearly show that exercise is effective for knee OA compared with no exercise
controls,122 that exercise should be supervised192 and that the number of sessions is important in terms of
achieving greater changes in pain and function.33,192 There is conflicting evidence from two recent systematic
reviews and meta-analyses about whether combining exercise types (such as strengthening, flexibility and
aerobic exercise)122 or focusing on single exercise types are more effective for knee OA.192 Pinto et al.269
focused their review of non-pharmacological and non-surgical interventions on cost-effectiveness and
showed that there is only limited evidence about cost-effectiveness of exercise and more high-quality
economic evaluations are needed.
No previous trials have specifically compared physiotherapy-led exercise approaches for older adults with
knee pain/OA in which key components of individualisation, supervision and progression or a focus on
exercise and physical activity adherence have been included. Other large trials in knee OA have found that
prolonged exercise interventions (involving up to 12 sessions of individualised, physiotherapy-led exercise
regimens) provide short-term (6 months) and smaller long-term benefits (12 and 30 months) and are
cost-effective compared with usual GP care.123,124,270 We have previously shown that physiotherapy-led
exercise is superior to usual GP-led care supplemented with an advice leaflet.34 In that trial, an average of
four treatment sessions was provided and this resulted in 37% of participants being classified as treatment
responders at 6 months. We showed that this increased to 43% when the exercise intervention was
provided over six treatment sessions and more attention was given to selling exercise to patients.203 By
long-term follow-up, these proportions had fallen to 36% and 48%, respectively. Our estimates from
the BEEP trial were better at 6 months (≥ 50% were treatment responders) with similar proportions at
18 months’ follow-up. Our trial results are similar to those of a recent Australian trial also comparing
different exercise approaches (neuromuscular versus quadriceps muscle strengthening) for patients with
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medial knee joint OA and malalignment.271 Their physiotherapists provided 14 supervised sessions and a
home programme. They showed no statistically significant between-group differences in knee adduction
moment, pain or function but, as is the case in the BEEP trial, all treatment groups showed similar
statistically significant within-group reductions in pain and physical dysfunction. There are some further
RCTs currently in progress comparing different exercise approaches in patients with knee OA, for example
Øiestad et al.272 is comparing 14 weeks of strengthening exercise, cycling and control and Messier et al.273 is
comparing high-intensity strength training [75–90% 1 repetition maximum (1RM)], low-intensity strength
training (30–40% 1RM) and healthy living education in START (Strength Training for Arthritis Trial).
Broader literature includes systematic reviews of the effectiveness of exercise referral schemes, which show
small effects on increasing physical activity in sedentary adults, and calls for further research to test ways
to improve adherence.31 In addition, a UK-based large randomised trial comparing leisure centre-based
exercise programmes, instructor-led walking programmes and advice alone for being physically active for
inactive adults referred for exercise by their GPs showed a net increase in physical activity in all three
groups with no differences between the groups.274
Strengths and limitations
The BEEP trial adds to the existing body of knowledge about exercise for knee OA. It is one of the largest
RCTs in the field, with long-term follow-up and linked qualitative interviews and cost-effectiveness analysis.
The key difference from earlier studies in the results of the BEEP trial appears to be in the maintenance
of the positive effects of exercise at longer-term follow-up. At 18 months, WOMAC pain and disability
scores were similar to those at 6 months and about half of all participants could be classified as treatment
responders. We have also provided the first cost-effectiveness study comparing short-term outcomes with
long-term outcomes from three approaches to physiotherapy-led exercise for older patients with knee pain
and clearly demonstrated that the treatment of choice for the UK NHS is UC.
There are some limitations to the BEEP trial. A small proportion of patients randomised did not receive any
physiotherapy treatment despite repeated attempts to engage those participants in treatment. The actual
proportion (7.6%) is lower than reported ‘do not attend’ rates within physiotherapy services (which have
previously been reported as 15%).275 In addition, analysis of the physiotherapy CRFs showed that, on
average, physiotherapists found it difficult to deliver the ITE and TEA interventions as specified in the
treatment protocols, both in terms of the number of treatment sessions and some of the adherence-
enhancing strategies within the TEA intervention. Despite being a key component of the TEA interventions,
only about half of those participants had a clear signpost to local physical activity facilities recorded on
their CRFs. A further limitation is the level of missing data on the cost outcomes, for which only 64% of
participants provided complete data. However, sensitivity analysis showed the results did not differ greatly
when a complete case analysis was undertaken. In addition, resource use data were requested from
patients in their 18-month questionnaire, requiring recall of resource use over the previous 12 months.
This length of time may have resulted in inaccurate estimates. However, this was the case for patients
in all three trial arms and so it is likely any inaccuracies are balanced.
Implications for clinical practice
The BEEP trial provides no evidence that increasing individual tailoring of, and targeting adherence to,
exercise and physical activity for older adults with knee pain related to OA, in the way that we did in the
ITE and TEA interventions, is either more effective or less costly than UC. The results showed that all three
interventions led to clinical improvements in pain and function, with no statistically significant differences
between the interventions. The cost-effectiveness analysis clearly demonstrates that UC based on up
to four sessions of exercise is the treatment of choice for this patient population, given the established
efficacy of physiotherapy-led exercise and physical activity for patients with knee OA. These results provide
guidance for clinicians in a variety of health professions who prescribe and oversee treatment and
prevention of older adults with knee OA. If it is the case that some patients benefit from more intensive
exercise approaches or greater support to engage in and maintain exercise over time, then further research
is needed to identify those patients.
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Unanswered questions and future research
Given that long-term adherence is required to maintain the benefits of exercise and physical activity, future
research needs to determine how best to support older adults with knee pain to sustain engagement
in exercise behaviour. Given the results of the quantitative and qualitative data from the BEEP trial, the
implications for research are to further test the clinical effectiveness and cost-effectiveness of regular
supervision or ongoing monitoring in particular on adherence and clinical outcomes. In addition, although
the trial showed that ≥ 50% of participants responded to exercise, this meant that up to half did not.
Further research that leads to better understanding and easier identification and prediction of those
patients who do and do not respond to exercise would be useful to better target health-care resources
and treatments. Some research is already under way proposing a preliminary clinical prediction rule to
identify the few patients who may not benefit from exercise.276 We used a range of available approaches
to measure adherence in the BEEP trial and although the broad patterns were similar for most of these,
the findings of some approaches appeared a little contradictory. Further research that develops better tools
with which to measure exercise adherence is needed. Finally, the qualitative research highlighted the
influence of the therapeutic alliance between the patient and physiotherapist in facilitating change in
patient knowledge and understanding of their knee pain and the role of exercise, and in their subsequent
exercise and physical activity attitudes and behaviours. Unfortunately, in this trial we did not include a
measure of therapeutic alliance, although such quantitative measures are available. We did, however, collect
data on perceived treatment credibility and this was high for all treatment groups. Future studies could
explore whether or not therapeutic alliance is a useful predictor of outcome for this patient population.
Overall conclusions
The most recent global burden of disease study showed that hip and knee OA is the eleventh largest
contributor to global disability.1 The rising age and obesity profiles of the population mean that health-care
professionals need to prepare for a large increase in demand for health-care services to treat lower limb
OA. Exercise is a recommended core treatment for knee OA and the BEEP trial investigated whether or
not patients’ outcomes of knee-related pain and functional disability could be improved by changing the
characteristics of physiotherapy-led exercise programmes to increase the individualisation, supervision
and progression of lower limb exercise and to more clearly supporting a shift from lower limb exercise to
general physical activity adherence over the longer term. The results show that neither the ITE nor the
TEA intervention led to superior pain or functional outcomes in comparison with usual physiotherapy-led
exercise and advice consisting of up to four treatment sessions over 12 weeks. Pain and disability scores
improved during treatment in all three groups and there were no differences between the groups over
18 months’ follow-up. Self-reported exercise adherence was high and remained higher for longer in the
TEA intervention group than the other groups, but by the long-term outcome at 18 months, this had
reverted to baseline levels or lower in all groups. Qualitative interview findings highlighted the benefits
that BEEP trial participants gained from the physiotherapy-led exercise interventions. Although there was
evidence of differences in the treatments received between the three treatment groups, there were
considerable similarities across treatment groups in terms of the therapeutic alliance developed with
physiotherapists and the challenges in sustaining behaviour change in the long term. The cost-effectiveness
analysis demonstrated that UC is the treatment of choice for service managers and commissioners.
WORKSTREAM 3: IMPROVING THE EFFECTIVENESS OF EXERCISE FOR OSTEOARTHRITIS – THE BEEP TRIAL
NIHR Journals Library www.journalslibrary.nihr.ac.uk
152
Chapter 5 Workstream 4: screening for distress in
persons with osteoarthritis – POST
Parts of this chapter have been reproduced from Mallen et al.300 © 2017 Mallen et al. This is an openaccess article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source
are credited.
A cluster randomised controlled trial of an electronic prompt for
comorbidity screening in clinical osteoarthritis consultations in
primary care with nested qualitative studies
Abstract
Background: Patients with painful, disabling OA constitute a ‘high-risk’ group for distress, anxiety and
depressive disorders. Comorbid depression and anxiety are potentially amenable to intervention and are
related to adverse future course and treatment response in OA. Screening for such symptoms is
recommended. Our objectives were to (1) evaluate the effectiveness of introducing GP point-of-care
screening for concurrent depressive and anxiety symptoms in patients consulting for clinical OA and
(2) explore GPs experiences of participating in a screening programme.
Methods/design: Pragmatic, cluster randomised, parallel trial in primary care. GP practices were randomly
allocated in blocks (1 : 1) to intervention or control using a balance algorithm. Participants were patients
aged ≥ 45 years consulting for OA or OA-related joint pain. In the intervention arm, GPs asked eligible
patients five questions, two each on depressive and anxiety symptoms and one on pain intensity, and they
were encouraged to treat OA, joint pain and depression and anxiety symptoms according to recommended
clinical guidelines. In the control arm, GPs asked eligible patients one question on pain intensity and
treated patients according to their ‘usual care’. Patient-reported outcomes were measured at post
consultation, 3, 6 and 12 months. The primary outcome was pain intensity time-averaged across all four
follow-up time points. GPs experiences were evaluated by brief questionnaire and interviews.
Results: A total of 1412 eligible patients from 44 randomised practices were recruited and consented to
take part (501 from 20 intervention practices and 911 from 24 control practices). For primary end-point
analysis there was a significantly higher average pain score over the four follow up time points in the
intervention group than the control group (mean difference 0.33, 95% CI 0.05 to 0.61; effect size 0.16,
95% CI 0.02 to 0.29). Key secondary outcomes also reflected better outcomes in the control group.
Conclusions: This trial provides evidence against a beneficial effect on patient-reported outcomes of
implementing screening for anxiety and depression in primary care patients consulting for clinical OA.
Trial registration: Current Controlled Trials ISRCTN40721988.
Background
Osteoarthritis is a chronic condition affecting the joints of older people. It is one of the most common
reasons for primary care consultation in the UK, with approximately 1 million people seeking treatment
each year.277 It is often associated with functional limitation and persistent pain, both of which can have an
impact on mood and QoL. Despite OA being a common disorder, the ability to effectively treat and
maintain an improvement in OA symptoms in primary care is limited.278 The majority of prognostic
indicators for poor outcome in OA patients are not modifiable at the point of presentation (e.g. older age,
female sex and long symptom duration prior to consultation).
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Depression has been shown to occur up to four times more frequently in individuals with persistent pain
conditions, such as OA, than in individuals without persistent pain,35,37,38 and depressive symptoms are
potentially modifiable.39 Furthermore, the results of a RCT showed that treating major depression in
patients with OA resulted in improvements in OA outcomes, including pain and function, and QoL.18,279
However, the detection of depressive symptoms in primary care is poor, particularly in those patients with
a chronic physical illness.36,280
Depressive symptoms that do not reach criteria for major depression, often termed ‘subthreshold’ or ‘mild’
depression, are still considered to be distressing and disabling, particularly for patients with a chronic
disease such as OA. Screening for depression as a routine assessment endeavours to improve identification
of depressive symptoms and consequently to facilitate implementation of the management of depressive
symptoms. Screening for depressive symptoms during primary care consultations for diabetes and coronary
heart disease patients, using two brief questions,281 had been stipulated as part of the Quality Outcomes
Framework282 for UK primary care practice since 2006. Indeed, screening and subsequent treatment of
depressive symptoms in patients with diabetes has been shown to be associated with health-care cost
savings283 and similar findings might have been expected among patients with other long-term conditions,
including OA.
Literature reviews prior to the development of this trial had recommended that such screening is also
carried out in high-risk groups with comorbid medical conditions,284,285 including chronic painful
conditions.36,286 Recommendations for depressive symptom screening had been included in the NICE
guidelines for holistic OA management.15 NICE guidelines for depression in adults with a chronic physical
health problem give details of how such comorbid depressive symptoms should be identified, treated and
managed.287 Ultrashort screening tools (two to three items) had been shown to be useful for identifying
depressive symptoms that warrant a subsequent more detailed assessment to determine their severity.288
Therefore, the anticipation was that identification of depressive symptoms through screening would result
in a change in care to address and, when appropriate, initiate treatment for such symptoms.289 It was this
screening combined with additional interventions to provide care of comorbid depressive symptoms that
appeared to be successful in reducing OA-related symptoms.279 Screening continued to be recommended
in clinical guidelines,15 yet how beneficial such a screening and subsequent modification of care approach
is for OA patients with subthreshold or mild depressive symptoms was yet to be determined.
Anxiety has also been shown to be common in primary care patients (14.6–19.5%).290,291 However, less
than half of anxious cases were estimated to be recognised by their GP.292 It is common for anxiety to lead
to the development of depression293 or co-occur with depressive symptoms294 in primary care patients, and
to have a potentially negative impact on well-being.295 Consequently, screening for anxiety symptoms in
OA primary care patients has been recommended as the first step in improving patient outcomes and to
help prevent the development of depressive disorders.296,297 A two-item screening tool for Generalised
Anxiety Disorder Assessment (GAD-2)291 is suitable to detect anxiety symptoms in patients across a
continuum of anxiety symptoms.
Therefore, we undertook a cluster RCT to investigate prompting for recommended holistic assessment of
OA by screening for both anxiety and depression in an OA primary care population. A cluster RCT rather
than an individual randomised trial was chosen for both scientific and practical reasons. GPs are likely to
find it difficult to act differently towards patients if those patients are individually randomised to control
and intervention arms during the consultation and, therefore, contamination between the two arms would
be likely in such a design. The cluster RCT in this situation represents a professional cluster intervention
type,298 in that the intervention involves professional activity during consultation and, although the patient
can opt out of their data being used, the intervention is still likely to have an effect on them as it involves
introducing specific questions to a consultation for diagnosed OA or peripheral joint pain suspected of
being associated with OA. [This is the identical set of Read codes to those used in the consultation studies
of workstream 2 (see Chapter 3).]
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The purpose of this workstream was to investigate the effect on clinical outcomes [pain intensity and a
measure of the extent to which pain interferes with daily activity (‘pain interference’)] of introducing
structured prompts to alert GPs to the possible presence of concurrent depressive and anxiety symptoms as
part of a holistic assessment in patients presenting to their GP with OA, as recommended in a systematic
review of literature regarding screening for depression in primary care.299 The qualitative work aimed to
explore how useful GPs consider case-finding for anxiety and depression in people with OA, and what the
possible barriers to and facilitators of such case-finding might be.
Aims
The overall aim of this trial was to develop and test a systems intervention to prompt holistic OA treatment
in primary care, specifically a screening tool for concurrent depressive and anxiety symptoms.
Primary objective
The primary objective was to determine whether or not screening for generalised anxiety and depressive
symptoms in patients who consult their GP with OA or peripheral joint pain results in an improvement in
their pain-related outcomes. The specific hypothesis was that the patients who are screened for depressive
and anxiety symptoms in their GP consultation will have a larger improvement in their self-reported current
pain intensity and pain interference with daily activity ratings (NRS 0–10) over the 12 months following
their consultation compared with the observed improvement in these measures among patients in the
control arm (who are not screened).
Consistent with our overall aim, an integrated qualitative study based within participating general practices
aimed to:
1. explore GP experience and the perceived value of including questions about anxiety and depressive
symptoms in the OA consultation
2. investigate how GPs engaged with the trial and in the use of the screening template during their
consultations, and whether or not there were differences between the two arms of the trial.
Study protocol: methods and design
Full ethics approval was given for this study from The Black Country REC (reference number 11/WM/0093).
Study design: main trial
The Primary care Osteoarthritis Screening Trial (POST) was designed as a cluster RCT with GP practices as
the unit of randomisation. The intervention component of the trial took place during a consultation for
OA. Following consultation, individual patients were invited to take part in a post-consultation postal
questionnaire and subsequent follow-up questionnaires at 3, 6 and 12 months following completion of
the post-consultation questionnaire. A summary of the study design is illustrated in Figure 14. The first
assessment is ‘post consultation’ and is considered an outcome time point as opposed to a true baseline.
A real clinical effect is possible at this early stage given the nature of the intervention both in terms of GP
behaviour and medication management. Thus, four outcome time points apply to this study relating to
(1) post consultation, (2) 3 months, (3) 6 months and (4) 12 months outcomes. The ‘summary outcome’
pain score (primary end point) concerns the average score across all four time points.
Participants
GP practices A total of 44 Royal College of General Practitioners-approved ‘research ready’ GP practices
that use the EMIS consultation system were recruited through Primary Care West Midlands North PCRN.
The GP practices involved in the study included those from both urban and rural areas, different
socioeconomic groups and all sizes of practice (based on patient list size and number of GP partners). It
was anticipated that the template would be active in each GP practice for approximately 3 months. GP
practices were recruited over a 1-year period and so the template was not active in all practices at any
one time.
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Potentially eligible
(n = 4238 patients)
Randomised to control
(n = 24 practices)
Received allocated intervention
(n = 24 practices)
[List size: mean (range) = 7397 (2197 to 21,173)]
Did not receive allocated intervention
(n = 0 practices)
Assessed for eligibility
(n = 63 practices)
Excluded
(n = 18 practices declined offer to participate)
Randomised
(n = 45 practices)
[List size: mean (range) = 6694 (2091 to 21,173)]
Randomised to intervention
(n = 21 practices)
Received allocated intervention
(n = 20 practices)
[List size: mean (range) = 5850 (2091 to 11,080)]
Did not receive allocated intervention
(n = 1 practice)
(List size: 4800; withdrew prior to patient recruitment)
Potentially eligible
(n = 3041 patients)
Mailed post-consultation questionnaire
(n = 1339 patients)
Post-consultation questionnaire
[n = 911 (68.0%) responders]
Follow-up
Analysed (primary outcome)
24 practices
903 patients who completed the primary
outcome measure at > 1 time point
• 3 months: 708 (77.7%) responders
• 6 months: 686 (75.3%) responders
• 12 months: 646 (70.9%) responders
Mailed post-consultation questionnaire
(n = 703 patients)
Post-consultation questionnaire
[n = 501 (71.3%) responders]
Follow-up
Analysed (primary outcome)
20 practices
498 patients who completed the primary
outcome measure at > 1 time point
• 3 months: 385 (76.8%) responders
• 6 months: 378 (75.4%) responders
• 12 months: 371 (74.1%) responders
Non-consent
Withdrawals
• Further follow-up, n = 103, 11.3%
• Medical records, n = 115, 12.6%
• Not OA, n = 387
• Too late, n = 109
• Already has mental health 
   problems, n = 96
• Does not want to take part, n = 50
• Vulnerable, n = 38
• In secondary care, n = 32
• Not suitable/red flag, n = 8/4
• Other, n = 84
• Reason not known, n = 907
Ineligible
(n = 1722)
Escapes
(n = 1177)
• Wants to withdraw, n = 9, 3.3%
• Surgery/other cointervention
   (e.g. steroid injection), n = 10, 1.1%
• Poor health, n = 8, 0.9%
• Feeling better, n = 6, 0.7%
• Died, n = 6, 0.7%
• Left practice, n = 5, 0.5%
• Withdrawn by GP/researcher,
   n = 3, 0.3%
• Not happy with treatment 
   received, n = 2, 0.2%
Non-consent
Withdrawals
Ineligible
(n = 1317)
Escapes
(n = 1021)
• Further follow-up, n = 55, 11.0%
• Medical records, n = 62, 12.4%
• Not OA, n = 310
• Too late, n = 42
• Already has mental health
   problems, n = 95
• Does not want to take part, n = 40
• Vulnerable, n = 38
• In secondary care, n = 25
• Not suitable/red flag, n = 4/1
• Other, n = 81
• Reason not known, n = 675
• Wants to withdraw, n = 10, 2.0%
• Surgery/other cointervention
   (e.g. steroid injection), n = 3, 0.6%
• Poor health, n = 1, 0.2%
• Feeling better, n = 2, 0.4%
• Died, n = 2, 0.4%
• Left practice, n = 5, 1.0%
• Withdrawn by GP/researcher,
   n = 1, 0.2%
• Family bereavement, n = 1, 0.2%
FIGURE 14 Flow chart of main study design. Reproduced from Mallen et al.300 © 2017 Mallen et al. This is an open access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
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Individual patients Individual patients aged ≥ 45 years who consulted their GP with OA [defined from an
identical designated set of pre-determined Read codes to those described in workstream 2 (see Chapter 3)]
formed the sampling base for the trial. The Read code list was developed by consensus using GPs with
expertise in musculoskeletal medicine. They included codes identified as being OA-specific, as well as
symptom codes commonly used by GPs to identify patients with OA-related joint pain.
Inclusion criteria:
l Aged ≥ 45 years.
l Registered with the participating GP practices during the specified study period of that practice.
l Read-coded OA consultation within the specified study period (termed the ‘index consultation’; may be
first, new episode, or ongoing problem).
l Provided full written informed consent to study participation and to further contact at time of
post-consultation questionnaire completion.
Exclusion criteria:
l Patients under active care for, or who have had a diagnosis of, depression and/or an anxiety disorder in
the past 12 months.
l Vulnerable patients, including any patients on the Quality and Outcomes Framework (QOF) mental
health register, or those who have a diagnosis of dementia or a terminal illness.
l Patients who reside in a nursing home.
l Red flag pathology – recent trauma associated with clinically significant injury: acute, red, hot swollen joint.
l Inflammatory arthropathy, crystal disease, spondyloarthropathy and polymyalgia rheumatica.
On behalf of the practice team, members of the informatics staff from Keele’s Institute of Primary Care
and Health Sciences (IPCHS) downloaded the names and addresses of eligible patients with a completed
template on a weekly basis. A study pack (a letter from their GP practice introducing the study, a patient
information leaflet and a post consultation questionnaire, including a consent form) was mailed to all
eligible patients. The information provided to patients was the same for both arms of the trial, helping to
eliminate contamination bias.298
Informed consent
As cluster randomisation occurred before individual participants were identified, each GP practice
consented, as ‘guardians’ for the patients in their care, that they were willing to both enter the trial and be
randomised into either arm of the trial.301,302 Individual consent for entry into the study and for follow-up
was obtained from each patient post randomisation. Individual patients were asked at the first postal
contact to consent to taking part. This contact incorporated the post-consultation questionnaire, plus
sections requesting consent for further contact and for their medical records to be accessed.
Intervention
The GPs in the practices in both arms were prompted to ask a standard set of questions to OA patients
during the consultation; however, the content of the screening template varied between the two trial
arms. Figure 15 shows a snapshot of the screening template for both arms. The template in the
intervention arm included a total of five questions (two each for depression and anxiety screening and a
fifth question on pain intensity), whereas the template for the control arm included only the one question
on pain intensity. Having information on pain intensity at consultation in both arms of the trial provided a
further measurement to check that a balance between the intervention and control arms is achieved.
Further details of the screening template are provided in Activation of the screening template.
Intervention arm In order to maximise ‘best practice’ in addition to the screening template in the
intervention arm, GPs were referred to and advised to follow NICE recommendations for the holistic
assessment and treatment of OA for all patients consulting with OA.15 At a post-randomisation meeting
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approximately 1 week prior to the template being activated in the practice, a GP research facilitator
employed by the PCRN explained and discussed the intervention and study procedures with GPs and
practice staff. Brief training was provided, explaining NICE-recommended evidence-based approaches to
managing comorbid anxiety and depression,287,303,304 and hard copies of the screening questions and quick
reference versions of the guidelines were placed in all consulting rooms in the intervention practices.
The control condition was not disclosed to intervention practices.
Control arm In order to keep the control arm as close to ‘usual care’ as possible, GPs were advised to
follow their usual approach for responding to a patient’s pain intensity rating. Asking a patient about the
intensity of their pain is common practice in a primary care musculoskeletal pain consultation and should
have little effect on the ‘usual care’ that the GP provides. No additional information on OA best practice
was disseminated to control practices by the research team.
During the consultation in both arms of trial, the GP provided patients with a short information postcard
introducing the study; therefore, patients were aware that they would be contacted by the research team
at a later date.
Activation of the screening template In both arms of the trial, the electronic screening template was
automatically activated when the GP entered a specific Read code (from the pre-determined study list) into
the electronic patient record. This only occurred at the first time such a Read code was entered for a
patient during the study period, ensuring that each patient was only sampled once. At this stage, GPs
applied the exclusion criteria. Activation of the main template prompted the GP to ask the patient the
questions on the template and to record their answers. The consultation then continued as the GP saw fit.
(a)
(b)
FIGURE 15 Snapshots of electronic screening template for (a) the intervention arm; and (b) the control arm.
(Note: the names are fictional).
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Outcomes
Primary outcome Pain severity for consulting site of pain (index pain) across the 12-month study period.
The Chronic Pain Grade was included in each of the postal questionnaires,229 which includes the question
‘How would you rate your pain on a 0–10 scale at the present time where 0 is “no pain” and 10 is
“pain as bad as it could be?” ’. This question is identical to the pain intensity question included on the
consultation screening template for both arms of the study.
Secondary outcomes Pain interference with daily activities was assessed on a NRS of 0–10. General
health status was assessed by the SF-12.171
Detailed assessment of depressive and anxiety symptoms was conducted using the self-complete Patient
Health Questionnaire 8 (PHQ-8) and GAD-7, respectively. The PHQ-8 is derived from the Personal Health
Questionnaire 9 (PHQ-9), a validated 9-item measure of depression designed to both diagnose and assess
the severity of depression.239,240 The GAD-7 was established using both Diagnostic and Statistical Manual
of Mental Disorders-Fourth Edition criteria for general anxiety disorder and items from previous existing
anxiety scales.239 As with the PHQ-8, the GAD-7 enquires about symptoms experienced over the past
2 weeks. The first two items on the PHQ-8 and GAD-7 comprise the Patient Health Questionnaire 2
(PHQ-2) and GAD-2, respectively, which were used to screen for depressive and anxiety symptoms in the
intervention arm of this trial.
Additional items included in the questionnaire gathered information about participants’ index pain
symptoms, other sites of pain, pain catastrophising scale,305 general medical health (including comorbidities
and medication use) and demographic details. Table 49 shows full questionnaire content at each time point.
Follow-up and mailing procedure
All eligible patients were sent a study pack as outlined above. Those who did not respond within 2 weeks
were contacted again with a postcard reminder. At 4 weeks, those who had not responded were sent a
second study pack and reminder letter. Participants who returned a post-consultation questionnaire and
consented to further contact were sent a follow-up questionnaire at 3, 6 and 12 months following their
index consultation. In order to maximise participation a short questionnaire, including only minimal data
collection items (outlined in Table 49), was sent to participants who had not responded to the full postal
questionnaire at 6 weeks. At 6- and 12-month follow-up points, an additional telephone call was used at
8 weeks (for those participants who provided a telephone number in their post-consultation questionnaire)
to attempt to contact non-responders in order to get information on their pain intensity at that time.
Three telephone call attempts were made to contact each participant.
Medical record review
A medical record review took place for participants who gave their consent (at the time of the
post-consultation questionnaire) to have their records reviewed. Data from the consultation screening
template was downloaded, alongside the date of consultation, general practice and index Read code
information. After the 12-month follow-up period, a more detailed review was carried out to assess
prescriptions, referrals for further treatment and number of consultations, and whether or not these were
for OA or mood problems. This was used to determine whether there had been any previous diagnosis
or treatment for depressive or anxiety symptoms. This data provided primary health-care resource use for
interpretation of clinical effects observed and for the health economic analysis. These data are not
presented in this report and will appear in future publications.
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TABLE 49 Summary of full postal questionnaire content
Conceptual domain Operational definition Empirical measure
Number of
items Time
Primary outcomes
Pain intensity Current intensity of the index
pain
NRS 0–10a 1 PC, 3FU, 6FU,
12FU
Secondary outcomes
Disability Composite characteristic pain
interference with daily
activities, recreation and work
during the past 3 months
Number of days (one item)
and NRS 0–10 (three items
provide composite disability
score of 0–100)a
4 PC, 3FU, 6FU,
12FU
Characteristic pain
intensity
Composite current and past
and average pain intensity
during the past 3 months
NRS 0–10 (three items
provide a composite
characteristic pain intensity
score of 0–100)a
3 PC, 3FU, 6FU,
12FU
Index pain location Site of index pain complaint Choice of anatomical site 1 PC
Nature of onset Traumatic onset Yes/no/unsure 1 PC
Episode duration Time since last whole month
free from this pain
Episode duration 1 PC, 3FU, 6FU,
12FU
Days in pain Days in past 6 months with
index pain
No days/1–30 days/
31–89 days/90 + days
1 PC, 6FU,
12FU
Multiple site/chronic
widespread pain
Pain in sites other than the
index site over the last month.
Manchester definition of
widespread pain264; Keele
definition of number of pain
sites; chronicity of pain; pain
in the knee or hip
Yes/no; body manikin 4 PC, 3FU, 6FU,
12FU
Pain consultation First consultation for this pain
complaint
Yes/no 1 PC
Pain improvement Improvement in pain at index
pain site
6-point Likert scale 1 3FU, 6FU,
12FU
Further pain
consultation
Consulted since index
consultation with the same
pain site
Yes/no 1 3FU, 6FU,
12FU
Satisfaction with
consultation
Satisfaction with questions
asked during consultation
Yes/no/unsure; details; list of
items asked
4 PC
Catastrophic coping Catastrophic coping relating
to index pain
Pain catastrophising scale 9 PC
Anxiety Generalised anxiety symptoms
in past 2 weeks
GAD-7 7 PC, 3FU, 6FU,
12FU
Depression Depressive symptoms in past
2 weeks
PHQ-8 8 PC, 3FU, 6FU,
12FU
Discussion of mood in
consultation
Did doctor ask about mood
during index consultation
Yes/no/unsure 1 PC
Diagnosis of
depression
Ever diagnosed by doctor as
depressed
Yes/no/unsure 1 PC
Diagnosis of anxiety Ever diagnosed by doctor with
an anxiety disorder
Yes/no/unsure 1 PC
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TABLE 49 Summary of full postal questionnaire content (continued )
Conceptual domain Operational definition Empirical measure
Number of
items Time
QoL measures
General health Mental and physical
well-being
SF-12 12 PC, 3FU, 6FU
12FU
General health Utility-based QoL EQ-5D-5L 5 PC, 3FU, 6FU
12FU
Comorbidities Ever been diagnosed with any
from a list of possible
comorbidities
Yes PC
Fractures Ever fractured hip/wrist/other
bones
Yes/no PC
Falls Falls in the past 12 months Yes/no 1 PC
Health-care costs
Medication usage Select from list of analgesic
and psychiatric medicines that
currently taking
PC
Health-care resource
use
Use of non-primary care
health-care resources
Yes/no and details of
resource use if yes
3 PC, 6FU,
12FU
Over-the-counter
medication
Over-the-counter medication
expenditure
Details of over-the-counter
medications
6FU, 12FU
Miscellaneous
Age Age at index consultation Date of birth 1 PC, 3FU, 6FU,
12FU
Sex Sex Male/female 1 PC, 3FU, 6FU,
12FU
Employment status and
absence from work
Employment status at time of
questionnaire and days of
work absence
Yes/no and details 10 PC, 6FU,
12FU
Socioeconomic status Occupational class based on
individual (1) current or
(2) most recent job title
Job title – categorised as
manual/non-manual
2 PC
Living arrangement Live alone Yes/no 1 PC
Marital status Marital status at time of post-
consultation questionnaire
Married/single/divorced/
widowed/separated/
cohabiting
1 PC
Social support Availability of instrumental
and emotional support
(yes/no/no need)
Single items 2 PC, 6FU,
12FU
Obesity BMI Height (metres/feet, inches),
weight (kg/stone, lb)
2 PC
3FU, 3-month follow-up; 6FU, 6-month follow-up; 12FU, 12-month follow-up; PC, post consultation.
a Seven items form the Chronic Pain Grade.
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Sample size
In order to estimate the time-averaged difference in the pain response between the two arms, we
calculated the number of subjects needed per arm as:
M = 2(zα + zβ)
2½1 + (n− 1)ρ / (nΔ2), (1)
using a significance level of α, power 1-β, Δ = smallest meaningful difference in SD units, n = number of
repeated measures.306 We took the effect size as an average of 0.2 over the four follow-up time points
(post consultation, 3, 6 and 12 months). Using ρ = 0.5 as an estimate of the autocorrelation, n = 4,
Δ = 0.2, α = 0.05, β = 0.10, gives 328 per arm. To adjust for the clustering of the practices, we modified
this figure by the design effect for unequal cluster sizes:
1 + ½(cv2 + 1)m−1 × ICC.49 (2)
On interim investigation of the first two blocks of practices (13 in total), the ICCs for key outcomes at
3 months were < 0.005 (a value of 0.015 was deemed a sufficiently conservative estimate for the ICC).
The average cluster size (m) was anticipated to be about 30 (incorporating approximately 70% participation
rate from 43 approached per practice) and the coefficient of variation (cv) to be about 0.5. Hence, the
design effect was calculated to be an inflation factor of 1.55; thus, requiring 510 for analysis per arm.
Allowing for 20% dropout, the total sample size requirement was 1280 (from 44 GP practices based on an
average per-practice recruitment of 30 participants).
Randomisation procedure
Allocation sequence generation GP practices were randomised in blocks using the balance algorithm
for clustered randomised trials.307 Baseline covariate data included PCT, GP practice list size and the Index
of Multiple Deprivation. GP practices were recruited over the period of 1 year so that blocks would form as
GP practices agreed to take part. The algorithm generates a set of allocations with the smallest imbalance
statistic across the two arms.
Allocation concealment Final allocations of GP practices were randomly selected by the independent
statistician on the Trial Steering Committee. This information was passed to the PCRN which was able to
install the appropriate template into each practice and arrange for a GP research facilitator to meet with
each practice to introduce the screening template and study procedures.
Blinding The principal investigator, chief investigator, trial statistician and members of the administration
team, who input data from the study questionnaires, as well as the GPs, were blinded to cluster allocation.
The Trial Steering Committee and Data Monitoring Committee were also blinded to cluster allocation
unless it became absolutely necessary to reveal allocation. Individual patients were unaware as to which
arm of the trial they were in.
Study administration
Two secure databases were designed specifically for use in this study. One was a mailing database in which
all details downloaded from practice databases were stored. A unique study number was applied to each
potential participant. The index pain site that triggered the initial consultation, noted in the post-consultation
questionnaire, was entered into the mailing database so that follow-up mailings could refer to the index
pain site. Following the reminder period of the mailing procedure, eligible patients who did not respond to
the post consultation questionnaire were recorded as non-responders in the mailing database and not
contacted again at any stage of the study. The name and address details of non-respondents were erased
after a reasonable amount of time. The NHS tracing system was used to search for any non-responders to
ensure a correct postal address.
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The second database was used to store all data collected during the study. In this database, participants
were only identified by study number. Data were entered into both databases by trained members of the
administration team blinded to cluster allocation. Access to the databases was restricted to those members
of the team that required access to this data. The coding schedule for the study questionnaires was
used to inform database design and to facilitate data entry. The data entry of a randomly selected 1 in
10 questionnaires was checked by a member of the administration team who had not been inputting data
from this study and who was blinded to cluster allocation. Throughout the entire mailing process, checks
were carried out at each practice, by a member of the PCRN, to determine any patient deaths and departures
and to ensure that there was no inappropriate contact of any patient. Questionnaires and study consent
sheets were stored securely in separate locations to ensure participant confidentiality.
General practitioner engagement
In order to maintain GP engagement throughout the screening period, the study co-ordinator made
regular contact with the practice manager to update them on the number of patients they had screened.
At a minimum, a 3-week phone call, mid-point detailed update and 10- to 12-week phone call took place.
If the number screened was lower than expected for that practice, then more regular communication was
initiated and the GP research facilitator was asked to contact the practice and ensure that template
training was sufficient.
Statistical methods
The main analyses were completed for the primary and secondary outcome measures based on the total
study population (i.e. all those who completed and returned the post consultation questionnaire). For the
primary outcome, current pain intensity (0–10 numerical rating scale), a linear mixed model was carried out
allowing all available data to be analysed and estimates of effect calculated for all individuals providing
outcome data on at least one occasion. Similarly, for all secondary outcomes, a linear or logistic mixed
model (as appropriate to the scale of the outcome data) was performed on all available data for the study
population in question. Analysis was performed on the basis of intention to treat and evaluation was
undertaken as per cluster randomised allocation.
A sensitivity analysis of the primary outcome was performed on a complete case subset of the mailing
response study population who provided consent to further contact and medical record review and
provided complete outcome scores for the primary outcome at all four outcome time points (post
consultation, 3, 6, 12 months) as well having a recorded pain template score (i.e. a ‘true’ baseline pain
score). This allowed a more inclusive baseline adjustment set of covariates for examining the robustness of
estimates of the primary outcome to possible confounding (notably in relation to potential imbalance in
pre-treatment NRS pain score), and assessment of the robustness of the effect estimates of the primary
outcome to different analytical models (and implicit model assumptions), specifically with respect to
attrition bias.
A further sensitivity analysis of the primary outcome focused on intervention per-protocol analysis using
CACE estimation of the effect of the intervention (among GPs who comply with protocol). Compliance is
strictly specified as a necessary ‘yes’ response recorded in the template to either of the two depression
items, ‘yes’ to either of the two anxiety items, or a ‘no’ response to both items in each – all other
combinations imply that the template was not sufficiently completed to aid in any diagnostic screening of
anxiety/depression.
As the data were collected from a cluster trial, coefficients were estimated using robust standard errors
to allow for clustering. This involved analysis using a three-level hierarchical model to take account of
clustering by practice and repeated measurements on individual participants. Estimated mean response
profiles between the two groups were compared: (1) across all follow-up time points simultaneously as an
aggregated summary (primary objective) and (2) across all time points distinctly (secondary objective to
determine whether effect differences, if any, are consistent or are different at the different time points
of assessment).
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The main analysis was adjusted for patients’ age and sex, the time interval between consultation and
questionnaire response, and the following practice-level variables: PCT, practice index of deprivation score,
total practice size, consultation rate in the 12 months prior to randomisation for OA and related codes
among patients aged ≥ 45 years, proportion of potentially eligible participants mailed, and proportion of
mailed participants who responded to post-consultation questionnaire. Current pain (recorded on template
at the first GP consultation) was only available for the subset population who consented to medical record
review; this measure was a baseline covariate in the complete case sensitivity analyses of the primary
outcome, along with duration of complaint and self-reported BMI.
Subgroup analyses focused on two evaluations for main investigation: age and severity of pain according
to template completion (based on median cut-off point). Effect estimates were derived through additional
modelling of the interaction term in regression analysis. Age cut-off points of 45–64 years, 65–74 years
and ≥ 75 years were used and were specified a priori.
Health-care use
Primary health-care resource use (GP and practice nurse consultations/home visits) and medications were
collected from a review of primary care medical records, covering the full 12-month follow-up period for
study participants who consented to a review of their medical records. These data are not included in
this report.
Potential bias
A number of steps have been taken in the design of this trial to minimise threats from selection and
recruitment bias, including ensuring that GP practices were given the same information about the study
prior to randomisation, patients in both arms of the trial were given the same information, the template
was active in each GP practice for a relatively short length of time (3 months) and the screening template
was automatically activated and opting out of template completion was recorded, including the reasons
for opting out. The trial commenced in July 2011. A 3-month ‘run-in’ period in four GP practices (two in
each arm) ensured that methods and key assumptions worked successfully and that the day-to-day
administration of the trial ran smoothly. Data from this phase of the trial was included in the analysis.
Study design: qualitative studies
General practitioner questionnaire
At the end of the screening period, GPs were asked to complete a brief feedback questionnaire. This was
a seven-item questionnaire (Table 50). Copies of the questionnaire were given to the practice managers to
distribute at the end of their practice’s study period (approximately 3 months). The questionnaires were
TABLE 50 Content of GP’s experience of POST questionnaire
Item Item description Item response
1 Impact on consultation time 5-point Likert scale
2 Amount of additional time 7 options plus free text option
3 Impact on doctor–patient communication 5-point Likert scale plus additional 4-point
Likert scale when there was an impact
4 Effect on patient management 5-point Likert scale
5 Reasons for excluding patients Free text
6 Ease of incorporating screening questions 4-point Likert scale
7 Additional comments Free text
Name If happy to provide
Contact details If happy to provide
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not addressed to specific GPs because of the likelihood that there would be locums or new staff at each
practice during the study period. The back page of the questionnaire asked GPs to consent to further
contact by providing their contact details. Completed questionnaires were returned to the research centre
in the stamped address envelope provided.
When a GP questionnaire was received at the research centre, the practice number was retained so as to
identify which arm of the trial the GP had participated in and a study number was assigned to each GP.
The information in the questionnaire was then entered into a database with all other data anonymised.
The back page of the questionnaire with any contact details was removed from the hard copy
questionnaire and stored separately in a locked filing cabinet.
General practitioner interviews
A subsample of GPs from across both arms who consented to further contact (in the questionnaire) were
invited to take part in an interview to explore their perspectives and experiences of participating in the trial
in more detail. Interviewers ensured that the study team remained blind to practice allocation. The focus
was on investigating GP views on the detection and management of anxiety and depressive symptoms
generally and in particular the value of including specific questions around these in the OA consultation. It
also explored training and support needs in addition to their views on taking part in the trial at a practical
level and their use of the screening template, and examined whether or not there were differences
between the two arms of the trial.
Applied thematic analysis with constant comparison was used to analyse the interview data. In order to
ensure reliability, a minimum of two members of the study team independently coded the data before
agreeing a coding frame.308 The questionnaire data was descriptively analysed. In addition, findings from
the qualitative study were mapped against trial data, looking for differences and similarities in treatment,
taking into account scores for the five questions, sociodemographic characteristics, comorbidities and
repeat attending.
The interview schedule was designed to complement the questionnaire and to seek more in-depth
clarification on responses in-keeping with a mixed-methods approach.309 In addition, GPs from both arms
of the trial were asked about the acceptability in general of case finding for patients with OA/joint pain.
However, those in the control arm did not ask the PHQ-2 or the GAD-2 and, therefore, questions relating
to the impact that these had on consultation time and doctor–patient communication were limited to GPs
in the intervention arm. Both arms asked the question regarding pain intensity and questions regarding the
impact that this had were included in the interview schedule for both groups.
To give as much flexibility as possible and to minimise the intrusion into practice time, telephone or
in-person interviews were offered as well as group interviews, and at a time and place to suit participants.
Copies of the information letter and consent form were e-mailed both at the time of the initial invitation
and again just ahead of the interview. Consent was again checked at the beginning of the interview and
audio-recorded. An outline of their content is given in Table 51.
Sampling
A convenience sampling approach was adopted, that is, one that involves drawing samples of persons
who are both easily accessible and willing to participate.310 Consequently, while being mindful of the need
to sample equally from both arms, any GP who consented to further contact was invited to interview until
data saturation was achieved (see Results).
Analysis
The questionnaire data were analysed descriptively. All audio files were transcribed and the data cleaned,
that is, transcripts were checked against the audio files for accuracy and anonymity. A thematic framework
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approach to analysis was adopted as this allowed a focus on the areas covered by both the questionnaire
and the interview topic guide while also allowing unanticipated themes to emerge.308,311 Analysis was led
by Bernadette Bartlam, with input from other coding team members (CC-G, CM, JR, DG and BN) as a
means of providing intercoder reliability and generating interdisciplinary perspectives. In the initial stage of
analysis, team members read a random selection of transcripts from each arm to familiarise themselves
with the data and independently identify preliminary themes. A coding frame was developed as a result,
which included a priori themes such as impact on the consultation, as well as any unanticipated themes.311
Team members discussed these preliminary themes and developed a more detailed coding frame, which
was applied to a small number of transcripts. The findings were then discussed further and a final coding
frame agreed.308 Data were searched for additional confirmatory or challenging evidence within and
between individual interviews, across the questionnaire responses, when available, and across the two
groups in a process of constant comparison.184,312 The process of analysis was on-going from the first
interview, and unanticipated responses were checked out for confirmation or contradictions in interviews
with subsequent participants.308
Results
Participant flow
A flow chart illustrating the flow of centres and individual participants through the trial is given in
Figure 14.
A total of 45 GP practices were randomised with an overall mean list size of 6694 patients. A total of
24 practices were randomised to the control group and 21 practices to the intervention group (one practice
in the intervention arm withdrew prior to patient recruitment). A total of 7279 patients were identified
as being potentially eligible for the trial; 3039 were deemed to be ineligible (reasons are shown in the
flow-diagram). The GPs avoided using the template for 2198 patients, but 2042 patients were screened
and posted a post-consultation questionnaire. The proportion of potentially eligible patients that were
screened and posted a post-consultation questionnaire by the GP was higher in the control group
(n = 1339, 31.6%) than in the intervention group (n = 703, 23.1%).
TABLE 51 Outline of interview schedule for GPs
Domains
Intervention
arm (yes/no)
Control arm
(yes/no)
General patient population including prevalence of psychological problems Yes Yes
Views of psychological problems in joint pain/OA Yes Yes
Presentation/detection of psychological symptoms in such patients Yes Yes
Management Yes Yes
Communication Yes Yes
Training and development Yes Yes
Taking part in POST Yes Yes
Ease of asking questions Yes No
Differences between GAD and PHQ Yes No
Usefulness of screening template Yes No
Patients included/excluded Yes No
GAD, Generalised Anxiety Disorder.
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A total of 1412 (69.1%) participants responded to the post-consultation questionnaire: 911/1339 (68.0%)
in the control arm and 501/703 (71.3%) in the intervention arm. The time between the date of
consultation and date of returning the post-consultation questionnaire was a mean of 24 days (IQR
17–35 days; range 9–149 days) in the control arm and 22 days (IQR 16–33 days; range 3–106 days) in the
intervention arm. Follow-up rates were similar in both arms, totalling 1093 (77.4%) at 3 months, 1064
(75.4%) at 6 months and 1017 (72.0%) at 12 months. Loss to follow-up was largely due to non-consent
to further follow-up and non-response to mailing, though a small number of participants withdrew from
the trial (reasons are provided in Figure 14).
Practice and patient characteristics
Practices were recruited from seven trusts in West Midlands North and practice deprivation scores spanned
roughly 30–90th percentiles for England (i.e. towards the less deprived end of the spectrum). There was no
difference in annual consultation prevalence for OA between the participating practices.
Under the minimisation algorithm, more practices were allocated to the control group and their total
average practice list size was also higher than practices allocated to the intervention group (Table 52).
Individual patients recruited from intervention and control practices had broadly similar characteristics
(Table 53). In total, the average age of participants was 65 years and 57% were female. The largest
difference was in the proportion of patients reporting the pain episode to be their first: 40% in the control
arm versus 33% in the intervention arm. For the subgroup of 1035 study patients [644 (71%) in the
control arm and 391 (78%) in the intervention arm] who consented to medical record review and had a
baseline template pain score (recorded at GP consultation), the mean pain score was 6.33 (SD 2.04) in the
intervention arm and 6.30 (SD 2.10) in the control arm.
TABLE 52 Cluster-level baseline characteristics according to study group
Characteristics of the participating general practices Control (N= 24) Intervention (N= 20)
PCT,a n (%)
Region 1 6 (25.0) 6 (30.0)
Region 2 1 (4.2) 2 (10.0)
Region 3 5 (20.8) 4 (20.0)
Region 4 4 (16.7) 4 (20.0)
Region 5 1 (4.2) 1 (5.0)
Region 6 4 (16.7) 1 (5.0)
Region 7 3 (12.5) 2 (10.0)
Practice deprivation score,a median (IQR) 16.8 (11.1–37.9) 20.3 (11.2–29.3)
Total practice list size,a,b mean (SD) 7397 (4250) 5850 (2693)
Practice list size for ages ≥ 45 years, mean (SD)c 3519 (2170) 2736 (1244)
Consultation rate for OA in past 12 months
(per 10,000 registered persons aged ≥ 45 years), mean (SD)
1590 (959) 1925 (746)
a Variable used in balance algorithm for randomisation.
b The sizes in the table relate to those used in the minimisation algorithm. Pre-audit figures are also available and the
mean (SD) were: 7497 (4420) for the control group and 6008 (2664) for the intervention group.
c Correlation between total practice size and practice size for the ≥ 45 ages: 0.96.
Reproduced from Mallen et al.300 © 2017 Mallen et al. This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
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TABLE 53 Participant baseline characteristics by study group
Control (N= 911) Intervention (N= 501)
Age (years), mean (SD) 65.4 (10.1) 65.6 (10.8)
Female, n (%) 509 (55.9) 290 (57.9)
White UK or European ethnicity, n (%) 888 (97.7) 492 (98.2)
Live alone, n (%) 182 (20.0) 108 (21.6)
Lack of emotional support, n (%) 41 (4.6) 36 (7.2)
Lack of support with daily tasks, n (%) 57 (6.3) 40 (8.0)
Currently in a paid job, n (%) 286 (31.4) 166 (33.1)
Time off work in previous 6 months, n (%) 102 (36.2) 65 (39.4)
Self-reported BMI (kg/m2), mean (SD) 28.7 (5.6) 28.6 (5.1)
Previous/current smoker, n (%) 457 (50.8) 247 (49.3)
Daily/weekly alcohol consumption, n (%) 491 (54.4) 245 (49.0)
Area of pain consulted GP with, n (%)
Neck 56 (6.2) 39 (7.8)
Shoulder 155 (17.0) 71 (14.2)
Elbow 20 (2.2) 20 (4.0)
Wrist or hand 121 (13.3) 77 (15.4)
Hip 224 (24.6) 130 (26.0)
Knee 496 (54.5) 282 (56.3)
Ankle or foot 126 (13.8) 63 (12.6)
First pain consultation episode, n (%) 355 (39.5) 163 (32.8)
Duration of complaint, n (%)
< 3 months 219 (24.7) 118 (24.2)
3–12 months 261 (29.5) 110 (22.5)
1–5 years 269 (30.3) 152 (31.2)
> 5 years 137 (15.4) 108 (22.2)
Belief that pain started after accident/injury, n (%) 168 (18.6) 89 (18.1)
Comorbidity,a n (%) 666 (73.1) 370 (73.9)
Previous bone fracture, n (%) 375 (41.2) 215 (42.9)
Previous falls in past 12 months, n (%) 248 (27.4) 147 (29.5)
Template pain score,b mean (SD) 6.30 (2.10) 6.33 (2.04)
a Comorbidity: any of the following self-reported conditions – previous heart attack or stroke, angina, raised blood
pressure, diabetes, circulation problems in legs, cancer, liver disease, kidney disease, asthma/bronchitis, deafness,
eyesight problems.
b Values based on 1035 participants who consented to medical record review and who had baseline recorded template
pain score (644 in the control group and 391 in the intervention group).
Reproduced from Mallen et al.300 © 2017 Mallen et al. This is an open access article distributed under the terms of
the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
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Clinical effectiveness
The results for analysis of the primary outcome measure (current pain intensity) including primary end
point and secondary end point evaluations along with pre-specified ancillary analysis (sensitivity and
subgroup analyses) are shown in Table 54. For the primary end point analysis there was a statistically
significantly higher average pain score over the four follow-up time points in the intervention group than
the control group (mean difference 0.33, 95% CI 0.05 to 0.61; effect size 0.16, 95% CI 0.02 to 0.29) (see
Table 54). The difference was not uniform across individual time points; the largest difference of 0.50 was
observed at 6 months follow-up. All three sensitivity analyses showed similar results and detailed analysis
suggests that selection bias (GPs in the intervention arm tending to complete the template for more severe
patients) was plausible, although not proven (data not shown). The estimates for the subgroup analyses
showed a statistically non-significant trend for decreasing difference in pain scores between intervention
TABLE 54 Evaluation of the primary outcome measure (current pain intensity)a
Phase of statistical
analysis
Post consultationb
(control, n= 898;
intervention,
n= 493)
3 months
(control,
n= 701;
intervention,
n= 383)
6 months
(control,
n= 680;
intervention,
n= 374)
12 months
(control,
n= 644;
intervention,
n= 368)
Overall
(control,
n= 2923;
intervention,
n= 1618)
Main analysis (primary end point shaded)c
Control,
n [mean (SD)]
5.3 (2.7) 4.5 (2.8) 4.2 (2.9) 4.0 (3.0) 4.6 (2.9)
Intervention,
n [mean (SD)]
5.7 (2.6) 5.0 (2.8) 4.8 (2.9) 4.3 (3.0) 5.0 (2.8)
Mean difference
(95% CI)d
0.34
(0.01 to 0.66)
0.17
(–0.18 to 0.52)
0.50
(0.14 to 0.87)
0.32
(–0.10 to 0.74)
0.33d
(0.05 to 0.61)
p-value 0.043 0.343 0.007 0.141 0.022
Effect size (95% CI)e 0.16
(0.00 to 0.32)
0.08
(–0.09 to 0.25)
0.24
(0.07 to 0.42)
0.15
(–0.05 to 0.36)
0.16
(0.02 to 0.29)
Sensitivity analysis (1)
Mean difference
(95% CI)
0.35
(0.00 to 0.69)
–0.02
(–0.39 to 0.35)
0.44
(0.06 to 0.82)
0.21
(–0.21 to 0.64)
0.25
(–0.02 to 0.52)
p-value 0.048 0.905 0.025 0.329 0.074
Control, intervention 595, 360 488, 292 451, 271 437, 254 1971, 1177
Sensitivity analysis (2)
Mean difference
(95% CI)
0.41
(0.04 to 0.78)
0.07
(–0.36 to 0.50)
0.36
(–0.12 to 0.85)
0.25
(–0.24 to 0.73)
0.37
(0.04 to 0.69)
p-value 0.029 0.753 0.137 0.324 0.030
Sensitivity analysis (3)
Mean difference
(95% CI)
0.39
(0.04 to 0.74)
0.19
(–0.19 to 0.56)
0.55
(0.16 to 0.95)
0.40
(–0.05 to 0.85)
0.37
(0.07 to 0.67)
p-value 0.030 0.335 0.006 0.083 0.015
Subgroup analysis (1)
Mean difference
(95% CI)
–0.15
(–0.44 to 0.13)
–0.35
(–0.67 to –0.03)
–0.14
(–0.47 to 0.19)
–0.32
(–0.70 to 0.06)
–0.21
(–0.46 to 0.03)
p-value 0.299 0.033 0.395 0.099 0.089
continued
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group and control group with increased age, but no strong evidence of an interaction with pain severity
recorded by the GP at the point of care.
Secondary outcomes were consistent with the primary outcome measure in reflecting better outcomes as a
whole for the control group than the intervention group (Table 55), including patient global assessment of
change (p = 0.015).
The proportion of patients reporting that the GP asked irrelevant questions in the consultation was low and
similar in both arms [41 (8.3%) in the intervention group and 50 (5.6%) in the control group] (Table 56).
The proportion of patients not satisfied with the consultation was higher in the intervention group than in
the control group [71 (14.5%) compared with 89 (9.9%), respectively].
General practitioner questionnaire
A total of 165 GP questionnaires were sent out and 82 were returned, giving a 50% response rate.
The results are shown in Table 57. Most doctors in both arms reported an impact of the screening on
consultation time at least sometimes but most did not find it difficult to incorporate in the consultation,
with no statistically significant difference between interventions and controls. However, estimated
TABLE 54 Evaluation of the primary outcome measure (current pain intensity)a (continued )
Phase of statistical
analysis
Post consultationb
(control, n= 898;
intervention,
n= 493)
3 months
(control,
n= 701;
intervention,
n= 383)
6 months
(control,
n= 680;
intervention,
n= 374)
12 months
(control,
n= 644;
intervention,
n= 368)
Overall
(control,
n= 2923;
intervention,
n= 1618)
Subgroup analysis (2)
Mean difference
(95% CI)
0.03
(–0.12 to 0.19)
0.08
(–0.09 to 0.24)
0.04
(–0.13 to 0.21)
0.06
(–0.14 to 0.26)
0.05
(–0.08 to 0.18)
p-value 0.673 0.365 0.655 0.569 0.468
a Current pain intensity (0–10 numerical rating scale): 0= no pain; 10= pain as bad as could be. Values based on analysis
of 4541 available data (n= 4541).
b Time between date of consultation and return of post-consultation questionnaire (days), median (IQR): control group 24
(17–35) days and intervention group 22 (16–33) days.
c Primary end point (overall pain intensity). The variance-partition for the random coefficients were as follows: ICC < 0.001
(for between-practice variation) and ICC = 0.591 (for between-individual variation).
d All analyses adjusted using GP practice and repeated measures as random-effects, and fixed-effect covariates at
practice-level (as outlined in Table 52) and patient-level factors (age, sex and time between consultation and
post-consultation response). Estimates at the individual follow-up time points were obtained by inclusion of interaction
terms for study group by time point of assessment. Evaluation was by multilevel linear regression analysis with
longitudinal random slope parameterisation.
e Estimated mean difference relative to SD of template pain score of 2.07.
Sensitivity analyses: (1) Estimates based on a subgroup of the study population who consented to medical record review
and had a baseline recorded template pain score (as well as available post-consultation data on duration of pain and BMI):
analysis based on 3148 available data by multilevel regression (as indicated in footnote d above with the addition of
baseline pain template score, duration of pain and BMI as covariates); (2) ‘per protocol’ evaluation through CACE analysis
of available data by instrumental variable analysis using two-step least squares regression; and (3) additional model
adjustment for post-randomisation practice-level variables of number of patients mailed and number of patients who
returned a completed post-consultation questionnaire (to account for selection bias in recruitment uptake to the study).
Further, multiple imputation estimates for overall pain= 0.25 (95% CI –0.02, 0.53).
Subgroup analyses: multilevel linear regression analysis was carried out (as detailed in footnote d above) and included
(1) group × age interaction term as the factor of interest, where age coefficients shown are based on units of 10 years
[predicted mean difference in study population: 0.82 (45- to 54-year age group), 0.55 (55- to 64-year age group), 0.41
(65- to 74-year age group), 0.10 (≥ 75 years age-group)] and (2) group × pain (template pain score) interaction term as the
factor of interest [predicted mean difference in study population: 0.17 (0–4 baseline pain template score), 0.37 (5–7
baseline pain template score), 0.61 (8–10 baseline pain template score)].
Adapted from Mallen et al.300 © 2017 Mallen et al. This is an open access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
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TABLE 55 Secondary outcome measures: mean (standard deviation), mean difference and p-value of difference,
unless otherwise indicated
Outcome measures
(range) (number
analysed)
Post
consultation 3 months 6 months 12 months
Overall time
points
Worst pain (0–10 NRS) (n= 4454a)
Control 7.7 (1.9) 7.0 (2.4) 6.0 (2.8) 5.6 (3.1) 6.7 (2.7)
Intervention 7.8 (2.1) 7.2 (2.3) 6.6 (2.7) 5.8 (3.1) 7.0 (2.6)
Mean difference
(95% CI)b
–0.01
(–0.30 to 0.28)
0.08
(–0.24 to 0.40)
0.54
(0.19 to 0.89)
0.52
(0.07 to 0.97)
0.15
(–0.09 to 0.40)
p-value 0.946 0.638 0.002 0.025 0.220
Average pain (0–10 NRS) (n = 4433)
Control 6.4 (2.1) 5.7 (2.4) 5.0 (2.8) 4.7 (2.9) 5.5 (2.6)
Intervention 6.7 (2.2) 6.1 (2.4) 5.6 (2.7) 5.1 (2.9) 5.9 (2.6)
Mean difference
(95% CI)b
0.25
(–0.03 to 0.53)
0.19
(–0.13 to 0.50)
0.54
(0.20 to 0.88)
0.48
(0.06 to 0.90)
0.30
(0.05 to 0.54)
p-value 0.081 0.240 0.002 0.026 0.017
Interference with daily activities (0–10 NRS) (n = 4535)
Control 5.2 (2.8) 4.5 (3.0) 3.9 (3.1) 3.8 (3.1) 4.4 (3.0)
Intervention 5.4 (2.9) 5.4 (3.0) 4.6 (3.0) 4.3 (3.2) 4.8 (3.0)
Mean difference
(95% CI)b
0.07
(–0.28 to 0.42)
0.11
(–0.27 to 0.48)
0.50
(0.12 to 0.89)
0.39
(–0.04 to 0.83)
0.20
(–0.10 to 0.51)
p-value 0.701 0.568 0.011 0.078 0.191
Interference with recreational activities (0–10 NRS) (n = 4443)
Control 5.1 (3.1) 4.4 (3.2) 3.8 (3.2) 3.7 (3.2) 4.4 (3.2)
Intervention 5.5 (3.1) 4.7 (3.3) 4.5 (3.2) 4.0 (3.3) 4.8 (3.3)
Mean difference
(95% CI)b
0.32
(–0.05 to 0.70)
0.12
(–0.28 to 0.52)
0.51
(0.09 to 0.92)
0.39
(–0.08 to 0.86)
0.32
(–0.01 to 0.65)
p-value 0.093 0.560 0.017 0.101 0.060
Interference with work (0–10 NRS) (n= 4440)
Control 4.6 (3.1) 4.1 (3.1) 3.7 (3.1) 3.5 (3.2) 4.0 (3.2)
Intervention 5.1 (3.0) 4.4 (3.1) 4.3 (3.2) 3.9 (3.6) 4.5 (3.2)
Mean difference
(95% CI)b
0.32
(–0.05 to 0.69)
0.09
(–0.30 to 0.48)
0.50
(0.10 to 0.91)
0.46
(0.00 to 0.92)
0.32
(–0.01 to 0.65)
p-value 0.092 0.655 0.015 0.049 0.059
Disability days in past month (n= 4432), n (%)
Control
0–3 348 (39.0) 326 (46.7) 361 (55.1) 355 (57.4) 1390 (48.6)
4–7 139 (15.6) 111 (15.9) 91 (13.9) 86 (13.9) 427 (14.9)
8–15 139 (15.6) 95 (13.6) 61 (9.3) 54 (8.7) 349 (12.2)
16+ 266 (29.8) 166 (23.8) 142 (21.7) 123 (19.9) 697 (24.4)
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TABLE 55 Secondary outcome measures: mean (standard deviation), mean difference and p-value of difference,
unless otherwise indicated (continued )
Outcome measures
(range) (number
analysed)
Post
consultation 3 months 6 months 12 months
Overall time
points
Intervention
0–3 158 (32.5) 156 (40.8) 166 (46.2) 170 (49.7) 650 (41.4)
4–7 88 (18.1) 69 (18.1) 65 (18.1) 54 (15.8) 276 (17.6)
8–15 73 (15.0) 57 (14.9) 50 (13.9) 44 (12.9) 224 (14.3)
16+ 167 (34.4) 100 (26.2) 78 (21.7) 74 (21.6) 419 (26.7)
OR (95% CI)b 1.16
(0.69 to 1.96)
1.14
(0.64 to 2.04)
1.26
(0.66 to 2.42)
1.54
(0.68 to 3.48)
1.19
(0.76 to 1.87)
p-value 0.574 0.660 0.481 0.303 0.443
CPG pain subscale (n= 4461)
Control 64.7 (19.4) 57.2 (22.9) 50.4 (26.6) 47.4 (28.1) 55.9 (25.0)
Intervention 67.1 (19.5) 61.0 (22.8) 56.7 (25.5) 50.3 (28.4) 59.6 (24.6)
Mean difference
(95% CI)b
1.84
(–0.85 to 4.53)
1.41
(–1.54 to 4.36)
5.36
(2.16 to 8.56)
4.59
(0.51 to 8.66)
2.47
(0.05 to 4.88)
p-value 0.181 0.348 0.001 0.027 0.045
CPG disability subscale (n= 4457)
Control 49.8 (28.1) 43.6 (29.5) 38.0 (30.1) 36.4 (30.5) 42.7 (29.9)
Intervention 53.2 (28.1) 46.7 (29.8) 44.7 (30.1) 40.0 (31.5) 46.8 (30.1)
Mean difference
(95% CI)b
2.33
(–1.10 to 5.77)
1.10
(–2.55 to 4.76)
5.06
(1.26 to 8.86)
4.70
(0.32 to 9.08)
2.79
(–0.33 to 5.90)
p-value 0.183 0.554 0.009 0.036 0.079
CPG grade (n= 4411), n (%)
Control
I 141 (15.9) 212 (30.4) 266 (41.0) 278 (45.2) 897 (31.5)
II 280 (31.6) 175 (25.1) 133 (20.5) 118 (19.2) 706 (24.8)
III 163 (18.4) 115 (16.5) 99 (15.3) 85 (13.8) 462 (16.2)
IV 301 (34.0) 196 (28.1) 151 (23.3) 134 (21.8) 782 (27.5)
Intervention
I 68 (14.1) 88 (23.1) 120 (33.4) 137 (40.2) 413 (26.4)
II 117 (24.2) 104 (27.3) 72 (20.1) 68 (19.9) 361 (23.1)
III 117 (24.2) 73 (19.2) 69 (19.2) 44 (12.9) 303 (19.4)
IV 181 (37.5) 116 (30.5) 98 (27.3) 92 (27.0) 487 (31.1)
OR (95% CI)b 2.18
(1.30 to 3.66)
1.24
(0.70 to 2.21)
1.51
(0.79 to 2.88)
1.37
(0.57 to 3.28)
1.72
(1.10 to 2.69)
p-value 0.003 0.461 0.215 0.478 0.016
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TABLE 55 Secondary outcome measures: mean (standard deviation), mean difference and p-value of difference,
unless otherwise indicated (continued )
Outcome measures
(range) (number
analysed)
Post
consultation 3 months 6 months 12 months
Overall time
points
Manikin – widespread pain (ACR) (n= 4401), n (%)
Group 0 221 (24.3) 149 (21.6) 136 (21.4) 150 (24.9) 656 (23.1)
Group 1 128 (25.6) 91 (24.2) 94 (26.7) 82 (24.6) 395 (25.3)
OR (95% CI)b 0.95
(0.53 to 1.70)
0.97
(0.50 to 1.89)
1.28
(0.65 to 2.50)
1.01
(0.51 to 2.00)
1.03
(0.64 to 1.64)
p-value 0.865 0.938 0.471 0.972 0.917
Manikin – widespread pain (Manchester), n (%)
Group 0 105 (11.6) 69 (10.0) 66 (10.4) 76 (12.6) 316 (11.1)
Group 1 69 (13.8) 62 (16.5) 63 (17.9) 44 (13.2) 238 (15.2)
OR (95% CI)b 1.09
(0.51 to 2.33)
2.77
(1.16 to 6.61)
3.94
(1.61 to 9.63)
1.24
(0.50 to 3.11)
1.77
(0.97 to 3.24)
p-value 0.816 0.022 0.003 0.641 0.063
WOMAC – physical functioning (0–32) (n = 4342)
Control 12.5 (7.6) 11.3 (7.8) 10.6 (7.6) 10.6 (7.9) 11.4 (7.8)
Intervention 13.0 (7.7) 12.5 (7.6) 12.2 (7.9) 11.0 (8.1) 12.3 (7.9)
Mean difference
(95% CI)b
0.42
(–0.41 to 1.25)
0.53
(–0.36 to 1.43)
0.70
(–0.23 to 1.64)
0.36
(–0.68 to 1.40)
0.49
(–0.27 to 1.26)
p-value 0.321 0.244 0.142 0.495 0.204
GAD-7 (0–21) (n= 4359)
Control 5.1 (5.7) 4.6 (5.3) 4.6 (5.2) 4.6 (5.3) 4.8 (5.4)
Intervention 5.6 (5.8) 5.2 (5.6) 5.7 (5.9) 5.5 (6.1) 5.5 (5.8)
Mean difference
(95% CI)b
0.18
(–0.49 to 0.84)
0.34
(–0.36 to 1.05)
0.44
(–0.28 to 1.16)
0.61
(–0.14 to 1.37)
0.34
(–0.27 to 0.94)
p-value 0.603 0.341 0.230 0.112 0.272
PHQ-8 (0–24) (n= 4376)
Control 6.0 (6.0) 5.2 (5.7) 5.3 (5.7) 5.4 (6.0) 5.5 (5.8)
Intervention 6.4 (6.1) 6.0 (6.1) 6.6 (6.3) 6.0 (6.1) 6.3 (6.1)
Mean difference
(95% CI)b
0.30
(–0.40 to 1.00)
0.52
(–0.22 to 1.26)
0.74
(–0.02 to 1.49)
0.36
(–0.41 to 1.14)
0.44
(–0.21 to 1.09)
p-value 0.402 0.172 0.055 0.360 0.181
SF-12 PCS (0–100) (n= 4263)
Control 36.0 (11.1) 37.9 (11.4) 39.3 (11.8) 39.1 (11.9) 37.9 (11.6)
Intervention 35.5 (10.5) 36.3 (10.8) 36.3 (11.3) 38.1 (11.6) 36.4 (11.0)
Mean difference
(95% CI)b
0.24
(–1.07 to 1.55)
–0.23
(–1.63 to 1.17)
–1.77
(–3.22 to –0.32)
–0.66
(–2.25 to 0.93)
–0.33
(–1.54 to 0.89)
p-value 0.717 0.749 0.017 0.419 0.598
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TABLE 55 Secondary outcome measures: mean (standard deviation), mean difference and p-value of difference,
unless otherwise indicated (continued )
Outcome measures
(range) (number
analysed)
Post
consultation 3 months 6 months 12 months
Overall time
points
SF-12 PCS (0–100) (n= 4263)
Control 49.9 (11.4) 49.6 (11.5) 49.0 (11.7) 49.2 (11.3) 49.5 (11.5)
Intervention 49.1 (11.2) 48.4 (11.5) 47.6 (12.0) 48.8 (11.6) 48.5 (11.6)
Mean difference
(95% CI)b
–0.61
(–1.98 to 0.76)
–0.79
(–2.26 to 0.69)
–0.12
(–1.62 to 1.39)
–0.32
(–1.88 to 1.25)
–0.50
(–1.73 to 0.72)
p-value 0.383 0.295 0.878 0.691 0.418
Perceived change (n = 2977), n (%)
Control
Completely
recovered
– 26 (3.8) 43 (6.8) 63 (10.5) 132 (6.9)
Much improved – 98 (14.3) 135 (21.4) 141 (23.4) 374 (19.5)
Improved – 177 (25.8) 140 (22.2) 104 (17.3) 421 (22.0)
No change – 237 (34.6) 166 (26.4) 154 (25.6) 557 (29.0)
Worse – 121 (17.6) 112 (17.8) 115 (19.1) 348 (18.1)
Much worse – 27 (3.9) 34 (5.4) 25 (4.2) 86 (4.5)
Intervention –
Completely
recovered
– 13 (3.5) 21 (6.0) 24 (7.2) 58 (5.5)
Much better – 52 (13.9) 47 (13.4) 69 (20.7) 168 (15.9)
Somewhat better – 70 (18.7) 62 (17.6) 57 (17.1) 189 (17.9)
No change – 139 (37.2) 109 (31.0) 101 (30.3) 349 (33.0)
Worse – 80 (21.4) 89 (25.3) 63 (18.9) 232 (21.9)
Much worse – 20 (5.4) 24 (6.8) 19 (5.7) 63 (6.0)
OR (95% CI)b – 0.66
(0.34 to 1.30)
1.81
(0.95 to 3.45)
1.88
(1.02 to 3.46)
1.37
(0.84 to 2.24)
p-value – 0.232 0.073 0.044 0.200
ACR, American College of Rheumatology criteria; CPG, Chronic Pain Grade; GAD, Generalised Anxiety Disorder.
a Total number of available longitudinal data that were analysed (in each case).
b All analyses adjusted using GP practice and repeated-measures as cluster-level random-effects and fixed-effect covariates
at practice level (as outlined in Table 54) and patient level (age, sex and time between consultation and post
consultation response). Analysis was carried out by linear-mixed model with unstructured covariance matrix.
Adapted from Mallen et al.300 © 2017 Mallen et al. This is an open access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
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TABLE 56 Acceptability and fidelity of screening from participants’ post-consultation questionnaires
Items on patient questionnaire Control (N= 911), n (%) Intervention (N= 501), n (%)
Statistical
significance
Doctor asked about
How long you have had your
pain
696 (76.4) 368 (73.5) p= 0.219a
The intensity of your pain 674 (74.0) 348 (69.5) p= 0.069
How your pain interferes with
daily activities
410 (45.0) 236 (47.1) p= 0.448
Your mood 90 (9.9) 157 (31.3) p< 0.001
Doctor asked irrelevant questions
No 743 (82.6) 391 (79.1)
Unsure 106 (11.8) 62 (12.6)
Yes 50 (5.6) 41 (8.3) p= 0.117
Irrelevant questions on mood,
nb
3 7
Satisfied with consultation
Yes 676 (75.5) 342 (69.8)
Unsure 130 (14.5) 77 (15.7)
No 89 (9.9) 71 (14.5) p= 0.025
a χ2 test.
b From free-text responses to an open-ended question on irrelevant questions, completed by 29 and 27 patients in the
control and intervention groups, respectively.
Reproduced from Mallen et al.300 © 2017 Mallen et al. This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
TABLE 57 Participating GPs’ perceived impact of screening questions on the consultation
Items on patient questionnaire Control (N= 51), n (%) Intervention (N= 31), n (%)
Statistical
significance
Ease of incorporation into the consultation
Very easy 11 (21.6) 5 (16.1)
Quite easy 19 (37.3) 9 (29.0)
Neither easy nor difficult 14 (27.5) 10 (32.3)
Quite difficult 5 (9.8) 7 (22.6)
Very difficult 2 (3.9) 0 (0.0) p= 0.1941
Impact on consultation time
Always 5 (9.8) 2 (6.5)
Often 3 (5.9) 8 (25.8)
Sometimes 18 (35.3) 14 (45.2)
Rarely 18 (35.3) 6 (19.4)
Never 7 (13.7) 1 (3.2) p= 0.0142
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additional time for screening was higher among intervention than control doctors. A statistically
significantly higher proportion of doctors from the intervention practices reported an impact on patient
management and communication with the patient, and reported feeling that this was positive.
To calculate chi-squared test for trend statistics, categories were merged and the following six categories,
as numbered, were used in the analysis: (1) ‘very/quite easy’, ‘neither easy nor difficult’, ‘very/quite
difficult’; (2) ‘always/often’, ‘sometimes’, ‘rarely/never’; (3) ‘< 1 minute’, ‘1–2 minutes’, ‘> 2 minutes’
(test excluded responders who reported ‘never’ to the question on ‘impact on consultation time’);
(4) ‘sometimes/often/always’, ‘rarely’, ‘never’; (5) ‘positive’, ‘not positive’ (test excluded responders who
reported ‘never’ to the question on ‘impact on doctor–patient communication’); (6) ‘always/often/
sometimes’, ‘rarely’, ‘never’.
TABLE 57 Participating GPs’ perceived impact of screening questions on the consultation (continued )
Items on patient questionnaire Control (N= 51), n (%) Intervention (N= 31), n (%)
Statistical
significance
On average, how much additional time
No additional time 2 (4.5) 1 (3.3)
Less than 1 minute 19 (43.2) 5 (16.7)
1–2 minutes 17 (38.6) 14 (46.7)
2–3 minutes 6 (13.6) 7 (23.3)
3–4 minutes 0 (13.6) 1 (3.3)
4–5 minutes 0 (0.0) 2 (6.7)
More than 5 minutes 0 (0.0) 0 (0.0) p= 0.0083
Impact on doctor–patient communication
Always 1 (2.0) 1 (3.3)
Often 4 (8.0) 1 (3.3)
Sometimes 11 (22.0) 16 (53.3)
Rarely 20 (40.0) 7 (23.3)
Never 14 (28.0) 5 (16.7) p= 0.0334
Nature of impact on doctor–patient communication
Positive 8 (26.7) 13 (56.5)
Negative 1 (3.3) 1 (4.3)
Both positive and negative 14 (46.7) 3 (13.0)
Do not know 7 (23.3) 6 (26.1) p= 0.0285
Impact on patient management
Always 1 (2.0) 1 (3.2)
Often 0 (0.0) 2 (6.5)
Sometimes 7 (13.7) 13 (41.9)
Rarely 22 (43.1) 7 (22.6)
Never 21 (41.2) 8 (25.8) p= 0.0056
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General practitioner interview study recruitment
Responses to the request (contained in the GP survey questionnaire) to take part in a further interview
phase of the study are summarised in Table 58. Out of the 82 GPs who returned questionnaires, six
declined any follow-up contact to discuss their experiences of the study. This gave a total of 76 GPs from
26 practices: 15 practices from the intervention arm and 11 from the control. On contact, a further 13 GPs
declined to be interviewed and three were lost to follow-up either through retirement or changing jobs.
It was not possible to make contact with a further 25 GPs despite frequent attempts based on the details
provided in the questionnaire, leaving 35 GPs available for interview.
A number of contact strategies were adopted. When GPs had given their e-mail addresses, these were
used in the first instance. However, only one response was received from the initial mailing to 15
individuals. As a consequence, the decision was taken to make follow-up contact through the practice
managers, and to adopt that approach in the first instance for other potential participants. The first two
attempts at contact with the practice managers were via e-mail and when there was no response this was
followed by a telephone call. The average number of contacts needed to obtain an initial response from
the practices was three. This response in all instances involved the practice manager agreeing to take the
matter to the GPs and a series of communications then often followed to remind them again of the study
and to arrange the actual interviews. Twenty-five GPs were interviewed in total. Twelve were interviewed
face-to-face; these included three who had not completed the questionnaire but who joined with four of
their practice partners when they were interviewed as a group, two other GPs who were interviewed
together, and three GPs seen on their own. The other 13 GPs had interviews conducted by telephone.
Interviews lasted between 15 and 40 minutes.
Despite these challenges, data saturation was reached by the tenth interview in both arms of the study. Data
collection continued for a further four participants in the control arm and two in the intervention arm with
whom interviews had already been arranged. This confirmed that no new data were emerging and data
collection then ceased. Ongoing liaison with the remaining practices to arrange interviews was cancelled.
This process gave a total of 25 interviews. Data saturation took a period of 7 months and ended in
March 2013.
General practitioner interview study: emergent themes
Results are presented under the headings of the three major themes identified through the analysis:
participation in the trial and using the screening tool, OA and accompanying psychological problems, and
the doctor–patient relationship.
TABLE 58 Summary of responses to request for interview (GPs)
Stage in recruitment of GPs for interview Number of GPs
Questionnaires sent 165
Questionnaires returned 82
Consent to follow-up 76
Declined at follow-up 13
Lost to follow-up 3
No response to follow-up 25
Available for interview 35
Agreed to interview without questionnaire 3
Total interviewed 25 (12 from control practices; 13 from intervention)
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There was substantial overlap in these themes.
Participating in the trial and using the screening tool
General practitioners were asked whether or not the training on participation provided by the research
team could be improved in any way, and the uniform response was that it had been very helpful and
appropriate with no suggestions of any areas that needed to be strengthened for future research:
I can’t really fault the way it works, I think I’m just grateful for the fact it was done quite simply. It
flagged up when the relevant coding or diagnosis was put in, and helped me obviously think, and just
a good reminder.
34:85 C
Although the account of recruitment given in the previous section illustrates difficulties in recruiting GPs to
the interview study, analysis of both the questionnaires and the interviews indicate that most GPs who
took part in the qualitative studies did not find taking part in the trial itself problematic. Nevertheless,
although GPs in the control arm reported that the study required < 1 minute of additional time in the
consultation, those in the intervention arm reported that it took between 1 and 3 minutes more.
There were some reports of excluding patients who were eligible for the trial in terms of the protocol and
a number of reasons were given. The most common of these was that the template fired after the patient
had left the room owing to a consultation style in which the GP entered computer data after the
consultation. One GP reported that:
On a few occasions I had to chase patients down the corridor to bring them back and ask
the questions.
18:5 I questionnaire free-text response
There were also reports of not including patients because of time pressures, as well as some reports of
patients declining. One GP wrote on the questionnaire that the patient declined because of ‘anxiety’, but it
was not possible to explore this in more detail as the GP gave no further information and declined a
follow-up interview. Another GP noted that a patient declined because they felt they could not complete
the questionnaires and, again, no further information was given and the GP declined to be interviewed.
When these issues were followed up with GPs who were interviewed, age emerged as a reason:
I believe one or two patients may not have been screened because of very complex ageing situations.
17:5 I
In general, GPs interviewed found screening tools to be of some use, particularly in referring patients to
other resources, but felt they were no substitute for their own clinical judgement:
Clearly we have to do the PHQ for QOF, for patients with anxiety and depression that needs to be
done. Our local EWB [Elderly Wellbeing] team . . . will not see a patient without it being filled in so it
kind of . . . it gets to be something that you just do . . . [it] helps to expand on questions, you say ‘well
I can see on this last question you’ve marked it as two, can you tell me a little bit about that?’ So it
can sometimes open up the conversation. It’s more useful as a tool so that I can record, and for
further services to be involved. I don’t need it for my skills in diagnosing depression, but it kind of
adds to it really.
5:20 I
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Although some GPs interviewed did not find the screening template intrusive, others did. One GP reported
not using it because of:
. . . knowing the patient had enough on their plate with other issues.
4:12 C questionnaire free-text response
Others found it formulaic and awkward, even a nuisance:
I think we feel they are of a nuisance value. If this were made routine I don’t think it would be difficult
to incorporate, but I think we’re generally trying to sort of speed up rather than give ourselves more
to do.
1:23 I
Moreover, it was screening on a topic for which they would avoid using a case finding approach anyway:
I don’t probe unless they say something about it because sometimes I feel it’s very difficult to put that
in their mind that they may be depressed or, if I feel that they are depressed I ask them, if I don’t feel
they are, then I don’t.
6:21 C
However, for others it was helpful:
In general coding gave opening to discuss ‘emotional psychological’ impact of pain on
patient’s situation.
17:5 I
For the majority, high workloads and competing demands were key factors in not routinely case finding
for anxiety and depression in this patient group:
The whole problem is there’s so many things you’ve got to do, you’ve got to prioritise and we’ve got
all the targets we’ve got to do, and all the QOF stuff . . . that there’s very little time to go searching for
things, so it tends to have to be opportunistic.
34:81 C
For some, however, taking part in the study raised awareness:
I think we always try to be patient centred anyway, but I think perhaps in a way, patients and doctors
fall into a trap of discussing things in the same way, time after time, and actually having you know,
entering into the study perhaps makes you focus on it slightly differently.
5:17 I
This increased awareness extended to some in the control group, even though it was only the numeric
pain rating item that was additional to the consultation in that arm:
It’s helped me to concentrate more on patients’ needs than I would do, like with the elderly with
arthritis, like with the wear and tear and things.
6:21 C
Although these views represent saturation in terms of the theme, the poor response to the interview study
must be taken into account when judging the representativeness of these views of GPs as a whole. Out of
the 165 questionnaires issued, just 35 GPs were available for interview (i.e. 21% of those mailed). The
extent to which OA and its concomitant mental health challenges are seen as pressing within primary care
must be considered with caution.
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Osteoarthritis and accompanying psychological problems
The presence of depression and/or anxiety was seen as common:
I wouldn’t say very common but certainly fairly common, I would say maybe 25% or so have got
something psychological going on at the same time.
5:18 I
Indeed, some GPs considered depression and anxiety a normal part of having OA, and felt it was viewed in
this way by patients:
I don’t think they see it as a separate problem. I think if they’re down because of their pain, I don’t
think most of them want to be given a label of psychological problems. I think they would understand
it is almost to be expected.
1: 23 I
Despite such prevalence, there was awareness that mental health issues were not always appropriately
recognised or addressed:
It’s a major part of it. I think it’s something that is potentially slightly under diagnosed or
slightly overlooked.
34:85 C
Prioritisation of the physical over the mental and of depression over anxiety
All interviewees recognised the potential impact of OA on overall well-being and the complexity involved.
However, GPs talked about prioritising the physical over the mental:
It’s still difficult to untie it from the physical symptoms, isn’t it? Because if they say ‘I’ve got poor
sleep’, well ‘that’s because you’ve got pain’; they’ve got poor appetite, that’s because I’ve got you on
non-steroidals.
F4: focus group C
Among younger patients, maintaining capacity for, or getting back to, work emerged as a key priority,
whereas for older patients it was seen as a more complex issue:
With most elderly patients presenting with joint issues, one of the things we’d always be keen to find
out is how their condition was impacting at home, say for example mobility issues, bathing issues, falls
that type of thing. The psychological aspects, I’d say that those get triggered with the more intractable
patients with more severe disease, or perhaps those in which pain analgesia hasn’t been easy to
achieve. Always does sort of make you think about depression and anxiety as issues.
14:28 C
Participants also reported that their patients prioritised the physical, as this interview extract in Box 3
highlights.
This was echoed in another interview when the GP participant was asked to talk through a typical
response to a patient with depression and joint pain:
Well, if somebody presented we would always fill in a PHQ-9 . . . and then you would talk through
them what the options are . . . ‘do you want some medication for this?’ A lot of people will
immediately say ‘no, I don’t want any more tablets’ and you say ‘OK, there are counselling options’
and mostly they don’t want that either. The impact clinic or the pain clinic, they will take that option.
34:81 C
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Again, this response was considered to be particularly common in older people:
Often I find elderly patients tend to rarely mention anything to do with low mood. They’ll admit there
is a problem to do with that when things are really, really desperate, or really bad. But some patients
were raised during an era when even just making a trip to the doctors you had to be really debilitated
before you got some help.
34:85 C
When it came to case-finding, depression was generally prioritised over anxiety, which tended to be seen
as a one-off issue at most, rather than anything that might accumulate over time and, again, both came
after the physical:
I wouldn’t identify anxiety as being a factor in patients with osteoarthritis. If it does rear its head, it
can usually be addressed fairly early on in the disease process by reassurance about what’s going on.
Whereas if we’re not able to get adequate pain control and people’s mood deteriorates, that makes it
more difficult to control the pain.
23–71 I
As previously highlighted, this notion of prioritisation was contextualised within the constraints of the
consultation and managing complex health needs in that time frame, but it was also very much framed by
how the Quality Outcomes Framework was perceived to determine the valid use of time and resources in
the face of such constraints:
We’ve got so many other things to do, is the problem . . . clearly if arthritis became a QOF target,
anxiety, depression, the same sort of questions that you’ve got for diabetes and ischaemic heart
disease, then that would be valid, wouldn’t it?
34:81 C
The doctor–patient relationship
For most participants, the complex relationship between OA, depression and/or anxiety was reflected in
the quality of the doctor–patient relationship, which emerged as key in being able to appropriately and
sensitively address complex physical and mental health issues, especially when it came to older patients
(Box 4).
BOX 3 Interview extract (34:82 C)
I: So, in your experience then how common are psychological or psychosocial problems in patients with
joint pain or OA would you say?
IV: Well, if you go fishing they’re very common. They don’t always present to start with.
I: So when you say they don’t always present, is that because patients tend not to self-report, or
something else?
IV: Yes, they tend not to self-report, and they feel more comfortable talking about the physical symptoms.
I, interviewer; IV, participant.
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Conclusions to the qualitative study of general practitioners
Difficulties in recruiting to the interview study reflect current resource pressures and demands on GPs.
Among those who responded, participation in the trial appears to have had little impact on the
consultation in terms of time and to have raised their awareness of mental health issues among patients
with OA. However, although case-finding was seen to be of some use, the use of screening tools was
considered limited and, at best, an adjunct to clinical judgement. There was a sense that low mood in
patients with OA was ‘normal’, particularly in older patients, and that GPs prioritised the physical over the
mental. These views were reinforced by the absence of OA within the QOF, with GPs indicating that
different QOF priorities might change their approach. When mental health was addressed, GPs prioritised
depression over anxiety, with the depression associated with OA generally seen as normal but the
importance of detecting and managing anxiety generally unrecognised. GPs also reported a paucity of
non-pharmacological resources available for those patients in whom mental health difficulties were
identified. Continuity of care was considered very important in the management of patients with long-term
conditions such as OA, and a high-quality doctor–patient relationship was seen as essential to the effective
management of consequential and coexisting mental health issues, particularly among older patients with
multimorbidities. The use of guidelines in the management of this patient population was seen as helpful
and the need for continuing professional training and updating was recognised.
Discussion
The primary objective was to evaluate the clinical effectiveness of introducing a point-of-care electronic
template to prompt GPs to ask brief questions about anxiety and depression symptoms in patients
consulting for clinical OA. Specifically, we hypothesised that patients in the intervention practices that
screened for anxiety and depression symptoms in the GP consultation would show greater improvements
in current pain intensity and pain interference with daily activity over the 12 months following their
consultation than patients in the control practices.
BOX 4 Interview extract (34:85 C)
IV: I think for the elderly patient, it’s much easier when they know that you’re an approachable, good
communicator. They can understand you; you approach the consultation in a way that allows them also
to say something to you, so time investment in that often helps. And I know it’s a very difficult thing
sometimes, to invest time because of pressures of work etc.
I: Yes. And of course that level of communication clearly affects the quality of treatment that
patients receive?
IV: Yes, absolutely. And they’re compliant as well. I think if they’re trusting you and they’re happy with the
care they get they’re likely to be more compliant and if they’re not happy with treatment they’re likely to
communicate it to you instead of keeping quiet about it.
I: And do you find those sorts of issues are any different for patients with anxiety as opposed to patients
with depression, or is it more or less the same?
IV: I think it’s pretty more or less the same. I think sometimes in depression and anxiety there’s the
tendency to feel a bit withdrawn. Maybe they don’t want to be opening up a lot, because they’re either
scared or you feel like you can’t be bothered to say anything, or you’re just so down in a mood that you
just have lost the will, or lost the zest, for life. So I think it applies to both groups of patients.
I, interviewer; IV, participant.
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Principal findings
This pragmatic cluster RCT in UK primary care provides evidence against a beneficial effect of introducing a
template to screen patients consulting with OA for the presence of anxiety and depression on patient-
reported OA outcomes.
The further observation of worse pain and functional outcomes across the 12 months following the index
consultation among trial participants in the intervention practices could be explained, at least in part, by
selection bias, although patient dissatisfaction with the consultation may also make a modest negative
contribution.
Summary comparison with previous findings
This is the first such trial in OA to our knowledge and, in particular, was novel in tackling the issue of
comorbid anxiety as well as depression in OA patients. The trial was highly pragmatic in nature in that it
simply introduced the screening as a potential prompt for action by GPs without specifying what that
action should be beyond highlighting the existence of NICE guidelines. Therefore, the trial took place in
the context of existing mental health services and allowed clinician judgement on how to respond to
screening questionnaires.
The results were generally consistent with limited effects of point-of-care reminders132 and also with the
idea that screening without addressing other important barriers (e.g. acceptability, referring on, having
good mental health services in place) is unlikely to have any effect.313
There was no strong evidence that the intervention posed major problems for the patients or practitioners,
although the themes that emerged from the nested qualitative study do highlight the variable views of GPs
on the value of such screening and appear consistent with Maxwell et al.314 Some of these concerns may
have been averted by selective application of the template by GPs, hence giving rise to the potential source
of selection bias in the study.
The hypothesis under test
Patients with painful, disabling OA constitute a ‘high-risk’ group for distress, anxiety and depression
disorders.35,37,315 Although many of the factors associated with the future course of OA are not modifiable
at the point of care (e.g. age, sex, symptom duration, severity of underlying structural changes to the
joint316–319) comorbid depression and anxiety are an exception as they are potentially treatable. They are
related to future course,320,321 treatment response36 and health-care use,322 and show a reciprocal
relationship with pain and functional outcomes.36,323,324 The initial idea for POST drew on evidence from
clinical trials of collaborative care approaches that had used psychological therapies and medication for
major depressive disorder in patients with OA to modify general and OA-specific clinical outcomes, and
shown beneficial effects on pain intensity, pain-related function and QoL sustained to 12 months.18,279,325
A novel component of POST was that it also considered anxiety, based on the idea that physical function
benefits might accrue from effective management of comorbid anxiety disorders in patients with persistent
painful disorders.326,327
The POST focused on screening for depression and anxiety in patients consulting about joint pain and OA.
Current NICE guidelines for OA, updated since the inception of the trial, remain ambiguous on the matter
of screening, recommending that patients be assessed for the effect of OA on mood, specifically including
‘screen for depression’ as a topic ‘worth assessing’, but acknowledging that it may not be of concern for
every patient.153 Evidence and guidelines that informed the design of POST encouraged practitioners to be
alert to depression in patients with chronic physical conditions287 and to consider asking two short
screening questions of patients who they suspect of having depression.328 Physician behaviour can be
expected to influence the expression of emotional cues and concerns by patients and there is evidence that
both elicitation and recognition is highly variable between practitioners.329 Closed questions regarding
psychosocial issues may facilitate the expression of emotional cues and concerns.330,331 In this alternative
perspective of screening, in which the purpose is to facilitate a more holistic assessment in order to
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improve pain and functional outcomes, POST has investigated whether or not there are beneficial effects
of raising the issue of anxiety and depression within the OA consultation and we hypothesised that these
need not be restricted to the relatively small minority of patients ultimately diagnosed with anxiety or
depressive disorder who access and receive high-quality mental health care (the ‘screen-diagnose-treat’
pathway). The recognition of subthreshold anxiety and depression symptoms, which are more common
than clinically diagnosed anxiety and depression, and still associated with less favourable pain and function
outcomes, could ‘open the door to a dialogue with clinicians who can then determine which unmet needs
have contributed to distress’.313 This could include exploring causes (e.g. poorly controlled pain,332 sleep
disturbance,333 inadequate social support38) as well as prompting greater use of pain management and
functional rehabilitation options, such as referral to physiotherapy for supervised exercise that is effective
for pain,92 function92 and mental health,334,335 but are typically under-utilised.101,336
This thinking informed and justified our approach, which was to test the effect of introducing screening
questions per se into the general practice consultation with OA patients without specifying or providing
additional treatments or resources beyond those which the GP would then choose to use in usual practice.
The results of POST provide no evidence of improved patient-reported pain and function to support this
strategy and intervention as a means to manage OA in general practice.
Contributing evidence to the debate about screening for psychological distress
POST found a statistically significant negative effect on pain in the intervention practices. Selection bias is
one plausible explanation for this, but the result may reflect a negative effect of screening in these
circumstances. This links to an evolving debate in the literature about the benefits and harms of routine
screening for depression in high-risk groups. In both unselected primary care populations and special
populations at high-risk of depression, several recent systematic reviews by Meijet et al.,337 Thombs et al.338,339
and others340 have highlighted the lack of direct evidence from appropriately designed clinical trials on
the effects of implementing routine depression screening versus no screening, either alone or in the
context of accessible, good-quality mental health care. Measured against this standard of evidence, the
recommendation of routine depression screening in general,339 and in high-risk patients with diabetes,341
cancer342 and coronary heart disease,343 has been criticised as premature. Furthermore, these and other
commentators344 have expressed concern over the inefficiency of screening, the diversion of scarce resources
from other clinical priorities, the potential for wasteful and unnecessary exposure to common side effects of
antidepressant medications, particularly in patients with mild, self-limiting depressive symptoms, and possible
nocebo effects and stigma from overt labelling. Counter arguments have stressed that, nevertheless, much
has been learned from previous studies,313 that the efficiency of screening improves if appropriately targeting
high-risk groups345 and both efficiency and acceptability may be helped by shifting the focus from
‘depression’ to a broader concept of distress.313 Although modest increases in the rate of new depression
diagnoses and in antidepressant prescriptions were observed following introduction of financial incentives
for depression screening in patients with diabetes and coronary heart disease in UK primary care in
2006,346,347 the appropriateness of these changes and their relation to patient outcomes remains unclear.
POST adds importantly to this debate by showing no benefit from screening in older patients consulting
about joint pain or OA. Although a negative effect of screening cannot be ruled out, bias is a more likely
explanation. However, failure to find a true beneficial effect because of selection bias is improbable.
Strengths
This trial is one of the few that actually addresses an evidence gap that is still being highlighted in the
current literature.348 The screening was done by the GP in the consultation at the point of care and not by
means of a remote questionnaire or a screening instrument applied separately to the consultation.284 There
was secure cluster allocation and minimal cluster attrition. Sample size was achieved and by the required
deadline.
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Limitations
There was cluster imbalance that resulted from variable list sizes of the randomised practices. However,
this was unlikely to have had an adverse effect on statistical power and was unlikely to have introduced
bias per se.
Eligibility criteria were broad. We have discussed, in Chapter 3, the potential problems in relation to the
MOSAICS trial raised by the variety of patients who consult with one of the Read codes for joint pain or
OA used to define initial eligibility in both MOSAICS and POST, a substantial proportion of whom may
have minor symptoms or non-OA diagnoses that may dilute the effect of screening because they are not
‘high risk’ enough to benefit or to show improvements in pain and disability. In addition, in POST, the
failure to exclude all those already known by the GP to be anxious or depressed may be regarded as a
limitation of a screening programme, although the purpose of the intervention (to shape the GP
consultation with the knowledge that a patient is anxious or depressed) could equally apply to a ‘reminder’
as to a ‘first ever’ structured prompt.
The qualitative study raises issues of fidelity of the intervention, namely the extent to which questions were
not asked in the consultation but inferred afterwards owing to entering data at end of the consultation.
This problem may have been selectively greater in the intervention than the control practices because of
the nature and length of the screening tool.
This was basic binary screening, using a small number of questions to establish if a state of depression or
anxiety was or was not present. The depression questions had been validated before for such use but
there was no previous validation of this approach to anxiety screening.
Selection bias is plausible.187 Cluster randomisation was chosen because the viability of individual
randomisation was not realistic in the context of point-of-care screening. Prior identification of eligible
participating patients could have been done, as per the method adopted for the MOSAICS trial; however,
the effect would have been to markedly increase numbers in trial but with the majority not receiving the
intervention and, therefore, even less likely to have an effect.
Implications
Whether or not the negative result was real or due to bias, it is clear that, at the very least, screening for
depression and anxiety at point of care did not improve pain or function in patients aged ≥ 45 years who
were consulting with joint pain or OA. The implication is that it is not possible to recommend this
intervention for general practice.
This is important evidence to contribute to a debate that has been evolving since the trial was planned
and designed, in which the value, role and usefulness of short systematic screening for symptoms of
psychological distress in primary care are being questioned, despite acceptance that such symptoms are
strongly associated with the health status of persons with long-term conditions such as OA.
Conclusion
Encouraging GPs to routinely ask screening questions for anxiety and depression of patients consulting for
painful OA (and then follow guideline recommended care for OA and mental health) has no appreciable
benefit on patient-reported pain and functional outcomes.
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Chapter 6 Conclusions
The conclusions from the individual workstreams of the programme have been presented in the relevantchapters and the overall conclusions from the programme have been presented in Chapter 1.
In this chapter we summarise briefly again the picture that emerges from the programme as a whole and
possible implications for research and practice (see The results of the programme and Recommendations
for future work), before presenting comparative data on the different populations studied in the
programme (see Overview of the workstream populations) and describing some other outputs that
emerged from the programme as a whole (see Outputs from delivery and dissemination of the
programme).
The results of the programme
Summary of the main findings
This programme has investigated primary care for OA patients.
Across four workstreams, the programme has investigated:
l the potential for primary care to have an impact on the prevention of progression of OA in
the community
l how and whether or not the delivery of NICE core guidance for OA care in general practice can be
improved, and whether or not delivery of NICE core guidance in general practice improves pain and
disability among OA patients in primary care
l whether or not adherence to exercise and physical activity can be improved by changes to
physiotherapy practice among patients with knee OA
l whether or not screening older patients who consult about joint pain and OA for depression and
anxiety leads to improvements in their pain and disability.
The conclusions are that (1) on the basis of available evidence about efficacy in tackling prognostic factors
for poor outcome in patients with OA, there is substantial potential for primary care to influence the
frequency and severity of OA in the community and (2) it is feasible, acceptable and achievable to
(i) improve quality of care in general practice for OA, in particular the delivery of NICE OA core guidance,
through GP and practice nurse training and through use of quality-of-care templates inserted in GP
records, (ii) deliver enhanced physiotherapy to support long-term adherence to exercise and physical
activity in patients with knee OA and (iii) identify the substantial numbers of patients presenting with joint
pain in primary care who also have symptoms of depression or anxiety.
However, the improved delivery of NICE core guidance by GPs and nurses achieved in this programme did
not result in statistically significant improvements in pain and disability in patients with OA compared with
usual general practice care, although there was evidence of more efficient prescribing and patient
satisfaction with their care. In addition, enhanced physiotherapy approaches to sustaining exercise and
physical activity in patients with knee OA did not result in statistically significant improvements in pain and
disability compared with UC, and screening for depression and anxiety in patients consulting about joint
pain did not improve their pain and disability.
Main implications for practice
l Improved implementation of NICE OA core guidance can be achieved in general practice through
patient-generated information, training programmes for health-care professionals, and structured
quality-of-care reminders.
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l New ways need to be found to sustain the known effectiveness of physiotherapy-led exercise and
physical activity interventions for persons with knee OA which declines shortly after contact with the
physiotherapist has ended.
l Screening patients who consult with joint pain in general practice for symptoms of depression or
anxiety cannot be recommended as a policy for improving pain and disability in these patients.
1. Possible explanations for lack of effect of successful implementation of NICE guidance in general
practice on patient clinical outcomes, and their implications for practice.
i. The content and level of the intervention achieved through GP consultation and practice nurse-led
clinics may be different from that carried out in the efficacy studies on which NICE core guidance for
OA was based.
– The implication is that, as improvements to the quality of general practice by delivering on NICE
core guidance were insufficient to have an impact on patients’ pain and disability, more intensive
or specialised interventions, such as physiotherapy-led exercise, may be routinely required in
primary care.
– Different models of primary care for patients with OA, which can deliver more intensive
evidence-based treatment, should be considered.
ii. Limited take-up of the offer of nurse-led follow-up clinics in MOSAICS may have been a barrier to
the implementation of optimal care in the intervention practices, but also the pool of patients
chosen for both MOSAICS and POST may have been too broad for ‘one-size-fits-all’ treatment or
screening, respectively.
– One implication is that the outcome of a shift in short-term pain and disability among all OA
consulters may be unachievable in primary care, however high quality the care delivered.
– New ideas, such as identifying patient sub-groups who may selectively benefit from different
intensity of primary care treatments, or about different outcome measures (satisfaction with care
or improved participation in social life), need to be debated and developed for research and
practice with patients who have OA.
Recommendations for future work
This programme has raised issues about the way we think about, treat and measure the experience of
patients with OA. Our recommendations are, therefore, grouped into two categories: the need for
conceptual thinking and debate, and suggestions for new research avenues.
The conclusions above raise important questions about the need for new conceptual thinking and
discussion, recommendations for new research, and wider implementation.
Potential topics for new conceptual thinking and discussion
1. NICE core guidance in practice.
i. Clarification of the expected benefits of implementing NICE core guidance for patients with OA as a
desirable end in itself (e.g. provision of appropriate information and of advice about exercise and
pain relief) regardless of whether or not it demonstrably improves clinical outcomes.
ii. Critical reflection on whether or not current NICE core guidance, even when implemented in the
way that MOSAICS has done, results in sufficient shifts in crucial components of patient behaviour
to achieve change in clinical outcomes in the short term. An example of this is physical activity
for which there is evidence from other research that implementation of physiotherapy-guided
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interventions as core treatment could achieve bigger change, so that adding such resource to the
MOSAICS package might deliver effects on pain and disability.
iii. Following on from this, review of the delivery of NICE core guidance for primary care and the
capacity of a GP- and nurse-led service alone to improve clinical outcomes without additional
resources, such as physiotherapy services, to provide individualised and supervised
exercise interventions.
2. Continuing debate and critical enquiry about the role, benefits and costs of systematic screening for
anxiety and depression in all people with long-term conditions in primary care.
3. The need for new concepts about OA within the research and clinical community.
i. Regarding achievable goals of long-term care for people with this condition, including whether or
not it is appropriate to seek more than small short- to medium-term clinical effect sizes in patients’
pain and disability in practice. Maintenance of activity and participation despite continuing pain may,
for example, be a better long-term measure of effect.
ii. Regarding a combined approach to the management of OA as a long-term condition (importance of
good information, adequate advice and resource for exercise and physical activity and other core
interventions, identification of individuals at high risk of unfavourable future course, and targeted
interventions for those most likely to benefit).
Recommendations for new research
1. Outcomes in long-term conditions.
Research into new models of long-term care for OA in the context of other long-term disabling
conditions that focus on the necessary and desirable process and clinical outcomes from patient,
clinician and societal perspectives.
2. Stratified care for OA patients.
Research to identify subgroups of patients with OA who may, on the basis of combined evidence from
previous cohorts, effectiveness studies and the successful implementation strategies described in this
programme, benefit from specific interventions in primary care. This includes identification of patient
subgroups such as:
i. those with good prognosis who can be supported to self-manage without additional investigation
or treatment
ii. those who will benefit from specific treatments, such as physiotherapy-led exercise.
3. Exercise and physical activity levels in people with long-term conditions.
i. Research to identify new approaches to improving long-term adherence to exercise and physical
activity among patients with OA such as regular monitoring.
4. Depression and anxiety in people with OA.
i. Research into more efficient and effective ways of identifying and treating clinically important levels
of anxiety and depression in patients with OA.
ii. Research into the effects of pain management on psychological outcomes in patients with OA.
Wider implementation
Taking the core NICE OA guidance as it stood, we showed it can be implemented in primary care. On that
basis, wider implementation with CCGs has begun. However, the hypothesis that it would change pain
and disability outcomes was unproven and, in Chapter 3, we reflected on one possible explanation for this:
that our implementation of NICE guidance in MOSAICS was insufficiently complete or practical. Therefore,
the next phase of dissemination incorporates lessons learned in MOSAICS and builds further opportunity
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for evaluation. We recommend continuing evolution and evaluation of the MOSAICS model of
implementation as it is more widely adopted, including addressing and researching the issues raised about
the content of the MOSAICS package in New conceptual thinking and discussion and Recommendations
for new research.
Overview of the workstream populations
Workstreams 2–4 investigated different aspects of the primary care management of OA. Although
conceptually linked, each was an independent study or set of studies. Each drew on populations based in
primary care, but used different practices and different starting points for the selection of the study
populations.
In this section, the populations involved in the three workstreams are compared in order to further inform
the interpretation and implications of the programme as a whole for all OA patients consulting in primary
care by comparing:
1. baseline data across the study samples from the 3 workstreams
2. outcome data across the study samples from the 3 workstreams.
Background
In workstreams 2–4, there were new studies involving a total of 117 general practices and their registered
populations. The practices were drawn from the NIHR PCRN in the West Midlands (North) and in the
North West.
Comparing baseline characteristics of the recruited populations
Aim
In this section, baseline characteristics of the recruited study populations (irrespective of subsequent
allocation arm in the trials) are compared in order to explore (1) selection issues and (2) the nature of OA
in primary care populations.
Methods of population selection
To recap and summarise, the selection of each of the samples was as follows:
1. MOSAICS baseline population sample: all persons aged ≥ 45 years, registered with eight participating
GPs, were posted a self-complete questionnaire. The response of 53% (n = 15,083) means that this
sample may not be fully representative of all older persons in the general population.
2. MOSAICS trial analysis: all persons aged ≥ 45 years who had responded to the MOSAICS baseline
questionnaire, reported pain in at least one joint, consented to follow-up, and who subsequently
consulted their GP about joint pain or OA during a 6-month period were included in the trial. This sample
of 525 recruited patients represented 26.8% of all patients in these practices consulting about joint pain
and OA during this period, and so cannot be assumed to be fully representative of all such patients.
3. The BEEP trial included patients aged ≥ 45 years with knee pain identified in one of three ways: review
of medical records in participating general practices to identify persons who had consulted about knee
OA in the previous 12 months (69% of participants), referrals (by the GP or self-referral by the patient)
to participating physiotherapy services (22.2%), and a screening survey of the registered practice
populations for eligible individuals with knee OA (recent consultation not necessary for inclusion)
(8.6%). Unlike the MOSAICS trial and POST, the BEEP population was not open to selection by the GP
when coding a consultation, but GP selection might operate in terms of which patients they refer for
physiotherapy, and patient selection may operate in terms of consent to participate or response to the
screening questionnaire. A minimum criterion of pain and disability was applied to all patients for
eligibility.
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4. The POST included patients aged ≥ 45 years who consulted in 44 GPs about joint pain or OA (an
identical set of morbidity or Read codes was used to define inclusion as in the MOSAICS trial). The
computer pop-up screen in all practices was fired automatically when the GP entered one of the
relevant Read codes and included a set of screening questions (different for intervention and control
practices). The GP could bypass these questions and selectivity in trial recruitment might occur.
However, unlike the MOSAICS trial, there was no selection prior to consultation by a pre-trial survey.
Therefore, each study population had possibilities for selectivity of the recruited versus their target
population of patients with clinical OA, and some of these differed between the studies. However, there
were also logical reasons why the recruited populations might differ between the studies:
1. Persons consulting with their GP about joint pain or OA compared with persons in the general
population responding in a questionnaire that they have joint pain or OA compared with patients
referred (by GP or by self) to physiotherapy because of OA.
2. Persons consulting with their GP about joint pain and OA who had previously consented to follow-up
compared with persons consulting their GP about joint pain and OA with no prior selection by consent
or survey response compared with persons with knee pain consenting to a physiotherapy-led
intervention.
Results
Table 59 compares some baseline characteristics in the recruited populations regardless of the arm to
which they (or their practices) were allocated in the trials. We have used subgroups with knee pain for
some of the comparisons in order to include all the main studies from the three workstreams. Such
subgroups include most people in the relevant study sample with joint pain or OA, although they
constituted only about half of the POST sample.
Discussion
Despite the variation in sampling strategies for the different studies, the populations of people aged
≥ 45 years who have joint pain and/or diagnosed OA do not differ dramatically in sociodemographic
characteristics, except that the MOSAICS trial population had a higher proportion of people out of work
than all the other study populations, including the wider population from which it was drawn (i.e. the
MOSAICS population survey). This means that the differences cannot arise simply from demographic
contrasts between the general practices selected for the different workstreams.
Specific similarities and differences
1. General population samples: persons with knee pain compared with persons without knee pain based
on self-reported questionnaire (the MOSAICS population survey).
As would be expected from published population surveys (e.g. O’Reilly et al.349 and Jinks et al.350),
persons > 45 years reporting knee pain are a little older, are more likely to be female, have a higher
mean BMI, are less likely to be employed, are more likely to have anxiety and depression, and are more
likely to have lower EQ-5D health status than persons reporting that they have not experienced knee
pain recently. The data have not been adjusted for age and sex, so the differences in the other variables
might be explained by age and sex.
2. Persons reporting joint pain in the general population (MOSAICS population survey) compared with
persons recruited when consulting their GP with joint pain or clinical OA (MOSAICS trial).
Consulters with knee pain recruited into the MOSAICS trial were, with the exception of one variable,
different from persons who reported knee pain in the baseline MOSAICS practice population survey:
they were a little older, more likely to be female, more likely to have a higher BMI, less likely to be
employed, and more likely to have a lower EQ-5D health status. This would be consistent with
consulters representing a subgroup with generally more severe problems than all persons reporting
knee pain in the general population. However, the possibility that GPs selectively recruited consulting
patients into the trial who had rather more severe problems cannot be ruled out.
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The exception to this general pattern was that anxiety levels were lower in the consulters than in
persons with knee pain in the general population; this is consistent with previous findings that suggest
that psychological distress is associated with lower rates of consultation among knee pain patients and
may act as a barrier to consultation.351
3. Persons recruited when consulting their GP with joint pain or clinical OA (MOSAICS trial) compared with
patients with knee pain recruited from primary care into a physiotherapy trial (BEEP trial).
TABLE 59 Baseline comparability of study populations
Study sample size
Study name
BEEP POST MOSAICS population survey
MOSAICS
patient-level
trial
(N= 514)a (N= 1412)a
All
(N= 15083)b
Knee pain
(N= 8159)a,c
No knee
pain
(N= 6751)b,c (N= 525)a
Age (years), mean (SD) 63.0 (10.0) 65.5 (10.3) 63.4 (11.2) 64.3 (11.2) 63.3 (11.2) 67.3 (10.5)
Sex, n (%)
Female 262 (51.0) 799 (56.6) 8198 (54.4) 4551 (55.8) 3551 (52.6) 313 (59.6)
Male 252 (49.0) 613 (43.4) 6885 (45.6) 3608 (44.2) 3200 (47.4) 212 (40.4)
Marital status, n (%)
Married 376 (73.9) 974 (69.1) 10345 (69.0) 5547 (68.4) 4693 (69.8) 354 (67.7)
Separated 6 (1.2) 20 (1.4) 203 (1.4) 112 (1.4) 90 (1.3) 6 (1.1)
Divorced 45 (10.6) 115 (8.2) 1114 (7.4) 624 (7.7) 476 (7.1) 42 (8.0)
Widowed 45 (10.6) 194 (13.8) 1879 (12.5) 1087 (13.4) 757 (11.3) 81 (15.5)
Cohabiting 19 (4.5) 51 (3.6) 661 (4.4) 336 (4.1) 319 (4.7) 19 (3.6)
Single 18 (4.5) 56 (4.0) 791 (5.3) 398 (4.9) 386 (5.7) 21 (4.0)
BMI (kg/m2), mean (SD) 29.6 (5.7) 28.7 (5.4) 26.9 (4.7) 27.6 (5.0) 26.1 (4.2) 28.3 (5.0)
Employed, n (%)
Yes 214 (42.2) 452 (32.0) 5330 (36.1) 2650 (33.3) 2639 (39.8) 136 (26.3)
No 293 (57.8) 959 (68.0) 9429 (63.9) 5317 (66.7) 3993 (60.2) 381 (73.7)
Knee pain, n (%) 514 (100) 778 (55.1) 8159 (54.7) – – 433 (82.5)
Knee pain score (NRS),d
mean (SD)
6.8 (1.7) 6.6 (2.1) – 4.4 (2.6) – 6.6 (2.4)
PHQ-8, mean (SD)
(depression)
4.1 (4.8) 6.1 (6.1) – – – 4.8 (5.0)
GAD-7, mean (SD)
(anxiety)
3.4 (4.6) 5.3 (5.7) 3.5 (4.7) 4.7 (5.3) 3.0 (4.4) 3.5 (4.7)
EQ5D, mean (SD) (general
health status)
0.64 (0.23) 0.58 (0.24) 0.75 (0.26) 0.68 (0.28) 0.84 (0.20) 0.58 (0.28)
It should be noted that the figures in the table may differ from those given in the individual chapters where the latter are
presented as median and IQRs rather than, as here, means and SDs.
a Populations complaining of joint pain or diagnosed with OA.
b Mixed populations including people with and without joint pain or OA.
c 173 responders did not answer the question on knee pain.
d Knee pain score among participants with knee pain at consultation. Pain score refers to average in last 6 months for
BEEP and in last 3 months for MOSAICS and POST. For BEEP, pain severity score was only available for participants
recruited via the medical record review or postal survey methods (n= 409).
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The BEEP trial participants were younger, less likely to be female, more likely to be employed and
more likely to have lower depression scores, had similar anxiety scores to MOSAICS consulters and had
better EQ-5D health status than MOSAICS consulters. All of this suggests that BEEP trial participants
represented a selectively healthier or rather less severe group than OA consulters in general. However,
the mean knee pain severity score of BEEP trial participants at baseline was similar to that of MOSAICS
consulters with knee pain. This is compatible with the recruitment criteria for BEEP (a minimum score on
the Chronic Pain Grade). The better general health and higher BMI of BEEP participants may reflect
selection factors for referral to physiotherapy and recruitment into physiotherapy trials generally.
Some of the differences may also represent demographic contrasts between the registered populations
of the practices recruited by the two workstreams, for example the proportions of people currently
in employment.
4. All persons consulting their GP with joint pain or clinical OA who had a screening template fired (POST)
compared with persons recruited when consulting their GP with joint pain or clinical OA who had
consented in the earlier population survey (MOSAICS trial) compared with all persons reporting knee
pain in the population survey (MOSAICS population survey knee pain subgroup).
For some characteristics (namely mean age, proportion of females, proportion of married persons,
proportion of employed persons), POST participants’ values were closer to those of the MOSAICS population
survey knee pain sample than were the values of the MOSAICS trial sample, suggesting that they were
more generally representative of older people with troublesome joint pain in the general population.
However, mean BMI score, mean EQ-5D health status and mean knee pain severity score among those
with knee pain were closer in the POST sample to the means for these variables in the MOSAICS trial
participants than to knee pain sufferers in the general population survey. This is consistent with
consulters generally representing a subgroup of everyone in the older population with currently more
severe pain and poorer general health.
The one major contrast between POST participants and all other study groups was that this population
had higher psychological distress on both depression and anxiety scales. In terms of criteria for inclusion
in the cluster randomised POST, the expectation was that mean anxiety and depression might be lower
in POST participants than in all other study groups, as patients with severe mental health problems
were excluded and all other consulters with joint pain and OA should have been screened. The
observation that distress was higher in POST participants than in all other study groups raises the
possibility that the purpose of the cluster trial (screening in the intervention group for anxiety and
depression) may have influenced GP behaviour (in the intervention group at least) to selectively include
patients with more severe problems. Such selectivity has been highlighted before as a potential source
of bias in cluster RCTs.187
Conclusion
The purpose of this section was to present comparative baseline data from primary workstream studies as
the basis for discussion, given that all these study populations were considered to represent primary care
patients with OA in one way or another. Each study had different objectives and different methods of
sampling and it was likely that different populations would be recruited.
The size of the crude differences are not large, which is important given the number of practices involved
and the many potential opportunities for variation between practices and for different types of selectivity
to be operating. As Table 59 makes clear, many of the differences are consistent with a simple explanatory
framework that persons aged ≥ 45 years who consult primary health-care services about joint pain are
likely to experience more severe symptoms and a greater impact on their lives at the time of consultation
than all persons who report current joint pain at any one time in the general population.
This explanatory framework should not have implications for the internal validity of the individual
workstream studies, but does raise critical questions about the potential of intervention trials in patients
with long-term conditions characterised by intermittent exacerbations that recruit at, or close to, the time
of consultation to demonstrate a post-consultation effect when there is likely to be post-consultation
improvement in mean pain and disability in all consulters.352,353
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The discussion above has also considered how some of these differences may have arisen because of
conscious or unconscious recruitment selectivity by clinicians of more severely affected patients or by
patients invited into exercise and activity trials. This should not have implications for the internal validity of
the BEEP trial, but needs to be considered in relation to the internal validity of the cluster trials.
Response to care
In one cluster trial (MOSAICS) and in one individually randomised trial (BEEP), clinical outcomes of pain and
disability were not improved in patients aged ≥ 45 years with clinical OA by new interventions. However,
all patients recruited were, in all arms of both trials, receiving components of OA care that might not
either be always routinely accessed (BEEP) or be available (MOSAICS) in current daily practice outside the
arena of the trials, and which were separate to the novel interventions being tested in the studies. These
included use of an e-template to record quality of care in consultations affecting implementation of NICE
guidance and physician behaviour (MOSAICS), and physiotherapy-led exercise and physical activity for knee
OA (BEEP). We looked at the response to care of exercise and physical activity across these two trials.
Aim
To compare ‘response to care’ across two trials, which included advice or action to support change in
exercise and physical activity behaviour among patients with OA as a component of all arms.
Method
The PASE scores and the change in these scores between 0 and 6 months were summarised and
compared between the two trials for all participants in intervention and control groups.
Results
Table 60 shows relevant variables at 0 and 6 months in the two studies.
Discussion
The PASE scores were different between the two trials, with patients seeing the physiotherapist in BEEP
scoring higher at the start of the trial than MOSAICS patients immediately after their index consultation.
However, there is also a clear difference between MOSAICS and BEEP trial participants in the extent of
change from baseline to 6 months of mean PASE scores. This is regardless of intervention or control status
within the two studies. There were increases in mean PASE scores of similar extent in all BEEP trial arms,
contrasted with declines in mean PASE scores among MOSAICS participants. This was explored in the
MOSAICS chapter, with walking identified as the component that declined in the intervention group while
muscle-strengthening exercises were reported as improving. Despite the lack of additional effect of the
new physiotherapy interventions, these overall findings suggest that physiotherapy-led exercise and activity
could enhance the NICE core guidance delivered by the MOSAICS model of care.
TABLE 60 Response to care in three trial populations: mean PASE scores and their change over time
Variable Group
Start of the trial 6-month follow-up Difference 6 months minus 0 months
MOSAICS BEEP MOSAICS BEEP MOSAICS BEEP
PASE Control 147.49 176 136.24 188 –1.25 + 12
Intervention (1) 138.71 175 123.02 189 –5.69 + 14
Intervention (2) 180 196 + 16
Higher PASE score denotes greater levels of physical activity.
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Outputs from delivery and dissemination of the programme
The programme included detailed study development, training programmes, project management and the
delivery of three trials, recruiting 2454 patients. The studies within the programme were supported by
117 general practices (members of the West Midlands North and Cheshire and Merseyside Comprehensive
CLRNs) and all five physiotherapy services in Staffordshire, Shropshire and South Cheshire. In this section,
we describe the partnerships that supported this work, innovations that were developed and applied to
support successful delivery of the programme, and key dissemination activities linked to, and arising from,
the programme. The PPI that has underpinned all phases of the programmes has been described
elsewhere in the report (see Appendix 1 and in the individual workstream chapters: see Chapters 3–5).
Partnerships and collaborative appointments
The North Staffordshire Primary Care Research Consortium
This is the body that formalises the research partnership in place between Keele and its NHS partners,
including North Staffordshire Commissioning Group (CCG), Stoke CCG, South and West Cheshire CCGs,
lead research active service GPs and physiotherapists, and public health and the community provider unit
in Staffordshire. The Consortium’s Board oversees joint University–NHS research activities, with the aim of
ensuring that the strategy reflects NHS and patient priorities and needs, and contributes to building
research capacity in the NHS and active NHS participation in delivering the research. North Staffordshire
CCG is the lead organisation in the Consortium and held the funding contract for this NIHR programme.
The Primary Care Research Network and the Primary Care delivery arms of West
Midlands North and Cheshire and Merseyside Comprehensive Research Networks
The NIHR CLRNs provided crucial infrastructure support and funding to enable NHS patients, GPs, research
nurses, practice nurses, physiotherapists and NHS managers to participate in, and benefit from, research.
The aim of the NIHR CLRN is to make the NHS a world-class environment in which to undertake research by
promoting a culture of research as a normal part of everyday clinical practice. Through the resources
provided by the CLRNs and innovative joint working between the Networks, Keele University and the
Consortium, a GP Research Network of 117 GP practices and 185 individual GPs, and a Physiotherapy
Research Network comprising all five physiotherapy services in our region and 74 individual physiotherapists,
were involved in delivering this large NIHR programme. Effective joint working across the NHS/network/
university interface resulted in development of innovative approaches to support fast and effective
recruitment of patients, early identification of barriers and solutions to overcome them, and early adoption
of trial findings to improve clinical practice.
New GP research facilitator (n = 5 posts) and physiotherapy research facilitator posts (n = 5) were
established as joint academic/network/NHS appointments, who helped to:
l disseminate the innovative methods we developed to support busy NHS clinicians to recruit patients to
the research
l contribute to developing the intervention packages that were tested
l identify and recruit GP and physiotherapy centres
l train NHS clinicians in the research procedures
l provide ongoing support for the delivery of specific projects.
Challenges and innovation in research delivery
Example: workstream 3 – the BEEP trial
This trial was based on extensive engagement of NHS staff and organisations across the North West
Midlands and South Cheshire, enabling successful recruitment ahead of target of 526 patients from 65 GP
practices and five physiotherapy services, involving clinics run by 47 physiotherapists.
DOI: 10.3310/pgfar06040 PROGRAMME GRANTS FOR APPLIED RESEARCH 2018 VOL. 6 NO. 4
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Hay et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
195
Innovation in methods of research delivery
Crucial to this engagement was the combination of infrastructure support provided by the CLRNs, the
creation of joint academic service physiotherapy research facilitator posts appointed between Keele, the
CLRN and the NHS, and the quality of engagement in the trial by local physiotherapy leads and clinical
champions (which was as a result of the support they received from the facilitators and the North
Staffordshire Primary Care Research Consortium).
Recruitment to the trial was highlighted as a challenge in the pilot and was successfully addressed in
the main trial through carefully planned coworking between NHS, Network and university staff. We
established new triage procedures in the physiotherapy referral pathway to identify those patients who
were potentially eligible to take part and direct them to research clinics. We also undertook regular
searches of GP consultation systems and clinical screening of those patients who had consulted with knee
pain, to ensure delivery of the right patients to the right physiotherapists. We provided support for NHS
staff to be released to receive training and periodic updates on the research interventions from the Keele
team and the research facilitators provided hands-on support and mentoring for all sites. As a result, this
large trial screened 5345 patients and recruited 514 people to the trial 2 months ahead of target.
A study dissemination day was held at the end of the trial for all physiotherapists and general practices
involved in the study.
Challenges
One key challenge was posed by the disappointment of intervention physiotherapists when they were
informed of the negative trial finding (i.e. that their enhanced exercise training schedules had not, after all
their effort, resulted in better long-term adherence to exercise or in better clinical outcomes than those
achieved by the group with physiotherapists delivering usual-care exercise and physical activity advice).
There was a clear feeling that an enhanced package had been delivered that made sense to the
physiotherapists. However, there was also a clear sense that the ‘usual-care’ physiotherapy had been
delivered well and, under the auspices of the trial, in optimal circumstances with optimal support
(compared with the variation observed in the usual daily NHS context). The practical challenge now is
how to improve care pathways so that the right patients benefit from the right kind of physiotherapy
intervention in everyday practice. Although physiotherapy exercise and activity advice has a strong evidence
base for effectiveness, the research challenge that remains is how to improve and maintain changes in
exercise and physical activity behaviour sufficiently to influence the long-term course of OA.
Example: workstream 4 – POST
The practical challenge here was different. We adopted a light touch approach to training clinicians and
provided practice-level e-templates for GPs to screen patients in real-time consultations as the main
intervention, with a pragmatic approach to the resulting treatment.
Innovation in methods of research delivery
A total of 44 practices were recruited and 150 GPs were supported to undertake systematic screening of
patients consulting with OA or joint pain over a 4-month period. ‘Pop-up’ electronic templates were
installed on GPs’ computerised consultation systems, which automatically fired on entry of Read codes
associated with patient consultation for OA or joint pain conditions. The templates prompted GPs to check
patients’ eligibility to be included in the trial, to screen for pain intensity (control practices) and for anxiety
and depression (intervention practices). Once completed, the templates added a trial recruitment code to
the patient record (to prevent duplication of recruitment and data collection). If the patient was deemed
ineligible, the template provided a prompt for the GP to record reason for exclusion from the trial.
The trial recruited 1415 patients on time. Trial recruitment and data collection procedures were embedded
into real-time GP consultation systems, reducing the administrative burden on GPs when completing
research and enabling the research team to undertake real-time audit and monitoring of recruitment and
research data collection.
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Dissemination
Example: workstream 2 – the MOSAICS suite of studies
This workstream identified and evaluated methods to improve and support implementation of NICE OA
guidance in primary care and to improve the quality of primary care for patients with OA. On the basis of
this evidence, dissemination activities have followed.
Study feedback day (autumn 2013) and associated regional and national quality, training
and implementation initiatives
After completion of the follow-up and analysis of the MOSAICS workstream described in Chapter 3, a
study feedback day was held for CCG representatives and all the health-care professionals, research
support professionals, RUG members and research team members who had been involved in the MOSAICS
workstream studies within the eight participating general practices. Separate generic feedback was
provided to participating patients through newsletters and poster displays in the practices.
A major outcome from the study day was that the GP clinical lead for Shropshire CCG led action to ensure
that the methods of implementing evidence that had formed our research was incorporated into quality
initiatives undertaken in a locality group of practices within the CCG. This included:
l The South Shropshire locality group (14 general practices) partnering with Keele to submit a successful
application to the NHS Regional Innovation Fund to adapt the MOSAICS intervention for roll-out across
the locality group (the JIGSAW initiative). The CCG supported the appointment of three GP clinical
champions and two practice nurse-led clinical champions, which ensured buy-in across the 14
practices. Keele provided training and mentoring support for clinicians and nurses on the MOSAICS
intervention, the patient guidebook and the e-template to guide quality care for OA. The MOSAICS
training was adapted to a more practical, 2-day duration for practice nurses and 1-day duration for
GPs. The e-template can be used in addition to monitor and audit subsequent primary care clinical
management of patients with OA and to facilitate continuing improvements in practice.
l This involved or linked to other dissemination initiatives to improve current clinical practice associated
with the NIHR programme and personnel.
¢ All participating GPs from the locality group have undertaken the OA section of the Royal College of
General Practitioners’ online musculoskeletal module, a national initiative developed by collaboration
between Arthritis Research UK and Keele, which includes components from the MOSAICS training
programmes developed by Porcheret et al.134,143
¢ Nurse training has been conducted by a team from the NIHR programme under a regional initiative
of the national body for training in the NHS (Education for Health, Warwick, UK) focused on nursing.
¢ Adoption by the West Midlands AHSN’s innovation programme for long-term conditions, as part of
their aim of adopting innovation to improve clinical practice. The AHSN has expressed an interest in:
¢ rolling out the MOSAICS implementation model to a second locality group (22 general practices
in Telford and Wrekin)
¢ supporting an initiative for non-surgical alternatives to arthroscopy led by Keele’s NICE Fellow
(Professor Krysia Dziedzic, principal investigator of the MOSAICS workstream) and the University
Hospital of Coventry and Warwick’s NICE Scholar (Mr Tim Barlow, Orthopaedic Surgeon)
¢ further work on developing and measuring the effectiveness of the pathway of care for OA
involving physiotherapy and general practice led by the North Staffordshire Primary Care
Research Consortium’s manager (Ms Helen Duffy).
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National and international dissemination
1. Conference presentations.
i. Chartered Society of Physiotherapists conference 2014: programme personnel and OA RUG
representative presented the MOSAICS workstream and the JIGSAW initiative.
ii. Royal College of General Practitioners’ annual conference 2012: the training programme for the GPs
was presented in a workshop session to an audience of 200 GPs.
iii. The annual named Droitwich lecture given at the British Society for Health Professionals in
Rheumatology was given in 2014 by Professor Dziedzic, principal investigator of the MOSAICS
workstream, and was largely based on the MOSAICS work.
2. Training packages led or written by programme personnel drawing on content of the training
developed in MOSAICS.
i. Royal College of General Practitioners’ online musculoskeletal training for primary care: OA module
(see also Study feedback day (autumn 2013) and associated regional and national quality, training
and implementation initiatives)
ii. clinical knowledge summary on OA for clinicians: NICE-linked evidence-based resource
iii. British Medical Journal educational module on OA for GPs
iv. EULAR teaching module on OA for rheumatologists.
3. Resources.
i. The NIHR programme is informing the work of NICE in introducing quality standards for its OA
guideline in the absence of a quality of care framework for OA.
Challenges
The MOSAICS programme of development and implementation of training, quality initiatives, patient
information resource and quality of care monitoring for the primary care management of the patient with
OA has struck a chord with professional leaders and educators, patients and some clinicians. We have
provided evidence that the MOSAICS programme delivers better information for patients, better systems for
improving and monitoring the quality of care delivered in the GP consultation, and improved use of simple
analgesia, physiotherapy referral and radiography. These are components of the evidence-based care of
long-term symptoms and diseases, and their improved quality and delivery by MOSAICS is therefore a
desirable outcome in its own right. We have completed successful dissemination of these components and
achieved high take-up in the NHS and with patients because these approaches do not lead to excessive new
costs. However, the challenge remains to understand why such activity is not appearing to improve the
desirable clinical outcomes of reducing pain and improving physical function. There remain practical barriers
to overcome in implementing or adapting features of implementation (such as the e-template), which may
be better delivered in the context of a short-term supervised trial than in the long term of real-life practice.
CONCLUSIONS
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Appendix 1 Patient and public involvement in
the programme
Patient and public involvement in the Research Institute for Primary Care
and Health Sciences, Keele University, prior to development of the
National Institute for Health Research osteoarthritis programme
The research institute, IPCHS, at Keele involved lay people systematically in development, design, oversight
and review of individual musculoskeletal research projects from the late 1990s.120 In 2006, a RUG was
formally established with the aim to embed PPI across the whole of its musculoskeletal programme and to
encourage engagement in setting priorities for the programme. Twelve participants, who had a range of
musculoskeletal conditions, including OA, were recruited from those who had been involved in earlier
projects. A senior researcher from the centre led the RUG with administrative support and funding was
provided. Activities of the RUG included formal discussion of new ideas and proposals with researchers,
active representation in all centre projects and steering groups, presentations to funders, and organising a
national conference for RUGs.
This was the broad background in place at the time that the idea for this programme grant was first mooted.
Patient and public involvement in development of the National Institute
for Health Research osteoarthritis programme
The RUG members were involved in three important and specific ways, which directly influenced the
development of the NIHR OA programme.
First, two members of RUG were playing an active role in the steering group of the institute’s Knee Pain
Prevention Project (KNEPP). This was a study, funded by the NIHR National Co-ordinating Centre for
Research Capacity Development through its Public Health Initiative (principal investigator: Jinks), designed
to investigate priorities for preventing disability in knee OA.355 This study had set up quantitative and
qualitative studies to carry out these investigations, together with a Community Knee Pain Forum,22 which
included patients and representatives from community and patient groups, voluntary agencies and health
and social care practitioners. The two RUG members on the steering group were involved in discussion
of the implications of the study findings. The evidence from the study was that self-management had
substantial potential. The views of the RUG representatives were clear: people with knee OA understand
the importance of self-management approaches (physical activity, weight control, self-medication with
analgesia, searching out local resources), but they needed help to take this on, including sources of
information about resources and advice about the details of an exercise programme. This input from the
two RUG members had a major impact on shaping the theme of the NIHR programme, coming as it did at
the same time as the idea of ‘supported self-management’ was emerging from research in other long-term
conditions.19 One of the two RUG members became a co-applicant on the funding proposal.
Second, and in parallel with KNEPP, one of the centre’s researchers had been working closely with five
RUG members on the development of a guidebook about OA for primary care patients, which had the
aims of representing patient and health-care professional views and input into such information and of
providing a guide and directory of local and national resources. Both of these aims contributed to the
evolving idea of primary care providing support for self-management of OA. The guidebook differed from
conventional patient education materials in that it contained lay as well as biomedical evidence-based
knowledge. The RUG members reviewed a summary of qualitative research of people’s experience of
living with OA and combined this with their own experiences of living with OA as the basis for proposing
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information for inclusion in the guidebook. They then reviewed a draft version. The guidebook
development was written up as a research paper142 by the lead researcher and the lead RUG member of
the group and the guidebook itself was used as a central component of the MOSAICS intervention.
Third, RUG members had been actively involved in a successful NIHR Research for Patient Benefit award to
IPCHS (principal investigator: Ong) to understand people’s ideas about self-management of OA. This study
had stemmed from the KNEPP study and in particular from the Community Knee Pain Forum discussions.355
It was a qualitative study that engaged OA patients through in-depth interviews and contributed important
information about the views and perceptions of OA patients in shaping and developing the OA programme.
The study has been published.22,176,356
Patient and public involvement in Institute of Primary Care and Health
Sciences during the programme
By 2009, the year in which the programme grant was awarded, the centre’s portfolio of musculoskeletal
research had grown substantially and in that year the RUG was expanded to 42 members. A dedicated
PPI co-ordinator was appointed to replace the senior researcher who had been doing this in a part-time
capacity. The new co-ordinator was a patient with chronic pain. Training and support was provided for
RUG members, such as ‘Contributing Assertively in Meetings’, and RUG members undertook training of
researchers in how to effectively involve lay people in their research. The formal activities of the RUG,
all of direct relevance to the NIHR OA programme, now included prioritising research questions, devising
effective and ethical recruitment strategies, interpreting findings and disseminating results.
By 2012, as the OA programme was entering its last phase, a PPI support worker, also a patient with
chronic musculoskeletal problems, was appointed to work with the RUG co-ordinator. The RUG continued
to be chaired by a senior academic from IPCHS during the period of the programme. This was perceived
to be important from the perspective of the RUG members because it symbolised the extent of IPCHS
commitment to PPI. From the institute’s perspective, PPI was highlighted at strategic level and represented
in senior management. This academic leadership ensured that all researchers understood that PPI was not
optional, but an integral part of the way the programme operated. New researchers appointed to the
programme learned about PPI as part of their induction. All research teams in the programme met with
the PPI co-ordinator to plan and match RUG members with the requisite skills to the funded work.
The NIHR OA programme was taking place during this period of expansion of the PPI membership and
infrastructure in IPCS, and the programme was one of the major areas of research in IPCHS that drew on and
incorporated the RUG members and their expertise. An example of RUG involvement in individual projects in
the programme is provided in Patient and public involvement in workstream 2 (the MOSAICS studies).
Patient and public involvement in workstream 2 (the MOSAICS studies)
Two RUG members sat on the overall MOSAICS steering committee.
RUG collaboration on MOSAICS projects included participation in the Delphi consensus study on the
content of the ideal OA consultation in primary care, engagement in the planning of the baseline
population survey, membership of the group developing and writing the precise wording for quality
indicators of OA care, analysis of the audio tapes of nurse-led OA clinics as part of one of the MOSAICS
qualitative studies, and direct involvement in framing the content and style of training for GPs and
health-care professionals for patients with OA.
The RUG involvement continues into the phase of disseminating the results of the programme to all people
who have participated in the research projects. RUG members are helping to translate the results into
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accessible language, including specific communications for control group participants who may feel they
have missed out on opportunities for treatment.
The potential complexity of organising and supporting RUG contribution and involvement in the suite of
studies in the MOSAICS workstream was managed by:
1. a glossary of terms used in the study literature
2. support for RUG members at meetings from the co-ordinator and support worker
3. lay summaries circulated in advance of meetings
4. continuing feedback to RUG members involved throughout the study
5. training.
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Appendix 2 MOSAICS supporting documents
MOSAICS eligibility criteria
General practices and health-care professionals
l Member of the Central England PCRN or a Keele Research Network Practice.
l At least two GPs willing to undertake the study as per protocol (i.e. act as a control or
intervention practice).
l Willing, and able, to allow one (or for preference two, to allow for cross-cover) of their practice nurses
to be trained to deliver the nurse OA clinics.
l Able to physically accommodate the nurse-led clinics in the practice.
l Uses the EMIS computerised consultation system.
l Nurses and GPs consent to interview and follow-up by the MOSAICS studies team.
l GPs willing to be trained to carry out the GP OA consultations.
l Nurses willing to be trained to carry out the nurse OA clinics.
l Nurses consent to being observed and audio-recorded in their clinics.
Patients
Inclusion criteria
l Males and females.
l ≥ 45 years.
l Registered with a MOSAICS studies practice.
l For the individual-level analysis: pain in at least one joint site (hand, hip, knee or foot), consenting to
further contact from the study team and medical record review (consent sought as part of the patient
population survey).
Exclusion criteria
l Excluded via GP screen of practice list.
l Unable to give fully informed consent (e.g. learning difficulties or dementia).
l Resident in a care or nursing home.
l History of serious disease (e.g. malignancy, terminal illness).
l Unable to consult in the general practice surgery.
l Flagged as excluded from research in that practice.
MOSAICS model consultation task list
The GP model OA consultation: specific tasks promoted in the GP training workshops ordered by key
model OA consultation tasks
Giving the diagnosis
1.1 The GP elicits the patient’s ideas or worries or concerns about what they think is the matter with them, or the cause
of their problem
1.2 The GP tells the patient the problem is due to OA, the word OA needs to be used
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Explaining the diagnosis
2.1 The GP elicits what the patient knows or understands about OA, the word OA needs to be used
2.2 The GP tells the patient that OA does not always/inevitably get worse, the word OA does NOT need to be used
2.3 The GP tells the patient that OA is treatable: that there are things which can be done to help, the word OA does
NOT need to be used
Addressing expectations
3.1 The GP elicits the specific expectation(s) the patient has of the GP about the problem
3.2 The GP responds to the patient’s specific expectations (as noted at 3.1)
Providing analgesia
4.1 The GP elicits what the patient has tried or is trying for the problem
4.2 The GP advises about, or prescribes for, pain relief
Promoting self-management
5.1 The GP elicits what the patient has tried or is trying for the problem, other than for the pain
5.2 The GP tells the patient that exercise(s) or physical activity is beneficial for patients with OA or for the patient’s problem
5.3 The GP tells the patient that losing weight, or not being overweight, is beneficial for patients with OA or for the
patient’s problem
Promoting self-management support
6.1 The GP offers, or gives, the patient general written information on OA
6.2 The GP offers, or gives, the patient an appointment with a practice nurse to help with OA
Parts of this text have been reproduced with permission from Porcheret M, Main C, Croft P, Dziedzic K. Keele University. 2017.
Items on the MOSAICS e-template
Parts of this section have been reproduced from Edwards et al.132 © The Author 2014. Published by Oxford
University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the
original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
Quality indicator item Possible response options Quality indicator achieved if recorded asa
Pain assessment None None OR mild OR moderate OR severe
Mild
Moderate
Severe
Functional limitation assessment None None OR mild OR moderate OR severe
Mild
Moderate
Severe
Topical NSAID use Tried full dose Tried full dose OR offered full dose OR
patient declined full dose OR not appropriate
Offered full dose
Patient declined full dose
Not appropriate
Unknown
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Quality indicator item Possible response options Quality indicator achieved if recorded asa
Paracetamol use Tried full dose Tried full dose OR offered full dose OR
patient declined full dose OR not appropriate
Offered full dose
Patient declined full dose
Not appropriate
Unknown
OA information given Verbal and writtenb Verbal and written OR verbal only OR not
appropriate
Verbal only
Not appropriate
Not this time
Weight loss advicec Verbal and writtenb Verbal and written OR verbal only OR not
appropriate
Verbal only
Not appropriate
Not this time
Exercise advice Verbal and writtenb Verbal and written OR verbal only OR not
necessary or Not appropriate
Verbal only
Not necessary
Not appropriate
Not this time
Consideration of physiotherapy referral Offered Offered OR not necessary OR not appropriate
Not necessary
Not appropriate
Not this time
a Indicator not achieved if another of the possible response options used or no entry recorded.
b Response option used for assessment of effect of core NICE recommendations.
c In those with a recorded BMI of ≥ 25 kg/m2 in the previous 3 years.
MOSAICS health economics methods
Parts of this section have been amended and reproduced from Oppong et al.172 © The Author(s) 2018.
Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open
Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License
(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and
reproduction in any medium, provided the original work is properly cited. For commercial re-use, please
contact journals.permissions@oup.com.
Overview
The aim of the economic evaluation was to determine the cost-effectiveness of the MOAC in comparison
with usual care in patients who consult with OA in primary care.
A cost–consequence analysis was initially conducted, describing all the important results relating to costs
and consequences (EQ-5D, SF-6D, ICECAP-A). Subsequently, an incremental cost–utility analysis was
then undertaken using patient responses to the EQ-5D-3L at baseline, 3, 6 and 12 months to estimate
incremental costs, QALYs and net benefits. The base case was conducted from a NHS and PSS perspective.
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Sensitivity analysis considered a wider societal perspective, for which private health-care costs and those
associated with productivity loss were measured.
Resource use and cost data
Resource use data as a result of joint problems were collected primarily from the MOSAICS self-report
postal questionnaires, which were completed by study participants at 6 and 12 months. NHS resource
use data obtained included primary care contacts (e.g. GP and nurse visits), secondary care contacts
(e.g. visits to the physiotherapist and occupational therapist) and medical investigations such as radiography
and prescribed medication. Information on a participant’s private expenditure included information on
over-the-counter medication and visits to non-NHS health-care professionals. Information on employment
status and time off work due to joint problems were also obtained from the participant questionnaire in
order to estimate productivity loss over the 12-month period.
Resource use was valued by obtaining unit costs (2012/2013 prices) from standard sources such as
PSSRU,173 BNF174 and NHS reference costs,175 and applying them to resource use data. As a result of the
lack of nationally representative unit cost estimates for private health care, this care was costed as the NHS
equivalent. Costs associated with over-the-counter medications were obtained from patient self-report in
the questionnaires or by allocating costs to the drugs mentioned in self-report. Unit costs of resource use
items are presented in Table 61. Costs of the intervention were obtained in discussion with the study
co-ordinators.
TABLE 61 Unit costs (£) of resource use items
Resource use Unit cost (£)
Primary care visits173
GP visits per 11.7 minutes 34
Nurse visits at practice per hour 44
Nurse visits at home per hour 60
Other healthcare professionals (attached to practice) Participant specific
Secondary care visits175
Orthopaedic surgeon 128
Orthopaedic surgeon (follow-up) 102
Physiotherapist 49
Physiotherapist (follow-up) 44
Occupational therapist 75
Occupational therapist (follow-up) 34
Podiatrist 74
Podiatrist (follow-up) 41
Other secondary care visits Participant specific
Other resource use
Private consultants Costed to the NHS equivalent
Private other health-care professionals Costed to the NHS equivalent
Hospital investigations/treatments Participant specific
Prescribed drugs174 Participant specific
Over-the-counter drugs Participant specific
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Health outcome data
Information on health-related QoL was obtained from participant responses to the EQ-5D-3L questionnaire
at baseline, 3, 6 and 12 months and the UK value set253 was used to obtain EQ-5D index scores which
were used to calculate QALYs over the 12-month period. Participants also completed the SF-12
questionnaire, which was used to generate SF-6D scores357 and the ICECAP-A questionnaire358 at baseline,
3, 6 and 12 months. The ICECAP-A is a measure of capability for adults, which aims to capture an
individual’s freedom to function in five key areas of their life: attachment, autonomy, enjoyment, stability
and achievement.358
Data analysis
The data analysis was carried out on an intention-to-treat basis and focused on determining whether or
not the MOAC is cost-effective when compared with usual care. Descriptive statistics were used to
summarise the main health economic outcomes (EQ-5D-3L, SF-6D and ICECAP-A). Multiple imputation
was used to account for missing EQ-5D, SF-6D, ICECAP-A scores at baseline 3, 6 and 12 months as well as
missing costs at 6 and 12 months. Using the area under the curve approach, QALYs over 12 months were
estimated for each study participant. Imbalances in baseline utility (EQ-5D scores) between the trial arms
were controlled for using a regression approach.257 Mean costs associated with each trial arm were
estimated and, owing to the skewed nature of the costs, 95% CIs were calculated using non-parametric
bootstrapping. Net monetary benefit, which is defined as the change in effectiveness (ΔE) multiplied by the
cost-effectiveness threshold (λ) minus the change in cost (ΔC), was also estimated for each participant.359
The threshold value (λ) used for the estimation of net benefits was £20,000 per QALY.
Multilevel modelling, an approach that has been recommended for the economic analysis of cluster trials,
was used for the analysis of data. Dependent variables included net monetary benefits, costs, QALYs and
cost of work absence while independent variables included sex and baseline EQ-5D. Model estimates of
the difference in costs, QALYs and net monetary benefits were used to derive an incremental cost per
QALY gained and an incremental net monetary benefit. Uncertainty was explored through the use of
CEACs, which plot the probability that the intervention is cost-effective against willingness-to-pay
threshold values.360
The human capital approach, which assumes that the value of lost work is equal to the amount of
resources an individual would have been paid to do that work, was used to estimate productivity costs.
The average wage for each respondent was identified using UK Standard Occupational Classification
coding and annual earnings data for each job type and this was multiplied by self-reported days off work
in order to estimate productivity costs.258,259
Sensitivity analysis focused on exploring uncertainties in the trial-based data by using QALYs generated
from the SF-6D to obtain cost-effectiveness estimates and exploring broader costs through the inclusion of
private health-care costs (e.g. over-the-counter medication costs and private health-care utilisation costs).
All analyses were carried out in Stata version 12, REALCOM-IMPUTE (Original version 2011; Centre for
Multilevel Modelling, University of Bristol, Bristol, UK)361 and Microsoft Excel® for Windows (Microsoft
Office v12 2010; Microsoft Corporation, Redmond, WA, USA). Discounting was not required as the
follow-up period was 12 months.
Results
A total of 525 participants were included in the study. Of these, 288 participants were randomised to
the model OA consultation arm and 237 randomised to the usual-care arm. Follow-up rates at 6 and
12 months were 424 (81%) and 384 (73%), respectively. A total of 354 (67%) completed the postal
questionnaire at both 6 and 12 months and a total of 305 (58%) participants provided complete EQ-5D
data at all time points.
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Resource use and costs
Resource use associated with the model OA consultation and usual-care interventions have been reported
in Table 62. Most primary care resource use items were higher in the usual-care arm. The only exception
was home visits by the GP, which were higher in the model OA consultation arm. With respect to
secondary care, most resource use items were higher in the usual-care arm with the exception of visits to
the orthopaedic surgeon which was significantly higher in the usual-care arm; all other secondary care
items did not record any significant difference between trial arms. Approximately 59% of participants in
the model OA consultation arm received a prescription compared with 65% in the usual-care arm, while
approximately 49% of participants in the model OA consultation arm purchased over-the-counter
medication for their joint problem compared with 46% in the usual-care arm.
Costs associated with resource use items are presented in Table 63. Both primary care and secondary care
costs were higher in the usual-care arm and, overall, the model OA consultation arm was associated with a
slightly lower cost (Table 64).
TABLE 62 Resource use mean (SD) over 12 months (complete cases)
Resource use category
Model OA consultation
(n= 199)
Usual care
(n= 155)
Difference
(bootstrapped 95% CI)
Primary care visitsa 1.52 (2.46) 1.99 (3.38) –0.48 (–1.18 to 0.13)
GP at practice 1.32 (2.11) 1.59 (2.62) –0.28 (–0.78 to 0.24)
GP at home 0.02 (0.12) 0.01 (0.08) 0.01 (–0.11 to 0.03)
Nurse at practice 0.19 (0.67) 0.39 (1.29) –0.20 (–0.48 to –0.01)
Nurse at home 0 0.01 (0.08) –0.01 (–0.03 to 0)
Other health-care professionals
(attached to practice)b
0.21 (0.86) 0.32 (1.15) –0.12 (–0.33 to 0.11)
Secondary care visitsc 1.11 (2.65) 1.43 (2.91) –0.32 (–0.96 to 0.27)
Orthopaedic surgeon 0.34 (0.89) 0.58 (1.37) –0.24 (–0.52 to –0.003)
Podiatrist 0.13 (0.92) 0.12 (0.80) 0.003 (–0.17 to 0.17)
Physiotherapist 0.61 (2.01) 0.65 (1.93) –0.04 (–0.47 to 0.36)
Occupational therapist 0.04 (0.21) 0.07 (0.58) –0.04 (–0.16 to 0.04)
Other secondary care visitsb 0.16 (0.91) 0.10 (0.51) 0.06 (–0.07 to 0.24)
Private consultantsd 0.39 (1.66) 0.57 (3.07) –0.18 (–0.79 to 0.29)
Private other health-care professionalsb 0.13 (0.85) 0.04 (0.28) 0.09 (–0.02 to 0.23)
Hospital investigations/treatmentsb,e 82 (41.21%) 72 (46.45%) 10
Prescribed drugsb,e 117 (58.79%) 101 (65.16%) 16
Over-the-counter drugsb,e 98 (49.25%) 72 (46.45%) 26
a Includes contacts with GP and nurse at home and practice.
b Patient specific.
c Includes contacts with physiotherapists, occupational therapists, etc.
d Includes contacts with private physiotherapists, occupational therapists, etc.
e The proportion of patients who reported that they had undergone a hospital investigation for their OA during follow-up
and the proportion who reported that they had been prescribed medication for their OA (presented separately for
‘prescribed’ and ‘over the counter’).
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Health outcomes
The EQ-5D and SF-6D scores increased at all time points over the 12-month period in both the model OA
consultation and usual-care arms, indicating an improvement in health status over time. Although these
scores were higher in the usual-care arm, the differences were not statistically significant. Compared with
baseline, ICECAP-A scores in the model OA consultation arm were higher at 12 months, indicating an
increase in capability over time, while the opposite was true for the usual-care arm for which ICECAP-A
scores at 12 months were lower than the baseline value. When QALYs were estimated, the usual-care arm
was associated with a marginally higher total QALYs (Table 65).
TABLE 63 Mean costs (SD) per patient over 12 months (complete cases) for each resource category in OA care
Resource use category
Model OA consultation
(n= 199) (£) UC (n= 155) (£)
Difference
(bootstrapped 95% CI)
Primary care visitsa 56.01 (83.53) 69.02 (103.31) –13.01 (–35.24 to 5.28)
GP at practice 44.76 (71.80) 54.18 (89.01) –9.42 (–29.03 to 7.41)
GP at home 0.81 (6.55) 0.35 (4.31) 0.46 (–0.71 to 1.55)
Nurse at practice 2.11 (7.46) 4.61 (15.07) –2.49 (–5.50 to –0.03)
Nurse at home 0 0.15 (1.87) –0.15 (–0.54 to 0)
Other primary care visitsb 8.33 (24.20) 9.74 (29.72) –1.41 (–7.37 to 3.97)
Secondary care visitsc 60.68 (130.42) 76.48 (156.38) –15.80 (–51.40 to 14.01)
Orthopaedic surgeon 27.09 (71.66) 44.31 (106.94) –17.22 (–37.95 to 1.18)
Podiatrist 5.32 (35.65) 4.34 (26.23) 0.98 (–5.03 to 7.93)
Physiotherapist 21.55 (77.01) 21.74 (70.72) –0.18 (–15.47 to 16.50)
Occupational therapist 2.06 (11.98) 2.24 (16.93) –0.18 (–3.50 to 2.61)
Other secondary care visitsb 4.67 (17.85) 3.85 (22.67) 0.81 (–4.45 to 4.65)
Hospital investigations/treatmentsb 109.71 (401.16) 92.36 (222.66) 17.35 (–42.40 to 83.75)
Prescribed drugsb 15.51 (20.34) 15.65 (21.47) –0.14 (–4.58 to 3.86)
Trial intervention cost 11.47 (20.69) 0 11.47 (8.69 to 14.42)
Over-the-counter drugsb 27.14 (255.67) 27.93 (121.01) –0.79 (–31.51 to 50.14)
Private health professionalsb 21.62 (76.54) 29.53 (135.05) –7.91 (–39.24 to 12.24)
a Includes contacts with GP and Nurse at home and practice.
b Patient-specific.
c Includes contacts with physiotherapists, occupational therapists etc.
TABLE 64 Mean total costs (SD) per patient over 12 months (imputed analysis)
Health-care setting
Model OA consultation
(n= 288)
Usual care
(n= 237)
Difference
(bootstrapped 95% CI)
Total NHS costsa 227.17 (411.84) 236.11 (345.35) –8.94 (–71.79 to 57.70)
Total Healthcare costsa 278.56 (535.43) 285.99 (400.43) –7.43 (–76.41 to 76.26)
a Unadjusted costs.
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Cost-effectiveness
The results from the base-case cost-effectiveness analysis showed that the model OA consultation was
associated with a smaller cost (p = 0.705) and is not as effective (p = 0.786) as usual care. However, the
difference was not statistically significant (Table 66). Net monetary benefit at £20,000 per QALY was
negative (p = 0.887) and the CEACs showed that, at a willingness-to-pay threshold of £20,000 per QALY,
there is a 44% chance of the model OA consultation being cost-effective (Figure 16).
TABLE 65 Health outcomes, mean (SD) over 12 months (imputed analysis)
Outcome measure and time of
measurement where relevant
Model OA consultation
(n= 288)
Usual care
(n= 237)
Difference
(bootstrapped 95% CI)
EQ-5D scores
Baseline 0.573 (0.298) 0.588 (0.272) –0.015 (–0.062 to 0.039)
Month 3 0.615 (0.280) 0.631 (0.264) –0.016 (–0.064 to 0.030)
Month 6 0.637 (0.264) 0.638 (0.259) –0.001 (–0.044 to 0.044)
Month 12 0.651 (0.262) 0.674 (0.224) –0.023 (–0.067 to 0.018)
QALYs 0.627 (0.244) 0.639 (0.224) –0.012 (–0.054 to 0.026)
QALYsa 0.632 0.634 –0.002
QALYsb –0.003 (–0.026 to 0.197)
SF-6D scores
Baseline 0.678 (0.139) 0.690 (0.148) –0.012 (–0.037 to 0.013)
Month 3 0.688 (0.141) 0.696 (0.141) –0.008 (–0.033 to 0.017)
Month 6 0.687 (0.142) 0.707 (0.144) –0.020 (–0.044 to 0.004)
Month 12 0.693 (0.139) 0.702 (0.138) –0.009 (–0.032 to 0.015)
QALYs 0.688 (0.128) 0.701 (0.129) –0.013 (–0.038 to 0.010)
QALYsa 0.692 0.696 –0.004
QALYsb –0.012 (–0.03 to 0.01)
ICECAP-A
Baseline 0.826 (0.166) 0.851 (0.155) –0.025 (–0.053 to 0.003)
Month 3 0.828 (0.151) 0.853 (0.155) –0.025 (–0.053 to 0.001)
Month 6 0.821 (0.160) 0.843 (0.158) –0.022 (–0.049 to 0.005)
Month 12 0.837 (0.153) 0.846 (0.155) –0.009 (–0.038 to 0.014)
a Adjusted for baseline utility.
b Adjusted for baseline utility and sex (regression model).
TABLE 66 Base-case cost–utility analysis (imputed analysis)
Cost or utility measure
Difference
(intervention–control) p-value CI Interpretation
NHS costsa –13.11 0.705 –81.09 to 54.85 Intervention less costly
and less effective. Positive
ICER but negative net
benefits
QALYsa –0.003 0.786 –0.03 to 0.02
Net monetary benefitsa –33.63 0.887 –497.56 to 430.30
a Adjusted for baseline utility and sex (three-level model).
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Sensitivity analysis with broader health-care costs indicated that the intervention was still less costly
(p = 0.768) and less effective (p = 0.786) than the usual-care arm and when the SF-6D was used as an
outcome measure, a similar result to the base-case analysis was achieved. Cost–utility analysis with QALYs
generated from the SF-6D yielded similar results to the base-case analysis, that is, the intervention was less
costly (p = 0.705) and less effective (p = 0.187) than usual care (Table 67).
Work-related outcomes
Participants in the intervention arm had fewer mean days off work than those in the usual-care arm
(p = 0.364). The associated productivity related cost was lower in the intervention arm but the difference
was not statistically significant (see Table 67).
Conclusion
In summary, implementing NICE OA guidelines15 in primary care using the MOSAICS intervention does not
lead to increased costs and appears to reduce demand for orthopaedic surgery and time lost from work.
However, QoL was barely changed.
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FIGURE 16 Base-case cost–utility analysis (imputed analysis): CEAC.
TABLE 67 Sensitivity analysis
Cost or utility measure
Difference
(intervention–control) p-value CI Interpretation
Cost-utility analysis with SF-6D
NHS costsa –13.11 0.705 –81.09 to 54.85 Intervention less costly
and less effective. Positive
ICER but negative net
benefits
QALYs (SF-6D)a –0.012 0.187 –0.03 to 0.01
Net monetary benefitsa –178.39 0.362 –561.74 to 204.96
Cost-utility analysis with health-care costs
Health-care costsa –14.14 0.768 –108.08 to 79.80 Intervention less costly
and less effective; thus,
the usual care dominates
QALYsa –0.003 0.786 –0.03 to 0.02
Net monetary benefitsa –34.95 0.883 –501.82 to 431.92
Time off work and productivity costs
Number of days off
over 12 monthsa
–1.05 0.364 –3.35 to 1.23
Mean cost (£) of work
absencea
–23.25 0.845 –256.32 to 209.83
a Adjusted for baseline utility, and sex (regression model).
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Appendix 3 BEEP trial supporting documents
Interview guides (post intervention)
The BEEP interview Study 
 
Interview Guide 1 (Version 1, 12/01/10) 
Probes/ prompts shown in italics 
 
PRELIMINARY POINTS 
• Check participant’s personal details 
• Explain purpose of study; researcher to introduce self; confirm confidentiality 
• Introduction – interested in participant experience of physiotherapy treatment 
received, particularly the exercise programme    
• No right or wrong answers 
 
COMPLETE CONSENT FORM A 
Introduction: 
1. Can you tell me a little bit about your knee problem?  
 
2. Have you had any previous treatments for your knee problem?  
 E.g. from GP/ previous physiotherapy/ previous exercise programme 
 
3. What do you think the future holds for your knee problem?   
 
4. What did you expect from your physiotherapy treatment?  
 Treatment expectation/ outcome expectation  
  
Main interview: 
5. Can you tell me what happened during your physiotherapy sessions? 
 Exercise/ other treatment/ advice/ number of sessions 
 
6. Can you tell me about your treatment? 
The exercise programme: type of exercises/ setting of exercise  
 
7. How was that exercise programme decided upon (i.e. that type of exercise, that setting of 
exercise)? 
Patient input/ physiotherapist decision/ acceptable 
 
8. Overall, how do you feel you got on with the exercises that you were asked to do?  
Did you do the exercises as often as you were asked/ Are you still doing the exercises 
now/ Do you think you will carry them on in the future? Why? 
 
9. Have you got any plans for the future with regards to treatment?  
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Possibility of return to physiotherapy/ onward referral/ how was this decision made/ 
acceptable? 
 
10. Do you think that your treatment helped? 
How/ why/ why not? 
 
11. Was anything particularly good (and bad) about your experience? 
 
12. Is there anything that you would have liked to have happened differently? 
 
Conclusion: 
13. Is there anything else that you would like to tell me about your experience of 
physiotherapy and exercise? 
 
COMPLETE CONSENT FORM B 
 
End of interview 
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Interview guide (18 months follow-up)
The BEEP interview Study 
 
Interview Guide 2 (Version 1, 12/01/10) 
Probes/ prompts shown in italics 
 
PRELIMINARY POINTS 
• Check participant’s personal details 
• Explain purpose of study; researcher to introduce self; confirm confidentiality 
• Introduction – interested in participant experience of physiotherapy treatment 
received, particularly the exercise programme    
• No right or wrong answers 
 
COMPLETE CONSENT FORM A 
Introduction: 
1. Can you tell me a little bit about your knee problem? 
 
2. Has your knee problem changed since your last interview?  
 
2. Have you had any more treatment for your knee pain, since your physiotherapy sessions?  
 E.g. from GP/ more physiotherapy/tried things yourself at home/ why? 
 
3. What do you think the future holds for your knee problem?   
  
Main interview: 
4. Can you tell me a little bit about the physiotherapy you received? 
 Exercise/ other treatment/ advice 
 
5. Did you feel that your treatment has helped? 
How /why/ why not? 
 
6. Overall, how do you feel you got on with the exercises that you were asked to do?  
Did you do the exercises as often as you were asked/ Are you still doing the exercises now/ 
Do you think you will carry them on in the future? Why? 
 
7. Was anything particularly good (and bad) about your experience? 
 
8. Is there anything that you would have liked to have happened differently? 
 
Conclusion: 
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9. Is there anything else that you would like to tell me about your experience of physiotherapy 
and being given an exercise programme? 
 
COMPLETE CONSENT FORM B 
 
End of interview 
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